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ABSTRACT 
 
 
A “chemical-biology” model has been created to study the mechanism of T cell re-
ceptor signaling. The T cell receptor (TCR) is a macromolecular complex that lies at the core 
of the activation, development and function of lymphocytes. Despite the large amount of data 
regarding the composition, structure and function of this receptor, there is no consensus 
about how TCR signaling is triggered after a stimulus. One hypothesis has proposed that ini-
tial signaling could proceed through an aggregation mechanism, in which multiple receptors 
copies cluster on the surface of the cellular membrane to promote signaling. To address this 
hypothesis we have designed a chemical approach based on a porphyrin-maleimide moiety as 
an aggregation reporter, the transmembrane region of a TCR, and phosphatidylcholine lipo-
somes as model membranes. This system is free of all the complexities present in the natural 
cell membrane, i.e. proteins, lipid rafts, and carbohydrates. This will allow the study of the 
TCR aggregation phenomena itself, without the interference of other molecular elements. For 
the analysis of TCR aggregation we have conjugated of the porphyrin via the maleimide 
moiety with the thiol group of the cysteine present on the transmembrane peptide through the 
so-called “click reaction”. 
 
The starting point of this thesis has been the chemical synthesis of the porphyrin-
maleimide probe. In order to define the best conditions to perform the conjugation reaction 
we achieved the labelling of some model thiols, e.g. N-acetylcysteine, γ-glutathione and a 
control peptide. In addition, we have optimized the methods to separate and identify the 
product of the labelling reaction by several analytical techniques. In conclusion, this chemi-
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cal-biological model proved useful for the study of the aggregation of targets of biological 
relevance in hydrophobic environments. 
The immunology studies carried out in the second part of this PhD project are focused 
on the role of the TCR in the development of the gamma delta (γδ) T cells. γδ T cells make 
rapid contributions to host defense of the host against invasive agents such as HIV, malaria, 
and tuberculosis, are also implicated in immunopathologies such as psoriasis and asthma. 
The ways in which these cells execute their function is through early provision of cytokines 
such as IFN-γ and IL-17. IFN-γ producers participate actively in anti-tumour activities while 
the IL-17 producers are involved in protection against extracellular bacteria and fungi. Inter-
estingly, the capacity of these cells to produce cytokines is acquired while they are still in the 
thymus, without antigenic stimulation. This is in acute contrast with the acquisition of effec-
tor phenotypes by αβ T cells in secondary lymphoid organs in the immediate aftermath of an 
infection after the interaction with antigen presenting cells. The development of both αβ + γδ 
lineages is thought to proceed from a common thymic progenitor. Commitments to the γδ 
lineage require a strong signal delivered to the thymocytes through TCRγδ. However, it is 
also thought that TCRγδ signaling dictates thymic differentiation of γδ progenitors into one 
of two effector phenotypes: IFN-γ or IL-17 secreting cells. In our lab, we have developed a 
flow cytometry methodology that allows the visualization of these committed cells. One of 
the goals of this project is to understand the role of TCRγδ signaling in commitment of early 
γδ progenitors to distinct effector fates. We hypothesize that characteristics of the TCR, like 
CDR3 specificities, usage of particular TCR chains, or the interaction with TCR ligands 
could dictate commitment into a IFN-γ or IL-17 fate. To begin to address this we have cloned 
a TCRγδ from and IL-17 secreting γδ T cell, and have transduced it using a retroviral vector 
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into TCR-null Rag2-/- thymocytes. This has established an in vitro culture to further assess 
the TCRγδ characteristics that are required for the acquisition of γδ T cell effector fate. 
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1.1 INTRODUCTION. 
1.1.1 Membrane Proteins 
 The cellular membrane is formed by a symmetrical two-layer structure of phospho-
lipids where the polar heads (phosphates) are facing the exo and cytoplasmic sides while the 
hydrophobic core (fatty acid chains) are compacted in the interior (Figure 1-1). 
 
 
 
 
 
 
 
 
A myriad of different proteins associates with one or both leaflets enabling the mem-
brane to carry out its particular activities. Based on the way in which the proteins interact 
with the membrane we can divide them into two major groups: peripheral and integral mem-
brane proteins. The peripheral membrane proteins do not interact with the hydrophobic core 
of the membrane, instead, they associate with the polar heads or other integral proteins. 
 
Figure 1-1. Schematic diagram of typical membrane 
with proteins embedded. 
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1.1.2 Integral Membrane Proteins 
The integral membrane proteins (IMP) present one or more segments that are embed-
ded in the lipid bilayer; they can span both leaflets or be anchored to only one. The IMPs that 
only interact with one leaflet are classified as “monotopic”. A few of the best characterized 
monotopic proteins are enzymes involved in the metabolism of lipids, e.g. prostaglandin H2, 
squalene-hopene cyclase, fatty acid amide hydrolase4. 
A special case of monotopic proteins is the glycosylphosphatidylinositol (GPI) an-
chored polypeptides. They are bound to the membrane by two or more lipid anchors. In hu-
mans, there are reported in literature around 150 GPI-anchored proteins, and they can func-
tion in different ways, such as receptors, adhesion molecules, enzymes, etc5-7. 
The most interesting group of IMPs contains one or more transmembrane (TM) do-
mains that span the lipid bilayer. Depending on their topology these proteins can be classified 
as bitopic, politopic or oligomeric4. The bitopic proteins span the membrane one time, and 
based on their orientation can be subdivided in type I if the N-terminus is exposed to the ex-
tracellular side or type II when the C-terminus is facing outside. Politopic proteins or type III, 
have multiple segments spanning the membrane connected by loops. Several bitopic proteins 
get associated through their TM domains to form clusters, this configuration is denominated 
oligomeric or type IV (Figure 1-2). 
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Figure 1-2. Schematic representation of the types of integral membrane 
proteins that cross the biological membrane. 
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1.1.3 Importance of Transmembrane Cell Signaling in Bi-
ology 
Transmembrane cell signaling is a fundamental process in living organisms that is re-
sponsible, among others, to sense the changes in their environment. Many critical functions 
in cell biology are downstream transmembrane signaling events, i.e. development, differenti-
ation, cell growth, immune response, apoptosis, among many others. Thorough comprehen-
sion of transmembrane signaling is crucial, due to its importance in cell fate decision and be-
cause its dysregulation is at the base of many diseases, i.e. autoimmune disorders, nervous 
malfunctions, and cancer.  
A key aspect to understand the transmembrane signaling is the spatial organization of 
receptors in the membrane, in special the formation of clusters or oligomers of receptors. 
Some evidence suggests that formation of clusters of receptors is regulated by some molecu-
lar recognition events such as the assembly of neighboring lipids into rafts8, 9, interaction 
with ligands10, 11, and is stabilized by the cytoskeleton12, 13. 
While some receptors function as discreet assemblies in the membrane14, some others 
function in aggregates. Of note, when the size of the assemblies is not determined they are 
known as clusters or oligomers15. In these clusters, the receptors are held by non-covalent 
interactions and they are in equilibrium with the non-clustered species. For example, it is 
well established that aggregates of neurotransmitter receptors are fundamental for the plastic-
ity of neuronal synapsis16. Triller et al.16 reported that in both, inhibitory and excitatory syn-
apsis, receptors are bound to a subjacent meshwork of scaffolding proteins that stabilize them 
in the postsynaptic membrane. This receptor-scaffold interaction is transient, and the synaptic 
receptors are in equilibrium with a population of extra synaptic receptors.  
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The immunological synapse is another example where the formation of clusters fol-
lows the ligand binding17. Dustin at al.18proposed a model for the formation of the immuno-
logical synapse. In the model, engaging the major histocompatibility complex (MHC)-
peptide complex by T cell receptors (TCR) induces a series of molecular recognition events 
that lead to formation of a stable synapse. The synapse area is characterized by two zones of 
assembly, the inner circle called the central supramolecular activation cluster (cSMAC) 
which concentrates most of TCR-MHC-peptide complex surrounded by the peripheral 
SMAC that is formed by integrins19.  
A similar study conducted by Munoz at al.10 described how the interaction of TCR 
with MHC-peptide complex, induces clustering of surface CD38 and recruitment of intracel-
lular pools of CD38 to the immunological synapse.  
In summary, these studies illustrate how binding of ligands induces changes in the re-
ceptor that lead to clustering.  
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 Another important component in the formation of clusters of receptors is the pres-
ence of lipid domains in the cell membrane called lipid rafts20, 21. Lipids rafts are nano-
assemblies of cholesterol, sphingolipids and proteins in the outer leaflet of the membrane 
(Scheme 1-1). The packed association of saturated hydrocarbon chains of sphingolipid and 
cholesterol form a distinct liquid-ordered phase in the lipid bilayer that is dispersed in patch-
es, in the liquid-disordered matrix of phospholipids22-24. These blocks of immiscible ordered 
lipids form platforms that can function in processes like membrane trafficking and 
signalling25, 26. Notwithstanding, the existence of lipid rafts is still controversial, mainly due 
to the difficulty to prove their existence on living cells27. 
 
 
Scheme 1-1. Panel showing the main components of the lipid rafts 
in cell membranes. 
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Despite some sceptical opinions, the participation of lipid rafts in clustering during 
cell signaling is well established. For example, the activation mechanism of immunoglobulin 
E (IgE) signaling was described to involve aggregates of immunoglobulins in lipid rafts. This 
signaling pathway is activated when the monomeric Fc epsilon receptor (FcRεI) is bound to 
the Fc region of an IgE (Figure 1-3). Fc receptor is a complex of four subunits (tetramer), α, 
β, and two γ28. The alpha subunit binds IgE, while the other three subunits contain the immu-
noreceptor tyrosine-based activation motifs (ITAMs) that participate in signal transduction. 
During allergic response, the FcRεI-IgE bound complex is crosslinked by oligomeric anti-
gens triggering the activation of the receptor. Activation recruits the double acylated non-
receptor Src-like tyrosine kinase Fyn that in turn phosphorylates the ITAMs initiating the 
signaling cascade by joining the Syk/Zap-70 through their phosphotyrosine residues29, 30. Fi-
nally, downstream of this signaling cascade is the increase of the intracellular calcium levels 
near the membrane, which in turn induces release of histamine from their granules. One of 
the first experimental observations in favor of raft associated signaling of immunoglobulins 
came from the fact that in steady state the FcRεI was soluble in Triton X-100, but after acti-
vation the receptor became insoluble, suggesting their incorporation on lipid insulates30. An-
other hint on the lipid raft-mediated activation was that after treatment with Methyl-β-
Cyclodextrin, which depleted the cholesterol concentration of the cell, the IgE signaling was 
abolished29. 
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Figure 1-3. Initial signaling events in rafts for the IgE receptor (FcεRI). The likely sequence of key 
events is illustrated numerically. 1. Ligand induced dimerization of the receptor and association with 
the lipid rafts. 2. Phosphorylation of the ITAMs in the immunoreceptor by the Src-family kinases 
LYN. 3. The phosphorylated ITAMs act as a membrane-docking site for the cytoplasmic kinase Syk. 
4. Recruitment and activation of the adaptor protein LAT and further cascade that leads to the down-
stream signaling events. Immunoreceptor tyrosine-based activation motifs (ITAMs), Tyrosine pro-
tein kinases (Syk and LYN), linker for activation of T cells (LAT), Immunoglobulin E (IgE), frag-
ment crystallizable region receptor (Fc receptor). 
 
More experimental evidence that suggests participation of lipid rafts in cell-signaling 
comes from the work of Roy et al on Ras-GTPase signaling proteins31. There are three 
isoforms of Ras. H-Ras and K-Ras isoforms are identical in their aminoacid sequence and 
have a carboxy-terminal prenylated sequence CAAX but while the isoform K-Ras has a pol-
ybasic region that target the protein towards the plasma membrane, the H-Ras isoform is 
palmytoilated, which probably direct this isoform to lipid rafts. In a very clever experiment, 
they produced a dominant-negative mutant for the protein caveolin. Caveolin is the main 
structural component of caveolae, which are small invaginations of the plasma membrane 
that plays an important role in the trafficking of cholesterol towards the plasma. In addition, 
it was suggested that caveolin participates in signaling transduction events. In this study, they 
Chapter 1 
 
22 
 
observed that activation of Raf mediated by H-Ras was inhibited, while activation of Raf by 
K-Ras isoform was not affected. This outcome was reproduced when they treated cells with 
Methyl-β-Cyclodextrin, which depleted cholesterol from the cell membrane as mentioned 
before. The explanation given to these observations was that the absence of caveolin in the 
mutants could reduce the cholesterol levels in the plasma membrane and this could affect the 
number of lipid rafts present on the cell membrane. This could explain why the activation of 
Raf mediated by H-Ras was prohibited. 
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1.1.4 Background on transmembrane receptors that trans-
mit signal via discreet self-assemblies. 
 
In this section, we will introduce some examples of receptors that form discreet as-
semblies by non-covalent interactions in response to an intracellular or an extracellular event, 
such as ligand binding. The key characteristic of these self-assemblies is that they are of a 
known stoichiometry regardless of ligand type. Below, we will present some examples with 
different types of ligands, such as small molecule for G-coupled receptors, receptor on an-
other membrane for gap junction and single or multivalent ligand for Bacterial chemotaxis. 
 
1.1.4.1 G-coupled protein receptors (GPCRs) 
The G-coupled protein receptors (GPCRs) constitute one of the largest family of cell 
surface receptors32. Structurally, each GPCRs is an integral membrane protein constituted by 
seven transmembrane domains33, an extracellular amino-terminal end and a cytoplasmic car-
boxy-terminal tail (see Figure 1-4). The transduction unit is formed by the trimeric (αβγ) G-
protein and an effector component. The mechanism of action can be briefly described as fol-
lows: after ligand binding the receptor suffers an allosteric change that leads to release of 
GDP and binding of GTP to the γ-subunit. This association destabilizes the trimeric complex 
and produces the dissociation of the GTP-α subunits from the βγ dimer. This “activated” 
form of the receptor interacts with the effector component through the Gα subunit or Gβγ di-
mer. Hydrolysis of GTP linked to Gα leads to the production of GDP, which is carried out by 
an intrinsic hydrolase activity of the Gα-subunit, switching off the receptor. 
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Receptor dimerization have been proposed as a key aspect of the activity of GPCRs. 
One of the more interesting observations in support of GPCR receptor dimerization come 
from studies with the GPCR GABAB receptor
34.It has been shown that co-expression of two 
isoforms of GABAB receptor, GABABR1 and GABABR2, is necessary for formation of a 
functional GABA receptor on the cell surface34-36. 
More experimental evidence suggesting the importance of receptor dimerization is the 
study conducted by Benkiran et al.37. Working with a truncated form of the chemokine recep-
tor CCR5 (CCR5Δ32), they showed that co-expression of this truncated form with the wild 
type counterpart produced intracellular retention of the heterodimer. The dominant-negative 
retention effect was associated with the slower onset of AIDS in patients that were heterozy-
gous for this mutation. 
Figure 1-4 Schematic diagram of the structure of the GPCR receptor. It con-
sists of seven trans-membrane domains, three extracellular loops and three 
intracellular loops with an N-terminus outside and a C-terminus inside. The 
membrane-bound heterotrimeric G protein complex is composed of 
three subunits: alpha (Gα), beta (β), and gamma (γ). The Gα subunit associ-
ated to GDP is in the inactive state. GDP, Guanosine diphosphate 
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1.1.4.2 Connexins gap-junction 
Gap junctions are plasma membrane structures that mediate translocation of small 
molecules and ions between adjacent cells38. Gap-junctions are constituted by several mem-
bers of integral membrane proteins denominated connexins39. Briefly, a connexin is a protein 
that spans the cellular membrane four times and contains both the amino and carboxyl-
terminus in the cytoplasmic space. This protein oligomerizes intracellularly into hexamers to 
form the so-called connexons that insert into the plasma membrane. Each connexon pairs 
with their counterpart in the neighboring cell to form an intercellular channel. These channels 
aggregate to form the gap-junctions40 (Figure 1-5). 
Figure 1-5. Diagram showing a gap junction and its principal elements. 
A) Structure of the connexin. B) Connexon, hexamer constituted by 6 
connexins. C) Representation of the Gap-Junction. 
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The intercellular channels or gap junction have been described in many important cel-
lular processes. For example, as mentioned before they allow the cell–cell diffusion of ions 
and small molecules between interacting cells38. In addition, the ionic conductance of these 
channels permits the rapid intercellular spread of action potentials in excitable cells, such as 
heart cells41 and neurons42. 
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1.1.4.3 Bacterial Chemotaxis 
Bacterial migration in response to chemical gradients is a well-described phenomenon 
reported in the literature43-46. During chemotaxis, chemoattractants such as amino acids and 
sugars, or chemorepellent, are recognized by specific chemoreceptors present in the bacterial 
plasma membrane and promote the flagellar response47. The molecular events that control 
bacteria chemotaxis have been well investigated and provide a good model to study receptor 
mediated responses48. For example, ligand binding induces the clustering of chemoreceptors 
in the plasma membrane which generate the signal transduction.  
In addition, some studies have reported the important role of ligand valency in the 
clustering of chemoreceptors. Ligand valency can be defined as the number of biologically 
active epitopes -sites- that a multivalent ligand have for the union with the chemoreceptor. In 
an elegant study, Gestwicky et al. chemo-stimulated the E.coli strain with galactose bearing-
ligands of different valency, i.e. a fixed number of galactose tethered to a backbone. Their 
results provided evidence that ligands with different valency differentially cluster the chemo-
receptors. This suggests that multivalent ligands bearing several sites of union can influence 
chemotactic responses by changing the extent of cell surface chemoreceptor clustering49 
(Figure1-6).  
Figure 1-6. Model of receptor clustering by multivalent ligand. 
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1.1.5 Transmembrane receptors that transmit signal via 
Non-discreet self-assemblies. 
In this section, we will briefly introduce some examples of receptors that signal via 
non-discreet assemblies. By non-discreet assemblies, we mean clusters of receptors with un-
known stoichiometry linked by non-covalent interactions. 
1.1.5.1 Ras proteins 
The first example to illustrate the importance of membrane association and clustering 
of receptors in signaling transduction comes from the Ras superfamily. As mentioned in sec-
tion 1.1.3, Ras is a family of related proteins that are widely expressed in several tissues and 
organs. Ras proteins are monomeric, low molecular weight GTPases50, that adopt their active 
state when complexed with guanosine triphosphate (GTP). After binding guanosine diphos-
phate (GDP) they switch off to the inactive mode. Ras proteins are very important in cellular 
processes such as signal transduction, cell growth, cell differentiation, and cancer. Particular 
attention in the literature was directed towards the three isoforms of Ras: H, N and K. All 
three exert their biological and oncogenic functions from the inner leaflet of the plasma 
membrane51. To be target and bind the membrane, Ras proteins are post-transcriptionally 
modified by covalent insertion of lipid groups52. There are experimental data from in vitro 
and in vivo studies that have shown the ability of these lipidated proteins to form fluid mi-
crodomains. It has being proposed that self-association of Ras proteins in small domains 
shortens the time for the receptor to meet other molecules, thus speeding up signaling pro-
cesses. In addition, it has being suggested that these nanoclusters are also sensitive to lower 
signaling inputs. The anchor motif is located in the three isoforms at the C-terminus, with a 
common S-farnesylcysteine carboxymethyl ester functioning in conjunction with one or two 
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adjacent S-palmitoylcysteine residues in N and H-Ras, and with a polybasic domain in K-
Ras53 (Figure 1-7). It is believed that S-palmytoylation directs N and H-Ras towards lipid 
microdomains also called lipid rafts, whereas the isoprenyl moiety has affinity for the non-
raft portions of the plasma membrane. It is important to mention that both, lipids and C-
terminus peptides are crucial for clustering and signaling of the Ras family50. 
 
 
 
 
 
 
 
 
Figure 1-7. Scheme depicting the C-terminal lipidation motifs for N, H and K-
Ras proteins. One palmitoyl and farnesyl anchor groups are known to be present 
in N-Ras; two palmitoyl and one farnesyl anchors in H-Ras, while in K-Ras a 
polybasic region rich in lysine’s (K) and a farnesyl group are found. 
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1.1.5.2 SNARE protein complex 
The SNAREs proteins are large complex proteins, more than 60 in mammalian cells, 
that play an important role in membrane fusion processes54. The most studied SNARE pro-
teins are those responsible for docking the synaptic vesicle with the presynaptic membrane 
during neuronal exocytosis. Briefly, this complex is constituted by three proteins located in 
two different membranes: synaptobrevin, also denominated VAMP (vesicle-associated mem-
brane protein) located in the vesicle membrane, and syntaxin along with synaptosomal nerve-
associated protein 25 (SNAP 25) located in the plasma membrane of the presynaptic neuron. 
It has been described that membrane fusion progresses through formation of a four-helix 
bundle known as a “core complex”: one helix from syntaxin and synaptobrevin, and two hel-
ices from SNAP 2555 (Figure 1-8). It has been shown by several authors that SNARE resid-
ing in the plasma membrane i.e. syntaxin, form microclusters that are critical in the fusion 
events. The study of Tamm et al. is of particular interest for us because they use an in vitro 
model close to our experimental design, but with a different fusion reporter and proteins to 
study the effect of the lipid membrane composition on the oligomerization of the syntaxin56. 
This paper will be discussed in depth later on, however, their results suggest that formation 
and stability of these oligomeric assemblies are dependent on the cholesterol concentration 
and is negatively affected by the presence of anionic lipids like: 1-palmitoyl-2-
oleoylphosphatidylserine (POPS), and phosphatidylinositolphosphate (PIPs). In addition, 
some studies57-59 suggest that the transmembrane region of the SNARE proteins is also in-
volved in the formation of assemblies. e.g. mutagenesis of syntaxin transmembrane region 
affects exocytosis59. 
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Figure 1-8. Molecular model of the membrane fusion and vesicle exocytosis. Syntaxin and SNAP 
25 are located in the presynaptic membrane whereas the syneptobrevisn (VAMP) is located in the 
vesicle membrane. After association of the helices during the formation of the SNARE core the 
membranes are fused and the neurotransmitter is released to the synaptic cleft, VAMP (vesicle-
associated membrane protein). 
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1.1.5.3 Adhesion proteins 
Cell adhesion molecules are a family of proteins that mediate contacts between 
cells60. They participate in a wide range of cellular processes such as differentiation of cell 
structures during development, tissue formation, and immune response, etc. 
 Adhesion molecules share a characteristic structure made up of an extracellular por-
tion constituted by several domains and responsible for the interaction with other adhesion 
molecules in cis (same membrane) or trans (different membrane) and the transmembrane 
segment that anchors the protein to the cellular surface61 (Figure 1-9). 
Figure 1-9. Schematic of interacting cadherin in membranes. The pic-
tures shows the Cis-interaction of cadherins embedded in the same 
membrane to form a dimer through one of their Ig-like domains 
(Grey). The trans-interaction trough the Ig-like domains (yellow) in 
cadherins located different membranes is also illustrated. Ig, im-
munoblogulin. 
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Some studies with the crystal structure of cadherins have revealed that the trans bind-
ing interaction are weak reflected by its Kd in the range 20-100 μM62. Cadherins englobe a 
large Ca2+-dependent superfamily of cell surface adhesion protein receptors that contain an 
extracellular region, also called ectodomain, composed of a tandem of immunoglobulin (Ig)-
like domains followed by a transmembrane region that spans the bilayer one time and the C-
terminal intracellular region that contains binding sites for other proteins. Immunoglobulin-
like domains are a type of motif found in many proteins. They are composed of around 125 
amino acids that are organized in two β-sheets, each one made up of approximately 7-9 anti-
parallel β-strands. 
 Ben-Shaul et al. investigated the aggregation of cadherins on cell surfaces, and their 
results suggested that weak trans binding capacity of the monomeric cadherins can be en-
hanced by their clustering on the cell surface63 (Figure 1-10).  
Figure 1-10. Illustration of two interacting cadherins in apposed cell 
membranes. The clustering of the cadherins enhances the adhesion of 
the cells to form tight junctions, while the association of the monomeric 
cadherins does not increase cellular adhesion. 
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Figure 1-11. TCRαβ receptor 
molecule. The immunoglobulin 
domain are represented with 
disulfide bridges. 
1.1.6 The TCR 
The T cell receptor (TCR) is a molecular dimer present in all T lymphocytes. 
This receptor is crucial for development, survival and differentiation of T lympho-
cytes64. It also plays a key role in antigen recognition and activation of T cells that leads 
to the immune response. 
1.1.7 TCR structure 
Structurally, TCR consist of a heterodimer of two integral membrane proteins, denot-
ed α and β, covalently linked by a disulfide bond65, 66 (Figure 1-11). There is another type of 
TCR, found in a small percentage of T lymphocytes that is made of a γ and δ chains67. Each 
α and β or γ and δ chain consists of one Ig-like N-terminal variable (V) domain, one Ig-like 
constant (C) domain, a hydrophobic transmembrane segment (TM) and a short cytoplasmic 
region. The extracellular part of the αβ (γδ) TCR is structurally similar to the antigen-binding 
fragment (Fab) of an immunoglobulin molecule. 
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Figure 1-12. TCR-CD3 complex structure. Figure shows the organization of the TCRαβ together 
with the signaling subunits CD3γε, CD3δε, and the ζζ. Also represented are the TCRγδ, with the 
signaling subunits CD3γε repeated and the homodimer ζζ. The TCR and CD3 subunits consist of 
an immunoglobulin domain exposed to extracellular media, followed by a short stalk region that 
connects with the transmembrane domain, and finish in the cytoplasmic portion that contains the 
ITAMS. 
1.1.8 TCR - CD3 Complex 
The TCR αβ (γδ) heterodimer is associated non-covalently with the CD3 and ζ pro-
teins in the surface of lymphocytes. Once the receptor recognizes the antigen during the im-
munological synapse, these associated proteins transduce the signal that lead to T cell activa-
tion18. CD3 molecules consist of three integral proteins that are denominated CD3ε, δ and 
γ66. CD3 proteins and ζ are the same in all T cells subtypes regardless of specificity, which 
reinforce their role in signaling and not in recognition (Figure 1-12). 
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The cytoplasmic regions of CD3 ε, δ and γ proteins vary between 40 to 81 amino ac-
ids residues, and each of these domains has a conserved characteristic amino acid sequence 
fundamental for the signaling called the immunoreceptor tyrosine-based activation motif 
(ITAM)68. Each ITAM contains two copies of the following sequence: tyrosine-X-X-
leucine/isoleucine, separated by six to eight amino acid residues from the next one. The 
ITAMs plays an important role in signaling by the TCR complex. The other protein, ζ, has an 
extracellular portion about nine amino acids long and a long intracellular chain that contains 
three ITAMs. All the proteins mentioned above are indispensable and sufficient for the ex-
pression of TCR in the lymphocyte surface in the absence of any other T cell-specific pro-
tein69. 
The organization of the four dimeric molecules within the membrane follows a spe-
cific pattern70. The lysine in the position 10 of the transmembrane segment of the TCRα 
chain interact with the two glutamic acid residues on the CD3δε forming a three helix com-
plex71. The specific mutation of the lysine 10 residue for alanine abolishes completely the 
expression of the complex in the cellular surface69. Similar studies demonstrated that assem-
bly of the CD3γε occurs through interaction of an aspartic and glutamic residues with lysine 
at position nine in the TCRβ chain. Interaction of the last dimer ζζ occurs between two aspar-
tic acids and an arginine residue at position 5 in the TCRα chain. In summary, the organiza-
tion of these subunits in the membrane is based on the interaction of three pair of polar resi-
dues located in the transmembrane domain of TCR-CD3 complex (Figure 1-13). 
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In addition, Call et al.72 showed that a tetracysteine motif in the membrane-proximal 
stalk region, defined as the sequence that spans from the transmembrane peptide until the 
first Ig-like motive- of CD3γε or CD3δε dimers is an important structural element in their 
assembly with TCR. They observed that a TCRα mutant lacking the entire Ig domain is ca-
pable of assembling with CD3δ. These results suggest that interactions among the mem-
brane-proximal segments, and not the variable or constant Ig-domains, might be involved in 
assembly of TCRα with CD3δε. This also indicates that ligand binding, which involves nec-
essarily the variable Ig-like domain, is not essential for receptor assembly. 
 
 
Figure 1-13. Organization of the TCR – CD3 complex assembly based on the inter-
action of three pairs of ionizable TM residues. (D)    aspartic acid, (E)    : glutamic 
acid,   (K):  lysine,   (R):   arginine, α: alpha chain of the TCR, β: beta chain of the 
TCR, ζ: zeta chain.  Source: (Matthew E, 2007) 
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1.1.9 TCR assembly and Signal Transduction  
There is controversy regarding the natural state of the heterodimer TCR in the plasma 
membrane, in particular whether it is found as a monomer or, on the contrary, as a cluster of 
receptors. There are experimentally based papers that suggest either one or the other theory 
(cluster73-75 or monomeric76-78). However, it is clear that ligand-induced clustering is an im-
portant event in early stages of T cell activation and clustering is important to initiate signal-
ing in TCRαβ T cells79, 80. Kupfer et al. observed that clustering of multiple copies of TCR-
CD3 complex in the lymphocyte surface is crucial to form the supramolecular activation 
complex81. Fluorescence imaging studies showed that antigen-dependent formation of TCR 
microclusters is concomitant with T cell activation and contribute to the immunological syn-
apse with the antigen presenting cell82, 83. 
Notwithstanding, Davis et al.84 argued that the TCR does not form clusters. Their evi-
dence is based on a special technique called bioluminescence resonance energy transfer 
(BRET). Briefly, BRET is an analytical technique that involves the energy transfer between a 
bioluminescent donor and a fluorescent acceptor without the necessity of fluorescence excita-
tion. It has been widely used in studies of protein-protein interaction. The investigation of 
Davis et al. indicates that exclusively monomeric or monovalent membrane proteins are like-
ly to drive receptor triggering in T cells, offering a simplified structural framework for un-
derstanding receptor triggering84. Is important to mention that studies of TCR assembly and 
triggering are very difficult in biological systems, mainly due to the intrinsic complexity of 
cells. 
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Several models85 have been proposed to explain how the TCR is triggered, in other 
words, how the ligand binding (agonist peptide-major histocompatibility complex MHC) 
produce the biochemical changes in the cytoplasmic tail of the CD3 molecules (phosphoryla-
tion) that leads to cell activation (Figure 1-14). 
 
 
 
 
 
 
 
 
 
 
Figure 1-14. Mechanism of TCR triggering. Illustration of three models: aggregation, conforma-
tional change and segregation or redistribution. In the aggregation model the binding of the recep-
tor to a high affinity agonist peptide-MHC induces the clustering of second receptors. In the con-
formational change model, the binding of the agonist peptide-MHC induces a conformational 
change in the TCR-CD3 complex, such as exposure of the cytoplasmic ITAMs that becomes ac-
cessible to the phosphorylation by kinases like LCK. In the third model, the binding of the TCR 
to the peptide–MHC ligand traps the TCR–CD3 complex in close-contact zones, segregating it 
from the inhibitory tyrosine phosphatase CD45, and leading to the steady phosphorylation of 
TCR–CD3 ITAMs by kinases like LCK. 
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1.1.9.1 Conformational changes 
This model proposes that ligand binding induces a conformational change in the TCR 
that triggers the response. Some particular mechanisms have being invoked in support to this 
model, i.e. changes in the TCR ectodomains, CD3 ectodomains, and CD3 cytoplasmic re-
gions. However, since the structure of the intact TCR-CD3 complex is not yet resolved, those 
currently proposed models cannot really address how the ligand binding promote any con-
formational change in the TCR-CD3 complex. 
1.1.9.2 Segregation-redistribution 
In this model, the ligand binding induces segregation or redistribution of TCR-CD3 
complex with respect to other membrane bound proteins. The TCR-CD3 complex is inserted 
in the membrane together with other proteins that enhance signaling (like the tyrosine kinase 
LCK) and molecules that inhibit the signal transduction (such as the tyrosine phosphatase 
CD45). Experimental evidence86 suggests that in resting T cells signaling enhancing mole-
cules are constitutively active but their action are counteracted by the presence of phospha-
tases. Clearly, any event that interrupts this balance will conduct to the increment of the 
phosphorylation of TCR-CD3 ITAMS, thus to TCR signaling. One way in, which this bal-
ance could be altered, is by redistributing the TCR-CD3 complex, for example by separating 
LCK and CD45 in the membrane surface.  
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1.1.9.3 Aggregation 
The aggregation model had been proposed a long time ago to explain the TCR trig-
gering mechanism. According to this model, aggregation of TCR molecules follows ligand 
engagement and can lead to trans-phosphorylation of ITAMS in the second receptors by the 
LCK protein in close proximity. However, some other mechanisms can be found in the litera-
ture that account for the triggering within the aggregation model. Some experimental data in 
support of this mechanism showed that forced aggregation of TCR by soluble antibodies or 
using multimeric peptide-MHC complexes is sufficient to initiate triggering. In fact, Eisen at 
al87, provided evidence that a single peptide-MHC molecule can elicit cytolitic response in T 
cells. More experimental evidence in support of the aggregation mechanism comes from the 
work of Irving et al. They showed that T cells expressing the CD4 co-receptor respond with 
transient signaling to even a single agonist peptide-MHC ligand, and that organization of the 
molecules in the area of contact between the T cell and antigen presenting cell (APC) adopt 
their characteristic immunological synapse when about ten agonist peptides are present. They 
suggest the formation of dimers or aggregates of TCRs leads to activation of the TCR and 
that the CD4 co-receptor plays an important role in the aggregation process88. 
 
 
 
 
 
Chapter 1 
 
42 
 
The inspiration of this project is based on the work of Pennington and colleagues89 
towards elucidating the structural and signaling requirements of TCRγδ in thymocyte devel-
opment. Their approach was based in the construction of two sets of truncated forms of the 
TCRγδ receptor (Figure 1-15): the first set lacks the variable regions that include the com-
plementarity-determining regions (CDR), involved in ligand recognition by analogy with the 
TCRαβ. The second set of truncated receptors lacked both the variable and the constant do-
mains. 
Figure 1-15. Truncated TCRγδ receptors. Figure show the full-length receptor 
and the truncated forms lacking one or all the Ig domains (Vγ, Vδ, Cγ, and 
Cδ) with the disulfide bonds indicated. 
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These truncated forms of the receptor were expressed in immature thymocyte progen-
itors and the development was analyzed. Interestingly, their results demonstrated that trun-
cated TCRγδ that lacked both the Vγ and Vδ, or that lacked all the extracellular Ig-domains 
are able to initiate signaling in immature progenitors. They concluded that in early progeni-
tors signaling initiation is independent of ligand binding. In addition, they also demonstrated 
that signaling initiation was not mediated by oligomerization of the extracellular Ig-domains 
of the TCR as previously proposed by other authors. Based on this result we decided to in-
vestigate how the TCR signal initiation occurs in the absence of any ligand binding. 
To address this question we will center our attention in the aggregation mechanism, 
due to the interest of this thesis in the study of clustering of receptors in model membranes. 
To answer this question we set the hypothesis that TCR undergoes aggregation 
through the transmembrane peptide in a ligand independent manner. By clustering, the recep-
tors are able to concentrate some key molecules e.g. Lck, that enhance phosphorylation of the 
CD3 ITAMs and triggers signaling initiation. We also hypothesize that the lipid composition 
of the membrane of early T cell progenitors play a critical role in the clustering of receptors. 
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1.1.10 Difficulties in the study of receptor clustering.  
The cellular membrane is a dynamic structure with many levels of structural com-
plexity90. Fujiwara et al. have proposed a mechanism for signal transduction in the plasma 
membrane that involves three hierarchical stages. The first stage is the membrane compart-
ments, composed of patches of membrane underpinned by the cytosqueleton, interacting with 
the cytoplasmic tails of the integral membrane proteins. Lipid rafts make the second stage in 
the organization, which depends of the lipid composition of the membrane. The third level 
involves the smallest domains constituted by transient aggregates of membrane associated 
proteins or integral membrane complexes.  
It is easy to envisage how complex it is to study the clustering phenomena in such a 
complex and dynamic system as the cell, where factors like lipid composition, intracellular 
and intercellular binding events, cytoskeleton interaction and many other parameters can be 
affecting the clustering of receptors. In addition, it is also very difficult to dissect systemati-
cally all these factors in order to understand their contribution to the clustering. Therefore, 
the use of model membranes, like lipid vesicles, constitute a good approach to focus our at-
tention in determine if spontaneous clustering of receptors can occur within a simplified li-
pid environment devoid of the typical complexity of biological membranes. 
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1.1.11 Synthetic approaches to study receptor clustering 
in lipid membranes 
As mentioned before, given the inherent complexity of biological membranes we 
have decided to use structurally and compositionally simplified model membranes, i.e. lipid 
vesicles. The principal advantage of such model systems is that they lack all the complexity 
of the plasma membrane, i.e. integral membrane proteins, glycolipids, etc. that could inter-
fere with the clustering process. However, it is important to mention that such a reductionist 
model has the disadvantage to simplify in-extremis the clustering process, eliminating the 
contributions that other biochemical elements can play in vivo. In the following paragraph, I 
will described the lipid vesicles, also denominated Liposomes, as these are the model mem-
branes relevant for our study. 
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1.1.11.1.1  Composition 
 Liposomes are artificially prepared vesicles consisting of lipid bilayers dissolved in a 
polar solvent91. They are formed when amphiphilic lipids such as phospholipids are dispersed 
in an aqueous solution92. Phospholipids are composed by two long hydrophobic chains joined 
to a phosphate group by a glycerol linker, forming a head to tail like molecule (Scheme 1.2).  
 
When phospholipids are dissolved in aqueous solutions, they tend to self-assemble 
acquiring a conformation in which the hydrophobic tails pack together avoiding contact with 
water molecules, shielded by the hydrophilic phosphate groups that stay exposed to the polar 
environment. During this rearrangement, phospholipids can adopt, among others, a spherical 
shape, which corresponds to one of the most entropically favorable conformations93, 94. In 
this process, part of the aqueous solution is trapped in the internal cavity of liposomes, mak-
ing them ideal vehicles for any kind of hydrophilic compounds dissolved on the media95, 96. 
On the other hand, the bilayer itself can be a carrier for any type of hydrophobic molecule as 
well (Figure 1-16). 
Scheme 1-2. General representation of the phospholipid structure, showing the phosphate group 
in blue (head), and the aliphatic chains (tail). The scheme also shows how the phospholipids 
arranged together to form the bilayer, exposing the polar heads to the aqueous solution while the 
lipids packed internally. 
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Figure 1-16. Schematic representation of liposome with hydrophilic and hydrophobic mole-
cules trapped in their respective part of the structure. Orange: hydrophobic substance; Pink: 
hydrophilic compound. 
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1.1.11.1.2  Types of liposomes 
 Liposomes can be classified attending to the size of the vesicles, lamellarity, or num-
ber of layers that are present in the vesicle into97 (Figure 1-17): 
a. Small unilamellar vesicles (SUV): 20–100 nm 
b. Large unilamellar vesicles (LUV): > 100 nm 
c. Giant unilamellar vesicles (GUV): > 1000 nm 
d. Oligolamellar vesicles (OLV): 100–500 nm 
e. Multilamellar vesicles (MLV): > 500 nm 
 
 
 
 
 
Figure 1-17. Classification of liposomes based 
on the size and lamellarity. 
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1.1.11.1.3  Methods of preparation  
There are four methods of liposome preparation94. The difference between them is 
based mainly in the way the lipids are dried from the organic solvent in which they are dis-
solved. For the purpose of this thesis I focus mainly in the classical technique also known as 
Bangham method98: In here, the phospholipid of interest is dissolved in an organic solvent. 
The solvent is then removed by rota-evaporation under reduced pressure leaving a thin film 
of the phospholipid attached to the vial wall. Then, an aqueous solution or buffer is added to 
the vial and the thin film is re-suspended with vigorous agitation. 
This method of preparation is very easy to handle but produce a very heterogeneous 
population of multilamellar liposomes with different sizes. To homogenize the previous lipo-
some mixture a few techniques are implemented. i.e. sonication to produce SUV, or extru-
sion through a polycarbonate membrane to render LUV liposomes99, 100. 
The extrusion technique (Figure 1-18) is a very straightforward method to produce 
LUV liposomes with similar size range. By means of a mini-extruder consisting of a stainless 
steel cylinder bearing the mechanism that contains the polycarbonate membrane and two gas-
tight syringes by transferring mechanically the solution multiple times from one syringe to 
the other obtain in a good quality and high efficiency the desired mixture of liposomes. How-
ever, the size of the pore in the polycarbonate membrane is of the utmost importance, due to 
the fact that only membranes with a pore size ≤ 0.2μm will yield the desired LUV 
liposomes101. 
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Figure 1-18. Mini-extruder instrument used for the produc-
tion of the LUV liposomes. Marked with an arrow is the 
location of the polycarbonate membrane where the extru-
sion of the crude vesicles takes place. 
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1.1.11.1.4  Applications of Liposomes 
Liposomes have been extensively used since their discovery by Bangham in the 
1960’s102. In the pharmaceutical field, liposomes have being used as systemic and topical 
drug delivery systems. In this regards, Rowland et al. have shown that liposomes can be used 
to transport encapsulated drugs through the gastrointestinal tract103. Dapergolas et al. pub-
lished results pointing towards the suitability of liposomes as candidates for oral delivery of 
peptides, i.e. insulin and proteins104. 
Alving et al. have described the usage of liposomes as carriers of antigens and adju-
vants in the development of vaccines105, 106.  The first liposomal vaccine against hepatitis A 
was approved in Europe107 in the 1990’s. 
In cosmetics94, the exploitation of the liposomes has grown since the late 1980’s. The 
capacity of the liposomes to retain water molecules in their interior is a major advantage to 
deliver hydration to the skin and combat dryness, which is one of the causes of ageing of the 
skin. Products such as Capture by Cristian Dior, Efect du Soleil by L’Oréal and Future Per-
fect Skin Gel by Estée Lauder are based on liposomes carrying different ingredients like:  
Vitamin E, A, cerebroside, ceramide, tanning agents, etc. 
Another important application of liposomes is in the agro-food industry. The lipo-
somes can be prepared with pesticides, fungicides or herbicides that can have a prolonged 
action time. By adding some components to the liposome membrane we can make it sticky 
thus, staying attached to the plant for a longer time delivering the active compound108. 
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1.1.12  Biomimetic models 
In this section, we will describe some examples of systems where synthetic approach-
es have been employed to study the clustering of proteins. Depending on the components, 
these systems can be synthetic when all the components are chemically synthetize or biomi-
metic. The biomimetic systems usually contains a biological molecule, as a protein or pep-
tide. 
1.1.12.1  Synthetic models 
Tomas et al.109 with the aim to study the relationship between embedded-receptor 
clustering and binding of ligands in the absence of any multivalence, developed a synthetic 
system based on a zinc-metalloporphyrin molecule as a model of membrane receptor, soluble 
nitrogen-containing molecules as ligands, and unilamellar liposomes as model membranes. 
(Scheme 1-3). When studying the binding of ligands to membrane embedded receptor, most 
of the published studies assume that ligand binding is based on: 1) the effect of the mem-
brane-water interface in the binding affinity of the ligands, 2) the effect of the membrane-
embedded receptor on the multivalent effect of the ligand. Working with monovalent ligands, 
Tomas et al. demonstrated that in fact a cooperative effect between the binding of monova-
lent ligands and the clustering of membrane-embedded receptors exists, that is only evident 
when the receptors are in-membrane and most important that is not dependent of any multi-
valent effect.  
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For the sake of clarity, we will describe briefly the synthetic approach used in this 
work to the reader; also because it was the model for the design of our experimental approach 
in this study. To generate an amphiphilic membrane embedded-receptor Tomas et al110 linked 
a cholesterol molecule to the zinc-metalloporphyrin (Scheme 1-3, A). Cholesterol is an im-
portant constituent of biomembranes. The porphyrin contains three ionized sulfonate groups 
that force the porphyrin head group towards the water media, and adopting a perpendicular 
position in respect to the plane of the membrane, as observed previously111. The zinc atom 
provides the receptor the capacity to form complexes with nitrogen bearing ligands that have 
Scheme 1-3. Porphyrin cholesteryl receptor and N-bearing ligands used 
in the study of Tomas et al. A) Chemical structure of the receptor. B) 
Chemical structure of some of the ligands used in the study. C) Represen-
tation of the equilibrium of membrane-embedded receptor with a ligand 
L. The change in colour represents the ability of the porphyrin to report 
on clustering. 
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moderate stability in aqueous media. In addition, the porphyrin is the clustering reporter due 
to its spectroscopic properties being different for the monomer and the aggregate forms.  
 This chemical approach was used to study clustering of embedded receptor in model 
membranes, and in particular, how ligand binding modulates clustering. The authors con-
cluded that a cooperative effect between ligand binding and receptor clustering exists. They 
observed that ligand binding was able to modulate clustering of receptors. Moreover, they 
also reported that clusters of receptors showed different affinity towards ligands in solution, 
compared to the monomers. However, this phenomenon was not obvious when both the lig-
and and receptor were in solution. Of note, they proposed a model to analyse the receptor 
clustering i.e. a binding-clustering thermodynamic cycle that in principle could be extended 
to any other system formed by a ligand and a membrane embedded receptor, like our biomi-
metic model. This study also demonstrated how simplified synthetic models can be used to 
address complex biological events. 
As a second example of a synthetic model we would like to present the work done by 
Clayden et al.112 In a recent study, they reported the design and synthesis of a photo respon-
sive helical molecule that can be inserted in the membrane bilayer to study the changes in its 
conformation when photo-stimulated. The aim of this study was to create a synthetic analog 
of the membrane-spanning segment of a protein conjugated with a molecule that can be used 
to track conformational changes in-membrane to study the effect of the phospholipid bilayer 
over the conformational changes of membrane-embedded molecules. The helical molecule or 
foldamer113 is a synthetic polymeric molecule with a known conformational state built from 
oligomers of 2-aminoisobutyric acid (Aib). This foldamer shows a strong preference for the 
helix conformation and can adopt alternatively two different modes, the left-handed or the 
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right-handed sense. To the foldamer, they linked covalently an azobenzene114 motif that is 
known to show reversible conformational changes driven by the light. The stimulation of the 
azobenzene at a certain wavelength triggered a conformational change that induced a change 
in the geometry of the foldamer that was tracked by proton magnetic resonance spectroscopy 
(1H-NMR), which is a technique that helps to determine the chemical structure of the mole-
cules. Briefly, with the 1H-NMR we can identify the proton framework of an organic com-
pound and from here elucidate its entire structure, in conjunction with other analytical tech-
niques such as mass-spectrometry and infrared spectroscopy. Their results showed that in-
deed it is possible to modify the conformation of this foldamer embedded in the lipid bilayer 
after being photo-stimulated, replicating the results observed for these molecules in solution. 
Most interesting, this work also demonstrates that simplified synthetic models can be design 
to mimic essential process, such as conformational changes of proteins that are embedded in 
lipid bilayer, that are not normally achievable in the more complex biological systems.  
In a different study conducted by Clayden et al.115 they designed, synthetize and char-
acterized probes of bis(pyrene) to report conformational changes in membrane embedded 
foldamer. The bys (pyrene) probe was designed to be able to distinguish between each of the 
conformers, left-handed (M) or right-handed (P) of the helix (Figure 1-19). As mentioned in 
the previous example, the foldamer is made of α-aminoisobutyric acid (Aib) peptide. The use 
of the pyrene as a fluorescence reporter of conformational changes is based on its capacity to 
show different emission spectra in the monomer and the dimer states (excimer). The excimer 
emission is observed when two pyrenes are close together as shown in Figure 1-19. In this 
study, they observed that this reporter successfully allowed the investigation of how the chi-
rality of phospholipids affected the conformation of the foldamer embedded in the bilayer. 
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Figure 1-19. Schematic representation of bis 
(pyrene) probe attached to M and P conformers, 
showing the change in the relative position of 
the fluorescence probe in each conformational 
position. 
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1.1.12.2  Semisynthetic models 
In this section, we would like to present three published examples of semisynthetic 
models used in the study of protein clustering and membrane fusion. 
1.1.12.2.1  N-Ras 
The first study consists of the work developed by Winter et al.52 With the aim to ex-
plore the insertion and partitioning of the protein N-Ras in model membranes, they synthe-
tized in solid phase a lipid modified peptide containing farnesyl and palmytoil anchors, 
which are known to drive protein insertion in membranes50. This lipidated-peptide was fur-
ther modified to have in the N-terminus a maleimidocaproic acid, and in the C-terminus the 
boron-dipyrromethene (BODIPY-FL) label, a fluorescent dye. In a similar approach to our 
project, the maleimide-peptide was tethered to N-Ras through a cysteine exposed on the pro-
tein surface. The addition of the sulfhydryl group to the maleimide function is shown in Fig-
ure 1-20. The model membrane was prepared from a binary phospholipid mixture of 1-
palmitoyl-2-oleoylphosphatidylcholine (POPC), sphingomyelin and varying levels of choles-
terol which is known to produce lipid microdomains with two fluid phases, liquid disordered 
(ld) and liquid-ordered (lo) in giant vesicles
116 (see section 1.1.11.1.2). Their results provide 
evidence that partitioning of N-Ras occurs preferentially into the liquid disordered (ld) lipid 
domains, concomitant with faster kinetics of incorporation into the fluid lipid bilayers. In ad-
dition, they detected that a large proportion of lipidated N-Ras locates at the interface of the 
ld/lo phases leading to a decrease in the tension localized in the two phases boundary. They 
suggested that this interfacial adsorption effect could be the vehicle for clustering of signal-
ling proteins in membranes. 
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Figure 1-20. Schematic representation of the labeling reaction between the semisynthetic 
Ras protein with the C-terminal peptide containing the palmitoyl and farnesyl anchors. 
The C terminal peptide is labeled with the BODI-PY fluorescent dye. It was introduced 
by a Michael addition between the surface accessible cysteine (181) and the maleimide 
function introduced in the peptide as shown by Winter et al. 
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1.1.12.2.2  Study on the effect of cholesterol and phosphatidylinositol 4,5-
bisphosphate PI(4,5)P2 over the syntaxin clustering.  
Tamm et al56 aimed to study the molecular mechanisms of cholesterol and phospho-
inositide’s mediated syntaxin (Syx) clustering. As mentioned in the section 1.1.5.2 the 
SNARE complex is a molecular machinery that governs membrane fusion in neuronal synap-
sis through the participation of syntaxin-1A, SNAP-25 in the presynaptic membrane and syn-
aptobrevin in the synaptic vesicle. There is ample evidence regarding the key role of syntaxin 
in the SNARE acceptor complex in interaction with the SNAP-25. However, the dynamics 
and equilibrium of the interaction of Syx-SNAP-25 is poorly understood. It has been shown 
that Syx oligomerization is dependent on the cholesterol concentration in several cell types. 
The importance in the clustering process of the residues located in the N-terminal segment of 
the SNARE domain was also explored. However, the authors of this study also believed that 
the polybasic region of approximately 10 residues that connect the SNARE motif with the 
transmembrane segment and the presence of anionic lipids is very important in the clustering 
process. Moreover, previous studies have demonstrated, that phosphatidylinositol 4,5-
bisphosphate (PI (4,5) P2) interacts with Syx electrostatically, disrupting the syntaxin clus-
ters. To understand the molecular events that control the interaction between Syx and anionic 
lipids they created a semisynthetic model of Syx coupled to a fluorescence cluster reporter 
and a model membrane composed of POPC/POPS/phosphoinositides and cholesterol. To 
generate the fluorescently labelled protein, they expressed the Syx protein with an extra cys-
teine in the C-terminal. The fluorescent tag, Alexa Fluor 647, contains the maleimide func-
tion that will react with the reduced cysteine for the addition of the tag. Of note, to check the 
orientation of the modified-protein in the proteoliposomes they used the trypsin digestion and 
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Figure 1-21. Cartoon model depicting how the cholesterol-dependent clustering of syntaxin-1A is 
reduced by the presence of anionic lipids, such as phosphatidylinositol 4,5-bisphosphate (PI (4,5) 
P2). The disaggregation of the syntaxin-1A is followed by the weakening in the self-quenching of 
the Alexa-Fluor 647 attached to the Sintaxin-1A. 
subsequent SDS-PAGE, observing that approximately 90% of the inserted protein was in the 
right orientation with the N-terminus exposed to the extra-liposomal side and the C-terminus 
with the fluorophore towards the lumen. The insertion efficiency of the protein was deter-
mined by fluorescence spectroscopy in samples of liposomes solubilized with detergents. 
Clustering-dispersion studies were conducted following the self-quenching of the fluores-
cence probe (Figure 1-21). 
The results of this study showed that all types of phosphatidylinositol (PI) disrupted 
the clusters of syntaxin. This result suggested that syntaxin disruption was not selective to-
wards a particular PI member. Moreover, they observed that after formation of Syx clusters 
the protein SNAP-25 was not able to bind it anymore. By contrast, when Syx was in the 
monomeric form the SNAP-25 was able to bind it and the union precluded formation of new 
clusters. They concluded that syntaxin-1A and synaptobrevin both interacted directly with PI 
(4,5) P2 and that this interaction activates fusion. 
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2.1 INTRODUCTION. 
In this chapter we will describe the synthesis of the maleimide-porphyrin derivative 
(Scheme 2-1), and the reason why we choose this molecule as the target compound. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2-1. Maleimide – porphyrin derivative (compound #5). 
Target molecule of this doctoral thesis. 
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2.2 OBJECTIVES 
One of the main objectives of this work was the synthesis in four steps of the com-
pound 5-(4-maleimide-phenyl)-10, 15, 20-tris (4-sulfonatophenyl) porphyrin. The interest in 
the synthesis of this compound was based on two major characteristics: 
1. The property of porphyrin macrocycle to respond upon aggregation displaying 
different optical signatures, with the traces belonging to the monomer and 
aggregate clearly differentiated. This application of porphyrins is based on 
previous work by Tomas and Milanesi109. As they demonstrated, the porphy-
rin group showed distinct optical properties when it formed aggregates at the 
lipid/water interface (see Introduction, Section 1.1.12.1). 
2. The possibility to link the hydrophobic peptide through a Michael addition re-
action between the sulfhydryl group in the flanking cysteine of the peptide 
and the maleimide function. As explained in Chapter 4 section 4.2.1, the hy-
drophobic peptide contains the amino acid sequence of the transmembrane 
segment of Vγ7Jγ1Cγ1 TCR chain. In this study, we aim to elucidate the ag-
gregation capacity of the transmembrane peptide inserted in model lipid vesi-
cles. We hope this approach will provide some preliminary results on the self-
assembling capacity of the TM peptide. This might help to elucidate some 
key aspects of the signaling mechanism of T cell receptor. The rationale in 
support of this approach is based on the work reported by Pennington’s group 
discussed in the Introduction, Section 1.1.9.3. 
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These properties will be used in the construction of a chemical model that might pro-
vide a better understanding of the mechanism of T cell receptor signaling in model lipid bi-
layers, which is the major objective of the first part of this thesis. 
2.3 PORPHYRINS  
The porphyrins are a group of heterocyclic and aromatic compounds constituted by 
carbon, hydrogen and nitrogen. The structure of porphyrins was elucidated by Hans Fischer 
in 1927117. Porphine is the simplest molecular member of the group, and was very important 
because its ring system is the fundamental ring system of all porphyrins. It is composed by 
24 atoms arranged in a macrocycle; the macrocycle is formed by four pyrroles rings linked 
by four methine bridges (Scheme 2-2). 
 
 
 
 This macrocycle is susceptible to several modifications. The flexibility in the number 
of substitutions produces a vast repertoire of different physical and chemical properties that 
confer great interest to the porphyrin family. The macrocycle can bear additions in the β posi-
tion of the pyrrole ring to render porphyrins similar to those found in nature. Moreover, it is 
also possible to add some substituents in the δ positions in the methine bridges –the so called 
meso-substituted porphyrins- and this product, by contrast, does not have an analog in bio-
logical systems. Based on these two types of substitutions porphyrins can be classified and 
Scheme 2-2. Porphyrin macrocycle 
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studied in two main groups: the β-pyrrole substituted and the meso-substituted poprhyrins 
(Scheme 2-3). 
 
The family of porphyrins has been much studied due to its electronic and optical 
properties as explained in chapter one. One of the major strengths of porphyrins reside in 
their flexibility towards modification. This advantage allows the introduction of many sub-
stituents in the macrocycle, with the concomitant variation in its general properties. These 
modifications can be used to tune porphyrins in different ways. Due to its almost limitless 
capacity of modification, porphyrins can be used in multiple applications e.g.: as sensors118, 
catalysts119, solar cells120, medicine due to their antitumor and radiosensitizing effects on 
cancer cells121, and in photodynamic therapy122. 
 
 
 
 
Scheme 2-3. Types of porhyrines. (A) β-pyrrol subsituted. (B) 
meso-substituted. 
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2.3.1 The meso-substituted porphyrins 
The first synthesis of this type of porphyrin was reported by Rothemund in 1935123. 
Reacting pyrrole in a saturated solution of acetaldehyde in methanol heated in a sealed tube 
at 85-90°C produced the α,β,γ,δ-tetramethylporphin. The same author published works in the 
synthesis of other meso-tetrasubstitutedporphyrins124. The synthesis of the α,β,γ,δ-
tetraphenhylporphin (TPP) was first described for Rothemund in 1941125. 
He condensed pyrrole and benzaldehyde in pyridine solution, in sealed tubes at 220°C 
for forty-eight hours. The product crystallized from the solution in the form of lustrous deep 
blue needles crystals (Scheme 2-4). 
 
 
 
 
 
 
 
 
The TPP is a commercially available reagent today, very important in the synthesis of 
many porphyrin derivatives, specially nitrosilated, and sulfonated porphyrins. 
 
Scheme 2-4. First synthesis of the α,β,γ,δ-tetraphenhylporphin 
(Rothemund’s synthesis) 
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2.3.2 Background to the nitration of the meso-
tetraphenylporphyrin. 
Interest in the production of asymmetrically functionalized aryl-porphyrins has led to 
extensive research. The use of this type of aromatic substitution is very useful in order to 
produce posterior modifications in the porphyrins that will allow the covalent incorporation 
of porphyrins into macromolecules, e.g.: monoclonal antibodies126, nucleic acids127, poly-
mers128, etc. One of the many problems related with this reaction is that any peripheral func-
tionalization of the porphyrin with electrophiles or radicals led to the modification of the 
macrocycle at either the meso or the β-pyrrole carbons129. The only exception known to this 
outcome is the electrophilic reaction with sulfuric where the aryl group is attacked without 
the parallel substitution of the macrocycle130, 131. 
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The first synthetic routes found in the literature to prepare the compound 5-(4-
Nitrophenyl)-10, 15, 20-tryphenylporphyrin (Scheme 2-5) are all derived from Rothemund’s 
condensation and were associated with a very low yield production (<5%)128, 132-134. 
 
 
 
 
 
 
However, in 1989 the group of Kochany et al129 published a procedure to produce the 
controllable and highly regiospecific nitration of tetraarylporphyrins. When a chloroform so-
lution of tetraphenylporphyrin (TPP) was treated with excess fuming nitric acid the selective 
and stepwise nitration of the aryl groups at the para position occurred. The yield of the reac-
tion was good (yield = 55%) although the dinitro-TPP side-product was also found, but in a 
much lower yield (7%). Use of chloroform proved very appropriate for the selectivity of the 
mononitration although other solvents such as methylene chloride had been tested. Although 
the use of a large excess of oxidant can result in damage to the macrocycle producing its deg-
radation. This procedure had been optimized by our group to achieve the mononitration of 
the TPP with a better yield and a reduction in the reaction time of nearly five-fold (66%, 25 
min vs 55%, 120 min). 
Scheme 2-5. Compound 5-(4-
Nitrophenyl)-10, 15, 20-
tryphenylporphyrin. 
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2.3.3 Background to the reduction reaction of the mono-
nitrophenylporphyrin. 
There are a few methods in the literature describing the reduction reaction of nitro-
porphyrin derivatives to render the amino products. The group of Dr Kochany describe a 
method of reduction based on the modification of Hasegawa’s procedure128. This procedure 
is used in our synthesis and will be explained in detail in the experimental section of this 
chapter (Scheme 2-6) 
 
 
 
 
 
 
 
In June 2017, shortly after we had already completed successfully the synthesis of the 
target molecule (Compound #5) in quantities sufficient for our experiments, a new procedure 
for the reduction of nitroarenes was published. Royo et al. described the use of a nickel–NHC 
(N-heterocyclic carbene) complex in conjunction with phenylsilane as a reducing agent of 
nitroarenes135 (Scheme 2-7). Their results showed that reduction is chemoselective towards 
the nitroarenes and tolerant with a wide range of functional groups like halogens, cyano, hy-
droxyl, ketone, amide, methoxy, and ester groups, likewise the reduction with tin chloride 
and hydrochloric acid. However, in terms of yield, their procedure showed an improvement 
Scheme 2-6. Compound #5-(4-
Aminoophenyl)-10, 15, 20-
tryphenylporphyrin. 
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in the conversion of the CuII β-nitroporphyrin of ninety-four per cent (94%), while the con-
version in the reduction of the mono-nitrophenylporphyrin was seventy-four per cent (74%). 
Unfortunately, the duration of the reaction stated in this protocol is longer compared to our 
reaction time (15 hours vs 3 hours). Hence, this catalyzed reaction, is a good alternative to 
the canonical reduction with tin chloride and hydrochloric acid, based on the better yield re-
ported in spite of the long reaction time. From the point of view of Health and Safety, it is 
also recommendable especially when taking into consideration the high toxicity associated 
with the use of tin salts. 
 
 
 
 
Scheme 2-7. Reduction of 5,10,15,20-tetra-(nitrophenyl)porphyrin (TNPP). 
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2.3.4 Background to the sulfonation of tetraphenylporphy-
rin. 
Functionalization of porphyrins by adding different groups to the macrocycle is a way 
to produce a huge amount of new compounds that will be otherwise difficult to synthetize 
with de novo routes. There are a few methods in the literature regarding the electrophilic 
and/or nucleophilic substitutions in the meso or the β-pyrroles positions dependable on the 
different conditions of reactions and the steric hindrance present in the molecules136-138. 
In porphyrins with the meso-positions available, the sulfonation occurred preferential-
ly at the β pyrrole carbons139. By contrast, in meso-tetraarylporphyrins (Scheme 2-3) the sul-
fonation occurred preferentially at the meso-aryl groups129, 140. The reaction of tetra-
phenylporphyrin (TPP) with sulfuric acid produces substitution in the para-positions of aryl 
groups and no substitution at the β-pyrrole carbons. The extension of sulfonation in TPP is 
variable as shown in Scheme 2-8141. 
Scheme 2-8. Sulfonated porphyrins after the reaction of TPP with H2SO4 conc. 
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2.3.5 Background to the reaction with maleic acid imides 
(maleimides) 
Maleimides are derivative compounds from the reaction of maleic anhydride with 
ammonia or any amine (Scheme 2-9). 
 
In 1948, Friedman et al142 studying the antimitotic effect of maleic acid and similar 
compounds determined the existence of a certain parallelism between the mitotic inhibition 
and -SH uptake. In 1955, Gregory et al143 studied the reaction of N-ethylmaleimide with 
sulfhydryl groups and concluded that the rate of the reaction was a function of the pH. The 
reaction performed at a pH close to neutrality (6.7 to 7.5) was enhanced while in the basic 
range hydrolysis of maleimide competes with the sulfhydryl’s addition reaction. These initial 
experiments demonstrated that the double bond in maleimides can undergo an alkylation re-
action with sulfhydryl groups to form stable thioether bonds at neutral pH (Scheme 2-10). 
Maleimides can also react with amino groups of peptides, with imidazole group of 
histidine144, and with α-amino of amino acids145, but the rate of reaction at neutrality is 1000 
times slower than the reaction with the sulfhydryl group146. Due to the presence of the thiol 
group in some rare aminoacids, and the fact that we can introduce them via synthesis or by 
Scheme 2-9. Synthesis of the maleimide derivate. 
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recombination technology in target proteins, their reaction with maleimides have become 
widely used in the construction of bio-conjugates, e.g. as a crosslinker147. 
 
 
The maleimide group can also suffer hydrolysis to become unreactive. This reaction 
also occurs after coupling of sulfhydryl groups. The opening of the ring is proportional to the 
basic strength of the solution, higher pH correlates with faster hydrolysis, and is also subject-
ed to the type of chemical group that might be attached to the maleimide function. For exam-
ple, some groups can provide an increase in the stability of the maleimide towards hydrolysis 
e.g. the cyclohexane ring of the succinimidyl 4-[N-maleimidomethyl] cyclohexane-1-
carboxylate (SMCC)146. 
 
 
 
 
Scheme 2-10. Generic reaction between the sulfhydryl group and maleimide to 
form a thioether bond. 
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2.4 RESULTS AND DISCUSSION 
2.4.1 Synthesis of 5-(4-Nitrophenyl)-10, 15, 20 try-
phenylporphyrin (Compound #2) 
For the synthesis of compound #2 we followed the method described by Kochany et 
al.129. However, this methodology was optimized in order to improve the velocity of the reac-
tion, the yield, and purification step. (Scheme. 2-11) 
 
In this reaction one of the phenyl groups of the TPP undergo an electrophilic attack 
from the nitric acid with the substitution of one of the aromatic hydrogens in the para-
position with a nitro group (-NO2).  
One of the optimizations that we had introduced in the protocol was the increase of 
temperature of reaction from 5 to 60oC, compared with the published protocol148. In this way, 
we could speed up the formation of the mononitro porphyrin. 
Scheme 2-11. Synthesis of compound #2 
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 However, due to the lack of selectivity in the nitration of the para positions of the 
tetraphenylporhyrin, this increment in temperature was problematic because it produced ra-
ther quickly the non-desired di, tri or tetra-nitroporphyrin derivative. To overcome this prob-
lem, we monitored the reaction via thin layer chromatography (TLC) regularly (every 5 
minutes) until we detected the second spot on the plate. Immediately after, the reaction was 
quenched by cooling down the mixture. Following this procedure, we were able to obtain a 
better yield in the formation of the mono-nitroporphyrin with a considerable reduction in the 
reaction time (66% 25 min vs 55% 120 min).  
Due to similarities in the molecular structure of the products in the crude, and the 
small differences in polarity, we observed very subtle variation in retention factor, hence, the 
separation of the mono from the dinitro-porphyrin derivative was very difficult when we 
used chloroform (CHCl3) as recommended in the original protocol. To improve the outcome 
of the purification we performed several trials with different combinations of solvents (see 
below). We found out that isocratic elution of the mixture using petroleum ether, 
ethylacetate, and methanol (97:2:1) produced best separation and yield. (Figure 2-1, Table 2-
1). Miss Priya Limbu, one master student in our group, working on the same purification, 
employed gradient elution starting from 30% chloroform in petroleum ether and finishing 
with 40% chloroform. Her results showed a low yield (28%) with this elution method. 
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Compound  Rf(97:2:1)   Rf(CHCl3)   Rf(DCM)  
Tetraphenylporphyrin 
(TPP) 
 0.83  0.92      0.91  
Mono-nitroporphyrin (#2)   0.60  0.90         0.87    
Di-nitroporphyrin  0.26  0.87                0.85  
 
 
The 1H-NMR spectrum recorded for the compound #2 is in agreement with the pub-
lished data129. The chemical shift and the calculated integrals are in accordance with the 
structure and the twenty-nine hydrogens presents in the purified mono-nitroporphyrin (Figure 
2-2). Twenty-seven of these protons showed resonances in the aromatic region of the spectra. 
Starting from the most downfield proton we found a doublet at 8.81 ppm with an integral 
value of two that corresponds to the proton a of the β-pyrrole ring. At 8.79 ppm we have a 
singlet with an integral value of four that correspond to the four protons assigned as b in the 
β-pyrrole ring. The next resonances appear at 8.67 ppm and belong to protons assigned as c 
at the β carbon of the pyrrole ring. The next doublet at 8.56 ppm and integral value of two 
TPP 
A B 
Solvent front 
TPP 
mono 
di 
Figure 2-1. TLC showing the migration of 
tetraphenylporphyrin (A), mono-
nitroporphyrin, and dinitroporphyrin com-
pounds (B). 
Table 2-1. Calculated Rf values for the reaction crude eluted with petro-
leum ether, ethyl acetate, and methanol (97:2:1), chloroform (CHCl3), 
and dichloromethane (DCM). 
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Figure 2-2. 1H NMR (400 MHz, CDCl3) spectrum of the 5-(4-Nitrophenyl)-10, 15, 20-
tryphenylporphyrin (Compound #2) at 25°C. 
corresponds to the protons d; they are located in the ortho-position, adjacent to the nitro 
function. The protons e in the meta-position appeared at 8.33 ppm and the integral value cor-
respond to two protons. Protons f in the ortho-positions of the three peripheral phenyl group 
appear as a multiplet in the region 8.27- 8.18 ppm with an integral that corresponds to six 
protons. Protons in the meta/para-position of the three phenyl rings assigned as g + h appears 
as a multiplet from 7.89 – 7.70 ppm; the integral showed a value that corresponds to nine 
protons.  
The last two protons correspond to the NH pyrrole inside the macrocycle. The nega-
tive value of the chemical shift -2.76 ppm is due to these protons being heavily shielded by 
the porphyrin electronic cloud, and the integral value corresponds to two protons. As this 
compound had already been synthetized, and the introduction of nitro group had been well 
characterized by 1H NMR; we considered this analysis to be sufficient to ascertain the suc-
cessful substitution.  
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2.4.2 Synthesis of 5-(4-Aminophenyl)-10, 15, 20 try-
phenylporphyrine (Compound #3) 
The next step in the synthesis was the reduction of the nitro function to an amino 
group. This reaction was also optimized relative to the published protocol148 by changing the 
temperature from 60°C to 80°C and extending the time of reaction from one to three hours. 
The desired product was extracted with dichloromethane and washed with sodium hydroxide 
to adjust the pH to 8. One of the problems, not reported in the original protocol, that we 
found after the addition of dichloromethane was the formation of a thick emulsion that was 
destroyed by adding brine to the separation funnel. Once the emulsion was removed, the or-
ganic phase was collected and dried over magnesium sulfate. After the evaporation of the 
solvent, we obtained a purple sparkly powder with a yield of 71%, comparable with the yield 
in the published protocol (Scheme 2-12)  
 
 
Scheme 2-12. Synthesis of compound #3. 
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TPP 
A B 
Solvent front 
TPP 
amino 
Figure 2-3. TLC showing the migration of 
tetraphenylporphyrin (A), and 5-(4-
Aminophenyl)-10, 15, 20 tryphenylporphy-
rine (B). 
The reaction was monitored by thin layer chromatography. The solvent tried as mo-
bile phase, that had produced the best resolution was a mixture of ethyl acetate and petroleum 
ether (20:80). The results of the TLC showed that our product was of sufficient purity to car-
ry out the next step of the reaction as only one spot was observed in the TLC plate with com-
plete clearance of the starting material. This was a considerable advantage relative to the 
published protocol (Figure 2-3, Table 2-2) because in the original procedure they performed 
a column chromatography to purify the product. In our procedure, we did not need to per-
form column chromatography, and this translated into direct savings of time and resources 
i.e. solvents, silica.  
 
 
 
 
 
 
 
 
 
 
 
 
Compound Rf  
Tetraphenylporphyrin (TPP) 0.79 
5-(4-Aminophenyl)-10, 15, 20 tryphenylporphyrine (#3) 0.22 
Table 2-2. Calculated Rf values for the TPP and 5-(4-
Aminophenyl)-10, 15, 20 tryphenylporphyrine (#3) eluted with 
petroleum ether and ethyl acetate (80:20). 
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Figure 2-4. 1H NMR (400 MHz, DMSO-d6) spectrum of the 5-(4-Aminophenyl)-10, 15, 20-
tryphenylporphyrin (Compound #3) at 25°C. 
 The 1H-NMR spectrum for this compound is identical to the one described in the lit-
erature148 (Figure 2-4). However, due to presence of the new amino group, there are new res-
onances. The doublet at 8.03 ppm corresponds to the protons d, located in meta-position in 
respect to the 4-aminophenyl function. Another doublet detected at 7.10 ppm with an integral 
value of two corresponds to the protons labelled f, located in the ortho-position next to the 
amino group. As expected, the chemical shifts of these two protons appear upfield in compar-
ison with the protons d in the same position on the compound #2 (Figure 2-2). The reason 
being is most probably due to the electron donor effect of the amino group. Its influence over 
the closest protons in ortho will increase the electronic density on the vicinity of these pro-
tons and generate a magnetic field that will be opposed directly to the magnetic field applied 
externally by the nuclear magnetic resonance. This produced a shift on the resonance of these 
two protons towards the upfield regions of the scale. A broad singlet was recorded at 4.06 
ppm, which corresponds to the protons of the amino function, and had an integral value of 
two, as expected.  
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2.4.3 Synthesis of 5-(4-Aminophenyl)-10, 15, 20 tris (4 - sul-
fonatophenyl) – porphyrin, Trisodium Salt (Com-
pound #4) 
The main objective for introducing three sulfonate functions into the porphyrin is to 
make this molecule soluble in aqueous solutions. As discussed before about the electrophilic 
aromatic substitution (SEAr), this reaction occurs preferentially over the para positions of the 
three meso phenyl groups with no substitution in the β-pyrrole carbons of the macrocycle 
(Scheme 2-13). 
 
The synthesis was carried out at 70°C under nitrogen atmosphere for five days. After 
completion the sulfuric acid was quenched by adding sodium hydroxide 10 M. Given the 
large amount of sodium sulfate that was generated it took considerable time to remove all the 
salt from the mixture. Despite the good quality of the NMR spectrum the mass of sample re-
covered of the product was greater than 100% suggesting that salts were still present. The 
good quality of the NMR spectrum was explained because the sodium sulfate does not have 
Scheme 2-13. Synthesis of compound #4. 
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Figure 2-5. 1H NMR (400 MHz, DMSO-d6) spectrum of the 5-(4-Aminophenyl)-10, 15, 20 
tris (4 - sulfonatophenyl) – porphyrin, Trisodium Salt (Compound #4) at 25°C. 
protons, so cannot produce any signal in the 1H-NMR spectrum. As this issue was not de-
scribed, it was decided to speed up the separation by introducing a centrifugation step. In the 
separation, the fact that sodium sulfate was not soluble in methanol unlike the sodium por-
phyrinate was very helpful. Centrifugation was performed in small volumes to achieve the 
best possible separation although the procedure required significant time. Finally, a filtration 
over celite was done to remove fine particles of salt that remain in suspension followed by a 
final centrifugation step. Methanol was eliminated by rota-evaporation to produce a green-
brown porphyrinate with a yield of 86%. 
 The 1H-NMR spectrum of the product was in agreement with the published spec-
trum148 (Figure 2-5). The relevant chemical shift changes are those related with the hydro-
gens in the positions ortho/meta respecting the sulfonic groups. A doublet at 8.18 ppm with 
an integral value of six corresponds to the c protons in the ortho-position of the 4-
sulfonatopenyl rings. A doublet at 8.05 ppm corresponds to protons d, located in meta-
position in respect to the 4-sulfonatophenyl function. 
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Figure 2-6. 1H NMR (400 MHz, DMSO-d6) spectra showing the negative chemical shift of 
the protons in the pyrroles of the compound #2 (blue protons) and the compound #4 (red pro-
tons), at 25°C. 
The heavily shielded protons inside the macrocycle are shifted from -2.76ppm as seen in the 
mononitro and amino tetraphenylporphyrin to -2.86ppm in the trisulfonatophenylpoprhyrin. 
This observed change in the chemical shift was unexpected, because the introduction of three 
electron-withdrawing groups should render unshielded pyrrole protons, with a downfield 
shift in the resonances (see Figure 2-6). 
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2.4.4 Synthesis of 5-(4-maleimide)-10, 15, 20 tris (4 - sul-
fonatophenyl) – porphyrin, tetrabutylammonium salt 
(Compound #5) 
Synthesis of compound #5 was carried out in two consecutive steps: A) reaction with 
maleic anhydride to produce maleic amide derivative (open ring), B) closure of ring to pro-
duce the maleimide function, compound #5 (Scheme 2-14). 
 
 
Scheme 2-14. Synthesis in two steps of the compound #5. A) Reaction with the maleic anhydride 
to produce the maleic amide (open ring); B) closure of the ring to produce the maleimide deriva-
tive in the presence of acetic anhydride and sodium bicarbonate (closure of the ring). TBA state 
for tetrabutylammonium. 
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Figure 2-7. 1H NMR (400 MHz, DMSO-d6) spectrum of mixture reaction after the conver-
sion of the sodium for the tetrabutylammonium bromide salt, at 25°C. 
To accomplish step A, compound #4 needed to be soluble in organic solvent, but the 
sodium salt form of compound #4 is only soluble in aqueous media. Therefore, the reaction 
involved initially the conversion of the trisodium salt form into the tetrabutylammonium salt 
by several washes with dichloromethane containing the tetrabutylammonium bromide. This 
is a common method to change polarity of porphyrin salts149. The procedure is rather quick, 
as soon as the conversion takes place compound #4 started to be solubilized in the organic 
phase, which was evident due to the transfer of the deep green color from the aqueous to the 
organic phase. The yield of the conversion was 93.3%. The conversion was followed by 1H-
NMR (Figure 2-7). 
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Evaporation of dichloromethane under vacuum yielded the tetrabutylammonium salt 
as an oily brown product. This product was dissolved in dry solvent to avoid its reactivity 
with traces of water. 
The reason being was that the closure of the ring is a dehydration reaction that will 
not proceed if traces of water are present in the media. In fact, we found that the reaction 
needed to be repeated several times because the automated drying solvent system of the de-
partment was not working properly and there were traces of water in the acetonitrile. This 
required a further step whereby we re-distilled the acetonitrile using calcium hydride as the 
drying agent. After stopping the reaction, we performed the analysis of the crude product by 
nuclear magnetic resonance. 
The 1H-NMR spectrum of the crude product showed 30 protons in the aromatic region 
(Figure 2-8). The spectrum showed a singlet at 10.92ppm that corresponds to proton i in the 
carboxylic group with an integral of one. A doublet at 6.72 ppm represents the protons g/h.  
These signals were very important because they can be used to ascertain that the reac-
tion had progressed successfully. Compared with the NMR spectrum of compound #4 (see 
Figure 2-7) it was clear that appearance of these two doublets were new, because in the re-
gion around 6.5 ppm in compound #4 there are no signals. The next doublet at 6.45 ppm with 
an integral value of one corresponds to proton g/h on the maleic amide. These two doublets 
were found at the position expected for olefin protons, and had the expected multiplicity and 
integral value. A singlet at 5.77 ppm with an integral value of 0.32 we suggest corresponds to 
proton j of the amide nitrogen. Moreover, we observed in the spectrum one signal at 6.27 
ppm with an integral value of two that could belong to the maleic anhydride that is in excess 
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Figure 2-8. 1H NMR (400 MHz, DMSO-d6) spectrum of the maleic amide (open ring), tet-
rabutylammonium salt (Compound #4*) at 25°C. The TBA state for tetrabutylammonium 
group. 
in the reaction mixture. No 1H-NMR spectrum has previously been published for this 
compound, since in the original protocol they did not isolate it150. 
 
The next step was the condensation reaction to produce the ring yield the maleimide 
derivative (see Scheme 2-14 B). The reaction is usually carried out in a mixture of acetic an-
hydride and sodium bicarbonate with the removal of the acetic anhydride under alkaline con-
ditions150. The product was obtained in the form of tetrabutylammonium salt with 24% yield. 
As we needed the product to be water soluble, we performed ionic exchange chromatography 
to replace the tetrabutylammonium cation for sodium151 (see Experimental Section 2.5.2.5). 
The product was characterized by resonance magnetic spectroscopy and mass spectropho-
tometry (see Figures 6-1, 2 and 3 in Appendix). 
The 1H-NMR spectrum showed in the aromatic region a total of 28 protons (Figure 2-
9). From the analysis of the spectrum, it was clear that the doublets g/h are no longer present 
(see Figure 2-8). The singlet at 7.36 ppm with an integral of two was assigned to the protons 
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Figure 2-9. 1H NMR (400 MHz, DMSO-d6) spectrum of the maleimide tetrabutylammonium 
salt (close ring), (Compound #5) at 25°C. TBA; tetrabutylammonium cation.  
 
g, which corresponded to the maleimide protons. Of note, the resonances of the maleimides 
attached to aromatic systems are located around 7.00 ppm150. Compound #5 is a molecule 
that possess one plane of symmetry, which means that protons in the same environment or 
equivalent appeared at the same chemical shift, as is the case.  
To ascertain whether we removed the tetrabutylammonium cation entirely we ana-
lyzed by NMR compound #5 before and after the ion exchange chromatography. Comparison 
of the spectrum with another of tetrabutylammonium bromide in deuterated methanol re-
vealed that exchange was accomplished successfully (Figure 2-10 and 2-11). Of note, Dowex 
Marathon proved to be efficient only when was used fresh. However, we did try the ex-
change using a regenerated resin that we obtained by doing three washes with hydrochloric 
acid (0.1 M) followed by deionized water, then sodium hydroxide (0.1 M) followed by de-
ionized water. The result clearly demonstrated that use of new resin provides a better out-
come with a 90% yield. 
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Figure 2-10. 1H NMR (400 MHz, MeOD) spectrum of the tetrabutylammonium bromide at 
25 °C. 
Figure 2-11. 1H NMR spectra at 25 °C (400 MHz, DMSO-d6) of Compound #5 after (A) and 
before (B) the ionic exchange chromatography. Circled in red are the signals corresponding 
to the tetrabutylammonium cation. 
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2.4.5 Summary  
We have successfully achieved the synthesis of the 5-(4-maleimide)-10, 15, 20 tris (4 
- sulfonatophenyl) – porphyrin, trisodium salt) (Compound #5). The analysis by mass spec-
trophotometry and proton nuclear magnetic resonance (see appendix) showed the compound 
#5 was obtained with 90% yield. The reaction protocol was improved in several aspects 
compared to the original method. For example, the rise in the temperature in the nitration of 
the porphyrin sped up the reaction from 120 min to 25 min. In addition, the introduction of 
the isocratic elution with a mixture of petroleum ether, ethylacetate, and methanol (97:2:1) 
considerably improved the separation of side products and the yield of mononitro-porphyrin. 
Moreover, during the processing of the sulfonation reaction to isolate the porphyrin lots of 
sodium sulfate was generated. The solubilization of the porphyrin in methanol and the intro-
duction of a centrifugation step proved very helpful, as sodium sulfate was very difficult to 
remove and time consuming when we followed the initial protocol. To remove the tetrabu-
tylammonium cation an ionic exchange chromatography was performed using a Dowex Mar-
athon resin with 90% yield151. 
 
 
 
 
 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
91 
 
2.5 EXPERIMENTAL SECTION 
2.5.1 Solvents and Reagents 
The chloroform (Fisher) for the synthesis was used without any previous treatment. 
For the liquid chromatography petroleum ether, ethyl acetate, and methanol (Fisher) were 
used with analytical grade purity and without further treatment. The acetonitrile (Fisher) for 
the synthesis of the compound #5 was refluxed with calcium hydride for 2 hours to remove 
water. Then the dry acetonitrile was distilled to separate it from the by-products of the reflux 
reaction, and was kept in a dark glass sealed bottle. The acetic anhydride (Alfa Aesar) for the 
synthesis was used without any further treatment as well as the dichloromethane (Fisher) for 
the synthesis. Deionized water was obtained from water purifier purelab option (ELGA). 
Nitric acid (69%, BDH), sulfuric acid (98%, BDH), hydrochloric acid (35%, BDH), 
ethanol, and inorganic salts used for the synthesis were of analytical grade purity. For the 
synthesis of compound #2 we used tetraphenylporphyrin (TPP) (> 99%, Merck). For the syn-
thesis of compound #5 we employed tetrabutylammonium bromide (TBA) (> 98%, Merck), 
and maleic anhydride (> 99%, Merck). 
The deuterated solvents for the 1H-NMR analysis were deuterium oxide (D2O) (iso-
topic purity 99.9%, Merck), deuterochloroform (CD3Cl) (99.96 %, Merck), dimethyl sulfox-
ide, (d6-DMSO) from Eurisotop.  
All the reactions were performed under nitrogen atmosphere and with permanent stir-
ring unless otherwise stated.  
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2.5.2 Synthesis, purification and characterization of the 
porphyrins. 
2.5.2.1 Synthesis of the of 5-(4-Nitrophenyl)-10, 15, 20 triphenylporphyrin (Com-
pound #2) 
Tetraphenylporphyrin (1.0 g, 1.63 mmol) was dissolved in 80 mL of chloroform. Ni-
tric acid (11.2 g, 178 mmol, sp gr = 1.4 g/cm3) was added to the stirred solution of porphyrin 
and the mixture was heated at 60°C for 25 minutes. The reaction was monitored at intervals 
by TLC to insure total conversion of starting material (Rf = 0.83) to product (Rf = 0.6) by 
using petroleum ether, ethyl acetate, methanol (97:2:1) in pre-coated aluminum-backed silica 
gel plates. When dinitro-porphyrin derivatives were detected the (Rf = 0.26) the reaction was 
stopped and cooled down. The dark green solution was extracted with 3 x 120 mL portions of 
a saturated solution of sodium carbonate and brine. The addition of this basic solution chang-
es the color of the mixture from dark green to purple. The organic layer was extracted and 
dried over magnesium sulfate and filtered. The chloroform was removed under reduced pres-
sure to obtain purple sparkle crystals. The solid was suspended in 5 ml of chloroform and 
loaded into the silica column (50 cm x 4 cm). Fractions containing only the mononitro deriv-
ative (compound #2) were combined, giving mono (nitropheny1) triphenylporphyrin in 66% 
yield (0.7 g, 1.07 mmol): 1H NMR (400 MHz, CDCl3) 8.81 (2H, d, J = 4.80 Hz, β-pyrrole), 
8.79 (4H, s, β-pyrrole), 8.67 (2H, d, J = 5.00 Hz, β-prrrole), 8.56 (2H, d, J = 8.72 Hz, nitro-
phenyl), 8.33 (2H, d, J = 8.59 Hz, nitrophenyl), 8.27-8.18 (6H, m, ortho triphenyl), 7.89-7.70 
(9H, m, meta/para phenyl), -2.76 (2H, s, NH of pyrrole). 
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2.5.2.2 Synthesis of 5-(4-Aminophenyl)-10, 15, 20 triphenylporphyrin (Compound 
#3)  
The (nitrophenyl)-triphenylporphyrin (220 mg, 0.334 mmol) was dissolved in 20 mL 
of concentrated hydrogen chloride. Tin (II) chloride dehydrate (0.630 g, 3.34 mmol) was 
added to the solution and the reaction was heated for three hours at 80°C. The reaction was 
cooled down and mixed with dichloromethane (50.0 mL), which solubilized the product and 
produced two phases. The green suspension was washed with 1 M sodium hydroxide (4 x 
50.0 mL), which transformed the porphyrin solution to purple. The dichloromethane was 
separated and dried over magnesium sulfate, filtered and evaporated under reduced pressure 
to produce the desired (aminophenyl)-triphenylporphyrin (250 mg, 0.40 mmol) which was 
obtained in a 72% yield. 1H NMR (400 MHz, d6-DMSO) 8.97 (2H, d, J = 4.50 Hz, β-
pyrrole), 8.86 (6H, s, β-pyrrole), 8.29-8.21 (6H, m, ortho triphenyl), 8.03 (2H, d, J = 8.00 Hz, 
4-aminophenyl), 7.84-7.72 (9H, m, meta/para triphenyl), 7.10 (2H, d, J = 8.10 Hz, 4-
aminophenyl), 4.06 (2H, br s, amino), -2.72 (2H, s, NH of pyrrole). 
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2.5.2.3 Synthesis of 5-(4-Aminophenyl)-10, 15, 20 tris (4 - sulfonatophenyl) – porphy-
rin, Trisodium Salt (Compound #4) 
(Aminophenyl)-triphenylporphyrin (250 mg, 0.40 mmol) was dissolved in 54 mL of 
concentrated sulfuric acid (98%, BDH, reagent grade) and heated at 75°C with stirring under 
nitrogen atmosphere for five days. The dark green solution was cooled down and neutralized 
with a saturated solution of sodium carbonate in an ice bath. The deprotonation of the mix-
ture was established when the solution turned purple. Methanol was added then to the mix-
ture to induce the precipitation of the sodium sulfate salt. The salt was vacuum filtered, and 
the remaining fine salt was centrifuged at 4000 rpm for twenty five minutes. The solution 
was then filtered, and evaporated under reduced pressure to give the green-brown desired tri-
sulfonate-triphenylpoprhyrin (320 mg, 0.35 mmol) with a yield 86%. 1H NMR (400 MHz, 
d6-DMSO) 8.95 (2H, d, J = 4.14 Hz, β-pyrrole), 8.84 (6H, s, β-pyrrole), 8.18 (6H, d, J = 7.98 
Hz, 4-sulfonatephenyl), 8.05 (6H, d, J = 7.98 Hz, 4-sulfonatephenyl), 7.89 (2H, d, J = 7.98 
Hz, 4-aminophenyl), 7.03 (2H, d, J = 8.28 Hz, 4-aminophenyl). 
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2.5.2.4 Synthesis of 5-(4-maleimide)-10, 15, 20 tris (4 - sulfonatophenyl) – porphyrin, 
tetrabutylammonium salt (Compound #5) 
5-(4-Aminophenyl)-10, 15, 20 tris (4 - sulfonatophenyl) – porphyrin, trisodium Salt 
(Compound #4) (320 mg, 0.35 mmol) was dissolved in 15 mL of deionized water and 
washed (3 x 20 mL) of a solution of dichloromethane containing tetrabutylammonium bro-
mide (690 mg, 2.2 mmol). The organic fractions were collected and pooled together. The 
green color confirmed the presence of the porphyrinate. The dichloromethane was evaporated 
under reduced pressure to produce a brown oily product. The oily product was dissolved in 
10 mL of dry acetonitrile and maleic anhydride (89 mg, 0.9 mmol) was added to the mixture, 
and the reaction was then refluxed for five hours. The reaction was cooled down and the sol-
vent was rota-evaporated. The crude was then re-dissolved in 2 mL of acetic anhydride (Alfa 
Aesar, reagent grade), and sodium bicarbonate (76 mg, 0.9 mmol) was added to the mixture. 
The reaction was heated at 80°C for one and a half hour. Then the mixture was cooled down 
and dissolved in 50 mL of chloroform; the organic phase was washed (3 x 50 mL) with de-
ionized water. The chloroform was dried over magnesium sulfate anhydrous, filtered and re-
moved under reduced pressure to produce the desired product (190 mg, 0.11 mmol) with 
25% yield. 1H-NMR (400 MHz, d6-DMSO) 8.93 (brs, 4H), 8.82 (brs, 4H), 8.31 (m, 8H), 8.22 
(d, J=8.1 Hz, 6H), 7.78 (d, J=8.4 Hz, 2H), 7.02 (s, 2H), 3.30 (m, 24H), 1.68 (m, 24H), 1.45 
(m, 24H), 1.04 (t, J=7.6 Hz, 36H). MS (positive) calculated. 949.1 [M+H]+, found 950.2. 
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2.5.2.5 Ionic exchange of tetrabutylammonium cation for sodium in the compound #5 
A Luer Lock, non-jacketed (1.5 cm × 30 cm) column was packed with 40-60 g of dry 
Dowex previously left in water for 1 hour. The stationary phase was washed with deionized 
water three times with the column volume (56 mL). The tetrabutylammonium salt of com-
pound #5 (190 mg, 0.11 mmol), was dissolved in 6 mL of deionized water and loaded into 
the column. The elution of the compound 5 is very fast, less than 2 min. The fractions con-
taining the colored compound 5 were pooled together and freeze/dried to render a brown cot-
tony product (110 mg, 0.10 mmol) with a 90% of yield. 
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2.5.3 Chromatographic techniques 
The thin layer chromatography was performed on coated aluminum-backed silica gel 
60, layer thickness 200 µm, particle size of 10-12 µm, with two inorganic fluorescent indica-
tors for UV detection of colorless substances (F254, Merck) 
Column chromatography was performed with silica gel for flash chromatography 
from VWR, SiO2 (60 A CC, 40-60 µm, 230-240 mesh, SDS). For the ionic exchange chro-
matography the matrix used was Dowex Marathon C sodium form, 20-50 mesh (Merck). The 
UV monitoring of TLC was performed with UVGL-58 handheld UV lamp (UVP) with visu-
alization under UV light (λ = 254 nm). 
2.5.4 Instruments 
Proton Nuclear Magnetic Resonance (1H-NMR): The 1H-NMR was performed on 
the departmental Nuclear Magnetic Resonance (NMR) service. The spectra were recorded on 
the Bruker 400 MHz spectrometers (Avance and Avance III). The description of the peaks is 
as follows: singlet (s), doublet (d), triplet (t), multiplet (m), broad (br). The coupling con-
stants are reported in hertz (Hz), the chemical shift (δ) in parts per million (ppm). 
Mass Spectrometry: Mass spectrometry was performed using an Agilent LC-MS, 
comprising an 1100 Series LC and SL Ion Trap MSD, located in the analytical service of 
SBCS.  
Rotary evaporator: The removal of the solvents under reduced pressure was per-
formed with a Hei-VAP Model rota-evaporator. The instruments include an integrated vacu-
um control, and a temperature accurate bath set on 40°C.  
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Freeze Dryer: The freeze/drying of the samples was performed with a Labconco 
Freezone Freeze Dry System.  
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In this chapter, we will determine the chemical conditions to perform and to follow 
up to completion the labeling of the hydrophobic peptide in the membrane of liposomes 
(Figure 3-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-1. Graphic depiction of the steps involved in the labelling of the full-length 
transmembrane peptide. A) Solubilization of the peptide through insertion in the lipid 
bilayers. B) Addition of the maleimide –derivative and reaction with the external nu-
cleophilic groups. C) Equilibrium established between the dispersed and the clustered 
forms of the peptide in the lipid vesicles. Peptide sequence: Ac-
CWQDKNDVLQLQFTITSAYYTYLLLLLKSVIYLAIISFSLLRRTSVC-NH 
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Due to lack of information regarding the conditions to perform the labelling of the 
hydrophobic peptide in lipid membranes, and taking into consideration the starting material 
is limited and expensive, we decided to start our study by using model thiols like N-
acetylcysteine, γ-glutathione, and 1-hexadecanothiol. These model thiols contain the same 
nucleophilic group as our hydrophobic peptide which can be used to follow up their reactivi-
ty with 5-(4-maleimide)-10, 15, 20 tris (4 - sulfonatophenyl)–porphyrin (compound #5), 
which is our clustering reporter (Scheme 3-1). Another desirable feature of these model thiols 
is that are easy to manipulate in the laboratory and less expensive. 
 
 
 
 
 
 
Scheme 3-1. Reaction of the compound #5 with a generic thiol to render the addition of the thiolate 
to the double bond of the maleimide with the formation of the thioether bond. R1: alkyl, aryl sub-
stituent. 
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3.1 OBJECTIVE 
The objective of this chapter is to study the chemical properties of the compound 5-
(4-maleimide-phenyl)-10, 15, 20-tris (4-sulfonatophenyl) porphyrin in terms of reactivity to-
wards model thiols, that have the same nucleophilic group as the hydrophobic peptide and 
are smaller in size, easier to manipulate, and less expensive. In order to achieve the labeling 
of the porphyrin-maleimide derivative we need to meet some requirements: 
1. The sulfhydryl group (SH) on the model thiols needs to be in the reduced state 
to be able to react as a nucleophile. 
2. The maleimide group in the porphyrin derivative needs to be stable under the 
conditions used to perform the labelling reaction. 
3. We need to be able to follow up and quantify the reaction between the porphy-
rin derivative and the model thiols. 
4. We need to determine to what extent the presence of lipids can affect the 
chemistry of the labelling reaction since the goal is to label the hydrophobic 
peptide solubilized in the membrane of the liposomes. 
In this chapter, we will describe the experiments done to address the points 1 to 3. 
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3.2  INTRODUCTION  
3.2.1 Thiol detection 
3.2.1.1 Ellman’s reagent (Aromatic disulfide) 
The chromogenic compound 5,5’-dithiobis-(2-nitrobenzoic acid) (DTNB) is the most 
employed reagent in the stoichiometrically quantification of thiols152. The reagent has a di-
sulfide bond that is highly oxidizing, that react with free thiolates present in solution to yield 
a yellow anion 5-thio-2-nitrobenzoic acid (TNB)153 (Scheme 3-2). The TNB anion is a very 
good leaving group because the electronegative nitro group and the conjugated aromatic sys-
tem help to stabilize the thiolate anion; the pKa value of the thiol is 4.5153. DTNB reacts irre-
versibly to produce one TNB anion per thiol oxidized. In this reaction, the absorbance of the 
TNB anion can be used as an indirect measure of the number of reacted sulfhydryl groups154. 
While DTNB absorbs weakly at 412nm, the TNB anion absorbs with an extinction coeffi-
cient (ε) equal to 14,150 M-1cm-1 at pH 7.2153. The TNB absorption is very sensitive to 
changes in the ionic strength or the pH. The molar extinction coefficient is stable from pH 6 
to pH 9.5. However, over pH 7, the DTNB is sensitive to hydrolysis, so special attention 
must be taken. Of note, under pH 6, TNB becomes protonated which highly affects the ab-
sorption of light155. In addition, alkylating agents can react with TNB suppressing the absorp-
tion; this property, for instance, has been used to determine the concentration of such rea-
gents in solution156. 
DTNB is an excellent reagent for the quantification of small thiols, and is particularly 
useful in determination of thiol concentration in stock solutions, such as N-acetylcysteine, 
glutathione, phosphines, L-cysteine ethyl ester, and dithiothreitol157. For example, when us-
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Scheme 3-2. Reaction of DTNB with free thiol to form stoichio-
metrically the colored anion TNB. R1: alkyl, aryl substituent 
ing a high molar excess of Ellman’s reagent in a buffer solution at pH around 7.3 the reaction 
is complete in approximately one minute.  
One of the disadvantages of the DTNB is the limited sensitivity of the reagent to the 
nanomolar scale, which means that detection of thiols in very diluted protein solutions could 
be problematic156. However, detection in the micromolar scale is achievable, and since we 
will use at least 10 µM of the hydrophobic peptide, the use of DTNB for the quantification of 
free thiol in our peptide will be feasible. 
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Thiols in aqueous solution can suffer oxidation to yield the disulfide158. This species 
is unable to act as a nucleophile, hence, cannot be used in the labeling reaction. To overcome 
this difficulty, there are two alternatives: 
1. Prepare the peptide solution stock in a reduced atmosphere. 
2. Add a reducing agent to the peptide solution before the labelling reaction. 
The first option requires the use of costly equipment i.e. hypoxic chamber; necessity 
of specialized training, and is time consuming. The alternative, instead, is more feasible in 
the lab, and it is widely described in the literature. Notwithstanding, to be able to employ 
these reagents we have to make sure they are compatible with maleimide chemistry. In addi-
tion, we might need to test the ability of these compounds to permeabilize the lipid bilayer, as 
we may not want to generate a reduced atmosphere inside the liposomes. 
In the next paragraph, we will summarize the main characteristics of maleimide 
chemistry described in the literature. In the results and discussion section, we will show the 
experiments we performed towards the identification of conditions to achieve the labeling 
reaction of model thiols with compound #5 in the presence of these reducing agents.  
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3.2.2 Maleimides 
The maleimides are exceptionally good reagents for the selective modification, quan-
titation and analysis of compounds that contain free thiols (Scheme 3-3). 
 
The chemistry of maleimides is well known nowadays. They selectively react with 
sulfhydryl groups, in the so called “click reaction” in aqueous media at a pH near neutrality 
to form a stable thioether, following a Michael addition mechanism159 . The thiolate anion is 
a reactive nucleophile that attacks the α, β- unsaturated carbon of the maleimide to produce a 
new thioether (S-C) bond. The rate of reaction is closely dependent on the thiol deprotona-
tion, thus on the pH of the reaction. In addition, the stability of maleimide is dependent on 
the pH. Some studies with the N-ethylmaleimide (NEM)159-161 showed that this compound 
was stable at pH < 6, whereas at pH = 7 the half-life was approximately 45hrs and at pH > 
9.0 was less than 1hr. The instability of maleimide is due to hydrolysis of the ring at basic pH 
leading to formation of maleamic acid and the concomitant loss of reactivity143, 162. Some thi-
ol adduct maleimides e.g. N-acetylcysteine-N-ethylmaleimide, can suffer intramolecular 
transamidation at pH values above 9144.A recent study by Baldwin et al.163 described that 
succinimides-aromatic thiols can suffer retro Michael-type addition reaction under conditions 
Scheme 3-3. Reaction of a maleimide with a thiol. R2: alkyl, aryl sub-
stituent. 
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of high reduction potential, and are easily cleaved by exogenous thiols like glutathione. 
Moreover, Beutler et al.164 observed slow regeneration of thiol in adducts of glutathione and 
N-ethylmaleimide between pH 7 and 9 (Scheme 3-4). 
 
 
Despite these reports in the chemistry of maleimides, they are still one of the best al-
kylating reagents compared with others, such as as iodoacetic (IAA) and iodoacetamide 
(IAM). For example at pH = 7 the alkylation rate of some thiols like TNB with NEM are 85 
and 20-fold faster than with IAA and IAM, respectively156. The superior reactivity of malei-
mides has been studied in alkylation of protein thiols165-168. Keillor et al.161 showed that N-
arylmaleimides at neutral pH are stable enough to undergo conjugation reaction, because ad-
dition of the thiol is faster than hydrolysis of the maleimide ring. Of note, maleimides are 
small, uncharged molecules that can react with thiols even in hydrophobic environment. 
Scheme 3-4. Common reactions involving maleimides. (A) Alkaline hydroly-
sis of maleimides. (B) Hydrolysis of the adduct glutathione with maleimide 
to render the free thiol. (C) Transamidation reaction involving the adduct of 
cysteine and N-ethylmaleimide. 
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Scheme 3-5. Reaction of NEM with NAC to form the thiol-maleimide adduct. 
3.2.3 Model thiols for this study 
The model thiols used in our experiments were N-acetylcysteine and glutathione as 
examples of hydrophilic thiols and 1-hexadecanothiol as hydrophobic. 
3.2.3.1 N-acetylcysteine (NAC) 
N-acetylcysteine (Scheme 3-5) is a cysteine derivative thiol of biological importance, 
e.g. has being used largely as a therapeutic drug against toxic overdoses of acetaminophen169. 
It is a small molecule, economically accessible, with a pKa = 9.52, very close to the pKa of 
many protein thiols170. Reaction of NAC with bis-maleimides has been studied in the context 
of the synthesis of low molecular weight hydrogelators150. 
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3.2.3.2 γ-Glutathione (Glu) 
Glutathione is a cysteine containing tripeptide (Scheme 3-6) formed by γ-L-glutamyl-
L-cystenyl-glycine that plays a very important role in the intracellular redox state of the 
cells171. The reason why we chose this molecule in our experiments was because it is slightly 
longer than the NAC, and chemically closer to the peptide that we intend to use in this study. 
In addition, the adduct of glutathione and compound #5 might be easier to separate by HPLC 
than the adduct of the compound #5 and the NAC (see Results). 
Interest on the glutathione as model thiol is based on its reactivity towards malei-
mides which is based on the presence of a cysteine with a pKa = 9.63 similar to that showed 
by NAC172. Formation of the adduct when combined with NEM at pH 7,2 is completed in 
less than 5 min164. The mechanism of the reaction is the Michael addition.  
 
 
 
 
 
 
Scheme 3-6. Reaction of NEM with GSH to form the thiol-maleimide adduct. 
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3.2.3.3 1-Hexadecanethiol (1-Hex) 
1-Hexadecanethiol is a hydrophobic thiol with global formula CH3(CH2)14CH2SH 
that we used in our experiments in order to study the reaction between the compound #5 and 
a hydrophobic thiol, similar to the peptide (Scheme 3-7).  
 
 
 
 
 
 
 
  
 
The aim of this experiment was to elucidate the conditions to carry out the reaction 
between the hydrophobic thiol and compound #5 in the presence of liposomes. The reaction 
was followed up by UV-vis spectroscopy and HPLC. This experiment might provide some 
preliminary data before the approach to the reaction with the hydrophobic full-length trans-
membrane peptide. However, we found several problems working with this hydrophobic thi-
ol: first, it was very difficult to handle and to solubilize it in aqueous solutions; second, the 
amount of reduced thiol was considerably low, which made the reaction with maleimides 
very difficult as mentioned before (see Results and Discussion). 
 
 
Scheme 3-7. Reaction of 1-hexadecanethiol with compound #5 to form the thiol-
maleimide adduct. 
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3.2.4 Reducing agents  
The experiments to check the status of the reduced thiol in the model compounds and 
the control peptide (see Results and Discussion) showed that a fraction of the thiol had been 
oxidized to disulfide. This phenomenon is a typical reaction of thiols present in peptides and 
proteins, in fact, many of the labelling reactions that involved biological thiol as reagents 
need to be carried out in the presence of reducing agents. Therefore, to achieve successfully 
the labelling of compound #5 we must first accomplish the reduction of the thiols present in 
the peptides173. There are a few methodologies reported in the literature to achieve complete 
labeling of maleimide-containing reactants with reducing agents: 
1. The reducing agents are removed prior to the addition of the maleimide-
containing reactant via column chromatography56. 
2. The thiol and the reducing agent are added first, then the maleimide reactant is 
added in 10-fold excess to be later on separated by column chromatog-
raphy174. 
3. There are some procedures described in the literature in which the labeling is 
compatible with the presence of some reducing agents like phosphines56. 
In the next section, we will summarize the benefits and disadvantages of the reducing 
agents that we decided to use in this study for the labeling of the compound #5 with the mod-
el thiols. 
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3.2.4.1 Thiol-based reductants 
Some of the most common reducing agents found in the literature are themselves thi-
ols. In particular, dithiothreitol (DTT) and mercaptoethanol (ME) (Scheme 3-8) are two of 
the most common reagents used for reduction of biological disulfides. 
 
One of the advantages of this type of reductant is the high degree of specificity they 
show against disulfides175 with little reactivity towards other functional groups in proteins or 
peptides. Moreover, due to these reagents being soluble in water we could use them to per-
form our labelling reaction in phosphate buffer. However, the main disadvantage of these 
thiol-containing reductants is that they will compete with the thiol present in the peptide for 
the thiol reactive reagent i.e. maleimides or iodoacetamide derivatives156. To overcome this, 
the most common methodology is to separate the DTT from the proteins or peptides prior to 
the addition of the maleimide reagent by column chromatography or reverse phase chroma-
tography56, 167, 168. An alternative procedure could be to add an excess of the maleimides rea-
gent to alkylate all the thiols present in solution and then use HPLC to separate the labeled 
Scheme 3-8. Reduction of disulfides. A) β-mercaptoethanol (β-ME), B) dithiothreitol (DTT). 
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compound from the side products174. However, the best option for us would be to use a re-
ducing agent that would be compatible with the labeling reaction, because in this way we 
could avoid any extra purification step or wastage of compound #5, which is hard to produce. 
Another problem associated with the use of these reagents is that they can easily cross the 
lipid membrane generating a reduced environment in both the inner and outer membrane 
compartments, i.e. inside and outside of the liposomes156, 176, 177 as illustrated in Figure 3-2. 
The ability of DTT and ME to permeabilize the lipid membrane represents a problem in our 
study because we want to mimic as close as possible the natural arrangement of the trans-
membrane peptide in the biological membrane. In this regard, the TCR receptor complex is 
stabilized by the presence of extracellular disulfide bonds between cysteine residues present 
in the short sequence immediately after the transmembrane peptide region of both TCRγ and 
TCRδ chains. Thus, in the design of our peptide, we have kept carefully this cysteine in order 
to allow formation of this disulfide bond and the concomitant stabilization of the transmem-
brane peptide clusters. Phosphines are reducing agents that seem a good alternative to over-
come this problem because they are highly polar compounds that do not permeate mem-
branes, thus keeping the reduced environment restricted to the outer space of the lipid vesi-
cles156, 177. 
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Figure 3-2. Illustration of the ability of the reducing agents used in this study to cross the bi-
layer and the effect on the clustering of the full-length transmembrane peptides. A) TCEP is 
restricted to the outer space. B) DTT can permeate the membrane of the liposomes, reducing the 
disulfide bonds that could stabilize the clusters of peptides. 
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3.2.4.2 Phosphines 
Trialkylphosphines, and especially Tris-2-carboxyethylphosphine (TCEP), reduce di-
sulfides to free thiols. In the first step, phosphine is the nucleophile that attacks the disulfide 
bond to form a phosphonium salt (limiting step) and liberate the first thiol. The second step is 
rapid hydrolysis to produce the second thiol and phosphine oxide (Scheme 3-9). Oxidation of 
phosphine is irreversible; hence, it is not able to further participate in another reduction reac-
tion. Phosphines, like thiol-containing reductants, are highly specific reducing disulfides with 
little reactivity towards other groups present in peptides178. In addition, TCEP is soluble in 
water, and negatively charged which makes its permeation through hydrophobic lipid mem-
branes difficult177. It is also very efficient, reducing low molecular weight thiols and disul-
fides exposed in the surface of proteins156, and a much more potent reductant than dithio-
threitol at pH < 8 due to the pKa of the phosphine being 7.6, and is also more stable at pH 
values higher than 7.5157. Some published protocols suggest that TCEP is compatible with 
maleimide-thiol chemistry159, 179-181. A recent article by Bowman et al. described the role of 
phosphines as catalysts in nucleophilic thiol-Michael addition reactions182. 
Scheme 3-9. General mechanism proposed for the reduction of disulfides by trial-
kylphosphines. 
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3.2.4.2.1  Sodium dithionite 
Dithionite has been extensively used for the reduction of disulfides in proteins and 
peptides.183, 184 The reaction must be carried out in basic solution to avoid decomposition by 
hydrolysis of dithionite ion in acid solutions185. The reactions can be carried out in water but 
sodium bicarbonate must be added to keep the solution basic thus avoiding the decomposi-
tion of the reagent as mentioned before. The dithionite ion can dissociate to a radical ion, and 
in the equilibria both species can act as reducing agents186 (Scheme 3-10). Some reports have 
described that sodium dithionite can permeate biological membranes187. However, there is 
not much literature available describing the reaction of sodium dithionite in the reduction of 
disulfides183, 188. 
 
 
 
 
 
 
 
 
 
Scheme 3-10. Dissociation of the sodium 
dithionite anion. 
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3.3 RESULTS AND DISCUSSION 
3.3.1 Quantification of free thiol in NAC with DTNB test. 
The aim of this experiment was to determine the minimum amount of reduced N-
acetylcysteine that we could quantify with the DTNB reagent. To achieve this, we prepared a 
stock solution of 2.5 µM of the model thiol NAC. Since the concentration of the hydrophobic 
peptide in our experiment will be 10 µM, this concentration would be appropriate to demon-
strate the effectiveness of the DTNB in measuring the amount of free thiols in the micromo-
lar scale. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-3. DTNB reaction to quantify the concentration of 
free thiol in a solution of 2.5 µM of NAC. The inset shows 
the changes in the absorbance at 412 nm. The reaction reach 
completion after 2 min. 
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Figure 3-3 shows the results obtained. The spectra of the reaction mixture between 
the DTNB (100 µM) and NAC (2.5 µM) in PB pH 7.2 were recorded at 0, 2, 10, 30, 60, 90 
minutes after addition of DTNB. The inset shows an enlargement in the range 400-420 (the 
TNB-2 species is known to show a maximum absorbance at 412 nm, see Section 3.2.1.1). 
From the inset graph, it is also possible to see the reaction took approximately 2 min to com-
plete (red line) and the stability of TNB-2 in solution started to decrease after 30 min. A 
graphic representation of absorbance at 412 nm versus time confirmed the reaction was com-
pleted at 2 min, noted by the location of Amax at this time point (Figure 3-4). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-4. Plot of absorbance (412 nm) versus time. The 
red start corresponds to the time point when the [TNB2-] is 
maximum therefore the reaction is completed. 
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 Quantification of the reduced NAC was performed with the Lambert-Beer law, based 
on the extinction coefficient of the TNB-2 species in PB pH 7.2, which was 14600 M-1cm-1 
(Table 3-1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Time (min) A412 Path cm ε M
-1cm-1 [SH] µM 
0 0.0342 1 14600 2.34 
2 0.0355 1   2.43 
10 0.0355 1   2.43 
30 0.0345 1   2.36 
60 0.0336 1   2.30 
90 0.0332 1   2.27 
Table 3-1. Quantification of the amount of free thiol in 
a solution of 2.5 µM NAC with the Lambert-Beer law. 
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3.3.2 Quantification of free thiol in peptide control with 
DTNB test. 
Prior to performing the reaction between compound #5 and the full-length transmem-
brane peptide, we decide to establish the chemistry with a surrogated peptide (control pep-
tide). The control peptide is an oligopeptide of 16 residues, Ac-CWQDKNDVLQLQFTIT-
NH2, which is actually contained in the full-length peptide. This control peptide contains one 
cysteine at the amino terminal end, which is the nucleophilic group. We used the tryptophan 
adjacent to that cysteine with the intention to use its fluorescence properties as an insertion 
reporter189. We might be able to follow the insertion and the orientation of the peptide in the 
lipid membrane by analyzing the changes in the fluorescence pattern of the tryptophan190. 
We quantified the fraction of reduced peptide in a fresh sample, prepared from the ly-
ophilized stock of the starting material kept at -20 oC. We also explored the rate of oxidation 
in aqueous solution with the DTNB test in a sample of 10 µM of peptide in PB pH 7.2 (Fig-
ure 3-5). This experiment is critical in order to define the conditions to perform the labeling 
reaction i.e. the necessity of a reducing agent. The results showed that at time point 0, 26% of 
the peptide control was already oxidized. 
 
 
 
 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
121 
 
 
 
 
 
 
 
 
 
 
 
The kinetics of the oxidation reaction was followed by UV-vis and the analysis of the 
traces showed that oxidation of the peptide progressed quickly from around 50% at 1 hr to 
62.6 % at 4 hrs (Table 3-2).  
Time (hr) A412 ε M-1cm-1 [SH] μM 
0 0.1079 14600 7.39 
1 0.0765   5.24 
2 0.0725   4.96 
3 0.0647   4.43 
4 0.0547   3.74 
 
 
Table 3-2. . Quantification of the fraction of 
reduced thiol in a solution of 10 µM of peptide 
control in PB (+ 3.3% DMSO).  
Figure 3-5. DTNB test to quantify the fraction of reduced 
peptide control and the rate of oxidation in a sample of 10 
µM peptide containing 3.3% DMSO in PB. UV-vis traces 
were recorded every hour in a 4 hours kinetic study. 
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In summary, this experiment demonstrated the necessity of using a reducing agent to 
keep the peptide in the reduced form before the labeling reaction with compound #5. This is 
especially important in reactions that require a long set up because the results showed that 
after 1 hour of incubation, half of the thiol in solution was already oxidized. 
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3.3.3 Quantification of free thiol in 1-Hexadecanethiol with 
DTNB test 
Here, we aimed to determine the fraction of non-oxidized thiol that was reduced in a 
solution of 10 μM of 1-hexadecanethiol in PB before the labeling reaction with compound 
#5. Additionally, we decided also to explore the conditions to perform the DTNB test with 
this hydrophobic thiol, which is similar to the full-length transmembrane peptide. Analysis of 
the data (Figure 3-6) (Table 3-3) showed that the reaction with DTNB was considerably 
slower when compared with NAC. Possibly, due to the hydrophobic nature of 1-
hexadecanethiol it tended to form micelles in aqueous solution. We suspect this might restrict 
the access of the DTNB reagent to the thiol group. The table also showed that after 180 
minutes around 14% of the thiol was oxidized to disulfide.  
 
Figure 3-6. DTNB test to quantify the fraction of reduced 1-
hexadecanethiol and the rate of oxidation in a sample of 10 
µM 1-Hex containing 3.3% DMSO in PB. UV-vis traces 
were recorded as indicated in the legend. 
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Time (min) A412 ε (M-1cm-1) pH 7.2 [1-Hex]μM 
0 0.0098 14600 0.7 
2 0.0232   1.6 
10 0.0403   2.8 
30 0.0767   5.3 
60 0.0966   6.6 
90 0.1050   7.2 
120 0.1098   7.5 
180 0.1172   8.0 
 
 
Figure 3-7 showed how after 120 min the reaction approximate to the plateau, which 
indicates that DTNB had reacted with all the reduced thiol available in solution. 
  
 
 
 
 
 
 
 
 
 
Table 3-3. Quantification of the amount of free thiol in a 
solution of 10 µM of 1-Hexadecanethiol. 
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Figure 3-7. Graphic representation of the absorbance at 412 
nm versus time in the reaction of the DTNB with the 1-
hexadecanethiol. The graph shows that after the 120 min the 
reaction reach the plateau. 
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In conclusion, the DTNB reaction with 1-Hexadecanothiol (1-Hex) is slower than the 
reaction with the peptide control, probably due to the hydrophobic nature of 1-Hex and the 
formation of aggregates in PB, although this is just speculation that needs to be further inves-
tigated. In the time period tested in this experiment, we could determine that after 180 
minutes ~14% of the thiol was oxidized. However, the oxidation rate of 1-Hex was slower 
when compared with the control peptide, which suggests the necessity to reduce the thiols in 
a previous step, before to proceed to the labelling reaction with compound #5. 
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3.3.4 Quantification of free thiol in the full-length peptide 
with DTNB test 
Similar to the experiment described in section 3.3.2, we decided to quantify the 
amount of reduced thiol and the rate of oxidation for the full-length transmembrane peptide. 
Briefly, the full-length transmembrane peptide is composed of 47 residues and contain two 
cysteines towards both ends of the peptide. A sample containing 10 μM of the full-length 
peptide and 3.3% DMSO was prepared in PB. The stock solution was freshly prepared in 
DMSO immediately before from a lyophilized stock of peptide kept at -20 oC. Figure 3-8 
shows the results obtained in the reaction with DTNB (100 μM) over a time period of 5 hrs. 
 
 
 
 
 
 
 
 
 
 
Figure 3-8. UV-vis spectra collected from the DTNB test to 
quantify the fraction of reduced full-length transmembrane pep-
tide control and the rate of oxidation in a sample of 10 µM pep-
tide containing 3.3% DMSO in PB. 
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The data from the kinetic study in Table 3-4 reveal that at time 0 approximately 32% 
of the full-length-peptide was already oxidized. In addition, and similar to the results ob-
served for the control peptide (Section 3.3.2) the rate of oxidation increased proportionally 
with time, hence, after 5 hrs of incubation approximately 66% of the peptide was oxidized. 
Time 
(hr) A412 
ε  
 M-1cm-1 
[SH] 
μM 
Percentage 
0 0.0985 14600 6.7 67.4 
1 0.0853   5.8 58.4 
2 0.0689   4.7 47.2 
3 0.0622   4.3 42.6 
4 0.0523   3.6 35.8 
5 0.0491   3.4 33.6 
 
 
It is important to mention that we found difficulties in solubilizing the full-length 
transmembrane peptide in solvents other than DMSO. To test the possibility that a fraction of 
the full-length peptide had precipitated in the actual sample prepared in PB, therefore altering 
the real thiol concentration, we decided to measure the peptide concentration by reading the 
absorbance at 280 nm (see Figure 6-5 in Appendix). The results showed the concentration of 
the peptide was approximately 10.1 μM immediately after the preparation of the sample. 
Moreover, we also observed that it was stable after 1 hour (9.8 μM) hence, demonstrating 
that the peptide did not precipitate in the sample. 
In summary, this experiment showed that to work with the full-length peptide it is 
necessary to add a reducing agent to ensure that all the thiol is reduced, in order to success-
fully achieve the labelling reaction with compound #5. 
Table 3-4.  Quantification of the amount of free thiol in 
a solution of 10 µM of the full-length transmembrane 
peptide. 
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3.3.5 Determination of the extinction coefficient (ε) of 
compound #5 in PB. 
We then decided to determine the extinction coefficient of compound #5 in phosphate 
buffer. Using a geometric dilution method (see Experimental Section) we performed a titra-
tion of compound #5 in 15 samples with increasing concentration of porphyrin. From the fit-
ting of the experimental data, i.e. absorbance at the maximum wavelength (413 nm) against 
the concentration of compound #5, it was possible to calculate the extinction coefficient in 
PB 100 mM pH 7.2 at RT based on the application of the Lambert-Beer Law (Figure 3-9). 
The fitting gave a value for the extinction coefficient of compound #5 in PB at RT equal to 
218200M-1cm-1. This value was used in all the following experiments. 
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A
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[#5] (mM)
Equation y = a + b*x
Intercept 0.04189 ± 0.0154
Slope 0.2182 ± 0.00457
Adj. R-Squar 0.99346
Figure 3-9. Lambert-Beer Law fit to determine the extinction 
coefficient, ε(M-1cm-1), of compound #5 at 413 nm. 
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3.3.6 Reaction of N-acetylcysteine with 5-(4-maleimide)-10, 
15, 20 tris (4 - sulfonatophenyl)–porphyrin (Com-
pound #5). 
Taking advantage of the optical properties of the porphyrin moiety, it was used in 
UV-vis spectroscopy experiments to follow the reaction with the model thiol N-
acetylcysteine (Scheme 3-11). 
Thanks to the high extinction coefficient of compound #5 (218200M-1cm-1) it was 
possible to follow the reaction with compound #5 in the low micromolar regions. 
In the experiment, NAC was added in 2000-fold excess compared to the compound 
#5 to force completion and the reaction was followed by recording the UV-vis spectra for 
100 minutes immediately after addition of NAC with 5 minute intervals between measure-
ments. Traces are shown in Figure 3-10. 
Scheme 3-11. Reaction of Compound #5 with NAC. Step 1: synthesis of the adduct maleimide-
NAC, Step 2: hydrolysis of the maleimide. 
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Spectra showed no major differences between them, and the position of the λmax was 
observed at 413 nm in each case. This result suggests that reaction of NAC and compound #5 
cannot be followed by UV-vis spectroscopy. We hypothesize the reason being is that NAC is 
a small molecule unlikely to produce a big impact in the absorbance of the porphyrin macro-
cycle. Moreover, its position is too far from the porphyrin moiety to generate any major per-
turbation in the electronic distribution of the macrocycle. Moreover, we think the hypo-
chromic effect observed in those traces recorded after the addition of NAC when compared 
with the trace of compound #5, might be due to a dilution effect. 
 
Figure 3-10. UV-vis traces from the reaction mixture of com-
pound #5 (10 µM) and NAC (20 mM) in PB. The traces were 
collected at 0, 30, and 90 minutes. 
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However, to rule out the possibility that compound #5 in the stock solution has suf-
fered hydrolysis and therefore became unable to react with the NAC, we collected an NMR 
spectrum of the stock solution to evaluate the integrity of the maleimide moiety (Figure 3-
11). 
 
The 1H-NMR spectrum shows a singlet at 7.12 ppm belonging to the maleimide (see 
Chapter 2). There are also two set of doublets at 6.71 and 6.43 ppm, which belong to protons 
g/h of the open ring (Scheme 3-12), respectively. From the integral ratios, we quantified the 
concentration of both species, hydrolyzed and non-hydrolyzed in the stock solution. The pre-
dominant species was the non-hydrolyzed maleimide (67.5 %), while the remaining 32.5% 
represented the hydrolyzed maleimide. 
 
 
Figure 3-11. 1H NMR spectrum (400 MHz, MeOD) of compound #5 stock solution at 25 °C 
in methanol. Circled in red the singlet belonging to the maleimide group, in blue, the two 
doublets showing some methanolysis of the maleimide function. 
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Based on the results we concluded that the reactive maleimide was the predominant 
form in the stock solution, hence, most likely the reaction with the NAC to produce the ad-
duct #5-NAC was successful, although we could not follow it by UV-vis spectroscopy. 
Scheme 3-12. Panel showing the chemical 
structure of the hydrolyzed compound #5. The 
proton g and h produce the doublets observed in 
the NMR spectra at 6.71 and 6.43 ppm, respec-
tively. 
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As mentioned before, due to subtle changes in the electronic configuration of the 
macrocycle between compound #5 and adduct 5-NAC, the reaction cannot be tracked by 
changes in the UV-vis spectra. Therefore, we decided to go further and explore whether the 
hydrolysis of the adduct might have yielded any changes in the molecule that could be trace-
able by UV-vis spectroscopy. To study this hypothesis, we left the mixture over a period of 
24 hours at room temperature to induce the hydrolysis of the maleimide. We recorded the 
UV-vis spectra over a 20 hour period with an interval of 1 hour between measurements (Fig-
ure 3-12).  
 
 
 
 
 
 
 
 
 
 
 
Figure 3-12. UV-vis traces of the compound #5  (10 µM), hy-
drolyzed compound #5, and the adduct compound #5 N-
acetylcysteine recorded in PB at 0, 10, and 19 hours after the 
beginning of the reaction. The inset graph illustrates the bath-
ochromic shift of the λmax of the Soret band.  
400 450 500 550 600 650 700
0.0
0.2
0.4
0.6
0.8
1.0
1.2
1.4
1.6
1.8
O
D
Wavelength (nm)
 0 hr
 10 hr
 19 hr
 5 Hydrol
 5 (10µM)
400 405 410 415 420 425 430
0.0
0.5
1.0
1.5
413 421
Chapter 3 
 
134 
 
Interestingly, the spectra showed a bathochromic shift in the λmax of the Soret band 
from 413 to 421 nm coupled with a hypochromic effect for the trace at time point 0 hr. By 
contrast, a visible hyperchromic effect was observed for the traces at 10 and 19 hrs. Presum-
ably, the changes in the intensity can be explained by aggregation of the porphyrin-adduct in 
the cuvette. In addition, aggregation might induce the participation of free monomer in solu-
tion which could explain why the intensity of the band at 413 nm also decreases with time. 
The formation of the aggregates could be followed by changes observed in the new Soret 
band at maximum of 421 nm. 
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3.3.7 Reaction of γ-Glutathione with 5-(4-maleimide)-10, 
15, 20 tris (4 - sulfonatophenyl) – porphyrin (Com-
pound #5). 
In order to test whether the addition of a longer thiol relative of NAC would produce 
significant changes in the UV-vis spectra of the adduct with compound #5, we decided to use 
a different model thiol: γ-glutathione (Scheme 3-13). The rationale behind this new approach 
was based on the fact that glutathione is a peptide, like the transmembrane segment that we 
will employ in our chemical model. However, glutathione is quite different in size and polari-
ty when compared to the hydrophobic peptide. 
Scheme 3-13. Reaction of Compound #5 with γ-glutathione. Step 1: synthesis of the adduct ma-
leimide- γ-glutathione, Step 2: adduct hydrolysis with opening of the maleimide ring. 
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To study the reaction with the γ-glutathione and compound #5, a solution of porphy-
rin (10 µM) was prepared and the UV-vis spectrum recorded. Immediately after we added the 
reduced glutathione to reach 10 mM in the cuvette, we mixed and recorded the traces up to 
45 minutes with 5 minute intervals in between measurements (Figure 3-13). 
 
 
 
 
 
 
 
 
 
 
Spectra of compound #5 alone and those recorded at 0, 25, and 45 minutes after initi-
ated the reaction showed no great differences in the position of the λmax (413 nm) or in ab-
sorption intensity of the Soret band. Moreover, no changes in the extinction coefficient at 413 
nm were noted. The glutathione, similar to NAC, most probably did not introduce any dis-
turbance in the electronic density of the porphyrin macrocycle that could produce a major 
Figure 3-13. UV-vis traces from the reaction mixture of com-
pound #5 (10 µM) and NAC (10 mM) in PB. The traces were 
collected at 0, 25, and 45 minutes. 
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change in the spectroscopic properties of the chromophore. Following the same rationale as 
described in the section 3.3.6 we decided to explore the effect of the hydrolysis over the 
spectroscopic properties of the porphyrin. To tackle this we extended the measurements for 
another 20 hours, recording traces every hour. We took special attention to avoid the photol-
ysis of the sample in the cuvette (see Experimental Section). 
Figure 3-14 shows UV-vis traces taken at time 0, 10, and 19 hours compared to those 
of compound #5 non-hydrolyzed, and hydrolyzed. Analysis of the spectra showed that there 
was a bathochromic shift combined with a hypochromic effect in the traces that corresponded 
to the adduct porphyrin-glutathione and the hydrolyzed compound #5. However, we do not 
know how to explain this observation but we suggest that presumably this could be due to 
aggregation of porphyrin monomers. If this was the case, then we could also add that the 
spectroscopic data suggest that the adduct glutathione-porphyrin is less biased towards ag-
gregation than the adduct of 5- N-acetylcysteine. 
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In summary, from this experiment we could not determine any spectroscopic changes 
in the porphyrin traces that were indicative of the formation of the adduct compound #5-γ-
gluthathione. However, if our hypothesis is correct, the glutathione seems to have a negative 
effect over the aggregation of the porphyrin in solution, presumably by affecting the nuclea-
tion of the monomers, which has been reported previously as the limiting step in the aggrega-
tion of porphyrins191. 
 
 
Figure 3-14. UV-vis traces of compound #5 (10 µM), hydro-
lyzed compound #5, and the adduct compound #5-γ-
gluthathione recorded in PB at 0, 10, and 19 hours after the 
beginning of the reaction. The direction of the arrows illus-
trates the changes in the Soret band. 
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3.3.8 Interaction of tris (2-carboxyethyl)phosphine (TCEP) 
with 5-(4-maleimide)-10, 15, 20 tris (4 - sulfona-
tophenyl)–porphyrin (Compound #5). 
The aim of this experiment was to study by NMR whether the reducing agent TCEP 
reacts with compound #5. Since the NMR spectrum of TCEP (Figure 3-15) does not show 
any signal above 5.0 ppm, where most of all the signals of compound #5 are located, NMR 
spectroscopy could be used to follow the reaction. To answer this question we prepared two 
samples from a unique stock, one containing compound #5 only, and the second containing 
compound #5 (0.5 mM) plus a 10-fold excess of TCEP (5 mM), both in deuterated methanol. 
Interestingly, after the addition of TCEP to the solution of compound #5, we observed imme-
diately the formation of a precipitate, with colour change from purple to green. To elucidate 
whether all the porphyrin in the sample containing TCEP had precipitated we performed the 
analysis by NMR, at 0, 1, 2, 3, 4, 48, and 72 hours. The sample containing only compound #5 
was also analysed. Figures 3-15, 16, and 17 show the 1H-NMR spectra recorded at 0 and 48 
hours, respectively. 
Figure 3-15. 1H NMR spectra (400 MHz) of the solution stock of TCEP at 25 °C. A) in deu-
terated methanol. 
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Figure 3-16. 1H NMR spectra (400 MHz, MeOD). C) Compound #5 alone. D) Compound #5 
after the addition of the TCEP at 0 hrs. 
Figure 3-17. 1H NMR spectra (400 MHz, MeOD). E) Compound #5 alone. F) Compound #5 
after the addition of the TCEP at 48 hrs. 
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Figure 3-16 shows the 1H NMR spectrum at 0 hrs. After addition of TCEP the signal 
belonging to maleimide at 7.13 ppm immediately disappeared. This result suggests that upon 
interaction between TCEP and compound #5 an insoluble product was formed, and this solid 
product was not visible by 1H-NMR. Another possible explanation is that TCEP reduces the 
double bond of the maleimide. However, in this case we should have observed two doublets 
from the maleimide protons, which in fact we did not see in the spectra, but this could occur 
in the case of a non-covalent interaction. During the course of this study we found a recent 
paper that indeed confirmed that TCEP reacts with maleimides under the conditions normally 
used in the bio-conjugation reactions to form the TCEP-maleimide adduct192. 
To continue exploring this reaction we decided to analyze the sample after 48 hrs in-
cubation. Figure 3-17 shows that in the sample of compound #5 alone the singlet at 7.03 ppm 
was still present although the intensity was clearly lower, presumably due to the methanoly-
sis of a large fraction of compound #5. However, in the sample containing the TCEP the sig-
nal belonging to the maleimide was absent, as it was before. 
These results showed that despite some porphyrin precipitate after the addition of the 
TCEP, probably due to aggregation of the monomers triggered by the protonation of the pyr-
role nitrogen, some porphyrin remains in solution as we can actually see it in the NMR anal-
ysis. However, upon addition of TCEP the characteristic singlet from the maleimide at 7.13 
ppm disappeared. The absence of the expected doublets from the succinimide ring was ex-
plained satisfactorily by the formation of the double bond (P=C) between TCEP and the ma-
leimide, to form an ylene as shown in Scheme 3-14. 
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To understand the reactivity of the TCEP towards maleimide we set up the reaction of 
TCEP with a model maleimide called N-ethylmaleimide (Scheme 3-14). The reaction was 
followed by NMR sprectroscopy.  
 
Figure 3-18 illustrates the 1H NMR spectrum of the product the reaction between 
NEM and TCEP and the assignment of each signal to their corresponding protons in the mol-
ecule. 
Figure 3-18. 1H NMR (400 MHz, D2O) spectrum of NEM-TCEP adduct. 
Scheme 3-14. Reaction of TCEP and NEM in 0.1 M phosphate buffer pH 7, RT, to render the ad-
duct TCEP-NEM (4-ylene). 
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Importantly, the multiplet at 3.2 ppm corresponds to the two protons c in the succin-
imide ring. From the analysis of the integrals, 89.3% of NEM reacted with the TCEP, leaving 
only 10.7 % of NEM available for the labeling reaction with the thiol. 
To investigate whether the unexpected precipitation of the porphyrin in methanol af-
ter adding the TCEP was due to acidification we decided to perform the reaction in a mix of 
phosphate buffer pH 7.2 and methanol. Before the sample preparation, we tested whether the 
methanol/phosphate buffer mixture does not alter the solubility of the phosphate buffer salt. 
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Figure 3-19. 1H NMR (400 MHz, MeOD) spectra of three solutions of compound #5 at 25 
°C. 1) 25% MeOD: 75% PB, 2) 50% MeOD: 50% PB, and 3) 75% MeOD: 25% PB. Circled 
in red the singlet belonging to the maleimide group. 
  Methanol 
(ml) 
1 2 3 4 5 6 7 8 9 
PB Buff-
er (ml) 
                    
9   S                 
8     S               
7       S             
6         S           
5           S         
4             S       
3               S     
2                 S   
1                   S 
 
Table 3-5 shows that for all the ratios tested the phosphate salt was completely solu-
ble. Therefore, we proceed to study the reaction with TCEP. To this end, we prepared three 
working solutions with the following composition: 1) 25% MeOD: 75% PB, 2) 50% MeOD: 
50% PB, and 3) 75% MeOD: 25% PB and a final concentration of compound #5 equal to 5 
mM (Figure 3-19). 
Table 3-5. Mix of methanol and phosphate buffer to study the solubility of the 
phosphate salt. S) completely soluble. 
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Figure 3-20. 1H NMR (400 MHz, MeOD) spectra of three solutions of compound #5 + TCEP 
at 25 °C. 4) 25% MeOD: 75% PB, 5) 50% MeOD: 50% PB, and 6) 75% MeOD: 25% PB. 
Circled in blue is the area where the peak belonging to the maleimide group is missing. 
From the integral ratios of the peaks located at 7.16 ppm, approximately 30% corre-
spond to compound #5 and 70% to hydrolyzed maleimide. The resolution of the peaks in the 
spectrum of 25MeOD: 75PB solution was poor compared with the other two spectra. To each 
solution we added TCEP to reach a final concentration of 5 mM. The samples were mixed 
and no change in color or precipitation was observed. Immediately after we recorded the 1H-
NMR spectra (Figure 3-20). 
 
These results demonstrated that the maleimide reacted with TCEP under the condi-
tions used. The three samples were centrifuged to precipitate any possible particles in sus-
pension, but no solid residue was observed. Absence of any precipitate or change in color 
ruled out the possibility that any physical phenomena, like aggregation or precipitation were 
the cause of absence of the maleimide peak in the 1H NMR spectra. 
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Figure 3-21. 1H NMR (400 MHz, MeOD) spectra of two samples. A) 5 mM of compound #5 
alone; B) 5 mM of compound #5 + 5mM TCEP at 25°C. Circled in red is the peak belonging 
to the protons in the maleimide group; circled in blue and pointed with an arrow is the chem-
ical shift where the peak belonging to the maleimide group is missing. 
In order to further study this reaction we performed another experiment. Here, we 
used a stock solution of TCEP prepared in PB pH 7. The aim of this experiment was to en-
sure there was no acidification of the reaction mixture after the addition of TCEP. The reason 
being is that due to the high acidity of the stock solution of TCEP, we suspect this could 
overcome the buffering capacity of the PB pH 7.2, therefore, changing drastically the pH in 
the reaction mixture upon addition. The compound #5 stock was freshly prepared in MeOD. 
A sample containing the porphyrin (5 μM) was analyzed by H-NMR and UV-vis spectrosco-
pies. Immediately after we added the solution of TCEP to reach a final concentration of 5 
mM. No change in color or formation of any precipitate in the NMR tube was observed. 
Then we recorded the NMR and the UV-vis spectra again (Figures 3-21 and 3-22). 
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From Figure 3-21 it is clear that initially the maleimide functional group was present 
in the porphyrin solution, however after addition of TCEP the signal disappeared, most prob-
ably due to reaction of the maleimide with the reducing agent. 
 
 
Figure 3-22 shows the UV-vis traces of both samples. No major differences can be 
identified which makes clear that the best way to follow up the reactivity of the maleimide 
double bond is by using 1H-NMR spectroscopy rather than UV-vis spectroscopy. 
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Figure 3-22. UV-vis trace of compound #5 (5 µM) in PB 
(100 mM) pH 7.2 and the compound #5 + TCEP (5 mM). 
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Figure 3-23. 1H NMR (400 MHz, D2O) spectra of the two samples. A) 5 mM of NEM alone; 
B) 5 mM of NEM + TCEP at 25 °C. Circled in red is the integrated peak belonging to the 
hydrogens of the double bond (between C4 and C3); circled in blue is the same peak after the 
addition of the TCEP. 
3.3.9 Study the reactivity of tris (2-carboxyethyl)phosphine 
(TCEP) with N-Ethylmaleimide (NEM). 
To elucidate the nature of the interaction between TCEP and the maleimide deriva-
tive, we decided to perform a control experiment with TCEP and the model maleimide NEM. 
The spectrum of a solution of NEM (5 mM) in PB 100 mM pH 6 containing 10% of D2O was 
recorded, and immediately after we added TCEP (5 mM) to the NMR tube and recorded the 
spectrum again (Figure 3-23). The spectrum of TCEP (5 mM) alone in DMSO was also rec-
orded (see Figure 6-6 in Appendix). 
As illustrated by the 1H-NMR spectra, the singlet at position 6.75 ppm with an inte-
gral of 1.21 that corresponds to the two protons in NEM, was reduced after addition of 
TCEP. Integration of the peak after addtition of TCEP was equal to 0.11, which means that 
more than 85% of the maleimide reacted with the TCEP reagent. This result confirmed the 
previous observation in section 3.3.8 and proved that TCEP reacts with the double bond of 
the maleimide. 
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In addition to the H-NMR spectra, we analyzed the reaction by UV-vis spectroscopy. 
As shown in Figure 3-24, the double bond in NEM absorbs in the UV region of the spectra 
with the maximum wavelength located near 304 nm (black line). TCEP, on the contrary, does 
not absorb in this region, as shown by the red line. After addition of TCEP stock solution to 
the NEM the intensity of the band at 304 nm clearly decreases with no change in the spectral 
position of the λmax.. Due to the stock of TCEP being 40-fold excess compared to NEM, we 
added a very small volume to reach the final concentration, in such a way that any dilution 
effect was minimal. In conclusion, TCEP reacts with NEM, with the double bond integrity of 
the maleimide compromised.  
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Figure 3-24. UV-vis spectra of NEM (0.5 mM) in PB (100 
mM) pH 6.0 and mixture of NEM + TCEP. 
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Figure 3-25. 1H NMR (400 MHz, D2O) spectra A) 5 mM of NEM alone; B) 1 mM of NEM + 
2 mM NAC; C) 2 mM of NAC at 25 °C. Circled in red is the integrated peak belonging to the 
proton of double bond (between C4 and C3); circled in blue is shown the disappearance of the 
peak after the reaction. 
3.3.10 Study of the reactivity of N-Ethylmaleimide 
(NEM) with N-acetylcysteine (NAC) in the presence of 
tris (2-carboxyethyl) phosphine (TCEP). 
The previous experiments have shown that TCEP reacts with the maleimide ring pre-
sent in both, compound #5 and NEM. This observation suggests that we will need to remove 
any reducing agent remaining in solution after the reduction of the thiol peptide, otherwise it 
will compete with the peptide for the maleimide moiety. We decided to test with a model thi-
ol, like NAC, to what extent the labeling reaction was achievable in the presence of TCEP. 
To this end, we prepared a solution of NEM (1 mM) in PB pH 6 with 10%D2O and recorded 
the 1H-NMR spectrum. Immediately after, we added the volume of NAC to reach a final 
concentration of 2 mM, and recorded the1H-NMR spectrum (Figure 3-25). This first reaction 
was a control that we used as a reference when analyzing the reaction between NEM and 
NAC in the presence of TCEP.  
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Figure 3-26. 1H NMR (400 MHz, D2O) spectra. A) 1 mM of NEM plus 2.5 mM NAC and 5 
mM TCEP; B) 1 mM of NEM + 2 mM of NAC at 25 °C. 
After the reaction with NAC the peak belonging to the maleimide double bond disap-
pears, which means the reaction was achieved. When we moved upfield in the chemical shift 
(ppm) scale, we could detect a new set of peaks in the region 2.5-4.5 ppm. The integrals and 
assignment of protons of this product were in agreement with the published data for the ad-
duct NEM-NAC150. 
For the second reaction we prepared a mixture of NAC and 2-fold excess of TCEP. 
This mixture was added to a fresh solution of NEM in PB pH 6 and the 1H-NMR spectra rec-
orded before and after the addition of the mixture (Figure 3-26). 
From the comparison of the spectra (Figure 3-26, Panel A and B) it is obvious that the 
reaction of NEM and NAC in the presence of TCEP occurred. However, analysis of the inte-
grals showed that formation of the adduct NEM-NAC reached approximately 75% in the re-
action without TCEP (Figure 3-26, Panel B). Whereas, in the presence of TCEP, the for-
mation of the adduct NEM-NAC was around 25% (Figure 3-26, Panel A). 
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In summary, although it is possible to achieve the labeling reaction in one-step with 
TCEP present, it is evident that TCEP will affect extensively the extension of the labeling 
reaction due to its high reactivity towards the maleimide function. We could overcome this 
problem by adding Compound #5 in excess in relation to both the thiol and the TCEP. How-
ever, due to the limited amount of Compound #5 synthetized, we discarded this alternative. 
Instead, we decided that the best way to proceed was to separate the TCEP from the reduced 
thiol before the labeling reaction with Compound #5. 
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Figure 3-27. 1H NMR (400 MHz, D2O) spectra. A) 1 mM of NEM alone; B) 10 mM of 
Na2S2O4; C) 1 mM of NEM + 10 mM Na2S2O4 at 25 °C. Circled in red is the peak belonging 
to the protons of double bond (between C4 and C3); circled in green is the change from a tri-
plet to a multiplet in the NEM after the addition of sodium dithionite. 
3.3.11 Study of the reactivity of N-Ethylmaleimide 
(NEM) with N-acetylcysteine (NAC) in the presence of 
sodium dithionite. 
Because TCEP, showed some cross reactivity with the maleimide, we decided to test 
sodium dithionite as a potential reducing agent. We followed an approach similar to that de-
scribed in section 3.3.10. We began by performing the same control experiment with NEM 
and NAC (Figure 3-25, Panel A and C). Sodium dithionite does not show any NMR signal 
and therefore was ideal to follow the reaction between the peptide and the maleimide by 1H-
NMR spectroscopy. We recorded the 1H-NMR spectrum of a solution of NEM in PB pH 6, 
and immediately after added the sodium dithionite in 10-fold excess (Figure 3-27). 
  
 
 
 
 
 
 
 
 
Chapter 3 
 
154 
 
Figure 3-28. 1H NMR (400 MHz, D2O) spectrum of the reaction product of NEM+NAC in 
the presence of Na2S2O4 at 25 °C. The green arrow indicates the multiplet belonging to the 
proton e in the adduct NEM+NAC, while the blue the arrow shows the peak belonging to the 
intact CH3 in the NEM. 
The analysis of the spectra showed that the peak of the maleimide at 6.82 ppm disap-
pears after addition of sodium dithionite. Moreover, the triplet at position 1.11 ppm belong-
ing to the CH3 on the NEM changed to a multiplet. There was also a new set of peaks in the 
range 2.7 – 4 ppm. Sodium dithionite appears to reduce the NEM, presumably the carbonyl 
groups and the double bond. These results indicate that the use of the sodium dithionite is not 
suitable for the one pot labelling reaction with Compound #5. 
The second step in the control experiment was the addition of the mixture NAC + so-
dium dithionite to the solution of NEM in PB pH 6 to explore whether the labeling reaction 
will be faster than the reaction with sodium dithionite. To this end, we prepared a solution 
containing NAC and sodium dithionite in 2-fold excess and followed the same procedure de-
scribed for the labelling of NEM in the presence of TCEP (Section 3.3.10). The mixture was 
incubated for 15 minutes to allow the reduction of NAC. Afterwards, we added the solution 
of NEM and recorded the 1H-NMR spectrum shown in Figure 3-28. 
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The reaction of NEM with NAC in the presence of sodium dithionite was successful 
as is evident by the presence of the multiplet at 3.96 ppm which was assigned to proton e, 
therefore indicative of formation of the adduct NEM+NAC. Moreover, the presence of the 
intact triplet at position 1.03 ppm belonging to protons h in the NEM+NAC adduct suggests 
that reduction of NEM by sodium dithionite is incomplete in the presence of NAC despite the 
fact we used sodium dithionite in excess (see Experimental Section 3.5.12).  
In conclusion, the sodium dithionite also reacts with the double bond of the malei-
mide. Therefore, it is clear that we need to remove the reducing agent to avoid competition 
for the maleimide during the labeling reaction with the peptide. 
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3.3.12 HPLC analysis. 
One of the analytical techniques that we also used in our experiments was the Reverse 
Phase High Pressure Liquid Chromatography (RP-HPLC). The main objective of its applica-
tion was: 
1. Identify the retention times (RT) of the different species involved in the label-
ing reaction with model thiols and Compound #5. 
2. Follow and quantify the extent of the labeling reaction. 
 
3.3.12.1 Study to define whether it is possible to detect micromolar concentrations of 
Compound #5 by HPLC. 
The aim of this experiment was to determine whether the analysis of a range of ten 
solutions of compound #5 on the micromolar scale was feasible by RP-HPLC. This study 
was very important, as the labeling reaction of the peptide with compound #5 would be car-
ried out using micromolar quantities of both reagents. To pursue this aim we prepared by se-
rial dilution 10 samples of compound #5 ranging from 50 to 2 µM and injected each one into 
the RP-HPLC column. The detection was carried out with a UV-vis lamp at 430 nm. 
Figure 3-29 illustrates the traces of eight injections of Compound #5 into the RP-
HPLC column. The traces belonging to the sample at 5 and 6 µM concentrations are not in-
cluded due to inaccuracies in their retention time as a consequence of the manual injection of 
the sample. 
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Figure 3-29. HPLC traces belonging to samples of com-
pounds ranging from 1-10 µM. Samples were injected in 
PB and detected at 430 nm. 
Chapter 3 
 
158 
 
The representation of the data as peak area versus concentration of compound #5 
shown in Figure 3-30, demonstrates nicely how the increment in the concentration of the 
compound #5 correlates linearly with the increment of the peak area, which is directly pro-
portional to the amount of porphyrin in the sample. 
 
From this experiment, we concluded that RP-HPLC was a suitable analytical tech-
nique for the detection of micromolar concentrations of compound #5. Of note, as shown in 
Figure 3-30 we were able to detect concentrations of porphyrin as low as 1 μM. 
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Figure 3-30. Plot of the Area of the peaks (mAU) vs [5] 
uM. 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
159 
 
3.3.12.2 Following the reaction of compound #5 with N-acetylcysteine (NAC) and γ-
glutathione (Glu). 
The labeling reaction of model thiols NAC (10 mM) and Glu (10 mM) with com-
pound #5 (195 μM) was followed by RP-HPLC. Figure 3-31 show that separation of the un-
reacted compound #5, hydrolyzed compound #5, and the adduct thiol-compound #5 is 
achievable. From the retention times of the adduct thiol-compound #5 for N-acetylcysteine 
(11.5 min) and γ-glutathione (10.9 min) it is evident that a better separation is achieved with 
the largest thiol i.e. glutathione. 
 
Figure 3-31. RP-HPLC traces showing the retention times of  
compound #5, compound #5 hydrolyzed, the adduct of com-
pound 5 and NAC, and 5-Glu. Abbreviations: NAC: N-
acetylcysteine, Glu: γ-Glutathione, 5-Hydro: Compound 5 
hydrolyzed. Detection lamp at 430 nm. 
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In conclusion, from the analysis of the chromatogram we determined that for the reac-
tion of compound #5 with NAC, 77.9% of compound #5 reacted with N-acetylcysteine, while 
the remaining 22.1% remain unreacted. When we looked at the reaction with γ-glutathione, 
we determined that approximately 84% of compound #5 reacted with the thiol to produce the 
adduct, while ~16 % remain unreacted. Quantification of the reaction was carried out using 
the integral of the peaks in each chromatogram automatically calculated by the Agilent Soft-
ware. 
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3.3.12.3 Following the reaction of compound #5 with 1-Hexadecanethiol (1-Hex). 
The labeling reaction of compound #5 (100 μM) with the hydrophobic compound 1-
hexadecanethiol (50 μM) was followed by RP-HPLC. Due to the strong hydrophobic interac-
tion of this long thiol with the C18 matrix of the column, we decided to perform the separa-
tion with a less hydrophobic column, i.e. C5, and increased hydrophobicity of the mobile 
phase to shorten the elution time (see Experimental Section) (Figure 3-32).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
As shown in Figure 3-32 we successfully achieved the reaction and most importantly 
we found optimal conditions to separate the 5-1-hexadecanethiol adduct. From the area of the 
peaks we determined that ~10 % of compound #5 reacted with 1-hexadecanethiol, whereas 
the remaining ~90% was a mixture of unreacted and hydrolyzed compound #5. 
13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
0
100
200
300
400
500
600
700
A
re
a
 (
m
A
U
)
Time (minutes)
 #5
 #5-Hydro
 #5 -1-Hex
25.3
1
5
.0
1
5
.2
1
5
.4
1
5
.6
1
5
.8
1
6
.0
1
6
.2
1
6
.4
1
6
.6
1
6
.8
1
7
.0
0
200
400
600
800
Figure 3-32. RP-HPLC traces. The inset graph illustrates the 
retention times of compound #5, compound #5 hydrolyzed,  
compound #5-1-hexadecanethiol adduct. Abbreviations: 1-
Hex: 1-hexadecanethiol, #5-Hydro: Compound #5 hydrolyzed. 
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3.4 SUMMARY 
In this chapter, we described the work done with Compound #5 and model thiols such 
as N-acetylcysteine, γ-glutathione and 1-hexadecanethiol towards the identification of the 
conditions needed to perform the labeling reaction. In addition, we demonstrated the difficul-
ties found in the work with thiols, especially their high susceptibility to oxidation in aqueous 
solution. Due to the necessity to work with the reduced thiol to achieve the labeling reaction 
we explored different reducing agents as potential candidates e.g. TCEP and sodium dithio-
nite. Our results demonstrated that both reducing agents cross-react with the maleimide 
group. Therefore, achieving the labeling reaction in one pot, as was our initial approach is not 
possible. Instead, we need to introduce a further step in which we separate the reducing agent 
before the addition of compound #5 to the reduced peptide. We will design further experi-
ments to address this problem. Moreover, in this section we also showed how we successful-
ly tracked the reaction of compound #5 and model thiols such as N-acetylcysteine, γ-
glutathione and 1-hexadecanethiol by RP-HPLC. Indeed, in here we demonstrated that RP-
HPLC is sensitive enough to detect, qualitativly and quantitativly, micromolar concentrations 
of the 5-thiol adduct. These results are very important as they suggest we will be able to fol-
low the labelling reaction with the transmembrane peptide in a similar way. 
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3.5 EXPERIMENTAL SECTION 
3.5.1 Solvents and Reagents 
The methanol (Fisher) for the preparation of the stock of the compound #5 was of an-
alytical grade. Deionized water was obtained from water purifier purelab option (ELGA). 
N-ethylmaleimide (NEM), N-acetylcysteine (NAC), tris (2-carboxyethyl)phosphine 
(TCEP), γ-Glutathione, sodium dithionite, and the sodium borohydride were purchased from 
Sigma-Aldrich with analytical grade purity. The inorganic salt, sodium phosphate monobasic 
dihydrate used in the preparation of the buffer was also of analytical grade purity. 
The deuterated solvents for the 1H-NMR analysis were deuterium oxide (D2O) (iso-
topic purity 99.9%, Merck), tetradeuteromethanol (CD3OD) (99.96 %, Merck), dimethyl sul-
foxide (d6-DMSO) from Eurisotop.  
The stock of 10 mM DTNB (0.05 mmol, 0.02 g) was prepared in 5 ml of acetonitrile. 
To solubilize the DTNB the solution was sonicated for 30 min. Mr (DTNB) = 396.35g/mol. 
The stock of 10 mM of 1-Hexadecanothiol (0.0153 ml, 0.0129 g). was prepared in 5 
ml of acetonitrile. Mr (1-hexadecanothiol) = 258.51 g/mol, d = 0.84 g/ml.  
The stock of 250 μM of peptide control (5 x 10-7 mol, 0.001 g) was prepared in 2 ml 
DMSO. Mr (Peptide control) = 1993.3 g/mol. 
The stock of 90 μM of full-length transmembrane peptide (1.79 x 10-7 mol, 0.001 g) 
was prepared in 2 ml of DMSO. Mr (Full-length peptide) = 5559.6 g/mol. All the reactions 
were performed at room temperature on the bench. 
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3.5.2 Quantification of free thiol in NAC with the DTNB 
test. 
To a 3 ml quartz cuvette were added in the following order: 
 2 ml of PB pH 7.2 
 2 μl of NAC stock (5 mM) [NAC]final = 2.5 μM 
 20 μl of DTNB (10 mM) [DTNB]final = 100 μM 
The solution was gently shaken and UV spectra at 240-700 nm were recorded imme-
diately and after intervals of 2, 10, 30, 60 and 90 minutes between each scan. A control sam-
ple without the addition of thiol and DTNB was used as a reference (Figure 3-3). 
 
3.5.3 Quantification of free thiol in the 1-Hexadecanethiol 
with the DTNB test 
To a 3 ml quartz cuvette were added in the following order: 
 3 ml of PB pH 7.2 
 3 μl of 1-Hexadecanethiol stock (10mM) [1-Hexdecanethiol]final = 10 μM 
 30 μl of DTNB (10mM) [DTNB]final = 100 μM 
The solution was gently shaken and UV spectra at 240-700 nm were recorded imme-
diately and after intervals of 2, 10, 30, 60, 90, 120, and 180 minutes between each scan. A 
control sample without the addition of thiol and DTNB was used as a reference (Figure 3-6). 
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3.5.4 Quantification of free thiol in the peptide control with 
the DTNB test. 
To a 1 ml quartz cuvette were added in the following order: 
 1 ml of PB pH 7.2 
 40 μl from the 250 μM Peptide control (0.5 μmol, 0.001 g) stock freshly pre-
pared in 2 ml DMSO. [Peptide Control]final = 10 μM 
 20 μl of DTNB (10 mM) [DTNB]final = 100 μM 
The solution was gently shaken and UV spectra at 240-700 nm were recorded imme-
diately and after intervals of 1, 2, 3 and 4 hours between each scan. A control sample without 
the addition of peptide and DTNB was used as a reference (Figure 3-5). 
To determine the concentration of the peptide control in the sample solution I record 
the UV spectrum before the addition of the DTNB was recorded. For correction of the ab-
sorption due to the DMSO, a sample containing 3.3% of DMSO was prepared by mixing 33 
μl of DMSO and 967 μl of PB pH 7.2 (see Figure 3-33). For the determination of the concen-
tration of peptide control we measured the absorbance at 280 nm with the extinction coeffi-
cient of 5810 mol-1cm-1. 
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3.5.5 Quantification of free thiol in the full-length peptide 
with the DTNB test 
To a 1 ml quartz cuvette were added in the following order: 
 890 ml of PB pH 7.2 
 110 μl from the 90 μM Full Peptide control (1.79 x 10-7 mol, 0.001 g) stock 
freshly prepared in 2 ml DMSO. [Peptide Control]final = 10 μM 
 20 μl of DTNB (10 mM) [DTNB]final = 100 μM 
The solution was gently shaken and UV spectra at 240-700 nm were recorded imme-
diately and after intervals of 0, 1, 2, 3, 4, and 5 hours between each scan. A control sample 
without the addition of peptide and DTNB was used as a reference (Figure 3-8). 
To determine the concentration of the peptide control in the sample solution the UV 
spectrum before the addition of the DTNB was recorded. For the correction of the absorption 
due to the DMSO, a sample containing 3.3% of DMSO was prepared by mixing 233 μl of 
DMSO and 6767 μl of PB pH 7.2 (see Figure 3-34). For determination of the concentration, 
the absorbance at 280 nm, with an extinction coefficient of 11050 mol-1cm-1, immediately 
and after 1 hr was used. 
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3.5.6 Determination of the extinction coefficient (ε) of 
compound #5 in PB. 
To determine the extinction coefficient from a 5 mM stock solution of compound #5, 600 µl 
working solution of 0.15 mM in PB 100 mM pH 7.2 was prepared. As summarized in Table 3-6 dilu-
tion of samples P0 to P15 was performed. These samples were further diluted 1:200 to produce the 
final samples D0 to D15. The traces were recorded with a Perkin Elmer UV-vis spectrophotometer in 
the range 240 < λ < 700 nm, with an increment of 1 nm. 
Volume (μl) [5] 
(μM) 
Sample 
Name 
  Sample 
Name 
[5]FINAL 
(μM) 
Vol Cu-
vette 
600 150 P0 50μl +950 μl 
buffer 
D0 7.5 
1ml 
500 P0 + 100 
buffer 
125 P1 50μl +950 μl 
buffer 
D1 6.25 
500 P1 + 100 
buffer 
104 P2 50μl +950 μl 
buffer 
D2 5.2 
500 P2 + 100 
buffer 
87 P3 50μl +950 μl 
buffer 
D3 4.35 
500 P3 + 100 
buffer 
72 P4 50μl +950 μl 
buffer 
D4 3.6 
500 P4 + 100 
buffer 
60 P5 50μl +950 μl 
buffer 
D5 3 
500 P5 + 100 
buffer 
50 P6 50μl +950 μl 
buffer 
D6 2.5 
500 P6 + 100 
buffer 
42 P7 50μl +950 μl 
buffer 
D7 2.1 
500 P7 + 100 
buffer 
35 P8 50μl +950 μl 
buffer 
D8 1.75 
500 P8 + 100 
buffer 
29 P9 50μl +950 μl 
buffer 
D9 1.45 
500 P9 + 100 
buffer 
24 P10 50μl +950 μl 
buffer 
D10 1.2 
500 P10 + 100 
buffer 
20 P11 50μl +950 μl 
buffer 
D11 1 
500 P11 + 100 
buffer 
17 P12 50μl +950 μl 
buffer 
D12 0.85 
500 P12 + 100 
buffer 
14 P13 50μl +950 μl 
buffer 
D13 0.7 
500 P13 + 100 
buffer 
12 P14 50μl +950 μl 
buffer 
D14 0.6 
500 P14 + 100 
buffer 
10 P15 50μl +950 μl 
buffer 
D15 0.5 
 
Table 3-6. Protocol for the titration of the compound #5 in PB pH 7.2 to determine the extinction 
coefficient. 
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3.5.7 Reaction of N-acetylcysteine with #5-(4-maleimide)-
10, 15, 20 tris (4 - sulfonatophenyl)–porphyrin (com-
pound #5). 
The first step was the preparation of a stock solution of compound #5 (0.01 M) in 
methanol. From this stock a working solution (10 µM, 2 ml) in PB pH 7.2 was prepared. The 
solution was split into two vials containing 1 ml each. The first vial label P1 only contained 
compound #5; to the second vial, labelled as P2, added 250 µl from a stock solution of NAC 
(100 mM) was added to reach a final concentration of 20 mM in the cuvette. Before the addi-
tion of the NAC to the P2 vial, the UV-vis spectrum was recorded in the range 388-460 nm. 
After the addition of NAC, both samples were loaded into the spectrophotometer. The spec-
tra were recorded using the multisampler option. The program was set up as follows: absorb-
ance ranges 388-460 nm, number of cycles: 20, interval: 5 minutes. The first position in the 
carrousel was left empty to avoid the photolysis of the sample by the constant irradiation of 
the beam in the periods between readings. Once the first round of measurements was com-
pleted, measurements were repeated increasing the interval to one hour with the same num-
ber of cycles. 
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3.5.8 Reaction of γ-Glutathione with #5-(4-maleimide)-10, 
15, 20 tris (4 - sulfonatophenyl)–porphyrin (compound 
#5). 
Glutathione reduced (0.15 mmol) stock solution (100 mM, 1.5 ml) was prepared in 
PB 100 mM pH 7.2. From the stock of compound #5 (10 mM) prepared previously 1 µl was 
pipetted into 1000 µl of PB 100 mM pH 7.2 to prepare a solution of 10 µM. The absorbance 
of this solution was recorded using the same set up as described in the section 3.5.7. Then, 
100 µl of the glutathione reduced stock solution were added to the cuvette to reach a final 
concentration in the cuvette of 10 mM. The content was carefully mixed and the absorbance 
was recorded under the same conditions. Once all the cycles were finished a new round of 
measurements were recorded using a one-hour interval over 20 cycles. 
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3.5.9 Interaction of tris (2-carboxyethyl)phosphine (TCEP) 
with 5-(4-maleimide)-10, 15, 20 tris (4 - sulfona-
tophenyl)–porphyrin (compound #5). 
A stock solution of tris (2-carboxyethyl)phosphine (TCEP) (0.05 mmol) in deuterated 
methanol was prepared initially. A solution of compound #5 (0.5 mM) was prepared and fur-
ther split into two separate samples. To one of these samples the stock solution of TCEP (100 
mM) was added to reach a final concentration of 5 mM, with the immediate formation of a 
green precipitate in the NMR tube and change of color in the solution from purple to green. 
1H-NMR spectra of both samples were recorded and repeated every 1 hour for 5 hours. Once 
the acquisitions were finished the samples were left at room temperature and spectra record-
ed again at 24 and 48 hours. The spectrum of a solution of TCEP (10 mM) in deuterated 
methanol and dimethyl sulfoxide (DMSO) was also recorded in order to perform the analysis. 
To find the best conditions to perform the 1H-NMR analysis of compound #5 in the 
presence of TCEP it was decided to buffer the mixture to keep the pH stable around 7.2. Be-
fore the preparation of the samples an investigation of whether or not the methanol/PB mix-
ture affected the solubility of the inorganic salt with the concomitant destruction of the buffer 
capacity was performed. To achieve this, we prepared a solution of PB 50 mM pH 7.2 and 
mixed with methanol in nine different ratios: buffer:methanol, 1:9, 2:8, 3:7, 4:6, 5:5, 6:4, 7:3, 
8:2, 9:1. Each mixture was agitated, and left at room temperature for several hours and exam-
ined for the formation of any precipitate or turbidity in the vial. 
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A stock of compound #5 was prepared (50 mM, 210 µl) in MeOD. From this stock 
were prepared three samples (700 µl) with the ratios of deuterated methanol: PB as follows: 
25:75, 50:50, 75:25 (Table 3-7). Once all the samples were prepared the NMR spectra were 
recorded using the water suppression mode option. 
 
 
 
 
 
 
 
 
 
 
 
Solution ratio MeOD:PB V(MeOD) 
µl 
V(Stock 5) 
µl 
V(PB)µl 
1 25:75 105 70 525 
2 50:50 280 70 350 
3 75:25 455 70 175 
Table 3-7. Mixtures of methanol and phosphate buffer used in the study of 
the interaction of compound #5 and TCEP by 1H-NMR spectroscopy. 
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3.5.10 Study the reactivity of tris (2-carboxyethyl) 
phosphine (TCEP) with N-Ethylmaleimide (NEM). 
Three stock solutions were prepared of NAC (100 mM), NEM (100 mM), TCEP (200 
mM) in PB pH 6.0 (Table 3-8). 
Stock solutions (PB pH6) MW (g/mol) C (mmol) m (mg) V (ml) 
NAC 163.19 100 32.6 2.00 
TCEP 286.65 200 114.6 2.00 
NEM 125.13 100 25 2.00 
A solution of NEM (5 mM, 700 µl) was prepared from the previous stock and the 1H-
NMR spectra recorded. Immediately after 17.5 μl from the stock solution of TCEP was add-
ed to the NMR tube to reach a final concentration of 5 mM. The mixture was mixed and the 
1H-NMR spectrum recorded using the watergate gradient mode (Table 3-9). 
 
 
 
 
Reagent Cstock (mmol) C NMR (mmol) Vstock 
(μl) 
V D2O 
(μl) 
V PB pH6 (μl) VNMR (μl) 
NMR 
Tube 
      70 577.5 700 
TCEP 200 5 17.5       
NEM 100 5 35       
Table 3-8. Details of the reagents used in the preparation of the three stock solutions. 
 
Table 3-9. Details of the reagents used in the preparation of the NMR samples. 
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The samples for the UV-vis experiments were collected from the NMR tubes after the 
recording of the spectra (Table 3-10). The UV-vis trace of the NEM (0.5 mM), was recorded 
first, followed by the trace of the mixture TCEP+NEM, and the trace of the TCEP alone (Ta-
ble 3-11). The parameters of the instruments were: wavelength: 700 – 200 nm, scan speed: 
600 nm/min, sampling interval: 1.00 nm. 
 
NMR 
Sample 
[NMR tube] 
(mM) 
[Cuvette] 
(mM) 
V PB pH 6 
(μL) 
V NMR tube 
(μL) 
DF 
NEM 5 0.5 900 100 10 
TCEP + 
NEM 
N/A  900 100 10 
 
 
NMR 
Sample 
[stock] 
(mM) 
[Cuvette] 
(mM) 
V PB pH 6 
(μL) 
V stock 
(μL) 
TCEP 200 0.5 997.5 2.5 
 
 
 
 
 
 
Table 3-10. Details of the reagents used in the preparation of the samples for the UV-vis 
experiments. 
 
 
 
Table 3-11.Details of the reagents used in the preparation of the samples for 
the UV-vis experiments. 
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3.5.11 Study of the reactivity of N-Ethylmaleimide 
(NEM) with N-acetylcysteine (NAC) in the presence of 
tris (2-carboxyethyl)phosphine (TCEP). 
 
3.5.11.1 Reaction between NEM and NAC: 
To a glass vial were added 623 μl of PB 100 mM pH 6.0, followed by 70 μl of D2O. 
Afterwards 7 μl was added from the stock of NEM (see Table 3-12). The mixture was mixed 
and transferred into an NMR tube to record the 1H-NMR spectrum using the watergate gradi-
ent mode. Once the spectrum was recorded the contents of the NMR tube were transferred to 
a new glass vial and 14 μl of the stock of NAC was added to reach 2 mM in the NMR tube, 
we mixed the mixture, checked the pH with paper strips and transferred the contents into the 
same NMR tube to record the spectrum again.  
NMR sam-
ple 
Cstock 
(mM) 
C NMR 
(mM) 
Vstock 
(μl) 
V D2O 
(μl) 
V PB pH6 
(μl) 
VNMR 
(μl) 
NMR Tube       70 623 700 
NEM 100 1 7       
NAC 100 2 14       
 
 
 
 
 
Table 3-12. Details of the reagents used in the preparation of the samples for the NMR ex-
periments. 
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3.5.11.2 Reaction between NEM and NAC in presence of TCEP: 
To a glass vial were added 623 μl of PB 100 mM pH 6.0, followed by 70 μl of D2O. 
Afterwards, 7 μl from the stock solution of NEM were added (see Table 3-13). The mixture 
was mixed and transferred into an NMR tube to record the 1H-NMR spectrum. Once the 
spectrum was recorded the contents of the NMR tube were transferred to a new glass vial. 
From the stock of NAC (100 mM) and TCEP (191 mM) a working solution was prepared by 
mixing 20 μl of both into an Eppendorf tube to produce a solution of NAC (50 mM) and 
TCEP (95.5 mM). From this working solution 36 μl were added to the vial containing the 
NEM solution. The mixture was mixed and immediately after transferred to an NMR tube 
and the spectrum recorded. 
NMR sam-
ple 
Cstock 
(mM) 
C NMR 
(mM) 
Vstock 
(μl) 
V D2O 
(μl) 
V PB pH6 
(μl) 
VNMR 
(μl) 
NMR Tube       70 623 700 
NEM 100 1 7       
TCEP + 
NAC 
95.5 + 50 5 + 2.6 36       
 
 
 
 
 
 
Table 3-13. Details of the reagents used in the preparation of the samples for the NMR ex-
periments. 
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3.5.12 Study of the reactivity of N-Ethylmaleimide 
(NEM) with N-acetylcysteine (NAC) in the presence of 
sodium dithionite. 
The solution stock of the sodium dithionite 100 mM (85 % purity) was prepared by 
weighing 24.7 mg and dissolved in 1 ml of PB 100 mM pH 6. The first experiment was the 
recording of the sodium dithionite spectrum by 1H-NMR using the watergate gradient mode 
(see Table 3-14). 
NMR sam-
ple 
Cstock 
(mM) 
C NMR 
(mM) 
Vstock 
(μl) 
V D2O 
(μl) 
V PB pH6 
(μl) 
VNMR 
(μl) 
NMR Tube             
Dithionite 100 10 70 70 560 700 
 
For the second experiment we prepared a solution of NEM 1 mM in PB 100 mM pH 
6 with 10% D2O and recorded the NMR spectrum. To this solution 70μl from the sodium di-
thionite stock was added to reach a final concentration of 10 mM. Afterwards, the solution 
was transferred to the NMR tube and the spectrum recorded (see Table 3-15). 
NMR sam-
ple 
Cstock 
(mM) 
C NMR 
(mM) 
Vstock 
(μl) 
V D2O 
(μl) 
V PB pH6 
(μl) 
VNMR 
(μl) 
NMR Tube             
NEM 100 1 7 70 623 700 
Dithionite 100 10 70       
 
 
Table 3-14. Details of the reagents used in the preparation of the samples for the NMR ex-
periments. 
 
Table 3-15. Details of the reagents used in the preparation of the samples for the NMR ex-
periments. 
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For the third experiment a solution of NEM (1mM) in PB 100 mM pH 6 was prepared 
and NMR spectrum recorded. A solution of NAC (25 mM) and sodium dithionite (50 mM) 
was prepared from the initial stock of both reagents. This solution was mixed and an aliquot 
was removed and added to the NEM (1 mM) to reach final concentrations of NAC and sodi-
um dithionite of 10 and 5 mM respectively. Immediately after the solution was transferred 
into an NMR tube and the 1H-NMR spectrum recorded (see Table 3-16). 
NMR sample Cstock 
(mM) 
C NMR 
(mM) 
Vstock 
(μl) 
V D2O 
(μl) 
V PB pH6 
(μl) 
VNMR 
(μl) 
NMR Tube       70  623  700 
NEM 100 1 7   700 
Dithionite+NAC 25 + 50 10 + 5 140       
 
 
 
 
 
 
 
 
 
 
Table 3-16. Details of the reagents used in the preparation of the samples for the NMR experi-
ments. 
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3.5.13 HPLC analysis. 
 
3.5.13.1  Reaction of compound #5 and N-acetylcysteine 
 Compound #5 (0.004 g, 0.0039 mmol) solution was prepared from frozen aliquots. 
N-acetylcysteine (0.00326 g, 0.02 mmol) stock solution was prepared fresh PB 100 mM pH 
7.2. The reaction mixture was prepared by adding N-acetylcysteine to the solution of com-
pound #5 (100 μM), mixed and injected in to the RP-HPLC immediately. Column (Phenom-
enex Jupiter C18, 250mm) Manual injection of 20 μl, λ = 430 nm, flow 1 ml/min, eluting 
with 0.1% TFA/MeCN and 0.1% TFA/H2O with the following gradi-ent: 0-20 min, 0-100% 
MeCN, 20-22 min, 100-100% MeCN, 22-23 min, 100-0% MeCN, 23-25 min, 0-0% MeCN.  
3.5.13.2  Reaction of compound #5 and γ-glutathione 
Compound #5 (0.004 g, 0.0039 mmol) solution was prepared from frozen aliquots. 
The γ-glutathione (0.00878 g, 0.0285 mmol) stock solution was prepared fresh in PB 100 
mM pH 7.2. The reaction mixture was prepared by adding the γ-glutathione to the solution of 
compound 5 (100 μM), vortexed and injected in to the RP-HPLC immediately. Column 
(Phenomenex Jupiter 5u C18, 300A) Manual injection of 20 μl, λ = 430 nm, flow 1 ml/min, 
eluting with 0.1% TFA/MeCN and 0.1% TFA/H2O with the following gradi-ent: 0-20 min, 
0-100% MeCN, 20-22 min, 100-100% MeCN, 22-23 min, 100-0% MeCN, 23-25 min, 0-0% 
MeCN.  
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3.5.13.3  Reaction of compound #5 and 1-Hexadecanothiol 
The compound #5 (0.004 g, 0.0039 mmol) solution was pre-pared from frozen ali-
quots. The 1-Hexadecanothiol (15.3 μl, 0.005 mmol) stock solution was prepared fresh in 
ethanol. The reaction mixture was prepared by adding the 1-hexadecanothiol (50 μM) to the 
solution of compound 5 (100 μM), mixed and injected in to the RP-HPLC immediately. Col-
umn (Phenomenex Jupiter 5u C5, 300A) Manual injection of 20 μl, λ = 430 nm, flow 0.5 
ml/min, eluting with 0.1% TFA/2IPA:1MeCN and 0.1% TFA/H2O with the following gradi-
ent: 0-20 min, 0-100% 2IPA:1MeCN, 20-40 min, 100-100% 2IPA:1MeCN, 40-42 min, 100-
0% 2IPA:1MeCN, 42-45 min, 0-0% 2IPA:1MeCN. 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3 
 
180 
 
3.5.14 Instruments 
Proton Nuclear Magnetic Resonance (1H-NMR): 1H-NMR spectroscopy was per-
formed on the departmental Nuclear Magnetic Resonance (NMR) service. The spectra were 
recorded on Bruker 400 MHz spectrometers (Avance and Avance III). The description of the 
peaks is as follows: singlet (s), doublet (d), triplet (t), multiplet (m), broad (br). The coupling 
constants are reported in hertz (Hz), the chemical shift (δ) in parts per million (ppm). 
UV-vis Spectrophotometry: The UV-vis spectra for all experiments were carried on 
the departmental Perkin Elmer Lambda 35, UV/VIS Spectrometer. The cuvettes for all the 
measurements were polystyrene and disposable with a pathlength of 1 cm and a volume ca-
pacity of 2.5 ml.  
pH-meter: The pH measurements were taken with a Mettler Toledo pH-meter with a 
glass electrode (InLab Ultra-Micro, Electrolyte Friscolyl) pH 1…11.0, 80 oC. All the read-
ings were performed at room temperature. The pH-meter was calibrated before each meas-
urement with standard solutions at pH 4 and 7 respectively. 
RP-HPLC: The RP-HPLC was performed using a Varian Prepstar pump with au-
tosampler and fraction collector. The stationary phase column was a Jupiter 4u Proteo 90A 
AXIA with a packed prep column (250 x 21.2 mm). 
All the measurements were recorded at RT, with no further treatment of the samples. 
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Figure 4-1. Schematic representation of the approach used in this study. Step 1 repre-
sents the random insertion of the full-transmembrane peptide into the lipid vesicles to 
form the proteoliposomes, with 50% distribution of the peptide in both possible orien-
tation. Step 2, illustrates the labeling of the proteoliposomes in the external thiol with 
a representation of the chemical structure of compound #5. 
 
4.1 INTRODUCTION AND OBJECTIVES 
 The aim of this chapter is to explore tools and analytical methods required to deter-
mine the extent of aggregation of the TCR transmembrane peptide. To accomplish this aim 
we need to design and synthetize peptide sequences that are biologically relevant, meaning 
they need to resemble the natural TCR transmembrane sequence. These peptides need also to 
have the reactivity required for the labelling reaction with compound #5. In other words, to 
have the thiol group incorporated to allow for covalent attachment to the porphyrin moiety of 
Compound #5 via the maleimide-thiol chemistry that we studied in Chapter 3 with small thi-
ols rather than peptides. The approach is shown in Figure 4-1. 
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Figure 4-2. Scheme showing the distribution of a porphyrin-cholesteryl based fluorescent 
probe on the outer leaflet of the lipid bilayer. They represent either the clustered form (C) 
or the dispersed form (D). 
 
For the sake of clarity, we will call the liposomes containing the porphyrin labelled 
peptides, proteoliposomes. A robust methodology for the preparation of the proteoliposomes 
must allow the measuring of peptide aggregation within the membrane by following the 
spectroscopy changes of the porphyrin moiety (UV-vis absorbance and/or fluorescence) at 
different concentrations of peptide within the membrane. In other words, we will aim to pre-
pare proteoliposomes containing different ratios of peptide-porphyrin to lipids and we expect 
that the spectroscopic properties of the porphyrin will change for those ratios in which pep-
tide clustering takes places. The rational for these experiments and the methodologies to de-
tect and analyze clustering have been already developed and tested on a system made purely 
of synthetic molecules, i.e. a receptor made of a porphyrin head connected to a cholesteryl 
tail (Figure 4-2). The model system and the analytical methods used to determine the equilib-
rium constant of clustered and dispersed receptor (KDC in Fig 4.2) are described in section 
1.1.12.1 of the introduction chapter of this thesis. 
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Figure 4-3. Scheme showing the distribution of a porphyrin-peptide based 
fluorescent probe on the outer leaflet of the lipid bilayer. They represent 
either the clustered form (C) or the dispersed form (D). 
In our approach, we aim to build up a similar system and use a similar analysis for the 
clustering-disperse equilibria of the TCR transmembrane peptides (Figure 4-3). 
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The objectives of this chapter are to set up the experimental conditions to construct 
the proteoliposomes and follow up quantitatively the peptide aggregation with the porphyrin 
cluster reporter. Specifically: 
1. To design and synthetize TCR transmembrane peptides sequences that can be 
used to build up the proteoliposomes 
2. To design and set up experiments for the analysis of the interaction between 
such peptides and lipid vesicles (in the absence of any added porphyrin) 
3. To determine any interaction between the porphyrin and the lipids vesicles in 
the absence of peptides. 
4. To investigate methodologies for the chemical attachment (labeling reaction) 
of Compound #5 to the lipid vesicles containing the peptides (Figure 4-1). 
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4.2 RESULTS AND DISCUSSION 
4.2.1 Design and synthesis of the transmembrane peptides  
For the design of the synthetic peptide we used the primary structure of the TCRVγ7 
(Figure 4-4) based on previous work described by Pennington et al193 and summarized in sec-
tion 1.1.9.3 of the introduction chapter. Their results demonstrated that TCR assembly and 
signaling initiation in early progenitors do not require the extracellular domains of the recep-
tor. Therefore, presumably the signaling initiation is not a consequence of ligand engagement 
or aggregation of the receptor through the extracellular immunoglobulin domains. Instead, 
they suggest that simply the expression on the cell surface of the appropriate TCR transmem-
brane chains might be enough to promote initiation of signaling. 
jkjkljkljkj 
jkjkljkljkjjjj 
Figure 4-4. A) Representation of the primary structure of the TCRVγ7. Letters in bold repre-
sent the sequence of the full-length transmembrane peptide used in this study. Black for the 
extracellular region containing the cysteine (red) and the tryptophan (blue) residues. In red 
the transmembrane region, and in green the cytoplasmic sequence of the receptor, containing 
the cysteine (red) important in our study. B) Schematic representation of the TCRVγ7 chain, 
in black, red and green are illustrated the residues that composed the full-transmembrane 
peptide synthetized in our study. Represented with their natural orientation are the cysteines 
and the tryptophan, red and blue dots, respectively. The control peptide sequence is repre-
sented in bold black letters and highlighted in yellow. 
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The designed peptide has sixteen residues from the stalk region, twenty-five residues 
from the transmembrane domain, and a short sequence of six aminoacids coming from the 
cytoplasmic region of the TCRVγ7 (Table 4-1 and Figure 4-4 B). The transmembrane region 
with 25 hydrophobic amino acids is long enough to span the hydrophobic interior of the bi-
layer –approximately 30 Å- according to the characteristic 1.5 Å of helical rise per residue194. 
This means that after insertion in the lipid bilayer of the vesicles the peptide will have two 
cysteines located at both ends facing the aqueous solutions outside and inside of the liposome 
bilayer. One important question to answer is how the peptide will be oriented in the bilayer 
after insertion. We hypothesize that orientation can be random, with a 50% of probability of 
finding the N-terminus lying outside against 50% of chances to found it in the internal cavity 
of the liposome. However, some studies in the field suggest that orientation of lipophilic pep-
tides is not completely random and there is a preferential orientation depending on the intrin-
sic chemical and physical properties of the peptide and lipid composition of the in vitro sys-
tem. For example, the electrostatic interactions of the polar heads of phospholipids can inter-
play with the charged groups in the peptide driving the special orientation of C-terminus over 
N-terminus, as the peptide approaches the membrane195; whilst the hydrophobic interactions 
between the phospholipids and the peptide will drive the insertion of the peptide in the mem-
brane. In our system, to explore the interaction and location of the lipophilic peptide with the 
lipid bilayer, i.e. insertion and orientation, we will use the optical properties of the trypto-
phan, which is naturally present in the peptide sequence. Tryptophan fluorescence is a com-
mon tool to monitor changes in the conformation- folded or unfolded- of proteins and help to 
make inferences about the local structure and polar environments189. For example, Mingarro 
et al. recently reported that the presence of aromatic amino acids, i.e. tryptophan or tyrosine 
Chapter 4 
188 
 
in transmembrane helices is biased. The author observed they are mostly found towards the 
end of the TM helix (between the hydrophobic core and the bulk water solution) suggesting 
that at this position the aromatic residues may serve as anchors for the TM helix in the lipid 
bilayer. Of note, the naturally occurring tryptophan in our peptide is located towards the C-
terminus of the peptide, and next to the cysteine that will participate in the labelling reaction 
with the porphyrin. 
In another seminal study, Costa et al.196 investigating the interaction of carrier pro-
teins, like human serum albumin (HSA) and β- lactoglobulin (βLG) with meso-tetrakis (p-
sulfonatophenyl) porphyrin sodium salt (TSPP), which is very similar to compound #5 used 
in this thesis (Scheme 4-1), described the binding characteristics of TSPP by absorption, and 
fluorescence. 
Scheme 4-1. Panel showing the similarities found in the chemical structures of compound #5 
and the meso-tetrakis (p-sulfonatophenyl) porphyrin (TSPP) used in the Costa et al.study196. 
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 Based on previous observations197 that addition of ligands to proteins can produce 
quenching of the intrinsic tryptophan fluorescence Costa and colleagues196 reported that addi-
tion of 2-30 μM of TSPP to HSA resulted in concentration-dependent quenching of trypto-
phan fluorescence. Because there is an important overlap between the tryptophan emission 
and the TSPP absorption spectrum, they hypothesized that quenching was due to an energy 
transfer mechanism. Moreover, they also observed a red shift in the tryptophan fluorescence 
(from 334 to 338 nm) upon addition of TSPP. Costa196 attributed this shift to the changes in 
the polar environment of the residue probably due to conformational changes in the protein 
produced by binding of porphyrin. By analogy, we hypothesize that the presence of the por-
phyrin moiety near the tryptophan in our peptide will have a quenching effect over its fluo-
rescence as previously described by Costa et al196. We expect to see quenching and/or a shift-
ing of the maximum absortion in the fluorescence spectra of tryptophan upon binding to 
compound #5 in a similar way to that reported by Costa et al. This spectroscopic data could 
provide information regarding the insertion and orientation of the peptide in the lipid bilayer 
of vesicles.  
In the design of the peptide, we maintained two cysteines residues, C256 and C302 (see 
Figure 4-4), which are naturally present in the primary structure of the full-length TCRVγ7 
receptor. Of the two cysteines, the residue C256 has an important role in the structure of the 
receptor because it links together the heterodimer through a disulphide bond with a second 
cysteine located in the TCRδ chain69. These cysteines are also convenient for the chemistry 
because the sulfhydryl functional group will be the nucleophile in the labelling reaction with 
the maleimide group (see Figure 4-5). The reader is refered to Chapter 3 where the reactivity 
of Compound #5 towards some model thiols, i.e. N-acetylcysteine and γ-glutathione is de-
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Figure 4-5. Schematic representation of the labelling reaction. In the cartoon, compound #5 
is mixed with the proteoliposomes (LUV + Peptide). As illustrated, the labeling reaction is 
restricted to the external thiols, due to compound #5 being incapable of crossing the lipid 
membrane based on the presence of three negatively charged sulfonate groups. The peptides 
are represented in both possible orientations. 
scribed as well as experiments that aimed to determine the optimal conditions to perform the 
labelling reaction before the work with the more expensive and valuable peptide. 
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4.2.1.1  Control peptide 
In order to establish the chemistry of the labelling reaction, we decided to proceed 
with the synthesis of a smaller peptide. This small peptide is in fact contained in the full-
length peptide but unlike its counterpart is less hydrophobic. Chemically, the control peptide 
is made of 16 amino acids, represented in black color as the extracellular bit of the full-length 
peptide, and contains one thiol in its sequence (see Figure 4-4 B). Although it is less lipo-
philic than the full-length peptide, because of its smaller size and content of hydrophobic res-
idues e.g. lack the transmembrane sequence, it is still lipophilic enough to interact with the 
lipid membranes of the vesicles as shown by its grand average of hydropathicity index 
(GRAVI) equal to -0.35. Negative GRAVY values indicate that the peptide is non-polar198. 
Due to its short length (16 residues) it is unlikely that it can span the lipid membrane199 We 
have denominated this small peptide the control peptide. The reason for the usage of the 
control peptide is to build up a system stripped of all the complexity of the full-length peptide 
such as, poor solubility, two reactive thiol groups, with which we can study the chemistry of 
the labeling reaction. By beginning to explore the labeling reaction with the control peptide 
and Compound #5 we expect to obtain an insight into the conditions that must be set to per-
form and analyze the reaction of Compound #5 with the more complex full-length peptide. 
As mentioned before, in the design of the peptides the presence of the amino acid 
tryptophan (W) is also very important. The tryptophan fluorescence is sensitive to the polari-
ty of its local environment189. Some studies have shown that tryptophan emission maximum 
(λmax) changes depending on the polarity of the surrounding i.e. hydrophilic vs 
hydrophobic200-202. Some authors have determined that in hydrophobic environments such as 
the membrane interior, tryptophan has a fluorescence emission maximum at λmax <330 nm 
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(blue), while in polar environments the maximum is shifted towards λmax >330 nm (red). In-
deed, one way to determine binding of peptides to lipid bilayers of large unilamellar vesicles 
(LUV) is to measure the affinity (binding constant) of the peptide in the presence of increas-
ing concentration of lipids by monitoring the changes in the tryptophan fluorescence spectra 
upon addition of LUV203. These kind of experiments were conducted for both, the full-length 
and the control peptides, to assess the fluorescence read out of the tryptophan in the control 
peptide that cannot cross the membrane and in the full-length peptide that presumably will 
span the lipid membrane. The reader can find these data reported in section 4.2.2. 
Notwithstanding, changes in tryptophan fluorescence alone might not be sufficient to 
determine the relative orientation of the peptide in the lipid bilayer. Two orientations, shown 
in Figure 4-6 A are possible in LUV, as they do not have the biological machinery that en-
sure the correct orientation and insertion of peptides in cell membranes. When the full-length 
peptide is in the correct biological orientation, the single tryptophan faces the aqueous envi-
ronment on the outer leaflet. This tryptophan is also adjacent to the cysteine that will be used 
in the labelling reaction with the porphyrin. If such a reaction happens, the porphyrin will be 
close to the tryptophan and we expect this will induce quenching of the tryptophan fluores-
cence (Figure 4-6 B) as reported in the work of Costa et al.196 that we have summarized in 
paragraph 4 section 4.2.1. 
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Figure 4-6. Schematic of the two possible membrane orientations of the full-length 
peptide showing the different orientations for the single tryptophan residue (W). A) 
Tryptophan exposed to outer leaflet and in close proximity to porphyrin, which might 
induce quenching. B) Tryptophan exposed to inner aqueous cavity, which is not ac-
cessible to porphyrin leading to full fluorescence as indicated by the green halo. 
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4.2.1.2 Method used for the preparation of LUV  
There are different methods for the preparation of lipid vesicles, some of the most 
common methods are described in the Introduction chapter of this thesis. In our work, we 
have used the extrusion method for the preparation of the liposomes (see Figure 4-7). 
 
All the LUV vesicles used in this work were prepared by extrusion of a stock solution 
of phosphatidylcholine (PC) in ethanol. The PC was the choice of preference because it is a 
neutral lipid present in natural biomembranes. In addition, it is readily available for the pro-
duction of vesicles and inexpensive. The PC-ethanol mixture was loaded into a glass vial and 
then the ethanol was evaporated by flushing with nitrogen gas until a white dry film of PC 
was formed on the wall of the vial. Upon-dryness, the film was re-suspended in phosphate 
buffer solution by mixing and further sonicated for one minute to destroy the foam and air 
bubbles in the solution. A milky appearance is a good sign of successful preparation. Imme-
diately after, the solution is loaded into one of the gas chambers of the mini-extruder. Then 
Figure 4-7. Mini-extruder instrument used for the produc-
tion of the LUV liposomes. Marked with an arrow is the 
location of the polycarbonate membrane where the extru-
sion of the crude vesicles takes place.  
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the extrusion takes place by transferring the PC solution from one gas chamber to the other 
for a minimum of thirty times. In the production of LUV’s we used filters of polycarbonate 
with 100 nm of pore size. This allows for the production of a homogenous lipid vesicle solu-
tion with a desirable size, small enough for in-solution measurements and sufficiently stable 
to stand for the duration of the experiments. For the purpose of this thesis we will use the 
term LUV predominantly, however lipid vesicle and liposome can be found and they must be 
taken as interchangeable.  
4.2.1.3 Analysis of LUV using UV/Vis spectroscopy 
Light scattering is the physical process by which light is forced to deviate its path due 
to some uniformities in the media it passes through. In our studies with LUV vesicles in solu-
tion, wavelength-dependent scattering of light was observed, the extent of which depended 
on the size of the lipid vesicle used. In fact, we used 100 nm vesicles because the scattering 
can be corrected, allowing us the use of in-solution measurements by traditional spectroscop-
ic techniques such as UV-vis and fluorescence. Regarding the stability of the lipid vesicle, it 
has been shown that smaller vesicles i.e. LUV, about 20 – 50 nm in size, possess high curva-
ture that induces structural tension and less stability, therefore we decided to use LUVs with 
less surface curvature and greater stability204. A common way to correct the contribution of 
the wavelength-dependent scattering of light in the samples is by subtracting the scattering 
spectrum obtained from control samples containing only lipid vesicles to the optical 
measures from the experiments where the proteoliposomes are present. Whenever we per-
formed experiments containing PC vesicles and porphyrin, peptide, or both we also deter-
mined the scattering of the vesicles alone. In our experiments, the concentration of PC in the 
vesicles was between 0.1 mM and 10 mM. These spectra were consistently subtracted from 
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the traces of the samples i.e. containing porphyrin, peptide, or both to eliminate the contribu-
tion of the PC (see Figure 6-10 in Appendix). 
Figure 4-8 shows that increase in light scattering is proportional to the concentration 
of the PC in the vesicles. 
 
 
In addition, we also subtracted the contribution of the phosphate buffer. For the entire 
LUV samples the spectra of the phosphate buffer was recorded and subtracted using raw 
spectral data rather than automatic instrument subtraction. A further correction was applied 
for the position of the baseline when it was necessary to compare multiple spectra with dif-
ferent positions of the baseline. This correction was applied using raw spectral data rather 
than the instrumental function as follows: the first 12 wavelengths (700 – 688 nm) were used 
Figure 4-8. Plot of optical density against concentration 
of PC (mM) (See appendix) at four different wave-
lengths indicated in the legend. 
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to calculate the average. This average was subtracted from each spectroscopic read-out ob-
tained from the instrument. This methodology was followed consistently as a pre-processing 
technique for the removal of backgrounds noise in all the experiments discussed in this chap-
ter. 
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4.2.1.4  Basic Theory for the Determination of Equilibrium Association Constants (Only 
1:1 System) 
In this section, we will describe briefly the basic theory and the methodology em-
ployed to quantify the interaction between the LUV with both peptides and compound #5. As 
described by Thordarson el al.205 the most common method to quantify the complexation in 
supramolecular chemistry is the titration. In general, titration is a powerful analytical tech-
nique in which one component (ligand) is added to a solution of a second component (recep-
tor) and the change of a physical property i.e. absorbance or fluorescence intensity that is 
sensitive to the molecular interaction is recorded. The information obtained from the titration 
is then plotted on a graph and the titration curve, also known as binding isotherm, is then fit-
ted to a binding model using appropriate software to calculate the binding constant which is 
also referred as association constant (Ka). 
In this thesis all the titration data were fitted using the simplest association model, i.e. 
a straightforward 1:1 model, which assumes that only two species are important in the bind-
ing equilibrium. The equation used for the fitting of the data was obtained from the 1:1 bind-
ing equilibrium (0): 
   (0) 
As follows: 
   (1) 
  (2) 
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  (3) 
Where equation 2 and 3 represents the mass balance for the 1:1 binding model. Due 
to fact that the concentrations of free ligand [L] and free receptor [R] cannot be directly 
measured we will use these three equations 1, 2 and 3 to write the concentration of the com-
plex [RL] as a function of the known total concentration [R]0 and [L]0: 
     (4) 
   (5) 
    (6) 
  (7) 
 (8) 
 (9) 
  (10) 
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The relationship between [RL] and the absorbance, assuming [L] does not absorb at 
the wavelength under study can be written as: 
    (11) 
If we substitute eq., 2 in 11 we obtain, 
  (12) 
   (13) 
   (14) 
If we now substitute eq. 10 in eq. 14 
  (15) 
Where A is the absorbance and εR, the extinction coefficient of Compound #5. 
From equation 15 it is possible to describe the expected changes in the spectroscopic 
properties of the titration experiment from two known parameters ([R]0 and [L]0) and two 
unknown parameters (Δε and K). In practice, the last two parameters can be obtained by non-
linear regression analysis from the titration data. In this thesis, we have inputted a version of 
equation 15 in the software Origin Pro and used its fitting routine procedure to calculate the 
value of K. The estimate of good fitting is given by the error parameter embedded in the 
Origin software. (see Experimental Section for details). 
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The choice of UV-vis spectroscopy as the technique to monitor the titration experi-
ments is subject to the availability of a good chromophore. In our system, this condition was 
successfully fulfilled with compound #5. Porphyrins are excellent chromophores with an in-
tense absorption in the UV-vis range. This capacity makes it possible to use them in concen-
trations as low as sub-micromolar range, allowing the determination of association constants 
as high as 109 M-1. However, in the selection of the concentrations, we must ensure that the 
absorption of the porphyrin and the complex porphyrin-lipids lie within the limits of the 
Lambert-Beer law (A<1). Additionally, it is desirable if the ligand [L] -lipids- does not have 
any absorption in the region of interest, as this simplifies the system considerably. In our par-
ticular system, the lipid vesicles did not absorb light in the wavelength range of interest in the 
porphyrin spectra. Although some wavelength dependent scattering of light was observed 
and further corrected as described in previous section 4.2.1.3. 
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Figure 4-9. Schematic of the two possible membrane orientations of the full-length pep-
tide and the control peptide in the lipid vesicle. As illustrated, the peptide control is una-
ble to span the lipid membrane, and the fluorescence of the tryptophan residue embed-
ded in the lipid bilayer should be different from the fluorescence of the residue when 
exposed to bulk aqueous solution. 
 
 
4.2.2 Fluorescence Experiments 
In this section, we will report the experiments that we performed to explore whether 
the full-length transmembrane peptide was inserted in the LUV and the orientation of the 
single tryptophan relative to the lipid bilayer as shown in Figure 4-9. 
 
 
 
 
 
 
 
4.2.2.1 Tryptophan–LUV Titrations 
The aim of these experiments was to determine the association constant of both the 
transmembrane and control peptide to LUV. Changes in the fluorescence of single trypto-
phan in peptide have been used to determine binding of such peptides to LUV, where the 
strength of such interactions is indicative of peptide insertion203, 206, 207. Because the control 
peptide lacks the sequence for membrane insertion, it is reasonable to expect that any differ-
ence in binding association to LUV between the two peptides might be indicative of mem-
brane insertion (see Figure 4-9). Typically, the association constant, which is a measure of 
peptide-membrane binding, is obtained by titration methods. 
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The titration was carried out keeping constant the concentration of the peptide against 
12 solutions of liposomes containing increasing concentrations of PC. The selection of the 
peptide concentration for this experiment was 6 μM. This is the lowest concentration that 
gives a good fluorescence spectrum and was selected taking into consideration that in the ti-
tration experiment the peptide-lipid interaction could quench the fluorescence of the trypto-
phan. The twelve point titration was repeated three times. LUVs with increasing concentra-
tions of PC (0-3 mM) were prepared by the extrusion method as discussed in sections 
1.1.11.1.3 and 4.2.1.2. The sensitivity of the fluorescence titration technique allows for the 
determination of association constant as high as 106 205. 
In order to prepare a working solution of tryptophan at 6 μM it was necessary to pre-
pare a concentrated stock solution, but this proved to be challenging, due to the poor solubili-
ty. Both peptides proved to be insoluble at a concentration of 250 μM in the following sol-
vents: 100 mM phosphate buffer pH 7.2, and acetonitrile, which was indicative of their am-
phiphilic character and was somewhat unexpected for the control peptide, as it is more hy-
drophilic. 
In addition, dithiothreitol was added to all solutions at a concentration 100-fold high-
er than the peptide to keep the cysteines in the reduced state during the titration experiment 
thus preventing the oxidation of the peptides, which does occur in time as was shown in sec-
tions 3.3.2 and 3.3.4 of Chapter 3. To determine the concentration of the peptides in solution 
we used the Von Hippel method208. The method reported an equation that allows the calcula-
tion of the extinction coefficient of any protein/peptide based on the presence of three amino 
acids: cysteine, tyrosine, and tryptophan, due to these residues being the only ones that con-
tribute to the absorbance of the protein/peptide in the range of 270-280 nm. Based on their 
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work, we calculated the extinction coefficient of the peptide control as 5810 M-1cm-1 and the 
full-length peptide as 11050 M-1cm-1. 
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4.2.2.2  Determination of the fluorescence spectra of both peptides in the absence of li-
pids  
As shown in Chapter #3 and mentioned in section 1.2.7 a fraction of the peptide was 
already oxidized, or does it quickly in solution; therefore, the concentration of DTT was 100-
fold higher than the peptide. Representative spectra of three different experiments are shown 
in Figure 4-10. The spectra for both peptides are very similar in terms of range of lambda 
max (approx. 350 nm) and intensity, the bathochromic shift (7 nm) observed in the maximum 
for the control peptide is also expected given that this peptide is more polar than the full-
length peptide.  
The objective of this experiment was to record the fluorescence spectra of both pep-
tides in the absence of lipids. Due to the poor solubility of both peptides in aqueous buffer 
the stock solutions of both peptides were prepared in dimethylsulfoxide. Due to the necessity 
of keeping the amount of non-aqueous solvent as low as possible (as this might damage the 
LUV) the samples used in the fluorescence measurements contained ~3.3% of dimethyl-
sulfoxide in phosphate buffer pH 7.2 and dithiothreitol (100-fold excess compared to pep-
tide). The excitation wavelength selected was 295 nm because using an excitation wave-
length shorter than 295 nm will result in excitation of other aromatic aminoacids (tyrosine, 
phenylalanine), which may obscure the shape of tryptophan’s emission spectra, and the fluo-
rescence emission was recorded from 300 – 600 nm (Figure 4-10). 
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Figure 4-10. Fluorescence spectra of both peptides (6 μM) in the 
absence of lipids. The samples were prepared in PB pH 7.2 with 
3.3% DMSO and 600 μM DTT. 
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4.2.2.3  Titrations of both peptides 
The aim of this experiment was to explore whether we could follow the insertion of 
the peptides, and possibly their orientation in the lipid vesicles by studying the changes in the 
fluorescence properties of the tryptophan, i.e. wavelength of maximum emission (λmax), 
emission intensity at λmax. Previous studies
190 have described that the fluorescence of trypto-
phan is solvatochromic, showing a strong correlation between its fluorescence and the polari-
ty of the solvent that surround the residue (see section 4.2.1.1). However, is important to 
mention that only the full-length transmembrane peptide contains the domain that will allow 
membrane insertion and spanning, while the control peptide lacks the transmembrane domain 
and therefore cannot cross the membrane (Table 4-1). 
Regarding the methodology followed for the peptide insertion, we found two methods 
described in the literature203, 209, 210. In the first method, the stock solution of lipid and peptide 
is mixed to achieve the desired ratio lipid/peptide. The solvent is then evaporated and the li-
pid/peptide film re-hydrated with the appropriate buffer to produce the lipid vesicles with the 
peptide inserted. In the second method, that the hydrophobic peptide is combined with pre-
formed lipid vesicles. Due to the lipophilic nature of the peptide, we expect it will insert 
spontaneously in the lipid membrane the second method was adopted. The reason why we 
discarded the first method is due to the possibility that with the extrusion method the peptide 
conformation result damage. In fact, in this method, often detergents are used to preserve the 
peptide conformation, and these detergents might interfere with the measurements we want 
to make, i.e. peptide in-membrane aggregation. In contrast, for the second method, given the 
hydrophobicity of the full-length peptide, it will likely incorporate spontaneously in the 
membrane of the vesicles. However, the insertion can take some time; therefore, we equili-
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brate the peptide-lipid vesicles mixture for 1 hour to allow the quantitative insertion of the 
peptides into the liposomes.  
As mentioned in sections 4.2.1 and 4.2.2, both peptides, the full-length transmem-
brane and the control peptides are highly hydrophobic, constituted by 47 and 16 aminoacids, 
respectively. Both peptides contain tryptophan as a reporter residue and cysteines for the la-
beling reaction with Compound #5 (see Table 4-1).  
 
Based on the methodology described in section 4.2.2.1, we perform both titrations by 
keeping constant the peptides at 6 μM in phosphate buffer plus ~3.3% dimethylsulfoxide and 
600 μM of dithiothreitol against twelve solutions of liposomes of increasing lipid concentra-
tions (0-3 mM) (Figure 4-11). 
 
 
 
 
Peptide Sequence AA PI 
E  
M-1cm-1 
MW 
gM-1 
GRAVI 
Control Ac-CWQDKNDVLQLQFTIT-
NH2 
16 4.2 5690 1993.2 -0.35 
Full-length 
Ac-
CWQDKNDVLQLQFTITSAYYTY
LLLLLKSVI-
YLAIISFSLLRRTSVC-NH2 
47 8.7 11050 5559.6 0.68 
Table 4-1. The sequence of the control and the full-length peptide as well as the main parame-
ters calculated by ExPASy, Abb: AA: aminoacids, PI: isoelectric point, E: extinction coeffi-
cient, MW: molecular weight, GRAVI: grand average of hydropathicity. 
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Fluorescence measurements were corrected by blank measurements of vesicles without pep-
tides as shown in the Figure 4-12. 
Figure 4-11. Fluorescence spectra of control and full-length peptide with vesicle 
lipids of increasing PC concentration. The twelve point titration samples con-
tained 3.3% DMSO and 600 μM of DTT. 
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Figure 4-12. Fluorescence spectra of twelve solutions of liposomes in 
PB pH 7.2 at increasing concentration of PC as indicated in the leg-
end. (λexc: 295 nm). 
Chapter 4 
210 
 
For the correction, we prepared 12 solutions of liposomes with increasing concentra-
tion of lipids (0-3 mM) in PB pH 7.2 without peptides, dithiothreitol or dimethyl sulfoxide. 
The fluorescence spectrum of each solution of PC was then subtracted from that of each 
sample containing the corresponding peptide as mentioned in section 4.2.1.3. 
 
 
 
To better visualize the dependence of the fluorescence intensity changes with lipid 
concentration, the normalized fluorescence intensity at 350 nm was represented as a function 
of the molar ratio of the phosphatidylcholine lipid to peptide (RLP). The data represented in 
the Figure 4-13 are the mean values of two independent sets of experiments (See raw data in 
Appendix, Figure 6-7). 
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Figure 4-13. Normalized fluorescence emission of tryptophan 
at 350 nm as a function of the molar ratio of phosphatidylcho-
line to peptide for the control and the full-length transmem-
brane peptides. The data represented are mean values obtained 
in at least two independent experiments. 
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The plot of normalized fluorescence against phosphatidylcholine lipid to peptide ra-
tio, shows that the intensity of fluorescence emission at 350 nm is constant up to RLP = 15.6 
and then decreases with the increasing of the lipid concentration. This suggests that addition 
of tryptophan containing peptides to neutrally charged lipid vesicles, affect the fluorescence 
of tryptophan in different ways depending on the polarity and net charge of the peptide and 
amino acid residues near to the tryptophan. For relatively short peptides, it has been observed 
that tryptophan fluorescence increases with increasing concentration of lipid whilst if the 
neighboring aminoacids are charged there are no significant changes in the fluorescence 
emission203, 206, 207. For both our peptides, we observed a quenching of the fluorescence inten-
sity with increasing lipid concentration which might indicate that tryptophan experiences a 
more polar environment upon addition of lipid vesicles. A possible explanation is that for 
both peptides the tryptophan is near to the QDKN sequence that contains polar amino acids 
(charged and hydrogen bonding prone)211. Within this polar environment, the tryptophan 
might be position at the lipid water interface and this environment would be more polar than 
the membrane interior. In addition, both peptides tend to aggregate in PB, therefore it is pos-
sible that in the aggregates the tryptophan fluorescence is higher (i.e. in hydrophobic envi-
ronments the tryptophan fluorescence is higher) than at the lipid/water interface. In other 
words, that upon addition of lipids vesicles the tryptophan prefers to lay in the more polar 
environment of the lipid/water interface. If this is the case then the data might also suggest 
that both peptides are oriented similarly to their orientation in biological membranes (i.e. 
with the N-terminus facing the outer water environment). Therefore, even if the data for both 
peptides are very similar and therefore cannot be used as an indication that the full-length 
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peptide is spanning the membrane relative to the control peptide, they are promising in terms 
of orientation of the peptide relative to the lipid bilayer.  
However, to lend support to this explanation, further experiments with external tryp-
tophan quenchers were carried out.  
In conclusion, from these titrations, we could not record any relevant difference in the 
fluorescence read-out of the peptide control compared to the full-length peptide. Therefore, 
monitoring the changes in the spectroscopic features of the intrinsic tryptophan in both pep-
tides did not help to elucidate whether the full-length peptide was spanning the vesicle bi-
layer when compared to the control peptide. Notwithstanding, the small absolute red shift of 
the maximum emission wavelength observed in the titration suggests that this tryptophan is 
located near the membrane/buffer interface. This might indicate that both peptides are orient-
ed with the N-terminus facing the bulk solution in a similar position with respect to their nat-
ural orientation.  
However, it is evident from the fluorescence data that the emission of the tryptophan 
was particularly weak in our experimental conditions, limiting the scope of our conclusions. 
In the light of these results, we decided to explore another method to unravel the peptide ori-
entation, i.e. fluorescence quenching techniques. We think that quenching experiments might 
be a good approach to explore the insertion and orientation of the peptides in the lipid vesi-
cles. The rationale of these experiments will be discussed in detail in the next section. 
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4.2.2.4  Determination of the optimal conditions to quench the fluorescence of the com-
pound #5. 
In order to be able to understand how both, the full-length and the control peptide are 
oriented in the membrane of the vesicles we decided to use a fluorescence quenching tech-
nique. This method uses a fluorophore quencher. A quencher is a compound that when added 
to a fluorophore either reduces the fluorescence intensity or quenches it completely. 
The rationale to carry out this experiment is based on the assumption that if we mix 
the peptide and the lipid vesicles following the methodology described in the section 4.2.2.1, 
the peptides can be inserted in the membrane, randomly distributed as discussed in section 
4.2.2. These proteoliposomes can be labelled at both ends of the full length-peptide facing 
the aqueous media, assuming the orientation of the peptide is 50:50 meaning that half of the 
peptide will be oriented with the N- terminus facing the outer leaflet of the lipid vesicles 
while the other half will be exposing the C-terminus as shown in Figure 4-14. The labeling 
will be performed by the addition of excess compound #5, in a similar way as described in 
Chapter 3 section 3.3.12.2. Taking into consideration that compound #5 is unable to cross the 
lipid bilayer, after washing the excess of porphyrin by gel permeation chromatography we 
will end with proteoliposomes labelled in the outer leaflet of the membrane, with the N or C-
termini labelled depending on the peptide orientation relative to the bilayer (three possible 
scenarios depicted in Figure 4-14). Therefore in the outer leaflet, the labelling will results in 
the tryptophan and porphyrin being in close proximity, which we expect will induce a 
quenching of the tryptophan fluorescence. This hypothesis is supported by the work de-
scribed by Costa et al.196 summarized in section 4.2.1. 
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Therefore, after the excitation of tryptophan at 295 nm the fluorescence recorded will 
come presumably from the tryptophan facing the internal cavity of the liposomes. In this 
way, we might be able to identify the relative orientation of the peptide in our system.  
 
 
 
 
 
Figure 4-14. Schematic of the three possible membrane orientations of the full-length 
peptide with different quenching extents (A–C). A) The peptides are oriented with the 
tryptophan residues next to the outer leaflet. B) The conformation of the peptides is 
50:50 randomly distributed. C) Both peptides present the tryptophan residue located in 
the internal cavity of the liposomes. As illustrated, the reaction with the porphyrin 
might quench the fluorescence of the tryptophan only when the peptide is oriented with 
the N-terminus towards the bulk aqueous solution. Upon addition of the quencher (Q) 
all the fluorescence from the porphyrin moiety will be quenched; therefore, the only 
fluorescence registered should come from the tryptophan residues lying in the interior 
of the liposomes. 
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However, to make sure the porphyrin does not contribute to the fluorescence we will 
add an external quencher that is unable to cross the membrane. In this way, any fluorescence 
must come presumably from the tryptophan facing the internal cavity of the liposome. This 
approach offers a qualitative way to follow the orientation of the peptides. However, the fluo-
rescence measurements will be coupled with high pressure liquid chromatography (HPLC) to 
determine the yield of the labeled peptide. 
Due to the need to find a porphyrin quencher that does not cross the lipid membrane, 
as a starting point we tried the molecules p-Xylene –bis-(N-pyridinium bromide) and 1,1′-
diheptyl-4,4′-bipyridinium dibromide, based on a previous work by Miss Rimsha, an MSc 
student in our group. 
Briefly, the aim of her project was to synthetize a fluorescent probe (POC16), to ex-
plore the extent of lipid aggregation in model membranes. To this end, the fluorescent probe 
POC16, made of a pyranine hydrophilic head group and a C16 hydrocarbon chain was syn-
thetized (see Figure 4-15). To explore whether there was a preferential distribution of the 
fluorescent probe between the inner or the outer leaflets she performed some experiments 
with two fluorescent quenchers, p-Xylene –bis-(N-pyridinium bromide) (DPX) and 1,1′-
diheptyl-4,4′-bipyridinium dibromide (DPB) (see Figure 4-15). Her results showed that both 
compounds were able to quench the pyranine fluorescence in the presence of lipid vesicles 
composed of phosphatidylcholine with 100 nm diameter and that both quenchers were mem-
brane impermeable. Moreover, her experimental data demonstrated that DPB was a better 
quencher of the pyranine probe both in solution and in the presence of lipids. 
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Figure 4-15. Scheme showing the chemical structure of POC16, DPB, DPX, 
compound #5, and pyranine. 
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Based on these preliminary results and the fact that both pyranine and Compound #5 
are made of an aromatic core and contain three negatively charged sulfonate groups, we 
thought that it might be possible to use these quenchers to quench the fluorescence of Com-
pound #5. 
To address this, the initial experiment was to determine the concentration of DPX 
needed to quench the fluorescence of compound #5 without lipids. A solution of compound 
#5 (0.2 μM) was excited at 413 nm, corresponding to the maximum absorption of the Soret 
band, and the fluorescence emission was recorded between 430-900 nm (Figure 4-16 B). The 
fluorescence spectra showed two intense bands with maxima at 645 and 705 nm. After add-
ing small volumes of the stock solution of DPX we detected a decrease in the fluorescence 
emission of compound #5 from 100% to 48.6%. Figure 4-17 show how as the concentration 
of DPX increased, the fluorescence of the Compound #5 is quenched until it reaches a plat-
eau, where further addition of DPX does not quench the fluorescence any further. From the 
results, we determined that with 16.6 mM of DPX we reached the plateau with a quenching 
efficiency of approximately 51.4 % of the total fluorescence of Compound #5 in solution.  
Based on the results with DPB and pyranine (Figure 4-15), we decided to also explore 
this quencher with Compound #5. Interestingly, it is also reported in the literature as an effi-
cient quencher of the tetrakis (4-carboxyphenyl)porphyrin212. In fact, the structure of DPB, 
containing two long alkyl chains suggests a better interaction with the amphiphilic compound 
#5. Albeit, the presence of the polar charges in the molecule will preclude the quencher from 
crossing the lipid membrane as demonstrated by Miss Rimsha Anjum (Unpublished data). 
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Following the same protocol as discussed above we added small aliquots of DPB to a 
solution of compound #5 (0.2 μM). Figure 4-17 shows the same trend in the quenching of the 
fluorescence as observed with DPX. We determined that 0.44 mM of DPB was the concen-
tration at which the fluorescence quenching curve reach the plateau, therefore subsequent 
additions of the quencher do not improve the quenching of Compound #5 fluorescence in so-
lution. It was quite evident from the Figure 4-17 that lower concentrations of DPB produce a 
higher fluorescence quenching of Compound #5 than DPX. Although, in both cases the fluo-
rescence quenching was never 100%.  
 
Figure 4-16. Effect of quenching by the molecules used in this study on Compound #5. 
(A) The observed fluorescence intensity of compound #5 decreases with increasing 
concentration of DPB. (B) The observed fluorescence intensity of compound #5 de-
creases with increasing concentration of DPX. 
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In conclusion, we determined that the best quencher of the fluorescence of Compound 
#5 in solution was DPB. It was found that 0.44 mM of DPB was able to quench up to 99% of 
the fluorescence of compound#5 in PB 100 mM pH 7.2. Although these results are promising 
further experiments have to be done to explore the quenching ability of DPB on Compound 
#5 in the presence of lipid vesicles as it might be the case that more hydrophobic environ-
ments can have an impact on the quenching ability of DPB. However, experimental data 
from Miss Rimsha conducted with POC16 in the presence of lipid vesicles showed that DPB 
was still an efficient quencher of the POC16 fluorescence.  
Figure 4-17. Dynamic fluorescence quenching of the compound 
#5 at increasing concentration of DPX (λem = 645 nm). For the 
sake of comparison, the inset graph represents the fluorescence 
quenching by DPB on compound #5.  
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4.2.3 Studies of tetrasulphonate porphyrin binding to LUV 
In this section, we will describe the experiments done to explore the interaction of 
Compound #5 with lipid vesicles in the absence of peptides. These experiments will provide 
some preliminary data that are necessary before we address the more complex experiment of 
aggregation of the transmembrane peptide with Compound #5 as a clustering reporter. We 
plan to begin with the insertion of the peptides in the lipid vesicles freshly prepared. The fol-
lowing step will be the adding of excess Compound #5 to force the equilibrium towards the 
reaction with cysteines. As discussed in section 3.2.4 in Chapter 3 we need to use excess 
DTT to keep the sulfhydryl groups in the reduced state, to be available to react with the por-
phyrin. Afterwards, we will remove the excess of Compound #5 and DTT in solution. 
Achieving the maximum separation possible of the unreacted compound #5 from the labelled 
lipid vesicles is critical to accurately evaluate the extension of the peptide aggregation. The 
reason being is free porphyrin in solution will interfere with the read-out of bound Com-
pound #5. To determine qualitatively and presumably quantitatively the extent of the label-
ling reaction we will destroy the liposomes with a detergent e.g. Triton and the mixture will 
be analyzed by HPLC. Based on the different retention times between the labelled and unla-
beled peptides we expect to quantify the extent of the reaction, and possibly the amount of 
any unreacted porphyrin. The general steps briefly described above are represented in Figure 
4-18. 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
221 
 
 
Figure 4-18. Schematic representation of all the general steps envisaged in this study to 
achieve the chemical (labeling) reaction. Step A) Labeling of the proteoliposomes with excess 
of compound #5 in the presence of reducing agent DTT. Step B) Removal of the unreacted 
porphyrin and DTT by GPC. Step C) Release of the labeled and non-labelled forms of the 
peptides by solubilization of the lipid vesicles with TX-100 (Triton). Step D) Qualitative and 
quantitative analysis of the labeling reaction by RP-HPLC.  
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4.2.4 Effect of phosphatidylcholine liposome on the optical 
properties of compound #5. 
As we want to use compound #5 as a reporter of clustering, the first thing we set out 
on was to determine the interaction of #5 with LUV in the absence of any peptide. UV-vis 
spectroscopy was the method of choice because the spectroscopic signature of the porphyrin 
combined with a high extinction coefficient allow for determination of clustering constants in 
the low micromolar region (Figure 4-19). To begin, we determined the extinction coefficient 
of compound #5 in PB to be 218200 M-1cm-1 which was in the range expected for tetrasul-
fonate porphyrins in phosphate buffer pH 7.2 at 25 oC213.  
Figure 4-19. UV-vis spectrum of the tetrasulfonate 
porphryrin with the two characteristic regions of the porphy-
rin spectrum showing the Soret band in the near ultraviolet 
and the Q bands in the visible range. The inset graph shows 
the Q bands enlarged (480 -700 nm). 
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To assess whether the optical properties, i.e. extinction coefficient of compound #5 
will change in the presence of phosphatidylcholine liposomes we prepared 4 solutions of 
compound #5 at 2, 3, 4, and 5 µM with PC liposomes at 2 mM. The high concentration of PC 
was selected to evaluate the effect of lipids over the spectroscopic properties of compound #5 
(Figure 4-20) (See raw data in Appendix, Figure 6-8). 
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Figure 4-20. (2, 3, 4, 5 μM) in PB solvent. The spectra were cor-
rected for LUV light scattering of the liposomes (2 mM PC).The 
Soret and Q band are highlighted with a star. Inset: plot of ab-
sorbance at the maximum wavelength of Soret band (413 nm) 
versus nominal concentration. 
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The goodness of the scattering correction was qualitatively assessed by plotting the 
increase in the maximum intensity of the Soret band (λmax= 413 nm) versus the nominal con-
centration of compound #5. It can be seen that the relationship is linear (see Figure 4-20 in-
set) which indicates that the scattering effect was subtracted correctly from each sample. 
However, the most important issue here was to determine whether the lipids affect the 
UV-vis spectra of #5. We addressed this question by comparing the spectra of #5 in PB sol-
vent and in solution with 2 mM PC as shown in Figure 4-21. 
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Figure 4-21. The bathochromic shift in the Soret band of compound #5 
by increasing the hydrophobicity of the solvent (2 mM PC). The spectra 
also show the dependence between the intensity of absorption of the So-
ret band and the polarity of the solvent. 
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It can be seen that: 
- the maximum of absorbance of the Soret band displayed a bathochromic shift of 6 
nm, from 413 to 419 nm, in the presence of LUV (Table 4-2). 
-the intensity at the maximum wavelength of the Soret band is reduced by 23.4% 
(Table 4-2). 
 
We suggest that the changes in the spectroscopic properties of the porphyrin induced 
by LUV might be due to a binding event between compound #5 and the lipid vesicles. Both 
traces were recorded in PB 100 mM pH 7.2. 
 
 
 
 
 
 
Sample λMAX Abs (λMAX)  
#5 + PC (5μM) 419 0.36 
#5 alone (5μM) 413 0.47 
Table 4-2. Spectral position of the Soret band and the intensity at λmax for compound #5 in PB and 
in the presence of 2 mM PC. 
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4.2.5 Titration of compound #5 with PC liposomes to study 
the effect of the lipids over the spectroscopic proper-
ties (binding). 
To explain the results observed in the previous section we performed a titration of 
compound #5 with increasing concentrations of phosphatidylcholine liposomes according to 
the general protocol described in section 4.2.1.4 and in the experimental section. Briefly, in 
all solutions the concentration of Compound #5 was constant at 1.5 μM, whereas the phos-
phatidylcholine increased from 0 to 3.0 mM. Twelve solutions of phosphatidylcholine were 
prepared and added to Compound #5. The solvent was phosphate buffer at pH 7.2. The rec-
orded spectra, corrected for the scattering of the lipids, are shown in Figure 4-22 (raw, uncor-
rected spectra are shown in the Appendix, Figure 6-9). 
The starting point of the titration, called S0, is a solution of compound #5 in PB at pH 
7.2 without lipids. The spectrum of this solution showed the typical porphyrin Soret band 
with the maximum located at 413 nm. Addition of Compound #5 to the first titration point, 
corresponding to the lowest phosphatidylcholine concentration (1.46 μM), did not produce 
any change in the spectral position of the Soret band (λmax = 413 nm). However, there was 
an increase in the band intensity of approximately 18.3%. At intermediate concentrations of 
PC, between 1.46 μM and 5.86 μM, there was no increase in the intensity of the Soret band 
nor change in the spectral position (λmax = 413 nm) (S1-S4). At higher concentrations of PC 
(2.34 x 10-5 to 3.0 x 10-3 M) (S5 - S12), the Soret band undergoes a bathochromic shift (413 
to 419 nm) with a concomitant increase in the absorption intensity. At the maximum phos-
phatidylcholine concentration (3 mM), the band (λmax = 413 nm) disappeared. Consistent 
with the conversion of one species of porphyrin into another there is one isosbestic point in 
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the Soret band around 415 nm. Isosbestic points observed in UV-vis spectra of titrations are 
usually indicative of formation of a binding complex205.  
 
 
To explore the spectral changes at the different titration points we performed further 
analysis at the wavelength of the maximum for three of the spectra (S12, S5, S3). The maxi-
mum for each spectrum was determined by subtracting the spectral data of the starting point 
of the titration (S0). A plot of absorbance at the maximum changes at 413, 419 and 421 nm 
as a function of PC concentration can be seen in Figure 4-23. 
Figure 4-22. Curves obtained by titrating 1.5 μM of compound #5 with 
12-solutions of PC liposomes (1.46 μM to 3 mM). Transition from the 
free monomer to the binding complex is accompanied by a batho-
chromic shift in the absorption maximum (413 to 419 nm). The pres-
ence of one isosbestic point in the region 410-425 nm is also evidence 
of the existence of a binding complex. 
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Figure 4-23 showed that two chemically distinct species are present in solution. These 
species showed a distinct spectral position and different intensities for their Soret band ab-
sorption maxima. At 413 nm (Figure 4-23, red line) compound #5 (unbound) in the absence 
of liposomes is the only component present in solution (λmax = 413 nm). The other compo-
nent is only present upon addition of lipid vesicles. The second component appears in the 
first titration point, which corresponds to the lowest phosphatidylcholine concentration (1.46 
μM). As shown in Fig 4.23 red line, addition is followed by an increase in the Soret band in-
tensity at 413 nm of 18.4%, which is constant up to the fourth titration point (1.17 μM) after 
0.
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Figure 4-23. Absorption intensity of compound #5 (1.5 μM) vs in-
creasing concentration of phosphatidylcholine (0 – 3 mM) at λ= 413, 
419, 421 nm.  
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which the intensity decreases whilst a new band at 419 nm is formed (Figure 4-23, black 
line). The 419 nm band showed an increment in the intensity of absorption that correlates 
with the increase of the PC concentration.  
We think the increase of intensity in the Soret band at first titration point (1.46 μM) is 
due to complete solubilization of porphyrin #5 which is not 100% soluble in aqueous solvent 
and it is a well-known phenomenon observed with amphiphilic porphyrins110. The disappear-
ance of the 413 nm band and the appearance of the 419 nm band follow the same trend, this 
and the presence of one isosbestic point suggests that two species are present throughout the 
titration as mentioned before, i.e. the free porphyrin and the porphyrin-vesicle complex. 
Therefore we decided to plot the traces at 419 and 421 nm showed in Figure 4-23 and 
fitted them using a binding isotherm. We assumed here a simple 1:1 binding equilibrium with 
porphyrin as one species and phosphatidylcholine lipids as the second species. 
 
 
 
 
 
 
 Figure 4-24. Experimental and best fitted curves of 1:1 binding model at 419 and 421 nm 
of the titration experiments of constant porphyrin (1.5 μM) and 12 solution of lipid vesi-
cles with increasing concentration of phosphatidylcholine (1.4610-6 – 3.010-3 M). The 
binding constants were calculated from equation 15 in section 4.2.1.4. 
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The binding constants were obtained from equation 15 (see Section 4.2.1.4) after the 
fitting of the UV-vis data and are reported in Table 4-3. 
         Ka (419 nm) M-1        Ka (421 nm) M-1 
   8577±759           8602±1090 
                           
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 4-3. Binding constant (Ka) and error, calculated using  
equation (15), from the fitting of the UV-vis data at 419 and 
421 nm.  
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4.2.6 Separation of the compound #5 from PC liposomes by 
GPC column. 
As mentioned in the introduction (see Section 4.2.3), for labelling peptides compound 
#5 will be use at least 10-fold in excess (100 μM) compared with the amount of peptide (10 
μM). This excess of porphyrin will ensure that all the peptide available will react, by forcing 
the equilibrium towards the formation of the adduct porphyrin-peptide. However, to guaran-
tee that all the spectroscopic data used in determination of the clustering is produced by the 
compound #5 –peptide adduct we need to remove all the unreacted porphyrin from the sys-
tem. Obviously, any excess of porphyrin will contribute to the absorbance and fluorescence 
in a similar way as the target adduct compound #5-peptide. This interference will be directly 
proportional to the amount of unbound compound #5 present in the system and will affect 
negatively the accuracy in the determination of the clustering constant. 
As shown in Figure 4-18 step B, the reaction between LUV containing peptide and #5 
will require removal of excess porphyrin. From the inverse of the binding constant deter-
mined in section 4.2.5 for binding complex compound #5-phosphatidylcholine we calculated 
the dissociation constant, Kd = 117 μM. The dissociation constant is usually used to indicate 
the strength of binding, thus, presumably we have around 50% porphyrin bound at 117 μM. 
To perform the separation we decided to use the gel permeation chromatography 
method (GPC)214, 215. GPC is a chromatographic technique that allows the separation of indi-
vidual components in the sample based on their differential size. Briefly, the sample of inter-
est is dissolved in a mobile phase that is forced to pass through the stationary phase, usually 
porous gels beads packed into a column. The smaller components of the sample are trapped 
in the adsorbent bed, thus taking more time to pass through the column. By contrast, the larg-
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est particles, i.e. lipid vesicles, cannot traverse the porous column easily and will pass 
through quickly, eluting first.  
It has been shown that Sepharose 4B (see Solution and Reagents section) is the best 
matrix that allows the separation of 100 nm sized vesicles from small molecules, therefore a 
column packed with that matrix was prepared110, 216. 
Based on the binding studies in section 4.2.5 that showed a relatively strong degree of 
interaction (Ka = 8577 M-1, Kd = 117 μM) in the sense that at 100 μM of Compound #5 we 
expect to find ~50% of the porphyrin bound to the phosphatidylcholine we decided to per-
form a GPC column separation to remove the excess of porphyrin. Briefly, we prepared a 
sample containing phosphatidylcholine vesicles (10 mM) and 100 μM Compound #5, we left 
it for 30 minutes at room temperature and then we proceed to inject the mixture into the GPC 
column. 
To determine how much porphyrin was effectively removed from the vesicles we 
pooled the collected fractions containing the liposomes. Fractions were easily identified due 
to the turbidity; we also collected the fractions immediately before and after the appearance 
of turbidity to ensure full recovery of lipid vesicles.  
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The determination of the amount of porphyrin bound to the lipid vesicles was calcu-
lated by UV-vis spectroscopy at 413 nm. The spectra were corrected for the scattering of li-
pid vesicles and the dilution factor was determined by measuring the volume of the pool frac-
tions containing the liposomes-porphyrin mixture. Of note, the volume of lipid-porphyrin 
mixture loaded on the column was also determined. The calculated amount of bound porphy-
rin was 22.3 μM. In summary, we were able to remove with this method around 77.7% of the 
total porphyrin added to the sample (Figure 4-25). 
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Figure 4-25. Plot showing the UV-vis traces –corrected for 
light scattering and Raw data-collected from the pooled 
fractions of lipid vesicles containing compound #5. The 
inset table shows the value of the maximum absorbance 
(λmax 413 nm) used to calculate the concentration of the 
compound #5 bound to the vesicles. 
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Despite achieving a good separation of porphyrin from the liposomes with one GPC 
column (~78%) the remaining porphyrin (~22%) was still too high. The minimum amount of 
unreacted porphyrin that can be tolerated should not exceed 3% of the total porphyrin (100 
μM), otherwise, the unbound porphyrin will interfere with the measurement of the clustering 
based on the relative values of association constants, i.e. 8577 M-1 for compound #5. There-
fore, we decided to add γ-glutathione (GSH) to the mixture of compound #5 and liposomes to 
improve the separation. Figure 4-28 shows graphically the aim of this experiment. 
 
Figure 4-26. Schematic representation of the equilibrium established during the separation of 
compound #5 from the liposomes by the GPC column. A) Addition of compound #5 and 
binding to the lipid surface. B) Addition of reduced hydrophilic glutathione to the mixture 
LUV + #5 and reaction of #5 with the glutathione. C) The more polar adduct compound #5-
gluthathione is now more susceptible to be detached from the hydrophobic surface of lipo-
somes facilitating the clearance of unreacted porphyrin.  
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γ-glutathione is a hydrophilic small tripeptide, composed of glycine, cysteine, and 
glutamic acid, of biological relevance (see Chapter #3, section 3.2.3.2). As we showed in 
Chapter #3, section 3.3.12.2 the adduct compound #5-gluthathione is more hydrophilic than 
Compound #5 alone as demonstrated by its shorter retention time of ~10.9 minutes against 
12.1 minutes, in reverse-phase high pressure liquid chromatography (RP-HPLC) (Scheme 4-
2). 
 
Based on this result, we decided to perform the reaction between the maleimide-
porphyrin and the glutathione to increase the polarity of the porphyrin. Presumably, the more 
polar adduct Compound #5-gluthathione will have less affinity for the phosphatidylcholine 
lipid vesicle, therefore we expect to remove more porphyrin. 
 
Scheme 4-2. Chemical structure of the compound #5, γ-glutathione and the adduct com-
pound#5-gluthathione used in this study. 
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Figure 4-27 shows how the separation was in fact improved. We were able to remove 
up to 93% of the total porphyrin present with ~7 μM of unreacted bound porphyrin.  
 
 
As mentioned before the limit of unreacted porphyrin tolerated in the lipid vesicles 
cannot exceed 3.0 μM. Thus, we needed to implement a different method to improve the pre-
vious results. Following the same principle as described above, with GSH included, we de-
cided to run the GPC and three washes with a concentrator device. 
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Figure 4-27. Plot showing the UV-vis traces of the fraction of 
porphyrin bound to the liposomes in the two experiments, without 
GSH and with GSH. The inset table shows the value of the max-
imum absorbance (λmax = 413 nm) and the concentration of  
compound #5 bound to the lipid vesicles. 
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With the GPC column, we removed the huge excess of porphyrin present in the mix-
ture as shown in the previous experiment. The fractions collected from the column were fur-
ther diluted with 20 ml of PBS containing GSH (1 mM) to wash the liposomes. The mixture 
was then concentrated to approximately 500 μl using a Vivaspin concentrator. This is a dis-
posable ultrafiltration device designed for the concentration of aqueous and biological sam-
ples. Each concentrator contains a molecular weight cut off (MWCO) membrane (50000 
PES), that allows the selective filtration of molecules smaller than the membrane cut off, 
while retaining those molecules with molecular weight above the MWCO. The membrane is 
placed in a vertical chamber that provides high-speed concentration, with low fouling, even 
with particle-laden solutions and is illustrated in Figure 4-28.  
However, in order to improve the separation the incubation with GSH was extended 
to one hour. The reason being was to force the reaction of compound #5 with the GSH, there-
fore removing more porphyrin from the liposomes by forcing the binding equilibrium to-
wards the dissociation from the vesicles. 
Figure 4-28. Vivaspin concen-
trator of 20 ml capacity used in 
this study. 
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Figure 4-29 shows the results obtained in the separation of the porphyrin with one 
GPC column and three washes with the 20 Vivaspin concentrator. After the third concentra-
tion step we achieved the removal of 98.2% of the total porphyrin added (100 μM). 
 
In conclusion, with the introduction of the concentration step using a 20 ml capacity 
dispositive we were able to remove up to ~98% of free porphyrin from liposomes. The re-
maining ~2% of compound #5 was within the acceptable range (less than 3.0 μM) that can be 
tolerated in the measuring of clustering. 
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Figure 4-29. UV-vis curves showing the amount of por-
phyrin bound to the liposomes after the first gel permea-
tion chromatography (Pool I), and the three steps of dilu-
tion and concentration (Conc. 1, 2, 3). The inset table 
shows the values of the absorbance at 413 nm and the 
concentrations of the porphyrin bound to the liposomes. 
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4.2.7 Study of LUV solubilisation by Triton-X and its effect 
on porphyrin optical properties. 
We next went on to determine the conditions to destroy the liposomes by measuring 
the scattering of the light in a solution of 1, 2.5, and 5 mM PC liposomes by UV-vis spec-
troscopy. Triton X-100 (Scheme 4-3) is one of the most common detergents to solubilize 
membranes in the laboratory and recover any component assembled in membrane217, 218. 
 
 
 
TX-100 is usually considered a fast solubilizing detergent that can easily flip from the 
outer to the inner monolayer causing a rapid solubilization219-221, but its surfactant function 
depends both on temperature222 and the lipid phase223. The solubilization mechanism pro-
posed by Goñi et al.221 is described in Figure 4-30. 
 
Scheme 4-3. Panel showing the chemical structure 
of Triton X-100 (TX-100). 
Figure 4-30. Illustration of the solubilization mechanism. The detergent mole-
cules approach the lipid bilayer (step A). Formation of mixed lipid/detergent ag-
gregates (step B). Dissociation of the whole bilayer into mixed micelles (step C). 
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Since we will perform the labeling reaction of Compound #5 with peptide in the pres-
ence of lipids, we need to define the conditions to get rid of the liposomes and liberate the 
thiol-5 adduct to be quantified by HPLC and spectrophotometry. This experiment will help to 
elucidate and optimize the method for the reaction with the transmembrane peptide.  
 
In conclusion, a solution of 75 mM of TX-100 was able to solubilize the lipid vesicles 
at 1, 2.5, and 5 mM PC in PB. Figure 4-31 shows the UV-vis traces recorded for each solu-
tion of liposomes at 1, 2.5, and 5 mM without TX-100 with the typical slope increase due to 
the light scattering of the lipid vesicles. As shown in the inset, after addition of TX-100, the 
light scattering disappears due to full solubilization, or destruction, of the lipid vesicles. 
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Figure 4-31 Solution of liposomes with 1, 2.5, 5 mM PC 
in PB and Triton X-100, respectively. The inset shows 
how in the region (300-700 nm) the light scattering dis-
appears when the liposomes are treated with TX-100. 
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4.2.8 Reaction of compound #5 and the peptide control fol-
low by HPLC. 
Reverse Phase High Performance Liquid Chromatography (RP-HPLC) is a technique 
in analytical chemistry that permits separation, analysis and quantification of components in 
a complex mixture. In this technique, the stationary phase is a non-polar matrix and the mo-
bile phase a mix of two solvents, usually water in combination with a less polar solvent, such 
as methanol, acetonitrile, etc. In RP-HPLC, the sample is first injected into the system and 
with the help of two pumps is forced to flow into the column. Once the sample enters in con-
tact with the stationary phase, the less polar molecules will be retained in the column longer, 
due to hydrophobic interaction with the matrix, while more polar molecules will elute earlier. 
Playing with the polarity of the mobile phase and the flow rate, the user can modify the reten-
tion times of the different components in the mixture.  
To analyze the reaction with compound #5 (see Figure 4-18, section 4.2.3) we decid-
ed to begin studying the reaction with the control peptide. The reason being is the control 
peptide is less hydrophobic than the full-length transmembrane peptide and contains only one 
thiol. Hence, the control peptide will presumably be easier to establish the conditions to 
achieve a successful separation. Our first aim was to determine the retention time of all the 
species involved in the reaction. For example, compound #5 and hydrolyzed compound #5 
which is a non-reactive species were investigated in the Chapter 3, section 3.3.12. In addition 
the retention time of reduced peptide control, and the compound #5-peptide control adduct 
will be determined. 
 
Chapter 4 
242 
 
However, we will also determine the retention time of the oxidized control peptide. 
Although the reaction will be carried out in the presence of 1, 4-dithiothreitol and presuma-
bly, no oxidized peptide will be present, by knowing the retention time of the oxidized form 
we will make sure the control peptide has been reduced to the reactive form. 
The first sets of measurements were performed with a C18 column to determine the 
retention time of the fresh peptide control. A C18 column contains an alkyl chain of 18 car-
bons tethered to the stationary phase of the column, granting a better hydrophobicity to the 
matrix and allowing the best retention times in the separation. To begin, we injected three 
solutions of 250, 100 and 10 μM of the peptide control dissolved in dimethylsulfoxide, re-
spectively. Figure 4-32 shows the chromatogram for the three samples. The run time was 15 
min, flow rate 1 ml/min, and the solvents were acetonitrile (0.1% trifluoroacetic acid)/water 
(0.1% trifluoroacetic acid). The detector lamp was set at 280nm, due to the presence of tryp-
tophan in the peptide control. 
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Figure 4-32. HPLC traces of three solutions of the peptide control at 10, 100, and 250 
μM. Run time 15 min, λ = 280 nm, MeCN/Water (0.1% TFA), 0-15 min, 0-90% MeCN  
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From these injections, we determined the retention time of the peptide control around 
11.5 minutes. In addition, we proved that RP-HPLC is also sensitive enough to detect con-
centrations of peptide control as low as 10 μM.  
Based on these results we concluded that it was possible to follow the disappearance 
of peptide should the labeling reaction occur from starting concentrations as low as 10 μM. 
Importantly, the results reported in Figure 4-32 were run with the same mobile phase used 
previously for the separation of compound #5 and hydrolyzed compound #5 (see Chapter #3, 
section 3.3.12). 
We decided then to determine the retention time of the peptide control under the same 
parameters used for the identification of the retention time of compound #5, i.e. run time 25 
min, flow rate 1 ml/min, acetonitrile (0.1% trifluoroacetic acid)/water (0.1% trifluoroacetic 
acid). Here, as mentioned before, the detector was set at 280 nm due to the presence of aro-
matic tryptophan. The aim of this experiment was to use a separation method that presuma-
bly could be used in the detection of all the components present in the reaction mixture. Fig-
ure 4-33 shows the retention time of the peptide control was around 14.7 minutes.  
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The injection (100 μM) was prepared from a stock of 250 μM of the peptide control 
in dimethylsulfoxide from the lyophilized starting material kept at -20 oC to avoid oxidation. 
All the injections of the peptide control were made from the stock in dimethylsulfoxide due 
to the poor solubility of the peptide control in phosphate buffer pH 7.2. From here onward, 
all injections done were made applying the separation parameters mentioned before. 
Figure 4-33. Chromatogram of 100 mM of fresh peptide 
control injected in the RP-HPLC. The peaks labeled at 
14.7 minutes belong to the reduced form of the control 
peptide. The first peak in the figure represents the 
DMSO that absorbs at 280 nm. 
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To determine the retention times of the oxidized forms of the peptide control we pre-
pared a sample of 100 μM from a stock of peptide control in dimethylsulfoxide that presum-
ably contained an important fraction of oxidized peptide control. In fact, in section 3.3.2 of 
Chapter 3 we demonstrated that 30% of the peptide control was oxidized in a fresh stock in 
phosphate buffer pH 7.2 at 0 minutes, and more than 50% of peptide control was oxidized 
after 4 hours.  
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Figure 4-34. Chromatogram of 100 mM of an old stock 
of the peptide control showing three peaks at 14.5, 15.3 
and 16.2 minutes. The first peak belongs to DMSO.  
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Analysis of the chromatogram showed there were three species present in the sample 
prepared from the old stock of the peptide control in dimethylsulfoxide. The first species 
eluted at 14.5 minutes and represented around 40% of the total sample. The next signal was 
recorded at 14.7 minutes and corresponded to the reduced form of the peptide control (17%). 
The last peak recorded at 15.3 minutes represented the 43% of the remaining peptide control. 
The calculation of the percentages was obtained from the integral of the peaks automatically 
calculated from Agilent Software. 
 Interestingly, instead of the two peaks expected, one for the reduced and one for the 
oxidized form of the peptide control, we recorded three peaks. A possible explanation for this 
observation could be the presence of two forms of the oxidized control peptide instead of 
one. In fact, in the literature the cyclization of the peptides is described. We hypothesized the 
species eluted at 14.5 minutes, very close in retention time to the reduced form of the peptide 
control -probably just a different conformation of the peptide- could be a cyclic form of the 
peptide but this is just a speculation that needs to be further demonstrated. The other species 
(RT=15.3 minutes) we think could belong to two peptides linked by the disulfide bridge; the 
higher hydrophobicity of this species could explain the long retention time in the column. 
The retention time of the reacting species i.e. compound #5 (as determined in Chapter 
#3 section 3.3.12), and the peptide control (as previously shown) is sufficiently distant to al-
low the study of the labeling reaction via RP-HPLC. 
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The first reaction followed by RP-HPLC was compound #5 (250 mM  and the fresh 
peptide control (10 mM) in PB pH 7.2 (Figure 4-35). The reaction was left for 30 minutes at 
RT and no reducing agent was added because the stock was freshly prepared from a lyophi-
lized aliquot of the peptide control kept at -20oC (See Data in Chapter #3 section 3.3.2 for the 
oxidation status of the peptide control in phosphate buffer pH 7.2 at time zero).  
 
 The separation was followed by the absorbance of the porphyrin at 430 nm. In this 
way, we make sure that all the signals recorded come from the different species of the com-
pound #5 in the mixture. The first signal recorded in the chromatogram was the peak at 11.4 
minutes, which corresponded, as previously shown, to the hydrolyzed form of compound #5. 
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Figure 4-35. Chromatogram illustrating the peaks ob-
tained in the reaction between 250 mM of compound #5 
and 10 mM of the peptide control in PB 100 mM pH 7.2. 
Labeled peaks at RT: 11.4, 12, 14.2 minutes, they corre-
spond to the hydrolyzed compound #5, the unreacted 
compound #5, and #5-peptide control adduct, respective-
ly. 
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The following signal at 12.0 min belonged to the unreacted compound #5. We suggest the 
peak with a retention time of 14.2 minutes represents the compound #5-peptide control ad-
duct. From the chromatogram, using the integrals of the peaks for each signal we determined 
that approximately 4% of the porphyrin reacted with the peptide control, which means that 
all the peptide control (10 mM) reacted with compound #5 (250 mM), as 10 μM is the 4% of 
250μM. From this experiment, we concluded that it is possible to follow up quantitatively the 
labeling reaction via RP-HPLC. 
Although the reaction with thiol and maleimide is really fast, and the control peptide 
freshly prepared shows little oxidation; the fact is that after 1 hour approximately 50% of the 
control peptide is oxidized (Chapter #3 section 3.3.2). Therefore, we decided to test the reac-
tion in the presence of the reducing agent glutathione. glutathione was introduced previ-
ously in this chapter in section 4.2.6; we just want to point out here that it is a small peptide 
of biological relevance that is widely used as a reducing agent. In this reaction, equimolar 
solutions of peptide control (20 μM) and glutathione (20 μM) were mixed and incubated for 
15 minutes. Then, a solution of compound #5 (50 μM) 2.5 times in excess was added taking 
into consideration that both, the unreacted glutathione and the reduced peptide control can 
react with the maleimide group of compound #5. The reaction was injected at time 0 and af-
ter 30 minutes of incubation and the detector was set at 430 nm (Figure 4-36). 
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From the previous determination of the retention time of adduct Compound #5-
gluthathione (Chapter 3, section 3.3.12.2) we assigned the first peak recorded at 11.1 minutes 
to the adduct #5-gluthathion. Based on the integral of the peaks retrieved from the chromato-
gram, we determined the percentages of each peak, by dividing the integral of each peak by 
the total area obtained from the sum of the integrals that were assigned to the porphyrin spe-
cies. In this way, we determined that the peak at 11.1 minutes represented ~62% of the total 
compound #5 used in the reaction. The following peak (11.5 minutes) belonged to the Com-
pound #5 hydrolyzed (24%) and the next peak at 12.1 minutes to the unreacted Compound #5 
(10%). The peak at 14.2 minutes constituted ~ 1% of the total Compound #5 and represented 
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Figure 4-36. Chromatogram illustrating the peaks obtained 
in the reaction between 50 mM of compound #5 and 20 
mM of the peptide control in the presence of 20 
mM glutathione. The peaks at RT: 11.1, 11.5, 12.1, 14.2, 
14.5 and 15.2 minutes, correspond to #5-gluthathion ad-
duct, compound #5 hydrolyzed, compound #5 unreacted,  
#5-peptide control adduct, and two unidentified peaks.  
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the adduct #5-peptide control. The peaks at 14.5 and 15.2 minutes, respectively, could repre-
sent the existence of some conformations of the reduced peptide control that reacted with the 
porphyrin. This suggestion implied the peptide control had available thiol groups to react 
with the maleimide function. From the analysis of these data, we concluded that glutathione 
competed with the peptide control in the reaction with Compound #5. These results reinforce 
the idea of the necessity to reduce the peptide control in a step before the labeling reaction. 
We think that separation of the reducing agent from the control peptide via GPC column sep-
aration or even HPLC before the labelling reaction would be a good approach to increase the 
yield of the reaction. 
We moved forward and decided to test the reaction in the presence of an alternative 
reducing agent.  As we had performed the reaction with TCEP (2-carboxyethyl-phosphine) 
(see Chapter 3, section 3.3.8) we decided to test this compound instead. As mentioned be-
fore, TCEP is a well know reducing agent of thiols, especially used in proteomics for the re-
duction of cysteines in peptides and proteins156. For the reaction 10 μM of peptide control 
was mixed with 50 μM of TCEP to ensure full reduction of the peptide control. To this mix-
ture, we added the solution of compound #5 to reach 100 μM. Compound #5 was added in 
excess to make sure the peptide control reacts with the porphyrin. As previously shown in 
Chapter 3 section 3.3.8, TCEP reacts with the maleimide group of Compound #5. The reac-
tion was injected into the RP-HPLC at time 0 and 30 minutes after incubation to qualitatively 
evaluate the kinetics of the reaction (Figure 4-37). 
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At time 0, we determined that 51% of Compound #5 remained unreacted (RT = 12 
min), whereas 13% corresponded to the hydrolyzed form of #5. The peak at 10.9 min was 
assigned to the #5-TCEP adduct, based on the high polarity of this complex we expect it to 
elute first. The peaks at 11.5, and 12.0 minutes, which were previously identified, will be de-
scribed later here. There was also a small peak at 11.3 min that we assigned to the hydro-
lyzed #5-TCEP adduct. In the inset graphic, we showed the adduct of #5-peptide control rec-
orded at 14.2 min, which represented ~1.5% of compound #5 available. The peak at 14.4 min 
accounts for 1% of the total #5. At 30 min, compound #5 present in the mixture diminished 
to 15% and the hydrolyzed #5 increased to 22.1%. The peak at 10.9 min that corresponds to 
the #5-TCEP adduct increased to 46% as well as the hydrolyzed form of the adduct that 
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Figure 4-37. Chromatograms of reaction of compound #5 and  
peptide control in the presence of TCEP. The graphic above rep-
resents the reaction recorded at time 0; while the chromatogram 
below the reaction after 30 minutes. The inset graph shows the 
two small peaks belonging to the product of compound #5 and 
the peptide control. 
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reached 14%. The signal belonging to the #5-peptide control adduct increased to 1.5%, while 
the peak at 14.4 min did not show any appreciable change.  
In conclusion, we could detect the presence of the compound #5-peptide control ad-
duct in the presence of the reducing agent TCEP at 14.2 min. However, the reaction of com-
pound #5 with the TCEP is considerably fast and competes with the peptide control in adduct 
formation. This data reinforce the idea of performing the reduction of the sulfhydryl group in 
a previous step, with the elimination of the reducing agent before the labelling reaction.  
In summary, although we could detect #5-peptide control adduct in the one pot reac-
tion with both γ-glutathione and 2-carboxyethyl-phosphine (TCEP) by RP-HPLC, the results 
shown in here suggest that the separation of the reducing agent before the labeling reaction is 
advisable in order to avoid competition for the maleimide moiety and improve the yield of 
the product. 
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4.3 CONCLUSIONS AND FUTURE WORK 
The first part of this thesis aimed to develop a chemical biology approach to elu-
cidate the mechanism of T cell receptor (TCR) signaling. We pursued to create an un-
complicated system constituted by a cluster reporter (porphyrin) and a model membrane 
(PC vesicles) to study in detail the aggregation of the TCR transmembrane peptide. The 
below point summarize the main accomplishments of the first part of this thesis: 
a)  The synthesis of the cluster reporter (5-(4-maleimide)-10, 15, 20 tris (4 - sul-
fonatophenyl) – porphyrin, trisodium salt) (Compound #5) was successfully 
achieved with optimization of the original method. 
b) Successful determination of the extinction coefficient of the Compound#5. 
c)  Reaction of the Compound #5 and model thiols e.g. N-acetylcysteine, and 
glutathione was successfully achieved in order to determine the chemistry to 
perform the labeling reaction with the transmembrane peptide. 
d) Interaction studies of the Compound #5 and PC vesicles with determination of 
binding parameters was achieved. 
e) Separation of the compound #5 from PC vesicles by GPC was successfully 
achieved. 
f)  Determination of the optimal conditions to quench the fluorescence of the 
compound #5 was accomplished. 
g) Successful reaction between the Compound #5 and the peptide control to form 
the adduct 5-peptide control was achieved. 
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This preliminary study have shown interesting results. However, there remains much 
work to be done on the construction of the chemical model to address the TCR signaling 
mechanism. One of the major achievements of this project was to synthetize the cluster re-
porter and to test the conditions to satisfactorily perform the labeling reaction. However, be-
cause the complexity of the chemical system require many optimizations and the time availa-
ble was limited we were unable to test the aggregation of the full-length transmembrane pep-
tide in the phosphatidylcholine vesicles. Therefore, future work could aim to: 
1. Test the aggregation properties of the full-length transmembrane peptide 
based on the preliminary results achieved in this thesis. 
2. Redesign the composition of the artificial membrane to introduce major struc-
tural lipids present in eukaryotic membranes, particularly in lymphocytes, 
such as phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, 
phosphatidylinositol, and phosphatidic acid. 
3. Include the transmembrane peptide of the TCRδ chain may be particularly 
important as the TCRγδ receptor is a heterodimer. 
4. Achieve the reduction of the sulfhydryl group is critical to ensure the labeling 
reaction with the maleimide moiety of the porphyrin reporter, therefore find-
ing appropriate reducing agents will be very useful and require more study. 
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4.4 EXPERIMENTAL SECTION 
4.4.1 Solutions and Reagents 
The ethanol (Fisher) for the preparation of the liposomes was of analytical grade. De-
ionized water was obtained from water purifier purelab instrument (ELGA). 
The L-α-phosphatidylcholine (PC) from egg yolk was from Avanti Polar lipids, Inc. 
The γ-glutathione, 1, 4-dithiothreitol (DTT), tris (2-carboxyethyl) phosphine (TCEP), was 
purchased from Sigma-Aldrich with analytical grade purity. The inorganic salt, sodium 
phosphate monobasic dihydrate used in the preparation of the buffer was also of analytical 
grade purity. The matrix for the GPC column was Sepharose 4B (4B200), 45-165 μm bead 
diameter, 30,000-50,000 Da fractionation range (Dextranus). 
The control peptide and full-length peptide were purchased from PeptideSynthetics. 
All the reactions were performed at room temperature on the bench. 
4.4.1.1 Compound #5 stock solution 
The stock solution of compound #5 (P1) (1015.96 g/mol) [5] = 5 mM was prepared in 
PB 100 mM pH 7.2 and aliquoted in several tubes (50 μl) and stored at -20 °C. The aliquots 
were defrosted one by one. The aliquot on use was frozen back until needed again. 
4.4.1.2 Phosphate Buffer 
For the preparation of the phosphate buffer 100 mM pH 7.2. 12.0 gr of sodium mono-
basic phosphate salt (119.98 g/mol) was dissolved in 500 μl of distilled water. This solution 
was treated with sodium hydroxide (10 M) to adjust the pH to 7.2. The solution was then 
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topped up with distilled water to reach a final volume of 1 L. The buffer phosphate was kept 
in a fridge at 4 °C. 
4.4.1.3 γ-Glutathione stock solution 
A fresh preparation of the GSH (307.32 g/mol) stock was carried out for every reac-
tion. As 30% of the glutathione in the stock was already oxidized, determined with the 
DTNB test, the amount of GSH was adjusted to correct for this. 8.78 mg of reduced GSH 
was dissolved in 2 ml of PB 100 mM pH 7.2 to produce a solution of [GSH] = 10 mM. 
4.4.1.4 Preparation of the stock of 1, 4-dithiothreitol (DTT) 
The stock of DTT was prepared by weighting 1.29 mg (8.4 x 10-6 mol) of solid DTT 
in 7 ml of PB 100 mM pH 7.2, the final concentration 0.0012 M. The pH was checked to be 
seven. 
4.4.1.5 Control peptide solution stock 
The control peptide stock (1.00 mg, 5.0 x 10-7 mol) was prepared in DMSO to a final 
concentration of 250 μM. From this stock two new stocks of 12 μM were prepared by dilu-
tion (Vf = 6 ml) in PB 100 mM pH 7.2 and in DTT 1.2 mM. 
4.4.1.6 Full-length peptide solution stock 
The full-length peptide stock (1.20 mg, 2.15 x 10-7 mol) was prepared in 0.5 ml of 
DMSO to a final concentration of 359 μM. From this stock two new stocks of 12 μM were 
prepared by dilution (Vf = 6 ml) in PB 100 mM pH 7.2 and in DTT 1.2 mM. 
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4.4.2 Determination of the light scattering of the phospha-
tidylcholine liposomes. 
A film of 10 mM PC was prepared by pipetting 1.85 ml of 6.5 mM stock solution of 
the PC in ethanol. The ethanol was evaporated under nitrogen until a dry white layer was ob-
served on the walls of the vial. The film was re-suspended in 1.2 ml of PB 100 pH 7.2, with 
1-minute mix and sonication. The milky solution was loaded in the extruder and extruded 25 
times. From the extrusion, 1 ml of liposomes was recovered and the UV-vis spectrum record-
ed in the range 240-700 nm. The buffer PB 100mM pH 7.2 UV-vis spectrum was also rec-
orded. Afterwards, the cuvette was washed and dried. The rest of the solutions were prepared 
in the cuvette by diluting the solution of the extruded liposomes by 50% with PB and up to 
100 µM PC. After the addition of the buffer every sample was carefully mixed and immedi-
ately introduced in the instrument and recorded. The cuvette was carefully washed and dried 
in between all the measurements. The final concentrations prepared for these experiments 
were: 5, 2.5, 1.25, 0.62, 0.31, 0.15, 0.07, 0.03, 0.01 mM.  
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4.4.3 Solubilization of the liposomes with Triton X-100. 
To Triton X-100 (1 g, 1.54 mmol) 20 ml of phosphate buffer 100 mM, pH 7.2 were 
added to prepare a 75 mM solution of Triton X-100. The solution was stirred until the Triton 
was completely dissolved. A fresh solution of 10 mM PC liposome (as described before) was 
prepared and from this stock were made six working solutions at 5, 2.5, 1 mM in PB or Tri-
ton (Tables 4-4, 4-5, 4-6) were made. Each working solution was homogenized and immedi-
ately after the measurements of the light scattering was done by UV-vis spectroscopy. The 
absorbance of 1 ml of PB 100 mM was measured and used as blank. The determinations of 
the absorbance spectra of all the sample solutions were performed quickly with a wash/dry 
step intercalated between measurements. The spectrophotometer was set up to record the 
spectrum between 240-700 nm with baseline correction. 
 
A (Stock PC (mM)         [PC]  (mM) VA (μl) V PB (μl) 
6.5 10 1.85 1200 
Table 4-4. Details of the reagents used in the preparation of the working stock solution of PC. 
 
[PC] (mM) VA 10mM (μl) V PB (μl) 
5 500 500 
2.5 250 750 
1 100 900 
Table 4-5. Details of the reagents used in the preparation of the three working solution 5, 2.5, 1 mM 
PC in PB. 
 
[PC] (mM) VA 10mM (μl) V TRITON (μl) 
5 500 500 
2.5 250 750 
1 100 900 
Table 4-6. Details of the reagents used in the preparation of the three working solution 5, 2.5, 1 mM 
PC in Triton X-100. 
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4.4.4 Effect of the phosphatidylcholine liposome in the op-
tical properties of the compound #5. 
Fresh solution of liposomes of 10 mM PC were prepared by extrusion as described in 
the previous pages. An aliquot of the compound #5 (3.9 mM) was thawed and diluted 1:100 
with 100 mM PB pH 7.2 to prepare a working solution of final concentration 39 μM. For the 
preparation of the samples PB 100 mM pH 7.2 was added to each tube previously labelled. 
Afterwards we added the amount of the working stock of 5 (39 μM) to have the solutions of 
2, 3, 4, 5 μM, and each solution was carefully mixed. Finally, we added the volume of the 
liposomes to achieve the final concentration of 2 mM in each solution. The samples were 
mixed and ready for the UV-vis (Table 4-7). 
The UV-vis measurements were recorded in a Cary Agilent brand Spectrophotometer. The 
quartz cuvette was filled with 1 ml of sample solution and recorded in the region 240 – 700 
nm with baseline correction against the buffer phosphate. The cuvette was cleaned and dried 
between measurements. 
[#5] (μM) [PC] (mM) V PC 10mM  (μl) V Stock 5 (μl) V PB  (μl) 
2 2 200 51.3 748.7 
3 2 200 76.9 723.1 
4 2 200 102.6 697.4 
5 2 200 128.2 671.8 
Table 4-7. Volumes of the solutions used in the preparation of the four working stocks at 2, 3, 4, 5 
μM of the compound #5 and 2 mM of PC liposomes. 
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4.4.5 Effect that Triton X-100 has over the optical proper-
ties of the compound #5.  
A fresh stock of PC liposomes 10 mM PC was prepared in PB 100 mM pH 7.2 by ex-
trusion.  The working solution (39 µM) of compound #5 was prepared by 1:100 dilution of 
freeze aliquot (A1) (3.9 mM). These two stocks were used to prepare two sets of experiments 
in which three samples of PC liposomes at 0.5, 1.0, and 2.0 where mixed with the compound 
#5 to reach a final concentration of 5 µM. The first the experiemnt was prepared with PB 100 
mM pH 7.2, while the second experiment was prepared with Triton X-100. The preparation 
of the samples were as follows: first the PB/Triton X-100 was added to the tube, immediately 
after the volume of stock solution of compound #5 was added to reach 5 µM. The mixture 
was stirred and then PC liposomes were added and mixed. UV-vis spectra were recorded us-
ing a quartz cuvette of 1 cm path length, range 240 < λ < 700 nm, and baseline against air 
(Tables 4-8 and 4-9). 
[PC] (mM) [#5] (μM) V stock #5 (39 μM) V stock (10mM PC) V PB 
0.5 5 128.2 50 821.8 
1 5 128.2 100 771.8 
2 5 128.2 200 671.8 
Table 4-8. Details of the volumes used for the preparation of the three samples of 0.5, 1.0, and 2.0 
mM PC in PB at a constant concentration of the compound #5. 
 
[PC] (mM) [#5] (μM) V stock #5 (39 μM) V stock (10mM PC) V TRITON 
0.5 5 128.2 50 821.8 
1 5 128.2 100 771.8 
2 5 128.2 200 671.8 
Table 4-9 Details of the volumes used for the preparation of the three samples of 0.5, 1.0, and 2.0 mM 
PC in Triton X-100 at a constant concentration of the compound #5. 
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4.4.6 Titration of the compound #5 with PC liposomes to 
study the effect of the lipids over the spectroscopic 
properties. 
For the titration experiment, the stock solution of the porphyrin control (PS) was pre-
pared from the stock P1 (5 mM) by dilution in PB 100 mM pH 7.2 to a final concentration 
[PS] = 3 μM], Vf = 7 ml. Since all PS had the same concentration, 7 ml was prepared as final 
volume to have enough material for all the titration samples (500 μl per titration sample plus 
one extra 500 μl accounting for transfer loses). 
 The liposomes were prepared by extrusion from the freeze stock of PC in ethanol 
(see previous chapter). After the extrusion, 1.2 ml of 6.0 x 10-3 M PC liposomes was ob-
tained. By serial dilutions mixing 600 μl of PB 100mM pH 7.2 with 600 μl of LS samples 
starting from L12 and repeating down to LS1 collection of samples (LS) were prepared to 
combine with the porphyrin stock and generate the target samples (S) to be used for the titra-
tion experiment. 
For the preparation of the titration samples (S) 500 μl of the lipid sample LS was 
mixed with 500 μl of the porphyrin sample (PS) to generate 1000 μl of (S) (Table 4-11). 
For the calculation of the absorbance (A) initial guesses for Δε and K, where Δε is the 
variation of the extinction coefficient of the free porphyrin and the complex #5 plus phospha-
tidylcholine and K is the binding constant. This theoretical absorbance (AT) was then com-
pared with the experimental absorbance (AE). The values of Δε and K were adjusted with the 
parameter R0 (Initial concentration of porphyrin) fixed (1.5 x 10
-6 M) until a good fitting was 
obtained (Table 4-10).  
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 Fitting 419nm
Model bindingequilibrium (User)
Equation
eR*Ro+(eRL-eR)*(Ro+Lo+1/
K-sqrt((Ro+Lo+1/K)^2-4*Ro*
Lo))/2
Plot Absorbance
eR 120639.79367 ± 2965.01302
eRL 287718.3949 ± 4511.02125
K 8602.2378 ± 1090.44864
Ro 1.5E-6 ± 0
Reduced Chi-Sqr 8.13558E-5
R-Square (COD) 0.99258
Adj. R-Square 0.99109
 Fitting 421nm
Model bindingequilibrium (User)
Equation
eR*Ro+(eRL-eR)*(Ro+Lo+1/K
-sqrt((Ro+Lo+1/K) 2̂-4*Ro*Lo)
)/2
Plot Absorbance
eR 169786.24069 ± 1857.61536
eRL 306529.4753 ± 2481.44969
K 8577.38708 ± 759.05679
Ro 1.5E-6 ± 0
Reduced Chi-Sqr 2.41967E-5
R-Square (COD) 0.99669
Adj. R-Square 0.99595
Table 4-10. Binding constant and other parameters calculated from the 1:1 
binding model from the fitting of the UV-vis data entering the initial concen-
tration of the free porphyrin as fixed parameter. eR, extinction coefficient of 
the free porphyrin; eRL, extinction coefficient of complex #5 and lipids; K, 
binding constant; Ro, initial concentration of the porphyrin. 
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Sample [LFinal] / M [PeptideFinal] / 
M 
Liposome 
Stock 
[LInitial] / 
M 
Porphyrin 
stock 
[PInitial] / 
M 
S0 0 1.5E-06 LS0 0 PS0 3E-06 
S1 1.46E-06 1.5E-06 LS1 2.93E-06 PS1 3E-06 
S2 2.93E-06 1.5E-06 LS2 5.86E-06 PS2 3E-06 
S3 5.86E-06 1.5E-06 LS3 1.17E-05 PS3 3E-06 
S4 1.17E-05 1.5E-06 LS4 2.34E-05 PS4 3E-06 
S5 2.34E-05 1.5E-06 LS5 4.69E-05 PS5 3E-06 
S6 4.69E-05 1.5E-06 LS6 9.38E-05 PS6 3E-06 
S7 9.38E-05 1.5E-06 LS7 1.88E-04 PS7 3E-06 
S8 1.88E-04 1.5E-06 LS8 3.75E-04 PS8 3E-06 
S9 3.75E-04 1.5E-06 LS9 7.50E-04 PS9 3E-06 
S10 7.50E-04 1.5E-06 LS10 1.50E-03 PS10 3E-06 
S11 1.50E-03 1.5E-06 LS11 3.00E-03 PS11 3E-06 
S12 3.00E-03 1.5E-06 LS12 6.00E-03 PS12 3E-06 
Table 4-11. Serial dilution used in the preparation of the samples LS. Started with 1200 μl of L12 and 
generating LS11 by mixing 600 μl of LS12 + 600 μl of PB buffer. This was repeated down to LS1. 
LS0 was only buffer. The PS solutions had the same concentration of the porphyrin (3x 10-6 M). The 
PS stock solution was prepared as follows: 500 μl for each one of the 13 samples and an extra 500 μl 
that account for loses for a total volume of 7 ml. The working solution was prepared by mixing 500 
μL of LS and 500 μL of PS, which generated a 1000 μl of the target sample (S). 
 
 
 
 
 
 
 
 
 
Chapter 4 
264 
 
4.4.7 Determination of the optimal conditions to quench the 
fluorescence of the compound #5. 
4.4.7.1 P-Xylene –bis-(N-pyridinium bromide) (DPX) 
DPX (26 mg) was weighed out and dissolved in 125 μl of phosphate buffer (100 mM, 
pH 7.2) to produce a final stock of 500 mM. A stock of compound #5 (50 µM) was prepared 
in PB 100 mM pH 7.2 from a frozen stock of compound #5 (5 mM) (10 µl of #5 in 990 µl of 
PB). The previous stock was used to prepare the working solution (1 ml, 0.2 µM) in PB 
100mM pH 7.2. The fluorescence emission of this sample was recorded and immediately af-
ter, 700 µl were withdrawn from the cuvette and the addition of DPX started (Table 4-12). 
After each addition, the solution was mixed and the fluorescence intensity recorded. The ex-
citation wavelength (λ = 413 nm), emission 430 < λ < 600. 
Measure  [5] μM n (DPX) Vcuv (μl) V [0.5M DPX] [DPX] mM 
1 0.2 0.000003 706 6 4.25 
2 0.2 0.000007 714 8 9.80 
3 0.2 0.000012 724 10 16.57 
4 0.2 0.000018 736 12 24.46 
5 0.2 0.000025 750 14 33.33 
6 0.2 0.000033 766 16 43.08 
7 0.2 0.000042 784 18 53.57 
8 0.2 0.000052 804 20 64.68 
9 0.2 0.000063 826 22 76.27 
10 0.2 0.000075 850 24 88.24 
11 0.2 0.000088 876 26 100.46 
12 0.2 0.000102 904 28 112.83 
13 0.2 0.000117 934 30 125.27 
14 0.2 0.000133 966 32 137.68 
15 0.2 0.00015 1000 34 150.00 
16 0.2 0.000168 1036 36 162.16 
17 0.2 0.000187 1074 38 174.12 
18 0.2 0.000207 1114 40 185.82 
19 0.2 0.000228 1156 42 197.23 
20 0.2 0.00025 1200 44 208.33 
Table 4-12. Volume of the stock of DPX (0.5 M) that were added to quench the fluorescence of 
compound #5. In the far right column is shown the final concentration of DPX in the reaction cu-
vette. 
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4.4.7.2 1,1′-Diheptyl-4,4′-bipyridinium dibromide (DPB) 
Initially a 50 mM stock was made by weighing out DPB (25.7 mg) and dissolving in 
1 ml of phosphate buffer (100 mM, pH 7.2), however 0.5 mM was required for the experi-
ments so this stock was simply diluted 10 fold in PB. The procedure was similar to the one 
described for the DPX (Table 4-13). The concentration of the DPB stock was 0.0025 M in 
PB 100 mM pH 7.2. 
Measure  [5] μM n (DPB) Vcuv (μl) V [0.0025M DPB] [DPB] mM 
1 0.2 0.000000015 706 6 0.02 
2 0.2 0.000000035 714 8 0.05 
3 0.2 0.00000006 724 10 0.08 
4 0.2 0.00000009 736 12 0.12 
5 0.2 0.000000125 750 14 0.17 
6 0.2 0.000000165 766 16 0.22 
7 0.2 0.00000021 784 18 0.27 
8 0.2 0.00000026 804 20 0.32 
9 0.2 0.000000315 826 22 0.38 
10 0.2 0.000000375 850 24 0.44 
11 0.2 0.00000044 876 26 0.50 
12 0.2 0.00000051 904 28 0.56 
13 0.2 0.000000585 934 30 0.63 
14 0.2 0.000000665 966 32 0.69 
15 0.2 0.00000075 1000 34 0.75 
16 0.2 0.00000084 1036 36 0.81 
17 0.2 0.000000935 1074 38 0.87 
18 0.2 0.000001035 1114 40 0.93 
19 0.2 0.00000114 1156 42 0.99 
20 0.2 0.00000125 1200 44 1.04 
 Table 4-13. Volume of the stock of DPB (0.0025 M) that were added to the cuvette to quench the 
fluorescence of the compound #5. In the far right column is shown the final concentration of DPX in 
the reaction cuvette after the addition of each aliquot. 
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4.4.8 Separation of the compound #5 from PC liposomes by 
GPC column. 
4.4.8.1 One GPC column with γ-glutathione 
1 ml of liposomes [PC] = 10 mM were prepared. 10 μl of stock solution of [5] = 5 
mM was added to this solution to reach a final concentration of 100 μM. The sample was 
split into two vials PCI and PCII (470 μl). The first vial (PC I) was mixed and incubated for 
15 minutes in the dark. 50 μl of the sample PC I was diluted 1:100 with PB 100 mM pH 7.2 
and the absorption spectrum was recorded (250-700 nm). The remaining volume (400 μl) 
was loaded into the column matrix (see Solutions and Reagents), and the fractions were col-
lected immediately. In total 20 fractions were collected from which the fractions 9, 10, 11 
and 12 appeared turbid. To monitor the separation the fractions 8-13 were separated and the 
UV-vis spectra measured. From the light scattering of each fraction collected and the porphy-
rin signal the targets fractions (9-12) were identified. Finally, the fractions 9-12 were pooled 
together (Pool) and the absorbance recorded for analysis. 
The second aliquot (PC II) was treated with fresh GSH stock (10 mM) to achieve a 
final concentration of 1mM. The sample was mixed and incubated 15 minutes in the dark. 
400 μl of PC II were loaded in a clean column and the collection of the fractions started im-
mediately. 20 fractions were collected from which the turbids (9-12) were poold together and 
analyzed by UV-vis spectroscopy (Pool + GSH). 
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4.4.8.2 Two consecutive GPC columns with an intercalated concentration step. 
A fresh solution of liposomes was prepared [PC] = 10 mM as previously described. A 
500 μl aliquot was separated and combined with compound 5 to get [5] = 100 μM. After-
wards, the GSH was added to reach [GSH] = 1 mM. The mixture was mixed and incubated in 
the dark for 1 hour. After the incubation period the mixture was loaded into the column and 
the fractions collection started immediately. The turbid fractions were isolated, combined 
together (Pool I), the final volume of the pool was measured and the UV-vis spectrum was 
recorded. Using a concentrator (Vivaspin 500), the pool I solution was concentrated by cen-
trifuging the liposomes 30’ at 13000 RPM. After each 10 min the centrifuge was stopped and 
the sample mixed by gentle pipetting the solution to avoid sedimentation of the liposomes 
and help the centrifugation process. Once the remaining volume was between 100 -500 μl the 
centrifugation was stopped. The concentrated solution was added to a cleaned second GPC 
column and the collection was repeated as previously described. The turbid fractions were 
once more combined (Pool II), the volume was measured with precision using a cylinder (5 
ml) and the UV-vis spectrum recorded for analysis (200-700 nm). 
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4.4.8.3 One GPC column plus three concentration/dilution steps. 
Compound #5 was added to a fresh solution of liposomes [PC] = 10 mM to reach a 
final concentration of [5] = 100 μM. The sample was incubated for 1 hour in the dark. From 
the solution were withdrawn 20 μl and further diluted (1:100) to be used as a reference to 
check the efficiency of the separation (precolumn). After the incubation GSH was added to 
the sample to reach a final concentration of [GSH] = 1 mM. An aliquot of solution was sepa-
rated, diluted (1:100), and the UV-vis spectra recorded (+GSH). 500 μl were loaded into the 
column and the collection of the fractions started as described in the sections above. The tur-
bid fractions were collected together (Pool), the volume was measured with a cylinder (5 ml), 
and the UV-vis spectrum was recorded. Before loading into the concentrator GSH was added 
to the Pool to reach a final concentration of [GSH] = 1 mM and was incubated for 15 
minutes. The concentrator was loaded, the volume brought up to 20 ml and then centrifuged 
for 15’ at 3 rcg. Once the volume was reduced to approximately 4 ml (identified with a mark-
ing in the concentrator tube) the concentrated solution (Conc 1) was mixed with GSH as de-
scribed above to reach [GSH] = 1 mM, mixed and top it up with phosphate buffer up to 20 
ml. The last steps were repeated twice, to achieve the concentrated solutions (Conc 2 and 
Conc 3). Finally, the traces were collected and analyzed by UV-vis spectroscopy. 
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4.4.8.4 Labelling of the full-length peptide with the compound 5 in the presence of 
liposomes and excess removal by GPC. 
The working solution (10μM, 3ml) was prepared from a previous stock solution of 
the full-length peptide (359 μM) in PB 100 mM pH 7.2. An aliquot from this solution was 
withdrawn and quantified by UV-vis spectroscopy using a Perkin Elmer spectrophotometer, 
range 200-700 nm (4.05 μM). A concentrated solution of DTT (0.0015 g, 9.72 μmol) was 
prepared in 1 ml vial. From this stock solution an aliquot was added to the stock of full-
length peptide to reach 100 μM of DTT. The liposomes [PC] = 10 mM were freshly prepared 
as described before and further diluted with 780 μl of PB 100 mM pH 7.2 100 μl. This solu-
tion was combined with 100 μl of stock solution of full-length peptide and DTT and incubat-
ed for 10 min. Once the incubation period finished 20 μl of P1 was added and the mixture 
was incubated for 15 minutes. 10 μl of this solution were diluted with 990 μl (1:100) of 
phosphate buffer, and the UV-vis spectra recorded (Rxn Mixture). The mixture was loaded 
into the Vivaspin PES MWCO 50.000 concentrator and centrifuged for 15 minutes at 4.4 
RPG. 1 ml of the filtrate solution was withdrawn and the UV-vis spectrum recorded (filtrate). 
The content of the concentrator was collected back (V = 640 μl) and 500 μl were loaded into 
a fresh and clean GPC column. The turbid fractions were collected together, the volume 
measured with a cylinder (1.6 ml), and the UV-vis spectrum recorded (Pool). A new concen-
trator was used to load the pool fraction and then centrifuged for 15’ at 4.4 RPG. When the 
volume was reduced to approximately 1 ml (identified with a marking in the concentrator 
tube), the concentrated solution was collected and the UV-vis spectrum recorded (Conc 1). 
Finally, the traces were combined and analyzed using the Origin Pro 8b software. 
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4.4.9 Experiments with the Control Peptide. 
4.4.9.1 Determination of the fluorescence spectra of the peptide control 
A 1:2 dilution of the peptide control 12 μM was prepared with PB 100 mM pH 7.2. 
Immediately after the pH was checked (pH = 7) and the fluorescence cuvette was we filled 
with 1 ml of peptide control solution. This sample was used to record the fluorescence spec-
trum with medium and high photomultiplier tube voltage (PMT) to determine the best condi-
tions to perform the fluorescence experiments. A second solution of the peptide control con-
taining DTT (600 μM) was prepared and the fluorescence spectrum recorded. For the 
measures the instrument was setup as follows: start 300 nm and stop 600 nm, Ex wavelength 
295 nm, ex lit 5nm, em lit 5nm, scan rate 600 nm/min, PMT voltage, high. The traces were 
collected and analyzed using the software Origin Pro 8b.  
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4.4.9.2 Titration of the Peptide Control 
For the titration experiment, the stock solution of the peptide control (PS) was pre-
pared by dilution of a stock solution (250 μM) in PB 100mM pH 7.2 to reach a final concen-
tration of [Peptide control = 1.20 x 10-5 M], Vf = 7 ml. 
Liposomes were prepared by extrusion from the stock solution of PC in ethanol (see 
Section 3.3.2). 1.2 ml of 6.0 x 10-3 M PC liposomes were prepared by extrusion and further 
diluted with PB 100 mM pH 7.2 to generate the samples (LS). LS samples were combined 
with the stock solution of peptide control to generate the target samples (S) that were used in 
the titration experiment (Table 4-14). 
Sam-
ple 
[LFinal] / 
M 
[PeptideFinal] / 
M 
Liposomes 
Stock 
[LInitial] / 
M 
Peptide 
Stock 
[PeptideInitial] / 
M 
S0 0 6.00E-06 LS0 0 PS0 1.20E-05 
S1 1.46E-06 6.00E-06 LS1 2.93E-06 PS1 1.20E-05 
S2 2.93E-06 6.00E-06 LS2 5.86E-06 PS2 1.20E-05 
S3 5.86E-06 6.00E-06 LS3 1.17E-05 PS3 1.20E-05 
S4 1.17E-05 6.00E-06 LS4 2.34E-05 PS4 1.20E-05 
S5 2.34E-05 6.00E-06 LS5 4.69E-05 PS5 1.20E-05 
S6 4.69E-05 6.00E-06 LS6 9.38E-05 PS6 1.20E-05 
S7 9.38E-05 6.00E-06 LS7 1.88E-04 PS7 1.20E-05 
S8 1.88E-04 6.00E-06 LS8 3.75E-04 PS8 1.20E-05 
S9 3.75E-04 6.00E-06 LS9 7.50E-04 PS9 1.20E-05 
S10 7.50E-04 6.00E-06 LS10 1.50E-03 PS10 1.20E-05 
S11 1.50E-03 6.00E-06 LS11 3.00E-03 PS11 1.20E-05 
S12 3.00E-03 6.00E-06 LS12 6.00E-03 PS12 1.20E-05 
Table 4-14 Serial dilution used in the preparation of the samples LS. LS11 was generated by mixing 
600 μl of LS12 + 600 μl of PB buffer. This operation was repeated down to LS1. LS0 was only buff-
er. The PS solutions had all the same concentration of control peptide (1.2 x 10-5). The PS stock was 
prepared using 500 μl for each titration sample and and 500 μl extra accountin for loses for a total 
volume of 7 ml. The target samples (S) were prepared by mixing 500 μL of LS with 500 μL of PS. 
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4.4.9.3 Determination of the liposomes fluorescence 
Determination of the liposome fluorescence was performed following the same pro-
cedure described in section 4.4.9.1. In here, the preparation of the target samples (S) was as 
follows: 500μl of liposomes (LS) was mixed with 500 μl of PB 100 mM pH 7.2. The fluores-
cence spectrum was recorded immediately after the preparation of the samples was complet-
ed. 
4.4.9.4 Titration of the Full Length Peptide. 
The preparation of the stock solution of the full-length peptide is described in the sec-
tion 4.4.1.6. The dilutions carried out for the preparation of the samples is described in Table 
4-11. 
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4.4.10 Reaction of compound #5 and the peptide control 
follow by HPLC. 
4.4.10.1 Determining the retention time of the peptide control 
The determination of the peptide control by RP-HPLC was carried out with three so-
lutions of 10, 100 and 250 μM. The working solutions were prepared by dilution with DMSO 
of a fresh stock solution of peptide control 250 μM (1.18 mg, 5.9 x 10-7 M). Each solution 
was manually injected into the RP-HPLC. The column was (Phenomenex Jupiter C18, 
250mm) Manual injection of 20 μl, λ = 280 nm, flow 1 ml/min, eluting with 0.1% 
TFA/MeCN and 0.1% TFA/H2O with the following gradient: 0-15 min, 0-90% MeCN. 
The retention time of the peptide control was determined under the same conditions 
used to identify the retention time of compound #5. A solution of 100 μM of peptide control 
freshly prepared in DMSO was injected. The column was (Phenomenex Jupiter C18, 
250mm) Manual injection of 20 μl, λ = 280 nm, flow 1 ml/min, eluting with 0.1% 
TFA/MeCN and 0.1% TFA/H2O with the following gradient: 0-20 min, 0-100% MeCN, 20-
22 min, 100-100% MeCN, 22-23 min, 100-0% MeCN, 23-25 min, 0-0% MeCN. 
The retention time of the peptide control oxidized was determined injecting an old 
stock solution of the peptide control (250 μM) using the same method described in the previ-
ous paragraph. 
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4.4.10.2 Reaction of compound #5 and peptide control 
A peptide control stock solution (250 μM) was prepared weighing 1.0 mg of peptide 
control dissolved in 2 ml of DMSO. Compound #5 solution was prepared from the frozen 
aliquot (5mM) (A1). The reaction mixture was prepared by diluting 25 μl of A1 stock with 
455 μl of PB. Afterwards, 20μl of the peptide control stock solution was added to the solu-
tion of compound #5 and mixed thoroughly. The reaction mixture was incubated for 30 
minutes in the dark and then injected in RP-HPLC column (Phenomenex Jupiter C18, 
250mm). Manual injection of 20 μl, λ = 430 nm, flow 1 ml/min, eluting with 0.1% 
TFA/MeCN and 0.1% TFA/H2O with the following gradient: 0-20 min, 0-100% MeCN, 20-
22 min, 100-100% MeCN, 22-23 min, 100-0% MeCN, 23-25 min, 0-0% MeCN. 
 
4.4.10.3 Reaction of compound #5 and peptide control in the presence of GSH 
A γ-glutathione stock solution of 10 mM (6.015 mg) was prepared in 2 ml of fresh 
phosphate buffer. The peptide control aliquot was taken from the stock (250 μM) as de-
scribed in the previous paragraph. A solution of 20 μM of peptide control and 20 μM of GSH 
was prepared in 1 ml PB 100 mM pH 7.2. The solution was mixed and incubated for 15 
minutes to ensure reduction of the sulfhydryl’s group. Afterwards, 10 μl from the stock solu-
tion of the compound #5 (A1) (5mM) was added to reach a final concentration of [#5] = 50 
μM. The reaction was injected into the RP-HPLC column (Phenomenex Jupiter C18, 
250mm). Manual injection of 20 μl, λ = 430 nm, flow 1 ml/min, eluting with 0.1% 
TFA/MeCN and 0.1% TFA/H2O with the following gradient: 0-20 min, 0-100% MeCN, 20-
22 min, 100-100% MeCN, 22-23 min, 100-0% MeCN, 23-25 min, 0-0% MeCN. 
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4.4.10.4 Reaction of compound #5 and peptide control in the presence of TCEP 
 A TCEP stock solution of 44 mM (10 mg) was prepared in 1 ml of fresh phosphate 
buffer 100 mM pH 7.2. The peptide control aliquot was taken from the stock solution (250 
μM) described in the previous paragraph. A solution of 10 μM of peptide control and 50 μM 
of TCEP was prepared with 1 ml of PB 100 mM pH 7.2. The solution was mixed and incu-
bated for 15 minutes to allow reduction of the sulfhydryl moiety. To this solution was added 
20 μl from the compound #5 stock solution (A1) (5mM) to reach a final concentration of [#5] 
= 100 μM. The reaction was injected at time 0 and after 30 minutes incubation into the RP-
HPLC column (Phenomenex Jupiter C18, 250mm). Manual injection of 20 μl, λ = 430 nm, 
flow 1 ml/min, eluting with 0.1% TFA/MeCN and 0.1% TFA/H2O with the following gradi-
ent: 0-20 min, 0-100% MeCN, 20-22 min, 100-100% MeCN, 22-23 min, 100-0% MeCN, 23-
25 min, 0-0% MeCN. 
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4.4.11 Instruments 
Balances: The preparation of all stock solutions, buffers, and samples, was done with 
the MS-TS Precision Balance with Draft Shield (Mettler Toledo). 
UV-vis Spectrophotometry: The UV-vis spectra for all these experiments were 
measured on the departmental Perkin Elmer Lambda 35, UV/VIS Spectrometer. The cuvettes 
for all the measurements were polystyrene and disposable with a path-length of 1 cm and a 
volume capacity of 2.5 ml.  
pH-meter: The pH measurements were taken with a Mettler Toledo pH-meter with a 
glass electrode (InLab Ultra-Micro, Electrolyte Friscolyl) pH 1…11.0, 80 oC. All the read-
ings were performed at room temperature. The pH-meter was calibrated before each meas-
urement with standard solutions at pH 4 and 7 respectively. 
RP-HPLC: The RP-HPLC was performed using a Varian Prepstar pump with au-
tosampler and fraction collector. The stationary phase column was a Jupiter 4u Proteo 90A 
AXIA with a packed prep column (250 x 21.2 mm). 
Fluorescence Spectrophotometer: The fluorescence spectra were recorded with the 
departmental Agilent Cary Eclipse fluorescence spectrophotometer. The cuvettes for all the 
measure were disposable with a length-path of 1 cm and 2.5 ml capacity. The data was ana-
lyzed with the software Agilent Cary WinFLR. 
All the measurements were recorded at RT, with no further treatment of the samples. 
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5.1 INTRODUCTION 
The immune system is a highly complex biological machinery that has evolved to 
identify and destroy harmful foreign challenges, for example, bacteria, viruses and parasites 
that can cause disease. In complex organisms, the immune system is further subdivided in 
two subsystems: the innate and the adaptive immune system. 
5.1.1 Innate and Adaptive Immunity 
The innate immune system constitutes the early line of defense against pathogens. It 
consists of cellular and biochemical host defense mechanisms that are ready before any in-
fectious challenges and that respond rapidly after the invasion. The components of the innate 
immune system include physical and chemical barriers, such as epithelial surfaces; phagocyt-
ic cells e.g. neutrophils and macrophages, dendritic cells, and natural killer (NK) cells; blood 
proteins such as the complement system, and messenger proteins called cytokines. The main 
function of the innate immune system is to control the early stages of infection by recogniz-
ing structures that are common to groups of pathogens, known as pathogen associated mo-
lecular patterns (PAMPs)224, 225.  
In contrast to the innate immune system, adaptive immunity developed much later in 
evolution, around 360 million years ago in jawed vertebrates65. The main characteristics of 
the adaptive system is the capacity to recognize many different molecules and the ability to 
“remember” repeated exposures to the same pathogen. The adaptive system can be subdivid-
ed in two main arms: humoral immunity and cell-mediated immunity226. Humoral immunity 
is mediated by soluble proteins called antibodies secreted by B-lymphocytes, while cell-
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mediated immunity is driven by the T cells. Both the innate and the adaptive immune sys-
tems are components of an integrated system that provides defense to the host (Figure 5-1). 
 
 
 
 
 
 
Figure 5-1. The mechanisms of innate immunity provide the initial defense against infections. 
Adaptive immune responses develop later and consist of activation of lymphocytes. The kinetics 
of the innate and adaptive immune responses are approximations and may vary in different infec-
tions. APC, antigen-presenting cell. 
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5.1.2 T cells 
All blood cells are derived from pluripotent stem cells, also denominated hematopoi-
etic stem cells (HSCs), in the bone marrow. HSCs mature into common lymphoid progeni-
tors (CLP) that give rise to myeloid and lymphoid progenitors65. T cell precursors travel from 
the bone marrow to the thymus where they complete their maturation to become mature T 
cells227. 
T cells are one of the main components of the adaptive immune system. T cells con-
sist of a group of functionally diverse cells such as, helper T cells, cytotoxic T cells, regulato-
ry T cells, and natural killer T (NKT) cells. The majority of T cells developing in the thymus 
are αβ T cells, but a small population γδ T cells227. 
The work presented in this chapter focuses mainly on γδ T cell biology and therefore, 
this introduction will review the state of the art in the development, effector subsets and func-
tion of murine γδ T cells. 
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5.1.3 γδ T Cells 
γδ T cells appeared in evolution around 450 million years ago with the emergence of 
jawed vertebrates228. They develop in the thymus together with αβ T cells, however they ex-
press a T cell receptor (for TCR structure see Section 1.1.6) consisting of a TCR-γ and TCR-
δ chain229,67. 
γδ T cells represent approximately 1-5% of murine peripheral T cells. Unlike αβ T 
cells, γδ T cells can mature in the absence of MHC-I and II, and β2m, because they do not 
follow the same stages of thymic selection or peripheral activation230, 231. Instead, they ex-
press innate-like receptors, e.g. NKG2D and TLRs, which allows them to respond early after 
pathogen invasion in an innate-like manner232. 
5.1.3.1 Anatomical location of γδ T cells 
γδ T cells are predominantly tissue-associated lymphocytes, where anatomical locali-
zation and function correlates with the expression of TCRγδ that include specific 
TCRγ/TCRδ combination, and that often have limited diversity233, 234. For example, the 
mouse epidermis harbours a population of γδ T cells expressing a Vγ5Vδ1 TCR, which mor-
phologically resembles a dendritic cell, thus are known as dendritic epidermal T cells 
(DETCs). These cells are thought to participate in epidermal skin homeostasis through the 
secretion of cytokines and other factors like keratinocyte growth factor (KGF) and insulin-
like growth factor 1 (IGF-1)235.  
The uterus, tongue236, lung237, liver238 and dermis239 of the mouse contain a popula-
tion of γδ T cells expressing a Vγ6Vδ1 TCRγδ and are restricted to the production of IL-17. 
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γδ NKT cells expressing a Vγ1Vδ6 TCRγδ are mainly localized in the liver and spleen, and 
secrete predominantly IFN- γ and IL-4240, 241. 
 
Cells containing Vγ1 and Vγ4 TCR chains are preferentially found circulating in the 
blood and residing in secondary lymphoid organs242 (Table 5-1). Interestingly, recent studies 
have shown that Vγ4+ γδ T cells are a heterogeneous pool of effector cells with the capacity 
to produce either IL-17 or IFN-γ243, 244. 
 
 
 
 
 
Table 5-1. Vγ-usage correlates with the anatomical localization of murine peripheral γδ T cells. 
Vγ5+ lymphocytes preferentially located in the skin epidermis, while Vγ6+ cells are preferentially 
located in the dermis, lung, peritoneal cavity, tongue and lining the genital tract. Vγ7+ cells mi-
grate to the intestinal mucosa and the pool of Vγ4+, Vγ2+ and Vγ1+ are found mainly circulating in 
the blood and populating secondary lymphoid organs i.e. spleen and lymph nodes. 
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5.1.3.2  γδ T cell effector subsets 
As shown in section 5.1.3.1 murine peripheral γδ cells can be segregated into several 
subsets based on their usage of certain TCRγ variable regions i.e. Vγ1+, Vγ2+, Vγ4+, Vγ5+, 
Vγ6+, Vγ7+. For the sake of clarity, the Tonegawa nomenclature for Vγ and Vδ usage will be 
followed in this chapter245. The mouse TCRγ locus comprises four clusters of V, J and C re-
gions containing seven V segments (V1 to V7), four J segments (J1 to J4)  and four C regions 
(C1 to C4)3. Each cluster has a C region, one J segment, and from one to four V segments as 
shown in Figure 5-2. However, the V3-J3-C3 cluster is believed to be non-functional in most 
mouse strains246. 
 
 
 
 
Unlike TCRγ, the TCRδ locus consists of six variable segments, two diversity seg-
ments, two joining regions and one constant region. Due to its location within the TCRα lo-
cus, the TCRδ locus is excised after the successful rearrangement of the TCRα chain, pre-
venting the expression of any γδ receptor in lymphocytes that are already committed to αβ 
lineage247. 
 
 
Figure 5-2. Schematic representation of the TCRγ locus in the mouse. The arrows indicate the 
transcriptional orientation. Three of the clusters are functional: C1 cluster, C2 cluster (orientation 
inverted) and C4 cluster. The C3 cluster is non-functional. The variable regions are represented 
with yellow boxes, the joining region with red boxes and the constant segments by blue boxes. 
Figure adapted from Pereira et al3. 
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5.1.3.3  γδ T cell effector function 
γδ effector subsets execute their function in their anatomical places through the pro-
duction of cytokines248. It has been observed that Vγ5+ DETCs secrete abundant IFN- γ249, 
and IL-13250 but not IL-17. Similarly, Vγ7+ γδ cells homing to the intestinal mucosa have the 
potential to produce IFN-γ after interaction with butyrophilin-like 1 (Btnl1) expressing epi-
thelial cells in the intestine1. This early provision of IFN-γ is believed to defend the host 
against viral infections e.g. cytomegalovirus infections in fetuses and infants251, 252, and also 
plays an important role in tumor surveillance. It has been reported in the literature that γδ T 
cells are one of the first sources of IFN-γ in the context of tumor immunity, being able to 
recognize stress molecules, e.g. Rae-1 and ULBP-1 expressed by tumor cells in mice and 
humans, respectively232, 253. 
In contrast to IFN-γ producers, Vγ6+ γδ T cells are restricted to the production of IL-
171. As shown in Table 5-1, these cells are found mainly in the tongue, peritoneal cavity, 
dermis, and lung. IL-17 producers provide rapid responses against intracellular and extracel-
lular pathogens by recruiting neutrophils and monocytes to the site of infection254. King et al. 
have reported that IL-17 secreting γδ intraepithelial lymphocytes (IELs) have a protective 
effect in mouse lungs after infection with Nocardia asteroids, a gram-positive bacteria255. In 
addition, other groups have confirmed the important role of the γδ17 effector cells during the 
early phase of the immune response against Mycobaterium256, Listeria238, and E.Coli257. 
The Vγ4+, Vγ1+, and Vγ2+ pool of γδ T cells have the potential to secrete either IFN-γ 
or IL-17, but barely both simultaneously244. They are found predominantly in secondary 
lymphoid organs, the liver and circulating in the blood1 (Table 5-2). 
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Interestingly, Prinz et al.258 recently reported a Vγ4(+) Vδ5(+) population of γδ cells re-
stricted to the γδ17 effector subset. As mentioned before, the pool of Vγ4(+) γδ T cells is het-
erogeneous with cells able to secrete either IFN-γ or IL-17243. With the aim of understanding 
the relationship between the Vγ4(+) TCR and Vγ4(+) effector function, Prinz and colleagues 
performed high resolution sequencing analysis of the mouse TCRγδ with special focus on the 
Vγ4(+) TCR258. They discovered an invariant subset of innate γδ T cells with a TCR com-
posed of Vγ4Jγ1 motif paired with a germline rearranged Vδ5Dδ2Jδ1 within the Vγ4+ popu-
lation that developed in the foetal or perinatal thymus. This innate-like γδ T cell subset was 
found mainly among the CCR6+ CD27- γδ T cells that are characterized as IL-17 
producers244, 259. Moreover, they identified that the Vδ5+ CDR3 amino acid motif ASGYIG-
GIRATDKLV was principally, but not exclusively, restricted to CCR6+ CD27-Vγ4+ γδ T 
cells. Single cell analysis of the corresponding TCRVγ4 chain in cells bearing the 
Vδ5Dδ2Jδ1 rearrangement revealed that seven cells share the Vγ4 CDR3 sequence SY-
GLYSSGFHKV. Based on these observations they suggested that the foetal thymus con-
tained a pool of IL-17 producing γδ T cells with a TCR composed of a germline-rearranged 
Vδ5Dδ2Jδ1 and a canonical Vγ4Jγ1 motif258. This TCR is the focus of this work. 
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Table 5-2. Terminally differentiated murine peripheral γδ T cell subsets can be classified by the 
Vγ- usage and the secretion of the cytokines such as IL-17 or IFN-γ. However, other cytokines 
like IL-13 and IL-22 can be produced alongside. DETC: dendritic epidermal T cells.  
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5.1.4 Overview of the developmental stages of murine thy-
mocyte development 
As mentioned in section 5.1.2, T cell precursors formed in the bone marrow migrate 
to the thymus to continue their maturation. These early thymic precursors are denominated 
double negative (DN) thymocytes because they do not express the CD4/CD8 co-receptors 
(See Figure 5-3). The developmental progression of DN thymocytes in the thymus can be 
characterized by the expression of CD44 (phagocyte glycoprotein-1), CD25 (IL-2 receptor α 
chain) and c-Kit (stem cell factor receptor) as described by Godfrey at al260. DN thymocytes 
progress through four stages of development, namely DN1 to DN4 where: DN1 thymocytes 
are defined by the expression CD44+CD25-c-Kit+, DN2 cells are CD44+CD25+c-Kit+, DN3 
cell CD44-CD25+c-Kit- and, DN4 cells are CD44-CD25-c-Kit-.  
The identity and differentiation potential of the DN1 subset is not fully understood. 
For example, it is not clear whether early thymic precursors can give rise to all lymphoid and 
myeloid cells or is restricted to T and NK cells2, 261. Despite these fundamental gaps in our 
knowledge of the biology of these early progenitors, it is quite clear that full commitment to 
the T cell lineage requires Notch-1 signalling in early thymic precursors262, 263. Notch-1 is a 
transmembrane receptor expressed in progenitor cells. It associates with the transmembrane 
ligands Delta-like 1 (DL1), DL3, and DL4 expressed in neighbouring cells. The interaction 
leads to the cleavage of the intracellular domain of Notch, which migrates to the nucleus 
where it acts as a transcription factor of some key genes in T cell lineage commitment, e.g. 
recombination-activating gene-1 (RAG-1)2. Schmitt et al264 have shown that Notch-1 signal-
ling is required to maintain progression from the DN1 to DN3 stages during T cell lineage 
development. 
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The progression to the DN2 stage is characterised by upregulation of CD25 and in-
tense proliferation265. DN2 cells are first detected in the mouse foetal thymus at embryonic 
day 13.5 (E13.5). These cells start to express RAG-1 and RAG-2 genes, fundamental for 
TCR rearrangement, as well as genes involved in TCR and pre-TCR complex formation266, 
267. 
The DN3 cell population can be detected around day E14.5, and are fully committed 
to the T lineage as they can only differentiate into αβ or γδ T cells268. At this stage, the thy-
mocytes that have rearranged a functional TCRγ and TCRδ chain and are able to express the 
TCRγδ complex at the cell surface will be committed to the γδ lineage.  
Those cells that produce a functional TCRβ chain start to express a surrogate receptor 
denominated pre-TCR269. The pre-TCR is expressed at the cell surface with CD3 molecules 
and is required for the transition of DN3 thymocytes through the “β-selection” checkpoint270, 
271. Pre-TCR signalling promotes down-regulation of CD25, cell survival, proliferation, and 
further differentiation beyond the DN3 stage269. 
DN4 cells can be detected in the mouse foetal thymus around E14.5. Before their 
progression to the CD4+CD8+ double positive (DP) stage, the thymocytes enter an intermedi-
ate stage known as the “immature single positive” (ISP) characterized by the expression of 
the CD8 co-receptor272. Afterwards, thymocytes upregulate the co-receptor CD4 to become 
“double positive” (DP). These double positive cells represent the majority of cells in the 
thymus273. TCRα rearrangements are initiated and completed during the DP stage. The TCRβ 
chain will then form TCRαβ heterodimers with the TCRα chain and with CD3 molecules69. 
Cells that express a TCRαβ complex that is able to recognize an MHC-self-antigen complex 
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presented by thymic epithelial cells are positively selected, i.e. cells survive and continue 
their maturation towards the single positive (SP) stage. However, thymocytes that express a 
TCRαβ with high affinity for the self peptide-MHC complex will enter apoptosis to avoid 
autoreactive responses in the periphery in a process denominated negative selection274. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5-3. Graphic representation of the different stages of thymocyte development in the 
murine thymus. The double negative thymocytes (DN) progress through a number of stages 
during their thymic maturation that culminate in the development of the γδ T cells, CD4+ 
and CD8+ αβ T cells. DP, double positive; ISP, immature single positive; SP, single positive. 
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5.1.5 Murine γδ T cell development 
5.1.5.1 Models for γδ lineage commitment 
Double negative thymocytes that successfully rearrange and express the γδ TCR are 
capable of developing along the γδ T cell lineage at some point between the DN2 and DN3 
stage of development275 (See Figure 5-3). However, the specific branch-point where this fate 
decision occurs and the molecular mechanisms involved in lineage fate commitment are 
poorly understood276. Notwithstanding, three models have been proposed to-date: the instruc-
tional model277, 278, the stochastic model279 and the signal strength model280. 
5.1.5.1.1 Instructional model 
In the instructional model, the γδ versus αβ cell fate decision is dictated by expression 
of a certain TCR, and the qualitatively different signals they transmit. In other words, DN 
cells that express a γδ TCR will commit to the γδ lineage, while those expressing the pre-
TCR will be diverted towards the αβ lineage. The initial proposal of this model was based on 
the experimental observation that γδ cells develop early in ontogeny (E14.5)277. It was sug-
gested that only those cells that failed to rearrange and produce a functional γδ TCR would 
then attempt the rearrangement of the TCRα and TCRβ chains. 
However, the discovery of the pre-TCR led to the reformulation of this model. The 
revised model stated that TCRβ, TCRγ, and TCRδ would undergo rearrangements simultane-
ously281. If the loci rearranged first were TCRγ and TCRδ, the cell would commit to the γδ 
lineage, whereas if TCRβ is rearranged first then the DN cell will become an αβ T cell.  
Fehling et al269 challenged this model in their work with mice deficient in TCRβ/pTα, 
in which they observed that TCRγδ was driving limited development of αβ committed DP 
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thymocytes as well as γδ T cells. Similarly, the work published by Bruno et al282 with trans-
genic mice where early expression of TCRαβ promoted development of γδ-like T cells 
demonstrate the necessity to formulate a model that better explained these observations. 
5.1.5.1.2 The stochastic model  
The stochastic model proposes that early double negative thymocytes do not possess 
the same potential to develop towards the αβ or γδ lineage, arguing that pre-existing factors 
bias the thymocytes towards one lineage or the other279. For this model, the expression of a 
particular TCR is just concomitant to the pre-commitment to a specific lineage. In support of 
this model are the observations of Raulet et al279 showing that while all DN1 cells express 
similar levels of IL-7 receptor α chain (IL-7Rα), DN2 thymocytes show heterogeneous ex-
pression. Most striking is the observation that IL-7Rα (-) DN2 thymocytes appeared to be di-
verted towards the αβ lineage, while IL-7Rα(+) cells preferentially developed as γδ T cells279. 
Other experimental evidence suggests that the transcription factor SRY-box-containing gene 
13 (Sox13) is required for γδ but not αβ commitment283. The authors found that Sox13 is ex-
pressed in only 45% of DN2 thymocytes, and correlated with the expression of IL-7Rα283. In 
addition, mice deficient in Sox13 showed normal αβ T cell development in comparison with 
γδ T cells that were reduced by more than 50%283. Moreover, overexpression of Sox13 was 
shown to compromise the normal development of αβ cells when compared with γδ T cells, 
suggesting that expression of Sox13 in combination with IL-7Rα in DN2 cells pre-selects 
these progenitors towards the γδ lineage. In contrast to the previous observation, the studies 
conducted by Gray et al284 with a spontaneous mutant for Sox13 demonstrated that this tran-
scription factor was not necessary for γδ commitment. Instead, it was important for the de-
velopment and function of the Vγ4+ subset of γδ T cells in particular. 
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5.1.5.1.3 The signal strength model 
The “signal-strength” model is the latest model to explain αβ versus γδ lineage com-
mitment. This model states that lineage commitment is determined by the strength of signal 
delivered by the TCR (TCRγδ or pre-TCR) in early progenitors. Specifically, the model sug-
gests that strong TCR signals promote the development of γδ cells, whereas weak TCR sig-
nals favour progression into the αβ lineage as illustrated in Figure 5-4. 
 
 
 
In support of this model, Hayes et al285showed that the expression of a single TCRγδ 
(TCR-Vγ6Jγ1Cγ1-Vδ1Dδ1Jδ2Cδ1) transgene was capable of driving both γδ and DP devel-
opment. Interestingly, surface expression levels of the TCRγδ were lower on DP thymocytes, 
compared with γδ T cells, suggesting that lower level of receptor expression promotes the 
Figure 5-4. The “signal-strength” model of γδ versus αβ line-
age commitment. The model proposes that fate commitment 
is dictated by the strength of signal delivered from the TCR. 
Strong TCR signals favor the development of γδ cells where-
as weak TCR signals promote progression into the αβ lineage 
(illustrated by the DP cells). DN, double negative; DP, double 
positive. 
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development of DP cells. To further understand the influence of TCR surface abundance on 
αβ versus γδ lineage fate commitment they used a further transgenic mouse model (TCRγδ 
Tg TCR-ζ+/-) where the TCR expressed is the TCR-Vγ6Jγ1Cγ1-Vδ1Dδ1Jδ2Cδ1 and one of 
the TCRζ alleles have been inactivated (ζ+/-). These transgenic mice expressed fifty percent 
less TCR on the cell surface than their wild-type counterparts, TCRγδ Tg TCR-ζ+/+ mice286. 
Analysis showed that this reduction correlated with an increase in the total number of DP 
cells and a decrease in γδ thymocytes. Introduction of a full-length TCRζ transgene reduced 
the number of DP cells and restored γδ thymocytes. The authors concluded that increasing 
the density of TCR expression correlates with increased signal strength and commitment to 
the γδ lineage. Conversely, a low density of TCR is translated into weak signal strength and 
this in turn favours the commitment of the progenitors towards the αβ lineage. 
More recently, Zarin et al.287 showed that Rag2(-/-) DN cells expressing both the pre-
TCR and TCRγδ developed along the γδ pathway, down regulating CD24 expression, and 
up-regulating CD73. However, in the absence of inhibitor of DNA-binding 3 expression 
(ID3) γδ-expressing cells showed a reduced propensity to commit towards the γδ fate. Im-
portantly, differentiation along the γδ lineage was restored by pre-TCR co-expression, which 
induced greater down-regulation of CD24 and higher levels of CD73. 
Altogether, these findings reinforce the view that the cumulative signal strength re-
ceived by developing DN cells serves to dictate lineage choice (αβ versus γδ) and not the 
type of receptor itself. 
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5.1.5.2 Waves of γδ T cell development 
γδ T cell development starts at the foetal stage and progresses in waves that correlate 
with usage of particular Vγ chains245 (Figure 5-5). The first wave of cells are Vγ5+ at day 
E13 until E17 that migrate to the skin epidermis248. The following wave that spans from the 
E14 to around birth, generates IL-17-producers that consist predominantly of Vγ6+ cells that 
migrate to the dermis, tongue and genital tract242. The next wave generates Vγ1+ and Vγ4+ 
cells from E16 onward, which populate the lymph nodes, dermis, peritoneal cavity and lungs. 
Near birth, Vγ7+ cells are generated which migrate to the gut242. There is limited explanation 
for these organized waves of development at the moment. However, Xiong et al275 have pro-
posed that the pattern of sequential γδ cell development is associated with the germline tran-
scription and rearrangement program of the TCRγ locus. 
Figure 5-5. Development of murine γδ T cells. The figure shows how 
different functional subsets of γδ T cells develop during ontogeny to 
populate different anatomical locations. The waves of development corre-
late with the usage of a specific Vγ chain. Dendritic epidermal T cells 
(DETC), intestinal intraepithelial lymphocytes (iIELs). 
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5.1.6 Assessment of γδ T cell development 
The developmental stages of γδ T cell maturation can be identified by flow cytometry 
using the markers CD25, CD24, CD44 and CD45RB (Figure 5-6 A and B). The first γδ 
thymic progenitors which are characterized by double expression of CD24(+) and CD25(+) can 
be detected in E14 thymic lobes1. Consensus holds that signaling through the TCRγδ pro-
motes the downregulation of CD25 and induces an increase in the surface expression of 
TCRγδ288. In the next step of development the CD24(+) CD25(-) population downregulates 
expression of CD24. This suggests a developmental progression in the early γδ progenitors of 
CD24(+) CD25(+) to CD24(+) CD25(-) to CD24(-) CD25(-) 1. It is around the latter stage that 
immature γδ cells commit to effector fate i.e. the ability to produce either IFN-γ or IL-17244 
(Figure 5-6 B). 
To identify γδ cells that are committed towards one of these two cytokine secreting 
pathways our lab (Sumaria et al1) developed a flow cytometry methodology (Figure 5-6 A). 
The staining strategy is based on the use of CD24, CD25, CD44 and CD45RB antibodies that 
segregate CD24(-) γδ T cells into two clearly different developmental pathways: CD44(+) 
CD45RB(-) thymocytes are committed to secrete IL-17, whereas CD44(-) CD45RB(+) are 
committed to the production of IFNγ. For the sake of clarity, we will use the terminology a, 
b, c, and d to denominate the subsets CD44(-)CD45RB(-), CD44(-)CD45RB(+), 
CD44(+)CD45RB(+), and CD44(+)CD45RB(-), respectively. Notably, CD44(-) CD45RB(-) (a) 
thymocytes have the potential to give rise to all other subsets (b, c, and d). 
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One of the advantages of this methodology is that cells remain alive after analysis for 
further analysis, an option that is precluded in the traditional fix/perm techniques where cells 
dye after intracellular staining for cytokines. 
 
 
Figure 5-6. Methodology to identify γδ thymocytes committed 
toward one of two effector phenotypes, IFN-γ or IL-17. A) Ma-
ture γδ T cells (CD24-) can be assessed using CD44 and CD45RB 
and four distinct populations can be identified; CD44-CD45RB- (a) 
are the early mature subset and have the potential to develop into 
either effector phenotype. CD44-CD45RB+ (b) and 
CD44+CD45RB+ (c) (green gate) are committed to the secretion of 
IFN-γ. CD44+CD45RB- (d) (red gate) develop towards the IL-17 
producer subtype. B) γδ maturation assessed by the expression of 
CD24 and CD25 in E14 thymocytes, or thymocytes isolated after 1 
or 2 days FTOC culture. Figure adapted from Sumaria et al.1. CD, 
cluster of differentiation; FTOC, fetal thymic organ culture. 
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5.1.7 The role of TCRγδ in γδ T cell development and 
commitment to effector phenotypes 
As mentioned in section 5.1.5.1 surface expression of TCRγδ on DN3 thymocytes is a 
key event for commitment to the γδ lineage288. The generation of a strong signal from TCRγδ 
in DN can be the result of higher expression of receptors on the cell surface, by comparison 
with the scant amount of pre-TCR expressed. However, the most plausible cause of a strong 
signal generated by TCRγδ is ligand (binding by analogy with αβ cell development). For ex-
ample, the absence of MHC-II has a profound impact on the generation of CD4(+) αβ T cells 
leading to impaired T cell mediated immunity289. Notwithstanding, the small number of 
TCRγδ ligands so far identified has made the demonstration of this hypothesis difficult. Fur-
thermore, it was observed that γδ T cells also acquire their effector function while residing in 
the thymus i.e. IL-17 or IFN-γ secretion capacity. In summary, γδ lineage commitment and 
acquisition of effector function have both been postulated to depend on the signal strength 
delivered by TCRγδ (strong versus weak), and this may correlate with ligand-dependent ver-
sus ligand-independent signal initiation (See Figure 5-7). In the next section some experi-
mental evidence in support of both hypotheses is presented. 
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5.1.7.1 Ligand independent signaling 
Evidence of ligand independent signaling through TCRγδ was presented by Jensen 
and colleagues290 who showed in vitro that TCRδ oligomerization was mediated by the inter-
action of the Ig-like variable domains. However, work carried out by our lab291 and discussed 
in section 1.1.9.3 in Chapter 1 of this thesis, provides experimental evidence that challenges 
the oligomerization theory. These experimental data suggest that signal initiation in DN thy-
mocytes, although ligand-independent is rather a consequence of successful pairing of TCR 
chains at the cell surface, and the strength of signal transmitted through the TCR is simply 
correlated to the abundance of TCR on the cell surface. 
 
5.1.7.2 Ligand dependent signaling 
As mentioned above (Section 5.1.7), the identification of TCRγδ ligands has been 
very limited; therefore, it is uncertain whether γδ progenitors require ligand interactions dur-
ing their development and acquisition of effector function. Despite that, some experimental 
evidence supports the ligand engagement hypothesis these studies are discussed in this sec-
tion but it should be emphasized that this is a field under active investigation. 
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5.1.7.2.1 Vγ5(+) Vδ1(+) dendritic epidermal γδ T cells (DETC) 
Strong support for the engagement of ligands in the development of γδ T cells comes 
from studies on the development of DETCs. A seminal observation in the FVB sub-strain of 
mice (FVB-Tac) revealed that they had very few Vγ5(+) Vδ1(+) skin homing γδ T cells, and 
impaired development of Vγ5(+)  Vδ1(+) thymocytes even though other subsets of γδ cells de-
veloped normally292. In contrast to FVB-Tac, the FVB-Jax mice had normal thymic devel-
opment and skin migration of Vγ5(+) Vδ1(+) thymocytes292. Interestingly, the transfer of FVB-
Tac thymocytes to the thymic stroma of FVB-Jax mice rescued the development of Vγ5(+) 
Vδ1(+) T cells. Conversely, the culture of FVB-Jax thymocytes on the stroma of FVB-Tac 
thymuses abolished the development of the Vγ5(+) Vδ1(+) T cells. These experiments illustrate 
the important role of the thymic stroma in the development of the Vγ5(+) Vδ1(+) subset. Fur-
ther analysis demonstrated that the thymic stroma of FVB-Tac mice is deficient for the im-
munoglobulin-like membrane protein Skint-1 (selection and upkeep of intraepithelial T cells 
1)293. It was also demonstrated that this protein is normally expressed in the thymus as well 
as the skin epithelium, therefore it was concluded that Skint-1 is indispensable for the posi-
tive selection of Vγ5(+) Vδ1(+) T cells in the thymus294. In addition, transgenic expression of 
Skint-1 expressed from a β-actin promoter, with the mature protein tagged with an amino-
terminal FLAG epitope that allowed its detection, fully rescued Vγ5(+) Vδ1(+) DETC matura-
tion in FVB-Tac mice293. The same study demonstrated that Skint-1 is mainly expressed by 
medullary thymic epithelial cells (mTECs). However, there is no evidence to demonstrate 
that the TCR is the direct target of the Skint-1 protein. Therefore, further studies are required 
to elucidate the target of Skint-1 and its particular role in the development of Vγ5(+) Vδ1(+) 
DETCs. 
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5.1.7.2.2 T10/T22 specific γδ T cells 
Ligand dependent signaling has also been investigated in relation to the non-classical 
MHC-Ib molecules T10 and T22. Briefly, T10 and T22 proteins are encoded in the thymic 
leukemia antigen (TL) locus and share approximately ninety-four percent sequence similari-
ty295. These molecules were first described for their capacity to bind to the G8 and KN6 γδ T 
cell hybridomas296. It was also demonstrated that T10/T22 pair with β2-microglobulin (β2m), 
similar to the MHC-I, but are not engaged in antigen presentation functions297.  
Development of γδ T cells that engage T10 and T22 is still unclear. Studies have used 
two TCRγδ transgenic models, TCR-Vγ2Jγ1Cγ1-Vα11DδJδ1Cδ1 (G8) and, TCR- 
Vγ4Jγ1Cγ1-Vδ5DδJδ1Cδ1 (KN6) and both have been introduced transfected onto the 
C57BL/6 background (expresses both T10 and T22), BALBc (only express T10) or β2m de-
ficient mice (absent for T10 and T22) to assess development of γδ T10/T22 specific γδ T 
cells298, 299. 
Dent et al.299 used the G8 model to study the development of this repertoire in the 
presence or absence of the T22 ligand. They observed that G8 γδ T cells were able to develop 
in the absence of T22 ligand, but they were scant in the periphery of T22-positive mice. They 
concluded that the absence of G8 cells in the periphery of T22-positive mice was the result of 
negative selection of these transgenic thymocytes in a similar way to negative selection of the 
self-reactive thymocytes. 
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In a different study Pereira et al.300 crossed KN6 transgenic mice with β2m(-/-)  mice. 
They reported that KN6 γδ cells were not detected in the thymus or the spleen of these mice 
in the absence of both T10 and T22, suggesting that the interaction with these MHC-Ib mole-
cules was required for the development of KN6 γδ T cells. 
In a further study Schweighoffer et al.271 showed that the number of mature G8 γδ T 
cells in β2m(-/-)  mice was normal, contradicting a requirement for T10/T22 ligand interaction 
during γδ thymic development. The experimental data presented in these different studies 
showed little agreement about the requirement for ligand recognition in the development of 
γδ T cells. 
Despite the lack of consensus on the role of T10/T22 in γδ T cell development, some 
interesting observations using a tetramer of the T22 protein showed that in WT mice there is 
a fraction of γδ cells reactive to T22297. Experiments conducted with T22-reactive γδ T cells 
from thymus, spleen and epithelial tissue from C57BL/6 and β2m(-/-) mice showed that the 
proportion of T22-specific γδ T cells was similar regardless of the genetic background290. 
Further analysis of phosphorylated ERK (pERK) which is a signaling molecule involved in 
TCR signal transduction and CD5, an indicator of TCR signal strength, revealed no differ-
ences between T22-specific γδ thymocytes from the C57BL/6 and β2m(-/-) backgrounds301, 
302. These results demonstrated that the T22 ligand is not essential for the development of 
T22-reactive γδ T cells. Therefore, assuming that these cells are not binding a different lig-
and, the authors concluded that thymic γδ T cell development could take place in the absence 
of ligand interactions. 
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Further analysis of T22 tetramer positive γδ T cells revealed that those cells coming 
from the β2m(-/-) mice acquired a “naïve phenotype” characterized by expression of CD44low 
and CD122low, while T22 positive γδ T cells from C57BL/6 mice were CD44Hi CD122Hi 290. 
Moreover, Jensen et al290 discovered that upon TCR triggering the “antigen naïve” γδ cells 
(CD44low CD122low) secreted IL-17 whereas “antigen experienced” γδ cells, (CD44Hi 
CD122Hi) secreted IFN-γ.  
Thus, they concluded that in the thymus, TCRγδ signal initiation can occur in a lig-
and-independent manner, similar to the pre-TCR, and that the thymic microenvironment 
seems to play an important role in the acquisition of γδ effector function290. 
 
 
 
 
 
 
 
 
 
 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
 
303 
 
5.1.7.2.3 Strong TCRγδ signaling prohibits development of all IL-17A secreting 
γδ T cells 
Recently, our laboratory provided important observations regarding the role of 
TCRγδ signaling in the acquisition of γδ effector function1. As mentioned before, in section 
5.1.7.2.2, general opinion considered that strong signals through the TCRγδ favored γδ T cell 
commitment to secretion of IFN-γ290. In agreement with this hypothesis, the addition of anti-
TCRδ antibody (GL3) which has been reported to promote strong signaling through 
TCRγδ303, to 7-day foetal thymic organ cultures (FTOC) of E15 thymic lobes, reduced the 
generation of IL-17 committed γδ T cells but increased the generation of CD44(+) CD45(+) γδ 
cells (the IFN- γ committed subset)1. In addition, cells committed to the IFN-γ pathway 
showed an increase in expression of CD73, a surface marker that correlates with strong 
TCRγδ signals as reported previously1, 304. 
To assess the effect of a weak signal through TCRγδ, a small molecule inhibitor tar-
geting the Extracellular Signal–Regulated Kinases (ERK) pathway was added to 7-day 
FTOC. ERK is involved in the signaling cascade downstream of TCRγδ301, 302, 305. The results 
showed that inhibition of ERK increased the development of IL-17-producing γδ T cells sub-
set when compared with control cultures. 
Based on these results it was concluded that modulation of signal strength delivered 
by TCRγδ, i.e. a strong signal generated by crosslinking the receptor with antibody, or a 
weak signal obtained through inhibition of the ERK protein, fundamentally influenced the 
development of IL-17 committed γδ T cells. This is consistent with the hypothesis that a 
strong TCRγδ signal is not compatible with the development of IL-17 producing γδ T cells1. 
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Figure 5-7. Schematic representation of the role of TCRγδ in γδ T cell develop-
ment and acquisition of effector function. (A) The development of Vγ5(+) Vδ1(+) 
DETCs and their migration to the skin epidermis is dependent on the Skint-1 
protein. (B) T22-specific γδ T cells that develop in the presence of the T22 lig-
and acquire the IFN-γ secretion phenotype. (C) T22-specific γδ T cells that de-
velop in the absence of their cognate ligand acquire an IL-17-secreting pheno-
type. Manipulation of signal strength delivered by the TCRγδ shows that a 
strong signal prohibits the development of IL-17-secreting γδ T cells. DETC, 
dendritic epidermal T cells; Skint-1, selection and upkeep of intraepithelial T 
cells. 
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5.2 Summary 
γδ T cells are important components of the immune system, with the capacity to re-
spond quickly to various challenges e.g. Malaria, HIV, tuberculosis, tumors, etc. They are 
regarded as one of the earliest sources of the proinflammatory cytokines IL-17 and IFN-γ in 
many diseases. Unlike their αβ T cell counterparts, γδ cells do not need peripheral activation 
to acquire their effector phenotype. Instead, they attain the capacity to secrete IL-17 or IFN-γ 
while still developing in the thymus; therefore, they are considered a “developmentally pre-
programmed” subset of T cells. However, the precise role of TCRγδ in the differentiation of 
γδ progenitors towards the two effector subsets remains unclear. Preliminary data have 
shown that strong TCRγδ signaling seems to drive the development of IFNγ-committed γδ T 
cells, while IL-17 commitment requires weak TCRγδ signaling or perhaps a ligand-
independent event1. In fact, it has been described that some subsets of γδ T cells character-
ized by certain Vγ usage are predominantly represented in one or the other effector subset i.e. 
Vγ5+ in the IFN-γ pathway, Vγ6+ in the IL-17 pathway, while some Vγ subsets are more het-
erogeneous and can be found in both effector groups such as Vγ4+ γδ T cells (IL-17 and IFN-
γ). To that end, the second part of this PhD project aimed to establish a system to begin to 
clarify the role of TCRγδ in the development and acquisition of γδ T cell effector function. 
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5.2.1 Statement of the Problem 
Specifically, this section of the thesis has attempted to address whether features of the 
TCRγδ directly dictate the effector fate of developing γδ progenitors. Simply put, it tries to 
answer the question, “Do γδ progenitors all adopt the same effector fate if they all express the 
same TCRγδ?”, and if so, “What features of the TCRγδ dictate this effect on developmental 
potential?”. 
5.2.2 Hypothesis 
We hypothesize that features of TCRγδ (e.g. CDR3 specificities, Vγ usage) directly 
dictate the thymic differentiation of γδ progenitors towards distinct effector phenotypes. 
5.2.3 Aim 
The initial aims of this project were to clone and express a specific TCRγδ in early 
thymic progenitors, thus establishing a system to study how TCRγδ instructs thymic progeni-
tors towards the acquisition of γδ T cell effector fates. 
5.2.4 Project Plan 
We will first identify and clone a TCRγδ containing the Vγ4Jγ1-Vδ5Dδ2Jδ1 chains 
into a retroviral vector so that this TCR can be transduced into Rag2(-/-) E14 or E15 thymo-
cytes. This TCRγδ is restricted to the CCR6+ CD27- IL-17-producing γδ T cell subset as de-
scribed in section 5.1.3.3258. The transduced thymocytes will be cultured for 7-10 days on the 
bone-marrow derived preadipocyte cell line (OP9DL1 cells) that allows their normal devel-
opment in vitro. Afterwards, we will assess development of γδ thymocytes by flow cytome-
try. Moreover, γδ fate commitment will be evaluated using the methodology described by 
Sumaria et al1. Briefly, CD44+CD45RB- cells are committed to the IL-17 effector pathway 
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and CD44+CD45RB+ cells to the IFN-γ secreting pathway (see Figure 5-6). If TCRγδ is se-
lecting γδ progenitors towards certain effector fates we expect to see that transduced Vγ4Jγ1-
Vδ5Dδ2Jδ1 cells all develop toward an IL-17 secreting effector fate (CD44+CD45RB-) (see 
Appendix). 
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5.3 METHODS 
5.3.1 MOLECULAR BIOLOGY 
5.3.1.1  Gel electrophoresis 
Gel electrophoresis was used for the separation, visualization and isolation of poly-
merase chain reaction (PCR) products and the restriction enzymes digestion products. Aga-
rose (Sigma, DNase and RNase free) was dissolved in TAE 1X buffer solution and the Gel 
Red Nucleic Acid Stain (BIOTIUM) was added to stain and visualize the DNA products. 
The PCR products were run at 1% Agarose at 100 V for 60 minutes. For the visuali-
zation and isolation of the digested plasmids and the subsequent cloning reaction 0.7% Aga-
rose gel was prepared. The reaction mixture ran at 100 V for 90 minutes.  
To load the samples on the wells the 6X TriTrack gel loading dye (ThermoScientific) 
was used. To determine the size of the DNA samples in every run a 100 bp quick purple load 
DNA ladder (BioLabs) was added to the first well. 
5.3.1.2  DNA gel extraction  
For the extraction of the DNA products, the gel was excised with sterile scalpels un-
der a UV lamp and the gel fragments were digested following the instructions provided with 
the Monarch Gel Extraction Kit (BioLabs, lot 0081804). The DNA was eluted with 30 μl of 
the elution buffer provided in the kit previously warmed up to 50 °C. The sample was kept at 
-20 °C until needed. 
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5.3.1.3  Plasmid DNA isolation 
5.3.1.3.1 Maxiprep 
To obtain enough plasmids for the molecular biology work, 100 ml of Luria-Bertani 
(LB) broth containing the appropriate antibiotic was inoculated with 5 ml of the bacterial cul-
ture (chemically competent DH5α strain) and left shaking overnight at 37°C. The following 
day the bacterial culture was pelleted and treated with the Plasmid Maxi Kit (Qiagen) to iso-
late the plasmids. The DNA was extracted in 50 μl of nuclease-free distilled water and stored 
at -20 °C until needed.  The concentration and grade of purity was determined with the 
nanodrop spectrophotometer ND-100 at 260 nm (Labtech). 
5.3.1.4 Restriction Enzymes 
Restriction enzymes were used for the double digestion of plasmids with 1 μg of 
DNA (Table 5-3). The enzymatic reaction conditions were as follows: 1 μl of the restriction 
enzyme, 5 μl of 10X NEBuffer, (x) μl of nuclease-free water to complete 50 μl of total vol-
ume. The reaction was incubated for 15 minutes at 37°C, and inactivated at 65°C for 20 min. 
Table 1 shows summarises the enzymes used in this thesis. All restriction enzymes used in 
this study were purchased from New England BioLabs.  
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Enzyme Restriction Site Buffer 
Age-HF 
5' A˄CCGGT 3'                    
3' TGGCC˄A 5'   
CutSmart 
PacI 
5' TTAAT˄TAA 3'                 
3' AAT˄TAATT 5'   
CutSmart 
PvuI 
5' CGAT˄CG 3'                     
3' GC˄TAGC 5'   
NEBuffer 3.1 
PflMI 
5' CCANNNN˄NTGG3'    3' 
GGTN˄NNNNACC 5'   
NEBuffer 3.1 
BamHI-HF 
5' G˄GATCC 3'                     
3' CCTAG˄G 5'   
CutSmart 
XhoI 
5' C˄TCGAG 3'                    
3' GAGCT˄C 5'   
CutSmart 
MluI 
5' A˄CGCGT 3'                    
3' TGCGC˄A 5'   
NEBuffer 3.1 
Table 5-3. List of the restriction enzymes, along with their respective 
restriction site and the buffer used in each reaction. 
  
5.3.1.5  Polymerase Chain Reaction (PCR) 
Polymerase chain reaction is a powerful technique in molecular biology that allows 
the production of many copies of a target DNA sequence. However, in this thesis, the PCR 
reaction was also used to engineer the single TCRVγ4 and TCRVδ5 chains to produce the 
bicistronic construct Vγ4-2A-Vδ5 (Table 5-4). 
The primers were manually designed and synthesis was performed by Eurofins Ge-
nomics (See Tables 5-5 and 5-6). The PCR polymerase used in this study was the Thermo 
Scientific Phusion High-Fidelity DNA Polymerase. The Phusion DNA Polymerase possesses 
the following activities: 5´→3´ DNA polymerase activity and 3´→5´ exonuclease activity. It 
generates blunt ends in the amplification products that allow the posterior cloning of the 
product into the pCR-Blunt II-TOPO vector. 
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The melting temperatures for each set of primers used in this study were provided by 
Eurofins. To estimate the annealing temperature of each pair of primer the online tool 
(https://tmcalculator.neb.com) was used, with a primer concentration of 2.5 pmol/μl. Howev-
er, in order to find the optimum conditions for each reaction, a gradient PCR was performed 
with every pair of primers. For the gradient PCR, the temperature chosen was ± 5°C of the 
lowest Tm provided from the NEB Tm calculator tool. All the reactions were performed in 
0.2 ml 8 strip PCR tubes individually attached with domed caps (StarLab). The PCR reac-
tions were run in a BioRad thermal cycler. 
 
 
 
Temperature/ oC Time / Cycles 
98 30 
  98 10 
30x TM 30 
72 30 
72 5 min 
Reagent Volume (μl) 
Template cDNA x 
HF Buffer 4 
dNTP mix (2.5mM) 2 
Forward primer (2.5pmol/μl) 1 
Reverse primer (2.5pmol/μl) 1 
Phusion polymerase 0.15 
ddH2O x 
    
Total Volume 20 
Table 5-4. PCR components and PCR programme used to construct the TCRVγ4Jγ1 and the 
TCRVδ5Dδ2Jδ1 chains. Phusion enzyme and HF buffer were purchased from Thermos Scientific and 
dNTPs from Takara Bio-Clontech. 
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5.3.1.6 Primers 
The primers used in the construction of the TCRγδ receptor in this study are present-
ed in the following tables. 
Primer Sequence (5'3') Tm °C 
Fp1γ GACAAAAGGCTTGATGCAGACATTTCCCCCAAG 
71 
Rp2γ CATGGGACCGGGGTTTTCTTCCACGTCTCCTGCTTGCTTTAACAG 
 
 
 
Fp3γ 
CAACCTGAAATATCAATTTCCAGAGCAAG 
60 
Rp4γ CTTGGGGGAAATGTCTGCATCAAGCCTTTTGTCTGCAGAGGGAATTACTATGAGCTTAGTTCC 
 
 
 
SPfg1 
CTCGGATCCACTATGAAGAACCCTGGCTCACAAG 
72 
SPrg2 CTTGCTCTGGAAATTGATATTTCAGGTTGTCCAAATGTCAAGAGGCATAAG 
Table 5-5. Details of oligonucleotide primers designed to generate TCRγ chain. Nucleotides in red 
correspond to overhanging sequences. Underlined nucleotides correspond to the restriction site se-
quence for BamHI. F, forward primer; R, reverse primer. 
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Table 5-6. Details of oligonucleotide primers designed to generate TCRδ chain. Nucleotides in 
red correspond to overhanging sequences. Underline nucleotides correspond to the restriction 
site sequence for BamHI and XhoI. F, forward primer; R, reverse primer. 
Primer Sequence 5'-3' Details Tm (oC) 
Fp1δ AGCCAGCCTCCGGCCAAACCATCTG   69 
Rp2δ 
CTCTAGATGCATGCTCGAGCG Contain the restriction site for XhoI 
(sequence underlined) 
59 
 
Fp3δ TGCATCACGCTGACCCAGAGCTCCACT   69 
Rp4δ 
GATGGTTTGGCCGGAGGCTGGCTCCTT-
GGTTCCACAGTCACTTGGGTT 
Overhanging sequence in red is com-
plementary to Fp1δ (will be joined to 
the 5'-3' chain) 
62 
 
Fp7δ 
GGAGACGTGGAA-
GAAAACCCCGGTCCCATGATTGTT-
GCCGCGACCCTTACCCTTCTG 
 
Overhanging sequence in red is com-
plementary to Rp2γ (will be joined to 
the 3'-5' chain) to joing the TCRγ - P2A 
with the TCRδ construct. ) 
68 
Rp6δ 
AGTGGAGCTCTGGGTCAGCGTGATGCACAG-
CACATCCTTGTAGGCAAACAGAAGG 
Overhanging sequence in red is com-
plementary to Fp3δ (will be joined to 
the 5'-3' chain) 
76 
 
Fp9δ 
GTGGCAATGAGAAGAAATCCGGCTCCGGAGC-
CACGAACTTCTCTCTGTTAAAGCAAGCAGGA-
GACGTGGAAGAAAACCCCGGTCCCATGATT-
GTTGCCGCGACCCTTACCCTTCTG 
Overhanging sequence in red is com-
plementary to Rp2γ (will be joined to 
the 3'-5' chain) to joing the TCRγ - P2A 
with the TCRδ construct. 
>72 
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5.3.2 CLONING 
5.3.2.1  Cloning into pCR-Blunt II TOPO 
The blunt topo vector provides an easy and fast way to insert blunt-end PCR frag-
ments into plasmid vectors. The vector is linearized and contains a DNA topoisomerase I co-
valently bound to the 3’ end of each DNA strand, providing a direct insertion into the vector. 
Furthermore, the plasmid contains the lethal E.Coli gene ccdB fused to the C-terminus of the 
LacZα fragment, which permits only positive recombinants to grow upon transformation. In 
addition, the plasmid contains resistance genes for Kanamycin and Zeocyn for positive selec-
tion of the transformants (Figure 5-8). 
Figure 5-8. pCR-Blunt II TOPO vector map the mul-
tiple cloning site. Plac is the lac promoter that is sepa-
rated from the lethal lacZ-ccdB gene fusion by the 
multiple cloning site. pUC ori is the origin of replica-
tion of the plasmid. The Kanamycin and Zeocyn re-
sistance genes allows for positive selection of trans-
formed bacteria on Kanamycin/Zeocyn containing 
medium.  
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The blunt ended PCR fragments were amplified using the Thermo Scientific Phusion 
High-Fidelity DNA Polymerase, isolated with the agarose gel electrophoresis and extracted 
from the gel with the Monarch DNA gel extraction Kit (NEB #T1020). The cloning reaction 
was performed with a 10:1 molar ratio of insert to vector as recommended in the reaction kit. 
The cloning reaction was set up as shown in Table 5-7.  
Reagent Volume (μl) 
Fresh PCR product 4 
Salt solution 1 
Water 0 
pCRII-Blunt-TOPO 1 
    
Total Volume 6 
 
 
 
 
 
 
The reaction was incubated at 22-23 oC (room temperature) for about 5 minutes be-
fore proceeding with transformation of the DH5α competent cells. 2 μl of the cloning reac-
tion was added to 50 μl of the DH5α competent cells on ice and incubated for 15 minutes. 
The cells were then heat-shocked for 45 seconds at 42oC and then transferred quickly into ice 
for another 15 minutes. After incubation, 200 μl of LB medium without antibiotics were add-
ed to the transformed cells and the vial was shaken for 1 hour at 37 oC. 2 μl, 20 μl and the 
rest of the transformation reaction was plated into three LB Agar plates containing kanamy-
cin (50 μg/ml). The plates were incubated overnight at 37oC. Positive transformants were an-
alysed by restriction digestion (EcoR I) and sent to Sources Biosciences to be sequenced 
(SP6 priming site). 
 
Table 5-7. Components used in the cloning re-
action of the blunt PCR fragment into the pCR 
II TOPO Blunt vector Invitrogen. 
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5.3.2.2  Cloning into pLZRS-IRES-eGFP (pLZ) retroviral vectors 
The pLZRS-IRES-eGFP (pLZ) vector306 is a retroviral vector that possess two long 
terminal repeats (LTRs) flanking the multiple cloning site (MCS) (Figure 5-9). Downstream 
of the multiple cloning site and between the two LTRs there is an internal ribosomal entry 
site (IRES) followed by a reporter gene, enhanced Green Fluorescent Protein (eGFP). The 
IRES lies downstream of the insert, and allows the translation of the insert and of the eGFP 
into two individual proteins. Upstream of the MCS is a packaging signal (Ψ) for packaging 
of the plasmid into virus particles. The pLZ vector contains Ampicillin and Puromycin re-
sistance genes for selection of positive bacterial transformants and transfected phoenix cells, 
respectively.  
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 In preparation for the cloning into the retroviral vector both plasmids, pLZRS-IRES-
eGFP (pLZ) and pCR-Blunt II TOPO that contains the full-length TCR were digested with 
BamHI (NEB) and XhoI (NEB) enzymes in two separate reactions. Both reaction mixtures 
were left for 15 minutes at 37 °C. The digested fragments were purified in 0.7% agarose gel 
for 1 h 40 min at 100 V. 
Figure 5-9. The retroviral vector pLZ-IRES-eGFP (pLZ). The multiple clon-
ing site lies between two long terminal repeats (LTRs) which permits the 
permanent expression of the cloned gene. The packaging signal () upstream 
of the cloning site allows the packaging of the plasmid into viral particles. 
The internal ribosomal entry site (IRES) upstream of eGFP permits the detec-
tion of cells transduced with the retroviral constructs. The ampicillin re-
sistance gene and the puromycin resistance gene will be used for the selec-
tion of transformed bacteria and transfected phoenix cells, respectively. 
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 The linearized form of the retroviral vector (12.4 kb) and the insert (full-length TCR) 
(1.9 kb) were extracted from the gel and eluted in pre-warmed ddH2O to improve the effi-
ciency of the elution. The concentration of DNA in each sample was measured using the 
Nanodrop spectrophotometer. 
The linearized fragments isolated were directionally ligated in a reaction at 20:1 insert 
to vector ratio, using 20 ng of the retroviral plasmid. To calculate the amount of insert to be 
added I have used the following formula: 
 
 
 
 
 
The ligation reaction was performed with the NEB Instant sticky-end Ligase Master 
Mix (M0370S). To the mixture of vector and insert, 5 μl of the Ligase master mix were add-
ed and mixed by thoroughly pipetting up and down 7-10 times, and placed on ice. Immedi-
ately after, the sample was ready for the transformation of the DH5α competent cells. The 
cells were incubated on ice for 30 min then heat shocked for 30 sec at 42 °C. The cells were 
then placed on ice for 2 min before addition of 250 μl LB broth medium (Invitrogen) and in-
cubated at 30 oC in a shaking incubator for one 1 h. 
 The transformed cells were spread on LB Agar (Invitrogen) plates containing 100 
μg/ml Ampicillin (Sigma) and incubated overnight at 37 oC. Single colonies of the positive 
transformants were cultured overnight at 37 oC in 10 ml of LB broth containing 100 μg/ml 
Ampicillin, and bulked up into 100 ml of LB broth containing ampicillin 100 μg/ml and the 
plasmid DNA was isolated. PCRs and/or restriction enzyme digests were performed on 
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plasmid DNA to characterize the transformants and to confirm the presence of the insert. The 
plasmids were sent to Sources Biosciences for sequencing using the pLZ-gag primer; 5’-
TCTTGTCTGCTGCAGCATCG-3’ and/or the primers complementary to the insert se-
quence. 
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5.3.3 CELL BIOLOGY 
5.3.3.1  Isolation of thymocytes and lymphocytes from thymus and skin-draining 
lymph nodes. 
C57BL/6 mouse thymus and skin-draining lymph nodes: brachial, inguinal and axil-
lary, were removed and added into different tubes containing ice-cold Roswell Park Memori-
al Institute Medium (RPMI)-1640 (Invitrogen). Afterwards, the organs were crushed using a 
5 ml plunger and strained through an 80 μm metal mesh (Sefar Ltd, UK) into appropriately 
labelled falcon tubes (15 ml). Fluorescence-activated cell sorting buffer (FACS buffer) (See 
Solutions section) was added to wash recover remaining cells from the strainer and obtain a 
single cell suspension. Cells were counted and stained for FACS analysis. 
 
5.3.3.2  Isolation of splenocytes 
C57BL/6 mouse spleens were removed and stored in ice-cold RPMI-1640 (Invitro-
gen). The organs were crushed and strained through an 80 μm metal mesh (Sefar Ltd, UK) 
into the respective labelled tubes (Falcon 15 ml). Immediately after, FACS buffer was added 
to recover all the cells from the strainer and obtain a single cell suspension. Cells were centri-
fuged at 1400 rpm at 4o C for 5 minutes. The red blood cells were destroyed by lysis with 500 
μl of ammonium-chloride potassium (ACK) lysis buffer (Invitrogen) incubated at 37 oC for 5 
minutes. Afterwards, the cells were washed in two steps by centrifugation at 1400 rpm at 4 
oC for 5 minutes with FACS buffer to eliminate any remaining debris of blood cells and wash 
out the lysis buffer. 
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5.3.3.3  Lymphocyte extraction from the dermis and epidermis 
The extraction of the skin cells from the dermis and epidermis of the C57BL/6 in-
volved the following steps. First, the ears were divided into dorsal and ventral sides. The sep-
aration was done mechanically using forceps. Each halve was then digested enzymatically in 
a process involving two steps. In the first step, 5 U/ml dispase I (BD) in phosphate buffer so-
lution (PBS) for 90 min at 37°C to allow for epidermal and dermal separation. In the second 
step, 1 mg/ml collagenase D (Sigma-Aldrich) in PBS for 45 min at 37°C was added to re-
lease cells from the skin matrix. At last, the tissues were filtered through an 80-µm stainless 
steel mesh to obtain single-cell suspensions. 
5.3.3.4  Isolation of γδ lymphocytes from adult thymus 
Adult C57BL/6 mouse thymuses were obtained by dissection and re-suspended in 
plain fresh RPMI-1640 (Invitrogen). The thymuses were crushed with a pestle and strained 
using a 80 μm cell strainer (Sefar Ltd, UK). The cell suspensions were made up to 7 ml with 
RPMI and 500 μl of hybridoma supernatant was added (a mix of anti-CD4 and anti-CD8 an-
tibodies IgM isotype for complement lysis). The cell suspensions were incubated at 37 °C for 
10 min. 1 ml of resuspended complement (Cedar lane Laboratories) was added and mixed by 
inversion. Cell suspensions were then incubated with complement at 37 °C for 30 min. To 
separate live thymocytes, including DN cells, from dead complement-lysed thymocytes that 
were CD4+ and/or CD8+, lymphocyte separation medium (MP Biomedical) was layered un-
derneath each cell suspension. Tubes were centrifuged for 20 min at 1,600 rpm at room tem-
perature in a bench-top centrifuge with no brake. Live thymocytes were removed from the 
Ficoll interface by pipetting the interface out using a glass Pasteur pipette and transferred to a 
FACS tube. Lysed dead cells, i.e. cells that expressed CD4 and/or CD8, form a pellet at the 
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bottom of the tube. The cells were washed with FACS buffer before staining for analysis in 
the LSRII flow cytometer. 
5.3.3.5  Phoenix (ØNX) Ecotropic Packaging Cell line 
Phoenix Ecotropic (phoenix) cells were kindly provided by the Nolan Laboratory 
(www.stanford.edu/group/nolan/). The cells were cultured in Phoenix media (see solutions 
section) at 37 °C and 5% CO2. For healthy cells, cultures were split when cells reached 70-
80% confluency. Cells were frozen in foetal calf serum (FCS) containing 10% DMSO (Sig-
ma), and aliquots were stored at -80 oC. 
5.3.3.6  Transfection of Phoenix cells 
18-24 hours prior to transfections, approximately 1 x 106 phoenix cells were plated 
per 60 mm x 15 mm culture dish (Corning) in 7 ml of culture media, for 60% confluency at 
the time of transfection. 2 μg of plasmid DNA was used for transfection. Fugene-6 reagent 
(Roche) was used for transfections. A DNA-Fugene complex was prepared with a 3:1 ratio 
(μl Fugene: μg DNA) in DMEM with a total volume of 200 μl. The 200 μl transfection com-
plex was added drop wise to cells and left to incubate for 48 h at 37 oC and 5% CO2. Two 
days after transfection, the cells were removed from 60 mm x 15 mm plates containing 
Fugene and plated in T175 flasks (BD-Falcon) in 25 ml phoenix media with 2 μg/ml of 
Puromycin (Sigma). Puromycin selection allows for stable transfection of the packaging cell 
line. Cells were cultured at 37 °C, 5% CO2 until they reached 70-80 % confluency, then split 
or harvested the retroviral supernatants. Cells transfected with pLZ vectors were visualised 
under the UV microscope to check GFP expression. 
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5.3.3.7  Harvesting Retroviruses 
Removal of growth medium containing puromycin from cells was necessary for har-
vesting retroviral supernatants. 25 ml of filtered-sterilized DMEM with 20% HI-FCS was 
added to the cells. This media did not contain antibiotics. Cells were incubated overnight at 
32 °C. The media on the cells or the supernatant contains the viral particles produced by the 
cell line. This retroviral supernatant was collected the following day and kept on ice. The su-
pernatants were centrifuged for 3 minutes at 1,000 rpm using a bench top centrifuge to re-
move any cells; and then filtered using a 0.45 μm filter (Millipore). 1 ml of the filtered su-
pernatant was aliquoted into 1.5 ml Eppendorf tubes. The retroviruses were concentrated by 
centrifuging the 1 ml aliquots at 13,000 rpm in a table-top micro centrifuge for 45 mins at 4 
°C. The surface liquid was discarded and 125 μl of the retroviral “pellet” from 10 aliquots 
were pooled into one. Concentrated supernatants were frozen and stored at -80 oC until used 
for transduction. 
5.3.3.8  Retroviral transduction of E15 thymocytes (Retronectin) 
Immature E14 or E15 thymocytes were transduced with retroviruses in the presence 
of a surface-bound transduction enhancer Retronectin (RN-Takara Bio Inc). 35 mm x 10 mm 
tissue culture dishes (Corning) were coated with 12 μg/ml of RN in 1 ml PBS (Invitrogen). 
Dishes were incubated at room temperature for 2 h then blocked with 2% BSA (Sigma) for 
30 mins before washing twice with 1 ml PBS. E15 embryos were dissected and their thymic 
lobes were extracted using Dumont forceps (Sigma-Aldrich) and a dissection microscope. 
The lobes were crushed in 1.5 ml Eppendorf tubes containing 250 μl FTOC media (See solu-
tions section) using a conical tissue homogenizer and strained to make a single cell suspen-
sion. The E15 thymocytes were counted and made up to 1 ml in FTOC media. Each 1 ml ali-
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quot of cells was then added to 1 ml of thawed, concentrated retroviral supernatant in a 
FACS tube and mixed. The retrovirus/ thymocyte mixture was added to RN coated plates and 
incubated at 37 °C for 5 h for transduction to take place. 
5.3.3.9  Retroviral transduction of E15 thymocytes (Spinoculation) 
1 hour prior to transfection a bench top centrifuged was equilibrated to 37 oC by hold-
ing at 2000 x g. Immature E15 thymocytes were isolated from the thymus and counted in the 
haemocytometer. The thymocytes were aliquoted into several FACS tubes depending on the 
number of conditions and centrifuged 1500 rpm for 5 minutes. During the centrifugation the 
viral stocks was thawed in 37 oC water bath. The media from the thymocytes was decanted 
and the cells were mixed with the neat virus stock produced in the protocol described above 
(See section 1.3.6). 200 μl/ well of 96 well U-bottom plates were aliquoted and then centri-
fuged at 1000 xg at 37 oC for 2 hours. After the centrifugation, the plates were carefully re-
moved from the centrifuge and incubated at 37 oC with 5% CO2 for 1 hour. Once the incuba-
tion was finished, the cells were washed three times (200 μL/ well each time) with room 
temperature PBS, re-suspend in OP9-DL1 media and incubated at 37 oC with 5% CO2 until 
the analysis by flow cytometry. 
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5.3.3.10  Foetal thymic organ culture (FTOC) 
Mouse embryos were harvested from time-mated, pregnant female C57BL/6 mice at 
E15-days post-conception (E15) and separated from one another. The individual embryos 
were cut transversely using scissors and washed with 1X PBS. Using a dissecting micro-
scope, thymic lobes were extracted with Dumont tweezers (Sigma-Aldrich) and transferred to 
a drop of 1X PBS on a petri dish. Up to 4 thymic lobes were placed on a nucleopore mem-
brane filter (Whatman) in 3 ml-filtered FTOC media (See solution section) in 6 well plates. 
FTOCs were incubated at 37 oC in 5% CO2 for 7-12 days (otherwise will be specified in the 
text). On the day of processing, thymic lobes were collected in 1.5 ml tubes, gently crushed 
using a pestle, and filtered through a 40 μm cell strainer to obtain a single-cell suspension. 
Subsequently, cells were counted using a haemocytometer and stained for FACS. 
 
5.3.3.11  OP9-DL1 cultures 
The OP9-DL1 cell line was kindly provided by the Zuniga-Pflucker laboratory. OP9-
DL1 stromal cell line264 is a bone-marrow derived preadipocyte cell line (OP9) that was ret-
rovirally transduced to express Delta-like-1 (DL1), a Notch ligand, to support growth and 
differentiation of lymphocyte progenitors. DL1 is expressed from bicistronic vector that has 
GFP as reporter gene. OP9-DL1 cells were cultured in OP9-DL1 media (see solutions sec-
tion, Table 5-9) at 37 °C and 5% CO2. For healthy cells, cultures were split, using trypsin 
(Invitrogen) when cells reached 75% confluency, normally a 1:4 or 1:5 passage every two 
days. Cells were frozen in HI-FCS (Invitrogen) with 10% DMSO (Sigma), and aliquots were 
stored at -80 oC. 
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5.3.3.12  OP9-DL1 and thymocyte co-cultures 
18-24 hours prior to transfections, a 75% confluent cells were transferred to 6 well 
plates in 4 ml of media for 75% confluency at the time of transfection. Following the 5 h 
transduction of E15 thymocytes, the cells were removed from the retronectin coated plates 
(see section 2.5) by repetitive pipetting. 1ml of cell suspension was pelleted by centrifugation 
at 2,500 rpm for 2 minutes in 1.5 ml tubes. The supernatant was removed and the second 1 
ml of cell suspension was added to the pellet and centrifuged again. The retronectin plates 
were then washed with 1 ml OP9-DL1 media to ensure that all the cells had been collected. 
After the wash cells were re-suspend in 1 ml OP9-DL1 media and 5 ng/ml of Flt3 ligand and 
1 ng/ml of IL-7 (both Miltenyi Biotech) were added to the media. 1 ml of media was re-
moved from the OP9-DL1 cultures and 1 ml solution containing the thymocytes and the cy-
tokines was added to the semi-confluent monolayer of OP9-DL1. Cultures were incubated 
for 6-7 days at 37 oC, 5% CO2. 
5.3.3.13  Analysis of cells in OP9-DL1 cultures 
Thymocytes were removed from the monolayer of OP9-DL1 cells by vigorously and 
repetitive pipetting. The cell suspension was filtered using a 40 μm cell strainer into a 1.5 ml 
Eppendorf tube and then centrifuged for 5 minutes at 1,400 rpm on a bench-top centrifuge. 
The supernatant was removed and the cells were re-suspended in 100 μL of FACS buffer and 
stained for extracellular markers as described in section 1.7.14.1. 
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5.3.3.14  Staining protocols for FACS 
5.3.3.14.1 Extracellular staining 
Between 1 and 10 x 106 cells were filtered through a 40 μm  strainer (BD) and trans-
ferred to a fresh FACS tube (Becton, Dickinson and Company, BD). The tubes were centri-
fuged and cells were re-suspended in 100 μl FACS buffer. All antibodies were used at 1:200 
dilution, unless otherwise stated in the text, and samples were stained at room temperature in 
the dark for 45 minutes (Table 5-8). The viability reagent Zombie Aqua Fixable dye (1:200 
dilution, Biolegend) was also included in the staining cocktail for dead cell exclusion. After 
staining, cells were washed with FACS buffer by centrifugation at 1400 rpm for 5 minutes at 
room temperature and then re-suspended in 200 μl of FACS buffer. 
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5.3.3.14.2 Mouse antibodies used in this project 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Protein Clone Fluorochrome Supplier 
TCRδ GL3 PerCp5.5 eBioscience 
TCRδ eBioGL3 APC Invitrogen 
TCRδ GL3 Pe-Cy7 Biolegend 
TCRβ H57-597 PerCp5.5 eBioscience 
CD24 M1/69 PB eBioscience 
MHC-II M5/114.15.2 PeCy7 eBioscience 
CD25 PC61 PeCy7 eBioscience 
CD44 IM7 V500 eBioscience 
CD45 30-F11 PE Biolegend 
CD8α 53-6.7 APCCy7 Biolegend 
Vγ4 UC3-10A6 APC eBioscience 
Vγ1 (Vγ1.1) 2.11 PE Biolegend 
Vγ5 (Vγ3) 536 PE Biolegend 
CD45RB C363-16A APCCy7 Biolegend 
Zombie Aqua NA  Biolegend 
TruStain fcX 93 NA Biolegend 
Table 5-8. Antibodies used in this thesis. The antibodies are anti-
mouse and the clone and supplier are shown. APC, allophycocy-
anin; Cy, cyanine dye; PE, phycoerythrin; PerCP, peridinin chlo-
rophyll protein; PB, pacific blue; TCR is T cell receptor, MHC-
II, major histocompatibility complex II. 
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5.3.3.14.3 Compensation 
Single colour controls were run before each experiment to set up the voltages and to 
be used to compensate for spillover in between the fluorochromes. The compensation was 
carried out semi-automatically with the FlowJo software. For the single colour control 15 μl 
of OneComp eBeads (eBioscience) were stained with 1 μl of antibody in 100 μl of FACS 
buffer. 
5.3.3.14.4 Gating strategy 
All lymphocytes were identified based on their size (Forward scatter, FSC) and gran-
ularity (Side scatter, SSC). Afterwards, doublets (FSC-area vs FSC-height and SSC-area vs 
SSC-height) and dead cells were gated out. 
5.3.3.14.5 FACS acquisition 
The acquisition of the flow cytometry data was done using a LSR-II Flow Cytometer 
(BD Bioscience) through FACSDIVA software (BD Bioscience). 
5.3.3.14.6 FACS analysis 
FACS data were analysed using the FlowJo software Version 10 (Tree star). 
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5.3.4 Mice 
C57BL/6 (B6) mice were purchased from Charles River Laboratories. RAG-2-/- were 
bred in house. The embryos were obtained by setting up timed-pregnancies. All animals were 
bred and maintained in individually ventilated cages (IVC) at Barts and the London School 
of Medicine and Dentistry. All experiments involving animals were performed in compliance 
with relevant Home Office UK laws and institutional guidelines approved by a local ethics 
committee. 
 
5.3.5 Solutions section 
Solution Composition 
OP9-DL1 Medium 
DMEM with Glutamax, 10% HI-FCS, 1% Pen/Strep, 1% NEAA, 50μM 
2-mercaptoethanol (all Invitrogen) 
FTOC media 
RPMI, 1% Pen/strep, 2mM L-glutamine, 50μM 2-mercaptoethanol – (all 
Invitrogen), 10% FCS (Stem Cell Technologies) 
FACS buffer 2% HI-FCS in PBS (both Invitrogen) 
TAE (50x ) 
2M Tris pH8 (Sigma), 50 mM EDTA (Invitrogen), 1M glacial acetic acid 
(Sigma) 
dNTP mix 
2.5 mM dATP, 2.5 mM dTTP, 2.5 mM dGTP and 2.5 mM dCTP (Takara 
Bio-Clontech) 
Table 5-9. Solutions used in this study. 
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5.4 RESULTS 
5.4.1 Experimental approach 
 To evaluate the relationship between the molecular characteristics of TCRγδ and the 
acquisition of γδ effector function during thymic development of γδ T cells, we want to es-
tablish a system in which we could express a TCRγδ restricted to the IL-17 effector popula-
Figure 5-10. Graphic representation of the experimental plan. TCR chains were 
cloned into Blunt-TOPO vector and subcloned into the retroviral vector. This plas-
mid was transfected into the Phoenix ecotropic packaging cell line. Retroviral parti-
cles were collected and used to infect E15 RAG-2-/- thymocytes. The transduced 
cells were seeded onto a monolayer of OP9-DL1 cells and cultured for 7 to 14-days. 
LTR, long terminal repeat; eGFP, enhanced green fluorescent protein; IRES, inter-
nal ribosomal entry site; CMV, cytomegalovirus; env, envelope protein; RSV, Rous 
sarcoma virus; Gag, group antigens. 
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tion (TCRγδIL-17) in thymocytes from E15 Rag2-/- mice, that cannot rearrange and therefore 
express endogenous TCR chains. 
 Retroviral particles were generated to deliver the TCRγδIL-17 chains into γδ progeni-
tors. The general approach is illustrated in Figure 5-10. 
The retroviral vector306 used in this study, pLZRS-IRES-eGFP (pLZ), possesses two 
long terminal repeats (LTRs) flanking the multiple cloning site (MCS). These LTRs mediate 
the integration of the cloned TCRγδ into the host genome and act as promoters for the tran-
scription of the cloned receptor. In addition, between the LTRs but downstream of the multi-
ple cloning site (See Figure 5-14), the retroviral plasmid contains an internal ribosomal entry 
site (IRES) sequence followed by the gene encoding the reporter enhanced green fluorescent 
protein (eGFP). The IRES sequence will allows the independent translation of the eGFP re-
porter alongside the cloned TCRγδ. 
The retroviral vector was transfected into the Phoenix (ØNX) Ecotropic cell line307. 
The ØNX Phoenix cell line is a retrovirus producer system based on 293T cells. The cells 
contain constructs that allow the stable expression of viral proteins, i.e. gag, pol and env, de-
rived from the Moloney Murine Leukemia Virus. The expression of the viral proteins is con-
trolled by different promoters, reducing the chances of inter-recombination and production of 
the empty helper virus. The incorporation of the retroviral vector into the viral capsid is me-
diated by the packaging Psi (Ψ) sequence located in the 5-LTR of the retroviral plasmid.  
Retroviruses collected from the supernatant of cultured ØNX phoenix cells were used 
to transduce E15 thymocytes. The transduction was performed with Retronectin (Clontech). 
Retronectin is a recombinant human fibronectin fragment (rFN-CH-296) that contains three 
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functional domains: the cell-binding domain, the heparin-binding domain, and the CS-1 se-
quence, which allow the enhancement of lentiviral- and retroviral-mediated gene transduc-
tion by aiding the co-localization of target cells and viral particles. 
In addition to Retronectin, we also performed the transduction using the Spinocula-
tion308 method. It has been shown that retroviral infection can be substantially improved by 
centrifugal inoculation (spinoculation) although the underlying mechanism of enhancement 
is unclear309. 
The transduced thymocytes were then transferred to a monolayer of OP9-DL1 cells to 
allow for their development in culture from for 7 to 14-days post-transduction. After the in-
cubation period, the cells were stained and analysed for the expression of the cloned TCRγδ 
by flow cytometry. 
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5.4.2 Cloning of the TCRγδIL17 receptor. 
As described above, we aimed to determine how a TCRγδIL17 composed of a canoni-
cal Vγ4Jγ1 and a germline-rearranged Vδ5Dδ2Jδ1 chains restricted to CCR6+ CD27- Vγ4+ T 
cells directs the development of Rag2-/- E14 fetal thymocytes towards a certain effector phe-
notype. Therefore, in the next sections the steps carried out to clone and assemble the 
TCRγδIL17 are described. 
5.4.3 Construction of the TCRγ chain 
The primary structure i.e. amino acid sequence of the TCRVγ4 chain used in this 
study consisted of 330 residues and is represented in Figure 5-11. As mentioned in the Meth-
ods (Section 5.3.1.6) the construction of the TCRVγ4 chain was engineered by a procedure 
that involved three steps, illustrated in Figure 5-12. 
Figure 5-11. Schematic representation of the primary structure of TCRVγ4 chain. The line shows 
the aminoacid sequence of the Vγ4 chain that will be assembled. The different colours represent 
different regions of the TCRVγ4 chain; leader peptide in orange, variable region in blue, constant 
region in dark red. The CDR3 is highlighted in bright red. 
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Plasmids (obtained from Immo Prinz, Hanover Medical School) containing the 
Vγ4Jγ1 and the Cγ1-P2A sequence were linearized with the restriction enzymes AgeI-PacI 
and Mlul-PflMl (step not shown, see enzymes on Table 5-3). In the first step (see Figure 5-
12, step 1), the linearized products were used as templates for two PCRs: reaction 1, PCR 
with primers Fp3γ/Rp4γ which generated product 7 (Vγ4Jγ1, 381 bp), and reaction 2, PCR 
with primers Fp1γ/Rp2γ which generated product 6 (Cγ1-P2A, 585 bp) (see Table 5-5) re-
spectively. Of note, primer Rp4γ had an overhanging sequence of 33 bp that was comple-
mentary to the Cγ1-P2A fragment. The PCR products were purified in agarose gel and ex-
tracted (Figure 5-13 B). In the second step, (Figure 5-12, Step 2), both gel-extracted and puri-
fied products Vγ4Jγ1 (product 7) and Cγ1-P2A (product 6) were used as templates in the 
next PCR. After denaturation of the DNA fragments, the single strands of each fragment will 
be hybridized by their 33 bp overlapping end, and this region acts as a primer for the amplifi-
cation of the annealed product. The amplification of the assembled fragments Vγ4Jγ1Cγ1-
P2A (product 8) (933 bp) is driven by primers Fp3γ/Rp2γ. The PCR product was run in aga-
rose gel and extracted (Figure 5-13 C). To evaluate the successful assembly of the fragments, 
product 8 was sequenced by Sources Biosciences. In the third step (Figure 5-12, step 3), the 
leader peptide sequence was added to product 8. The TCRVγ4 leader peptide sequence was 
obtained from the international ImMunoGeneTics information system (IMGT). The single 
strand oligonucleotide (117 bp) molecule was chemically synthetized by the Eurofins Com-
pany. In a similar approach, the single strand was used as a template for PCR to generate the 
double strand leader peptide (product 9) with primers Spfg1/Sprg2 (Figure 5-13 A). Of note, 
primer Sprg2 contains a 29 bp overhanging sequence that is complementary to product 8. An 
additional PCR was set up with product 9 and product 8 as templates to generate product 10 
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(LeaderVγ4Jγ1Cγ1-P2A, 1062 bp) (Figure 5-13 D). After denaturation, the single strands of 
product 8 and product 9 are hybridized via their 29 bp complementary sequence and this 
fragment acts as a primer in the amplification of the chains. The final amplification of the 
LeaderVγ4Jγ1Cγ1-P2A (product 10) is driven by primers Spfg1/Rp2γ. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 5-12. Experimental approach to engineer the construction of the TCRγ chain. Two plasmids 
containing the Vγ4Jγ1 and the Cγ1-P2A were used as initial templates. In the first step the linearized 
plasmids were used as templates in two PCRs to generate multiple copies of the Vγ4Jγ1 (product 7) 
and the Cγ1-P2A (product 6) fragments. The primer Rp4γ contains an overhanging sequence of 33 bp 
that is complementary to the first 33 bp of the product 6. In step 2, products 6 and 7 were denatured 
and used as templates for the PCR; the single strands hybridize via their 33bp overlap, and subsequent 
amplification was driven with the primers Fp3γ/Rp2γ to obtain the fragment Vγ4Jγ1Cγ1-P2A (prod-
uct 8). In the last step, the leader peptide (product 9), that contains a 29 bp overhanging sequence 
complementary to the Vγ4 fragment was used together with product 8 as templates in a new PCR. 
After denaturation, the single strands hybridize via their 29 bp complementary sequence and the 
fragment is further amplified with the set of primers Spfg1/Rp2γ. The primers Spfg1 contain the re-
striction site for the BamHI that will be used for the cloning of the full construct into the vector. 
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Figure 5-13 Agarose gels showing the PCR products generated in the construction of the 
TCRVγ4 chain. A) Leader peptide of the Vγ4 chain (LPVγ4) (Product 9) with molecular 
weight of 158bp. B) Fragments Vγ4 (381bp) that contains the sequence Vγ4Jγ1 (Product 7) 
and Cγ1-P2A with a molecular weight of 585bp (Product 6). C) Fragment Vγ4Jγ1Cγ1-P2A-
atg of 933bp denominated Product 8. D) Fragment LeaderVγ4Jγ1Cγ1-P2A-atg (Product 10) 
with a molecular weight 1062bp represents the final product in the construction of the 
TCRVγ4 chain. The number of the products are indicated alongside with the size of the frag-
ments. For each PCR the control negative (H2O) is also indicated together with the molecular 
ladder. The number on top of the bands indicates the number of PCR replicas that were run to 
generate enough product for the next step.  
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C
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5.4.4 Construction of the TCRδ chain 
In a very similar approach to that described in the previous section, we tackled the 
synthesis of the TCRVδ5 chain. The primary structure is made of 292 aminoacid residues, 
which is represented with a one-letter code in Figure 5-14. The joining of the fragments for 
the construction of the TCRVδ5 chain was engineered also in three steps, similar to the pro-
cedure described in the section 5.3.1.7 and is illustrated in Figure 5-15. 
 
 
 
 
 
 
Figure 5-14. Schematic representation of the TCRVδ5 chain. The line shows the primary se-
quence of the TCRδ chain that will be assembled. The different colours represent the different 
regions of the TCRVδ5 chain; leader peptide in green, variable delta 5 in yellow, diversity region 
in light blue, joining region in pale red, and the constant region in dark blue. The CDR3 is high-
lighted in red. 
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The cloning of the TCRVδ5 chain was accomplished in three steps (Figure 5-15). Be-
fore step 1 the plasmids containing the Vδ5Dδ2Jδ1 and the Cδ1 sequence were linearized 
with the restriction enzymes AgeI-PacI and MluI-PvuI, respectively (Not shown, See Table 
5-3). In the first step, the linear products were used as a template for two PCRs with primers 
Fp3δ/Rp4δ and Fp1δ/Rp2δ (See Table 5-6) to generate the fragments Vδ5Dδ2Jδ1 (product 2) 
and the Cδ1-vector (product 1), respectively (Figure 5-15, step 1). The primer Rp4δ contains 
an overhanging sequence of 23 bp that is complementary to the Cδ1 fragment. The PCR 
products were purified in agarose gel and extracted. The Vδ5Dδ2Jδ1 (product 2) is a frag-
ment of 385 bp and the Cγ1-vector (product 1) of 585 bp (Figure 5-16 A). In the second step 
(Figure 5-15, step 2), both products Vδ5Dδ2Jδ1 and the Cδ1-vector were used as templates 
in the next PCR. After denaturation of the DNA fragments, the single strands of each frag-
ment hybridize by their 23 bp overlapping ends, and this region acts as a primer for the am-
plification of the annealed sequence. The amplification of the assembled fragments 
Vδ5Dδ2Jδ1Cδ1-vector (Product 3) (877 bp) is driven by primers Fp3δ/Rp2δ (Figure 5-16 B). 
Before the third step, the leader peptide (Product 4) was amplified with primers Fp7δ/Rp6δ. 
Rp6δ contains an overhanging sequence of 27 bp that is complementary to Vδ5Dδ2Jδ1Cδ1-
vector (product 3). The third step (Figure 5-15, step 3), was performed with Vδ5Dδ2Jδ1Cδ1-
vector (Product 3) and leader peptide (Product 4) as templates. After denaturation, the frag-
ments hybridize via their 27 bp complementary sequence and this fragment acts as a primer 
for the amplification of the chains. The final amplification of the LeaderVδ5Dδ2Jδ1Cδ1-
vector (product 5) (Figure 5-16 C) is driven by the set of primers Fp7δ/Rp2δ. Importantly; 
the Fp7δ contains a 27 bp sequence that is complementary to the Cγ1-P2A fragment that will 
be used to engineer the assembly of both TCR chains illustrated in Figure 5-17. To evaluate 
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the successful assembly of product 5 the PCR fragment was sequenced by Sources Bi-
osciences with 100% match between the expected and the synthetized sequences. 
Figure 5-15. Experimental approach to engineer the TCRδ chain. Two plasmids containing the 
Vδ5Dδ2Jδ1 and the Cδ1, respectively were used as initial templates. In the first step the linearized 
plasmids were used as templates in two PCRs to generate multiple copies of the Vδ5Dδ2Jδ1 
(product 2) and the Cδ1-vector (product 1) fragments. The primer Rp4δ contains an overhanging 
sequence of 23 bp that is complementary to the first 23 bp of the product 1. In the step 2, products 
1 and 2 were denatured and used as templates for the PCR; the single strands hybridize via their 
23bp overlap, and subsequent amplification was driven with the primers Fp3δ/Rp2δ to obtain the 
fragment Vδ5Dδ2Jδ1Cδ1-vector (product 3). In the last step, the leader peptide (product 4), that 
contains a 27 bp overhanging sequence complementary to the Vδ5 fragment was used together 
with product 3 as templates in a new PCR. After denaturation, the single strands hybridize via their 
27 bp complementary sequence and the fragment is further amplified with primers Fp7δ/Rp2δ. The 
primers Rp2δ contain the restriction site for XhoI that will be used to clone the full construct into 
the vector.  
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Figure 5-16 Agarose gels showing the PCR bands corresponding to the different frag-
ments amplified for construction of the TCRVδ5 chain. A) In this panel (from left to 
right) is represented the bands corresponding to the fragment Cδ1 (513bp) (Product 1), 
Vδ5 (385bp) that enclosed the Vδ5Dδ2Jδ1 (Product 2), and LPδ (125bp) that represent 
the leader peptide (Product 4). B) This panel shows the eight bands corresponding to 
the fragment Vδ5Dδ2Jδ1Cδ1 (877bp) (Product 3). C) Panel showing the fragment 
LeaderVδ5Dδ2Jδ1Cδ1-vector (975bp) Product 5 and final fragment in the synthesis of 
the TCRVδ5 chain. The name of the product and the molecular weight of each fragment 
is indicated on the top of the bands. The negative control of each PCR (H2O) is also 
shown as reference together with the molecular ladder. The figure on top of the bands 
indicates the number of the replica amount loaded in the gel.  
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5.4.5 Assembly of the TCRγ and TCRδ chains  
The TCRγ-2A-TCRδ construct was generated following the same overlapping ends 
PCR methodology described above for the synthesis of the TCRγ and TCRδ chains (Figure 
5-17. The fragment denominated LeaderVγ4Jγ1Cγ1-P2A (Product 10) and the amplicon 
called LeaderVδ5Dδ2Jδ1Cδ1-vector (Product 5) were used as templates in a new PCR. The 
product 5 contains an overhanging sequence of 27 bp that is complementary to the P2A se-
quence in Product 10, and will act as a primer for the assembly of the single strands of TCRγ 
and the TCRδ fragments upon denaturation. The final amplification of the annealed fragment 
will be driven by primers Spfg1 and Rp2δ, which contain the restriction sites for BamHI and 
XhoI, at the 5’, and the 3’ ends, respectively. These restriction sites are going to be used in 
the cloning of the TCRγ-2A-TCRδ construct into the retroviral vector pLZ-IRES-eGFP. To 
ascertain whether the joining of both fragments, Product 5 and Product 10, is correct, we de-
signed the primer 5’-CTGCCTACTACACCTACCTT-3’, called joining primer (see Figure 
5-17). This primer will bind the Cγ1 sequence; specifically the region located 119 bp before 
the 2A motif and will allow the amplification of the stitching zone. The sequence data ob-
tained from Source Biosciences demonstrated the joining of the LeaderVγ4Jγ1Cγ1-P2A 
(Product 10) and LeaderVδ5Dδ2Jδ1Cδ1-vector (Product 5) was achieved successfully and 
we have now generated the final construct TCRγ-2A-TCRδ (see Appendix). 
 
 
 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
 
343 
 
 
 
 
 
 
 
Figure 5-17. Scheme of the experimental approach used to engineer the final product TCRγ-2A-
TCRδ. The TCRγ and TCRδ fragments were joined in one step overlapping ends PCR. The 
LeaderVγ4Jγ1Cγ1-P2A (Product 10) and LeaderVδ5Dδ2Jδ1Cδ1-vector (Product 5) were used as 
templates together with the SPfg1 (containing BamHI) as forward primer, and Rp2γ as reverse 
primer. Product 5 was engineered to contain a 27 bp complementary overhanging sequence to the 
P2A within the Product 10. The final product TCRγ-2A-TCRδ (1987 bp) includes restriction sites 
for BamHI and XhoI at the 5’and 3’ ends, respectively. These two restriction sites were inserted by 
homology to primers Spfg1 and Rp2δ. The joining primer (shown as a red line) was used check 
the stitching of both fragments was successful. Agarose gel showing the final product Vγ4–2A-
Vδ5  that contains the desired TCRγδIL-17 (1987bp) and the negative control (H2O) (size of the 
fragment is indicated).  
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5.4.6 Cloning the Vγ4-2A-Vδ5 into BLUNT TOPO and 
pLZ-IRES-eGFP 
The blunt ended Vγ4-2A-Vδ5 PCR fragment was cloned into the pCRII-Blunt-TOPO 
vector and transformed into the DH5α E-Coli strain. After isolation by Maxiprep, the plasmid 
was analysed for the presence of the Vγ4-2A-Vδ5 insert. For the analysis, we performed a 
double digestion of the TOPO plasmid with the restriction enzyme EcoRI, which was cut at 
each end of the Blunt PCR product (see Figure 5-8), releasing a linear fragment containing 
the Vγ4-2A-Vδ5 insert. The digested product was tested in a new PCR reaction with primers 
Spfg1/Rp2δ in a similar approach as described in the Section 5.4.5 and Figure 5-17. The 
analysis of the PCR reaction illustrated in Figure 5-18 A, revealed a band with a molecular 
weight near 2000 bp that is in agreement with the expected size of the Vγ4-2A-Vδ5 fragment 
(1987 bp). Moreover, we decided to double check whether the cloning reaction was success-
ful by performing a double digestion of the pCRII-Blunt-TOPO vector containing the Vγ4-
2A-Vδ5 with BamHI and XhoI. As mentioned in section 5.4.5, these two restriction sites 
were introduced into the sequence of the final construct Vγ4-2A-Vδ5 to facilitate its direc-
tional insertion during the cloning reaction into the retroviral backbone (see Figure 5-9). The 
theoretical analysis of the digestion products of the TOPO plasmid containing the Vγ4-2A-
Vδ5 predicts two bands of 3519 and 1961 bp, corresponding to the linearized TOPO vector 
and the Vγ4-2A-Vδ5, respectively (see Methods, Figure 5-8). The analysis of the gel indeed 
revealed (Figure 5-18 B) two bands that co-localize near the ladder and correspond to the ex-
pected molecular weight of the fragments.  
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Sequencing of the pCRII-Blunt-TOPO plasmid was performed by Sources Bioscienc-
es with a primer provided by the company (SP6). The analysis of the sequence confirmed the 
successful incorporation of the Vγ4-2A-Vδ5 fragment into the plasmid backbone (Data not 
shown). 
 
 
 
 
 
 
 
Figure 5-18. Agarose gel electrophoresis. A) Analysis of the product of the digestion reaction of 
pCRII-Blunt-TOPO vector containing the Vγ4-2A-Vδ5 construct with EcoRI. The two bands, corre-
sponding to the same reaction co-localize near 2000 bp on the ladder, which is in agreement with the 
expected molecular weight of the Vγ4-2A-Vδ5 fragment (1987 bp). B) Double digestion of the pCRII-
Blunt-TOPO vector containing the Vγ4-2A-Vδ5 with BamHI and XhoI. The gel shows two fragments 
with molecular weight in correspondence with the expected sizes of the product: linear TOPO vector 
(3519 bp) and full construct Vγ4-2A-Vδ5 (1961 bp). The negative control of each PCR (H2O) is also 
shown as reference together with the molecular ladder. The figure on top/bottom of the bands indicates 
the number of lanes run in the gel. 
A) B) 
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To clone the TCR into the pLZ vector we digested the Blunt II Topo containing Vγ4-
2A-Vδ5 and the pLZ-IRES-eGFP with BamHI-HF/XhoI in separate reactions (see Table 5-
3). The digested products were run on agarose (0.7%) and the desired bands (1961 bp and 
12443 bp) extracted and purified. To ligate Vγ4-2A-Vδ5 and pLZ we used the instant sticky-
end Ligase Master Mix (Biolabs) with 20:1 insert to vector ratio. For the analysis of the in-
sertion of the Vγ4-2A-Vδ5 fragment into the pLZ-IRES-eGFP retroviral vector, we carried 
out a PCR reaction using as templates the double digested retroviral plasmid with the BamHI 
and XhoI restriction enzymes. Furthermore, we also decided to test the reaction with un-
digested (circular shape) retroviral plasmid. The primers used for the amplification were 
Spfg1/Rp4δ. The primers will amplify the sequence LeaderVγ4Jγ1Cγ1-P2A-
LeaderVδ5Dδ2Jδ1 that will contain approximately 1496 bp. Figure 5-19 shows the bands for 
both digested and undigested plasmids.  
Figure 5-19. Agarose gel electrophoresis of un-digested and double digested 
(BamHI/XhoI) pLZ-Vγ4-2A-Vδ5-IRES-eGFP showing the two products: pLZ 
backbone (12,443 bp) and the amplified fragment (1496 bp) in the double digested  
plasmid and the 1496 bp fragment in the un-digested vector. The negative control 
(H2O) is also shown together with the ladder as molecular weight reference.  
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The position of the fragments are slightly lower than 1500 bp on the ladder, which is 
in agreement with the expected size of the amplicon (1496 bp). In the lanes corresponding to 
the undigested plasmid, is it possible to observe as well two faint bands above 10 Kbp that 
we suspect corresponds to the retroviral backbone used as template.  
In conclusion, the data presented in these sections suggest that the cloning of Vγ4-
2A-Vδ5 (TCRγδIL-17) fragment into the pCRII-Blunt-TOPO and pLZ-IRES-eGFP retroviral 
plasmid was successfully achieved. 
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5.4.7 Monitoring the stability of the Phoenix Ecotropic 
packaging cell line (ϕNX) 
The Phoenix Ecotropic cell line is the retrovirus producer line, based on 293T cells 
that our lab has extensively used for the transduction of mouse thymocytes. The line is a 
helper-free virus producer that can be easily monitored for the production of the viral packag-
ing proteins, i.e. gag-pol and envelope proteins. Downstream of the gag-pol construct is an 
IRES-CD8 surface marker that can be monitored as an indirect reporter of the gag-pol pro-
duction by flow cytometry. To assess the stability of our stock of phoenix cells we prepared 
three conditions (Figure 5-20): 1) un-transfected cells as a negative control, 2) cells transfect-
ed with the pLZ-Vγ4-2A-Vδ5 vector to evaluate the transfection protocol, 3) cells unstained 
as a negative reference for CD8 expression. Figure 5-20 shows that approximately 90% of 
phoenix cells expressed CD8 on the cell surface, regardless of whether they were transfected 
or un-transfected with our pLZ construct. 
Summary 
These results demonstrates that our retroviral system for the delivery of the TCRVγ4-
2A-Vδ5 into the Rag2-/- thymocytes has been successfully tested for the production of the 
gag-pol viral packaging proteins and that the retroviral vector pLZ-Vγ4-2A-Vδ5 is effective-
ly transfected in our conditions and leads to the production of GFP+ cells (by means of the 
IRES sequence). 
 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
 
349 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 5-20. Transfected Phoenix cell line with the pLZ-Vγ4-
2A-Vδ5 plasmid and Fugene 6 transfection reagent. Flow cy-
tometry analysis of the transfected Phoenix cell line used in the 
packaging of the retroviral particles (left, untransfected; middle, 
transfected right, unstained). The transfected packaging cell line 
was analyzed for the expression of GFP and CD8a. CD, cluster 
of differentiation; ϕNX, phoenix cell line (n=1). 
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5.4.8 Assessing the efficiency of transfection of pLZ-Empty 
and pLZ-Vγ4-2A-Vδ5 into 293 T cells and the Phoenix 
Ecotropic cell line 
To assess the transfection efficiency of the pLZ-Vγ4-2A-Vδ5 vector, both 293T and 
the Phoenix Ecotropic cell lines were transfected. As negative control we used non-
transfected cells (see Figure 5-21 A and B).  After transfection the cells were left resting in 
culture for 48 hours. The 293T cells were analysed by flow cytometry and fluorescence mi-
croscopy (Figure 5-21 A), whilst the Phoenix cells were evaluated solely for GFP expression 
by flow cytometry (Figure 5-21 B). 
 
 
Figure 5-21. Transfection of 293T and Phoenix cells with control plasmid (pLZ-Empty) and the 
TCRγδ containing plasmid (pLZ-Vγ4-2A-Vδ5) and Fugene 6 transfection reagent. A) Flow cy-
tometry results 48 hr post-transfection of 293T cells with the pLZ-Vγ4-2A-Vδ5 and pLZ-empty 
plasmids (middle and right panels). The results show the percentage of transfected cells, based on the 
expression of GFP. Untransfected (293T cells) were used as a negative control (left panel). Second 
Row: Cells analyzed by microscopy. Non-transfected cells are shown in the left panel (negative con-
trol) with an inset showing the bright field image. Middle and right plots represent 293T cells trans-
fected with pLZ-Vγ4-2A-Vδ5 and pLZ-empty plasmids, respectively. B) Analysis of the transfection 
efficiency of phoenix cells with pLZ-Vγ4-2A-Vδ5 (right plot). Untransfected cells were used as neg-
ative control (left plot). GFP, Green fluorescent protein; ϕNX, phoenix cell line (n=1). 
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As the FACS plots show (Figure 5-21 A), near fifty percent of the total 293T cells in 
the culture were transfected with the pLZ-Vγ4-2A-Vδ5 vector and a good expression of GPF 
can be observed by microscopy. Similarly, the number of GFP+ cells with the pLZ-empty 
vector is above fifty percent with a homogenous GFP pattern by microscopy. The transfec-
tion of the Phoenix Ecotropic cell line shows that almost ninety percent of the cells were 
GFP+, therefore successfully transfected with the pLZ-Vγ4-2A-Vδ5 plasmid in the conditions 
tested in this experiment.  
Summary 
In conclusion, these data demonstrate that the pLZ-empty and pLZ-Vγ4-2A-Vδ5 vec-
tors could drive expression of GFP when transfected into the 293T cell line, with a transfec-
tion efficiency of approximately fifty percent. In addition, we also show the transfection effi-
ciency was near ninety percent in the Phoenix Ecotropic cell line, which is the system that 
will produce the retroviral particles. 
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5.4.9 Assessing the development of Rag2 -/- and B6 WT  em-
bryonic thymocytes in the OP9DL1 system. 
To investigate whether thymocytes could be successfully cultured using the OP9DL1 
system, we cultured E14 Rag2-/- thymocytes for 9-days and E15 C57BL/6 wild type thymo-
cytes for 7-days and assessed their development by flow cytometry (Figure 5-22). 
The OP9DL1 cell line264 is a bone marrow derived preadipocyte cell line, OP9310 that 
was genetically manipulated to express the Notch ligand, Delta-like 1 (see Introduction 
5.1.4). The key aspect of this cell line is that it is able to support growth and differentiation of 
thymocytes from progenitor cells, therefore has been extensively used in studies of T cell de-
velopment in vitro1, 264, 291. 
E14 Rag2-/- thymocytes left in culture for 9 days developed successfully as demon-
strated by the sizable fraction of live cells observed, i.e. around ninety percent (Figure 5-22 
A). Further analysis showed that Rag2-/- thymocytes did not express TCRαβ nor TCRγδ, as 
expected. Moreover, the staining of the double negative population with CD44 and CD24, 
which are phenotypic markers of murine T cell precursors2 allows the identification of three 
distinct populations: DN1, DN2 and DN3. These populations are characterized by the expres-
sion of CD44+CD24- (DN1), CD44+CD24+ (DN2), and or CD44-CD24+ (DN3). Most of the 
thymocytes were DN1 or DN3 cells (see Discussion 5.5.2.3). We did not observe progression 
beyond the DN3 stage. This is due to the inability of the thymocytes to rearrange any TCR, 
as signaling through the TCR is necessary for the progression to the DN4 stage291. 
 The analysis of the E15 C57BL/6 thymocytes showed that cells survived and devel-
oped with development of both TCRαβ+ and TCRγδ+ cells (Figure 5-22). The double nega-
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tive subset (αβ- γδ-) was further analysed with CD44 and CD24 markers and we identified 
that most of the cells (ninety-seven percent of all αβ- γδ-) are in the DN3 stage of develop-
ment. A small fraction of thymocytes had progressed to the DN4 stage.  
We next decided to analyse the developmental progression of the TCRγδ+ subset 
based on the expression of CD24. Sumaria et al1 have shown that E14 thymocytes show a 
developmental progression from CD25+CD24+ to CD25-CD24+ to CD25-CD24-, where 
CD24- thymocytes represent a mature stage in the thymus. Based on these data we performed 
a similar analysis and both γδ24+ and γδ24- thymocytes were further subdivided by the expres-
sion of CD44 and CD45RB to identify the effector fate profile. As Figure 5-22 B shows, im-
mature γδ24+ have not yet entered any effector fate pathway and almost all the cells are CD44-
CD45RB-. By contrast, mature γδ24- cells have already entered one of the two pathways of 
development (IL-17, or IFNγ) as illustrated in the summary graph (Figure 5-22 C). 
Summary  
In summary, these data show that in our lab we can drive satisfactory development of 
both E14 Rag2-/- thymocytes and E15 C57BL/6 wild type thymocytes cultured on OP9DL1 
cells. 
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5.4.10 Retroviral transduction of E14 Rag2-/- thymocytes 
with retroviruses generated with the pLZ-empty and 
pLZ-Vγ4-2A-Vδ5 vectors 
To analyze the effect of the Vγ4-2A-Vδ5 TCRγδIL-17 on development and effector 
fate acquisition of γδ progenitors E14 Rag2-/- thymocytes were transduced with Vγ4-2A-
Vδ5-expressing retroviruses. To ensure stoichiometric co-expression of the Vγ4 and Vδ5 
TCR chains the 2A sequence of the Porcine teschovirus 1 (PTV-1) was placed between the 
two TCR sequences in the pLZ vector. Briefly, the 2A peptide sequence functions as a cis-
acting hydrolase element to mediate cleavage between two proteins311. The 2A peptide se-
quence seems to abort the formation of a Glycine-Proline peptide bond at the end of the 2A 
sequence via a ribosomal skip mechanism312. We chose the PTV-1 2A sequence (22 amino 
acids long) due to its high cleavage efficiency (> 95%) and observations from previous stud-
ies showing successful stoichiometric expression of TCRαβ312, 313. 
E14 Rag2-/- thymocytes were transduced with pLZ-Vγ4-2A-Vδ5 or pLZ-empty retro-
viruses using Retronectin to enhance the binding of virions, and subsequently, co-cultured on 
OP9DL1 cells. After 9-days of culture, approximately 10% of the thymocytes transduced 
with the pLZ-empty were GFP+, whilst the transduction efficiency for the pLZ-Vγ4-2A-Vδ5 
was about 6% (Figure 5-23 A and B). The analysis of the GFP+ Rag2-/- thymocytes trans-
duced with the pLZ-empty showed that these cells were unable to express any TCR on their 
cells surface, and consequently, the development of the Rag2-/- thymocytes was blocked at 
the DN3 stage as previously reported in the literature267, 314 (Figure 5-23 A). In addition, the 
staining of the DN3 subset for CD44 and CD45RB shows a similar pattern to that of imma-
ture γδ24+ subset (see Figure 5-32 A). On the other hand, analysis of thymocytes transduced 
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with the pLZ-Vγ4-2A-Vδ5 showed that ~2.4% of the GFP+ cells expressed TCRγδ and 
around 94% were double negative (Figure 5-23 A). Interestingly, analysis of the DN popula-
tion revealed that 16% of the cells had progressed beyond the DN3 stage of development and 
become DN4 cells (see Discussion 5.5.2.1). Moreover, the analysis of the DN4 subset with 
CD44 and CD45RB showed that 44% of these cells had upregulated CD45RB. Although we 
observed these cells within the TCRγδ- (TCRαβ-) population it is well established that pro-
gression to the DN4 stage is TCR-dependent. For example, it has been shown that TCR sig-
nal transduction by TCRγδ or the pre-TCR is indispensable for T cell development278. More-
over, the absence of some key components of the signal transduction machinery, e.g. LAT315, 
ZAP-70316and Syk317 halt the development of double negative cells at the DN3 stage. 
As mentioned before, downregulation of CD24 correlate to γδ T cell maturation1, 305. 
The analysis of the TCRγδ+ population (Figure 5-23 B) shows that 71% of the cells have 
downregulated CD24 expression whereas 25% of the cells express high levels of CD24. In-
terestingly, staining of the γδ24- thymocytes with CD44 and CD45RB showed that 100% of 
the γδCD24-population had upregulated CD45RB and CD44, suggesting commitment to IFN-γ 
production (Figure 5-23 B). 
The analysis of the mean fluorescence intensity (MFI) of CD24 on the GFP+ DN3 
subset was observed to be higher on cells transduced with the pLZ-empty vector than in the 
thymocytes transduced with the pLZ-Vγ4-2A-Vδ5 vector (Figure 5-23 D). 
The percentage of DN4 cells within the GFP+ population revealed that around 16% of 
the thymocytes transduced with pLZ-Vγ4-2A-Vδ5 were able to progress beyond the DN3 
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stage whereas virtually no progression was observed for thymocytes transduced with the 
pLZ-empty vector (Figure 5-23 E). 
Next, we analyzed the GFP- population for thymocytes transduced with pLZ-empty 
and found that similar to the GFP+ counterpart, there was no expression of TCR on the cell 
surface and the development of DN thymocytes was arrested at the DN3 stage (Figure 5-23 
C). Interestingly, the analysis of GFP- thymocytes transduced with the pLZ-Vγ4-2A-Vδ5 
vector revealed that 10% of the thymocytes had progressed beyond the DN3 stage. This re-
sult suggests that the IRES is not thoroughly efficient in expressing GFP and in fact some 
transduced thymocytes may be GFP-. The analysis of the GFP-DN4 population for the ex-
pression of CD44 and CD45RB demonstrated that indeed 87% of the thymocytes had upreg-
ulated CD45RB (Figure 5-23 C), similar to the GFP+DN4 subset (Figure 5-23 A).  
Summary 
Collectively, these data show that the transduction of Rag2-/- thymocytes with retrovi-
ruses containing pLZ-empty and pLZ-Vγ4-2A-Vδ5 was successful, although the transduction 
efficiency was lower than expected. Transduction with the pLZ-Vγ4-2A-Vδ5 vector can 
drive progression of Rag2-/- thymocytes into the DN4 stage of development and induce 
downregulation of CD24 levels in the TCRγδ+ subset which has been associated with γδ T 
cell maturation. In addition, we observed that the IRES was not completely efficient as some 
GFP- thymocytes progressed towards the DN4 stage of development. Interestingly, the analy-
sis of the TCRγδ+ thymocytes from progenitors transduced with pLZ-Vγ4-2A-Vδ5 revealed 
that γδ24- cells developed towards the IFNγ effector pathway (See Discussion 5.5.2.2). 
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5.4.11 Retroviral transduction of E15 Rag2-/- thymocytes 
with retroviruses generated with the pLZ-empty and 
pLZ-Vγ4-2A-Vδ5 vectors 
As described in the previous section 5.4.10, the transduction efficiency of E14 Rag2-/- 
thymocytes was low, i.e. approximately 10% and 6% for pLZ-Empty and pLZ-Vγ4-2A-Vδ5, 
respectively. Our lab had previously noted that transduction of early progenitors such as E14 
thymocytes can yield low transduction efficiency. Based on this observation, we decided to 
transduce E15 Rag2-/- thymocytes. Moreover, instead of transfecting the cells using Ret-
ronectin as a transfection enhancer, we used the spinoculation method308. 
The spinoculation method is based on centrifugal inoculation. The mechanism is not 
clear. However, some preliminary observations with HIV-1 suggest that modest G forces, 
e.g. 1200 g, can concentrate the viral particles close to target cells, thus improving transduc-
tion efficiency considerably308. 
After spinoculation, thymocytes were cultured for 9-days on OP9DL1 cells. As pre-
dicted, the transduction efficiency improved with approximately 37% of E15 Rag2-/- thymo-
cytes transduced with the pLZ-Vγ4-2A-Vδ5 construct expressing GFP (Figure 5-24 A). By 
contrast, the transduction efficiency with pLZ-empty was lower with approximately 8% 
GFP+ cells observed (Figure 5-24 A). As expected, the GFP+ Rag2-/- thymocytes transduced 
with pLZ-empty did not express any TCR and consequently the development of these cells 
was blocked at the DN3 stage (Figure 5-24 A). By contrast, a sizable proportion of GFP+ 
cells from E15 Rag2-/- thymocytes transduced with pLZ-Vγ4-2A-Vδ5 retrovirus expressed 
TCRγδ on their cell surface (Figure 5-24 A). In order to be consistent, we analyzed the 
TCRγδ- population, which revealed that 38% of the cells had progressed beyond the DN3 
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stage of development to become DN4. However, analysis of the DN4 subset with CD44 and 
CD45RB showed a decrease (6.7%) in the number of cells that upregulated CD45RB (Figure 
5-24 A and E) compared to the 43.9% observed in the previous experiment (see Section 
5.4.10, Figure 5-23 A). 
As mentioned before, downregulation of CD24 has been reported as an indicator of 
γδ maturation1, 305. However, CD24 is not the only useful marker of γδ cell maturation. CD25 
has also being described as a thymic determinant of γδ cell progression1, 2. Since the majority 
of mature γδ thymocytes do not express CD25, downregulation of CD25 can be used as an 
indicator of γδ cell maturation. Therefore, to assess the maturation of the γδ cells we ana-
lyzed the expression of CD25 and CD24 upon transduction of E15 Rag2-/- thymocytes with 
the pLZ-Vγ4-2A-Vδ5 construct. 
The analysis of the TCRγδ+ population (Figure 5-24 B and D) showed that 55% of the 
cells were γδ24+25+, whereas ~43% had downregulated CD25 and probably expressed lower 
levels of CD24. However, we found only 1% of γδ+ cells among the mature γδ24-25- compart-
ment. Further analysis with CD44 and CD45RB among γδ24+25+, γδ24+25-, and γδ24-25- subsets 
showed that the immature populations, γδ24+25+ and γδ24+25-, were double negative, whilst the 
γδ24-25-subset showed upregulation of CD45RB, similarly to the γδ24- thymocytes in Figure 5-
23 B. The upregulation of CD45RB (Figure 5-24 D) suggests commitment to the IFNγ effec-
tor pathway; however, the scant number of cells found within this population makes any con-
clusions speculative at this stage. 
Next, we analyzed the changes in the mean fluorescence intensity (MFI) of CD25 
within the DN3 subset. Both, the GFP+ and GFP- DN3 thymocytes among pLZ-empty and 
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pLZ-Vγ4-2A-Vδ5 were analyzed (Figure 5-24 C). We observed that among the GFP- cells, 
the CD25 MFI for DN3 thymocytes transduced with pLZ-Vγ4-2A-Vδ5 was lower than the 
DN3 cells transduced with pLZ-Empty. However, when we looked at the GFP+ population 
we found striking differences, with DN3 thymocytes transduced with pLZ-Vγ4-2A-Vδ5 
showing almost a 3-fold decrease in CD25 MFI compared to GFP+ DN3 thymocytes trans-
duced with pLZ-Empty (Figure 5-24 C). 
When assessing the GFP- population, thymocytes transduced with pLZ-empty 
showed, as expected, lack of TCR expression and blocked development of thymocytes at 
DN3 stage (Figure 5-24 A and 5-25 A). Noticeably, the analysis of the DN subset among 
GFP- thymocytes transduced with the pLZ-Vγ4-2A-Vδ5 vector showed that ~3% of the thy-
mocytes had progressed beyond the DN3 stage. Further analysis of the GFP- DN4 population 
for the expression of CD44 and CD45RB showed that 21% of the thymocytes had, in fact, 
upregulated CD45RB (Figure 5-25 A), similar to the GFP+ DN4 subset (Figure 5-24 A, third 
row). 
Finally, we assessed the percentage of DN4 thymocytes within the GFP- and GFP+ 
subsets for both pLZ-Empty and pLZ-Vγ4-2A-Vδ5 transductions (Figure 5-25 B). It is im-
portant to note that progression beyond the DN3 stage of development is TCR-dependent, 
therefore in Rag2-/- thymocytes treated with retroviruses containing pLZ-empty, no progres-
sion beyond the DN3 stage of development should be observed. By contrast, we observed 
that 2.6% of the GPF- thymocytes were among the DN4 compartment in the pLZ-Vγ4-2A-
Vδ5 condition. 
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Summary 
In summary, the data demonstrate improvement in transduction efficiency with E15 
Rag2-/- thymocytes. We observed a higher frequency of GFP+ thymocytes when we em-
ployed the spinoculation method. We showed that cells transduced with pLZ-Vγ4-2A-Vδ5 
progressed to the DN4 stage of development, which suggests successful signaling through 
the TCR. Moreover, we recorded downregulation of CD25 levels in the DN3 subset, which is 
an indicator of maturation. In addition, we also showed that a fraction of GFP- thymocytes 
progressed towards the DN4 stage of development, which reinforces the idea that the IRES is 
not completely efficient in promoting the translation of GFP. Interestingly, the analysis of 
TCRγδ+ thymocytes with CD44 and CD45RB revealed that few cells in the γδ24-25- subset 
were CD44-CD45RB+, which suggests commitment to the IFNγ effector pathway (See Dis-
cussion 5.5.2.2). 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
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5.4.12 Evaluating the development of Rag2 -/- embryonic 
thymocytes in FTOC and OP9DL1 systems 
In the previous section, we demonstrated how the transduction of E15 Rag2-/- thymo-
cytes seems to be more productive in terms of yield of transduction. Based on these results 
we asked ourselves whether leaving the thymocytes resting in FTOC for 2 days before isola-
tion and transduction would also be translated into an enhanced transduction yield. Before 
proceeding with the transduction of thymocytes, we first decided to assess the development 
of E15 Rag2-/- thymocytes in two different experimental conditions. To this end, we set up an 
experiment where E15 Rag2-/- thymocytes were placed in two different culture systems (Fig-
ure 5-26): 1) cultured for 9 days in FTOC; 2) cultured in FTOC for 2 days and subsequently 
transferred to OP9DL1 cells for 7-days. After 9-days incubation the thymocytes were isolat-
ed and stained for analysis. Figure 5-26 A shows that from 9-day FTOC culture we recovered 
around 22.5% of E15 Rag-/- with 99.3% of the cells alive. Double staining with CD44 and 
CD25 was used to assess the development of double negative thymocytes. As Figure 5-26 A 
and B show, the majority of the thymocytes (76.4%) develop to the DN3 stage, and 14.4% of 
cells remain in the DN1 stage, with a low number of DN2 cells (3.2%) (see Discussion 
5.5.2.3). As expected in Rag2-/- mice, there was no further development beyond DN3 stage. 
By contrast, 2 day FTOC followed by 7-days on the OP9DL1 cell we only retrieved 
around 3.4% of E15 Rag2-/- thymocytes with 98% rate of survival. Assessment of develop-
ment revealed that almost all the thymocytes (97%) remained in the DN1 compartment with 
no observed progression beyond this stage (See Discussion 5.5.2.4). 
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Summary 
From this experiment, we can conclude that a 9-day FTOC, as expected, better sup-
ports proliferation, survival and development of Rag2-/- thymocytes. The results from the 
OP9DL1 system, when compared with the FTOC system, suggest limited proliferation and 
survival. In addition, the cells may need more than 7-days to develop beyond the DN1 stage. 
However, for the viral infection the thymocytes needs to be released from the thymic stroma 
and be accessible to virions, hence the requirement for the use of the OP9DL1 culture sys-
tem. 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
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5.4.13 Retroviral transduction of E15 Rag2-/- thymocytes 
and culture for 2d in FTOC and 7d in OP9DL1 
As we have shown in section 5.4.11, transduction of E15 Rag2-/- thymocytes seems 
better than transduction of E14 Rag2-/- thymocytes. Thus, we decided to evaluate whether 
further maturation of embryonic day 15 thymocytes for 2 days in FTOC prior to infection 
with retroviruses would further enhance transduction efficiency. To this end, we isolated 
thymic lobes from E15 Rag2-/- mice and placed them in culture for 2 days. Afterwards, thy-
mocytes were isolated, infected with retroviruses using the spinoculation method (See Meth-
ods 5.3.3.9) and transferred to a monolayer of OP9DL1 cells. After 7-days of culture, the 
cells were processed for analysis (Figure 5-27).  
The analysis of the GFP+ population (Figure 5-27 A) revealed that 2% and ~5% of the 
thymocytes were transfected with pLZ-Empty and pLZ-Vγ4-2A-Vδ5, respectively. However, 
developmental evaluation with CD44 and CD25 of the double negative thymocytes trans-
duced with the pLZ-Empty showed 71% were DN1 (CD44+CD25-) while 25% of the cells 
were DN3 (CD44-CD25+) (Figure 5-27 A and C). No further development beyond DN3 was 
observed. Moreover, staining of the DN3 subset with CD44 and CD45RB did not reveal up-
regulation of CD45RB, similar to the results described in previous sections 5.4.10 and 5.4.11. 
The development of the GFP+ double negative thymocytes transfected with pLZ-Vγ4-2A-
Vδ5 showed that 67.9% were DN1 (CD44+CD25-), 10.8% were DN3 (CD44-CD25+), and 
19.1% of the thymocytes had matured further into the DN4 stage (CD44-CD25-) (Figure 5-27 
A and D). Consistent with previous observations, the analysis of the DN3 subset with CD44 
and CD45RB did not segregate this homogenous immature population. By contrast, the anal-
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ysis of the DN4 compartment showed that ~45% of thymocytes had upregulated CD45RB 
(Figure 5-27 A and E). 
Moreover, the comparison of the mean fluorescence intensity of the CD25 between 
the DN3 populations of both pLZ-Empty and pLZ-Vγ4-2A-Vδ5, revealed that the latter un-
derwent a 2-fold decrease in CD25 MFI (Figure 5-27 C). This observation may suggest these 
thymocytes had started to downregulate CD25 stimulated by TCRγδ signaling, although we 
could not record any expression of surface receptor. 
We went next to analyze the ~5% of GFP+ thymocytes that expressed the TCRγδ on 
the surface (Figure 5-27 A orange square, and B). As mentioned previously (Section 5.4.11, 
paragraph 4) the maturation of γδ thymocytes can be assessed with the markers CD24 and 
CD25. The evaluation of the TCRγδ+ subset revealed that ~45% of the thymocytes were 
γδ24+25+, ~29% were γδ24+25-, and ~21% had progressed to the mature γδ24-25- stage (Figure 5-
27 B and F). Further analysis for the expression of CD44 and CD45RB (Figure 5-27 B and F) 
showed that while the immature subsets γδ24+25+ and γδ24+25- did not express either of these 
two markers. The mature γδ24-25- population did upregulate both CD44 and CD45RB (~80%), 
which, as demonstrated by Sumaria et al1 indicates commitment towards the IFNγ secretion 
effector pathway. 
The analysis of the GFP- thymocytes showed that the majority of thymocytes under 
all conditions, appeared to be arrested at the DN1 stage of development (CD44+CD25-) (Fig-
ure 5-27 G) with no progression towards the next stage of development (DN2) (See Discus-
sion 5.5.2.3). 
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Summary 
The data presented here suggest that culturing E15 Rag2-/- thymocytes for a further 2-
days in FTOC followed by 7 days on OP9DL1 cells did not have a great impact on transduc-
tion efficiency. However, some of the results previously observed are repeated under these 
conditions. Interestingly, despite the drawback in the transduction yield, we observed a con-
siderable increase in the percentage of γδ24-25- cells with upregulation of CD44 and CD45RB, 
suggesting commitment to the IFNγ effector pathway (See Discussion 5.5.2.1). 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
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5.5 DISCUSSION  
5.5.1 Introduction 
It is clear that in mice, γδ T cells are a heterogeneous group of lymphocytes that can 
be classified based on the usage of the Vγ variable chain228, their tissue location242 or their 
effector function1. In development, γδ and αβ T cells arise from a common double negative 
(DN) precursor291. Experimental evidence suggests that commitment into the γδ or αβ lineage 
occurs at some point between the DN2 and DN3 stages of development driven by the 
TCR285. Furthermore, it is well established that fully committed γδ T cells adopt subsequent 
effector function and in this process, the TCR plays a key role. For example, our lab has 
demonstrated that increasing the signal strength delivered by TCRγδ is deleterious for the 
development of the IL-17 effector subset, but enhances the development of IFNγ committed 
cells1. However, due to limited knowledge regarding the natural ligands of TCRγδ, it is not 
clear how these signals i.e. strong vs weak, are generated in vivo. Interestingly, some studies 
with truncated forms of TCRγδ, that lack the Vγ and Vδ domains (critical for ligand engage-
ment) showed that truncated receptors were able to initiate signalling in DN thymocytes291. 
These observations suggest that TCRγδ itself, in a ligand independent-manner, might be crit-
ical in promoting development of γδ T cells towards certain effector fates. In fact, it has been 
shown that some gamma variable regions (Vγ) are predominantly represented in either the 
IL-17 effector pathway (Vγ4 and Vγ6) or the IFNγ effector pathway (Vγ5 and Vγ1).318 
Therefore, we decided to begin to address how characteristics of TCRγδ, for example the 
CDR3 regions, instructs γδ thymocyte progenitors towards the acquisition of one of the two 
major effector fates. 
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5.5.2 Summary of Results 
To begin to evaluate the role of TCRγδ in the acquisition of γδ effector function we 
expressed a TCRγδ restricted to the IL-17 effector pathway (Vγ4Jγ1-Vδ5Dδ2Jδ1) in thymo-
cytes isolated from fetal Rag-2-/- mice and assessed their effector commitment outcome. The 
points below summarize the major accomplishments of the second part of this thesis: 
h) A Vγ4Vδ5 TCRγδ from an IL-17 secreting γδ T cell was successfully cloned 
into a retroviral vector for transduction of Rag2-/- thymocytes that themselves 
cannot express TCR chains. 
i) Successful generation of infectious retroviral particles was achieved. 
j) Successful transduction of WT and Rag2-/- early thymocytes progenitors was 
observed. 
k) Productive development of early thymocytes was observed in culture on 
OP9DL1 cells. 
l) Retroviral transfection of Rag2-/- embryonic thymocytes with TCR Vγ4Jγ1-
Vδ5Dδ2Jδ1 allowed progression beyond the DN3 stage of development, sug-
gesting that the TCR is signaling competent. 
m) Thymocytes expressing the TCR Vγ4Jγ1-Vδ5Dδ2Jδ1, restricted to the IL-17 
secretion pathway appear to develop along the CD45RB pathway, suggesting 
commitment towards an IFNγ secreting effector fate. 
n) The OP9DL1 culture system is not as efficient, in our hands, for development 
of Rag2-/- thymocytes, when compared to conventional FTOC. 
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5.5.2.1  Retroviral transfection of Rag2-/- embryonic thymocytes with TCR Vγ4Jγ1-
Vδ5Dδ2Jδ1 allows progression beyond the DN3 stage of development. 
Rag2-/- thymocytes are an invaluable tool to understand the role of the TCR in the 
context of development due to their inability to rearrange their endogenous TCR genes. The 
lack of TCR and the absence of the concomitant signals produce a developmental arrest of 
thymocytes at the DN3 stage of development, also known as β-selection checkpoint. To 
overcome the arrest at the DN3 stage thymocytes need to receive a CD3-mediated signal291. 
Thus, the expression of a functional TCR that is able to initiate signaling can promote pro-
gression of Rag2-/- thymocytes beyond the DN3 stage. Indeed, it has been reported that ex-
pression of a truncated form of a TCR, lacking any variable domains, permits signal initiation 
in DN cells, and subsequent development to the DP stage291. 
Here, fetal Rag2-/- thymocytes were retrovirally transduced with TCR Vγ4Jγ1-
Vδ5Dδ2Jδ1which was previously described as restricted to the IL-17 γδ T cell pathway. For 
those Rag2-/- that were transfected with TCRVγ4Vδ5 a fraction of GFP+ secreting restricted 
TCR Vγ4Jγ1-Vδ5Dδ2Jδ1, we found that a fraction of TCRγδ- DN GFP+ DN cells progressed 
beyond the DN3 stage of development to the DN4 stage. Moreover, DN3 cells from the 
TCRVγ4Vδ5 cultures had much lower surface expression of CD25. Thus, these results sug-
gest that the Vγ4Vδ5 TCR is capable of being expressed and is competent to signal in DN 
cells. To support this, we observed from CD44 vs CD45RB analysis that the DN4 population 
displayed a substantial upregulation of the CD45RB expression, a marker that is known to be 
upregulated after TCR signaling319, 320. 
Our experiments also demonstrated that within the GFP+ subset, a small of cells ex-
pressed the TCRγδ on the cell surface. To evaluate the signaling capacity of these TCRγδ we 
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double-stained with CD24 and CD25 to monitor γδ development. Our observations on the 
maturation within the γδ population clearly suggest that the TCRγδ is delivering signals that 
instruct γδ progenitors to first downregulate CD25 followed by CD24. 
Analysis of the GFP- subset showed maturation beyond the DN3 stage of develop-
ment for those Rag2-/- infected with the retroviruses containing the TCRIL-17. Control of gene 
expression of both the TCRγ and TCRδ chain is regulated by the retroviral promoter long 
terminal repeats (LTR). The LTRs contains all the signals required for gene expression: en-
hancer, promoter, transcription initiation, transcription termination and polyadenylation sig-
nal321. In contrast, eGFP translation is controlled by an internal ribosomal entry site that lies 
downstream of the TCRIL-17 sequence. Thus, our observations suggest that a fraction of Rag2-
/- thymocytes successfully transcribe and translate the TCRIL-17 without translating eGFP. 
Based on the stochastic probability of this process we did not expect that one-hundred per-
cent of TCR+ thymocytes would be also eGFP+. Therefore, we believe that a fraction of thy-
mocytes were infected and expressed the TCRIL-17-although undetectable on the cell surface 
by flow cytometry- but did not express GFP. Further evidence pointing towards the expres-
sion and signaling of the TCR within the GFP- subset comes from looking at CD44 vs 
CD45RB expression, in which upregulation of CD45RB was observed. 
In summary, our results demonstrate that a TCRIL-17 was successfully transduced into 
Rag2-/- thymocytes. We could also demonstrate that only transduced thymocytes were able to 
progress beyond the DN3 stage of development to the DN4 stage, although we could not al-
ways observe TCR surface expression. We could also provide evidence that a fraction of the 
cells expressed a TCRγδ that was functional and capable to promote maturation within the γδ 
subset. In addition, we demonstrated that the efficiency of the internal ribosomal entry site 
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leading to the translation of GFP in infected thymocytes was not 100% efficient, as some 
GFP- thymocytes were clearly infected and developed beyond the DN3 stage.  
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5.5.2.2  Foetal thymocytes expressing an IL-17 secreting γδ T cell-derived TCR 
Vγ4Jγ1-Vδ5Dδ2Jδ1, appears to drive commitment towards an IFNγ secreting 
effector fate, on OP9DL1 cells 
Having established the successful delivery of the TCRIL-17 construct into fetal Rag2-/- 
thymocytes, we went on to evaluate the development of γδ T cells and their acquisition of 
effector fate. We observed that Rag2-/- thymocytes that expressed the TCR were able to ma-
ture to become γδ24- cells. Importantly, when these γδ24-were assessed for expression of CD44 
and CD45RB, they uniformly displayed a CD44+CD45RB+ phenotype that is consistent with 
commitment to the IFNγ pathway. We did not record any evidence of development into the 
IL-17 pathway, which is the opposite to what we expected as we hypothesized that TCRIL-17 
would drive development of Rag2-/- towards the IL-17 pathway. This is an intriguing result 
and is the basis for the expansion and continuation of this project in the Pennington Lab. It 
may be that the development of thymocytes on OP9DL1 cells might not support entry into 
the γδ T cell IL-17 pathway. If the TCR has a critical role in the selection of thymocytes to-
wards an IL-17 effector fate it is logical to think that some sort of ligand engagement might 
be important, one that the OP9DL1 cell culture system cannot provide. However, if this is the 
case, any such ligand is unlikely to be conventional, as it would need to reduce rather than 
promote signaling to induce an IL-17 secreting phenotype. Therefore, we suspect that 
OP9DL1 cells do not support the development of IL-17 secreting γδ T cells, and in turn, en-
hance (or do not affect) the development of the IFNγ effector subset. 
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5.5.2.3  The development of DN2 cells seems to be restricted on the OP9DL1 system 
We observed a low number of thymocytes within the DN2 subset from E14 Rag2-/- 
and C57BL/6 mice background after 9-days of OP9DL1 culture with IL-7 and Flt3-ligand at 
1 and 5ng/μl respectively. Similarly, Rag2-/- E15 thymocytes cultured for 2-days in FTOC 
and a further 7-days on OP9DL1 culture showed a marked reduction in the DN2 and DN3 
populations, with many cells arrested at the DN1 stage. By contrast, Rag2-/- E15 thymocytes 
cultured for 9-days in FTOC developed to the DN3 stage, as expected, with a fraction of cells 
at the DN1 stage and a small percentage of DN2. We do not know why in our OP9DL1 cul-
tures, the fraction of thymocytes at DN2 is so small compared with previous published 
data322. However, we suspect that the reduced number of Rag2-/- thymocytes at the DN2 
stage might be the cause of our low efficiency in the transduction experiment. Retroviral 
transduction is only successful in dividing cells as retroviruses are only capable of entering 
the nucleus during the mitotic period when the nuclear envelope dissolves for cell division323. 
It has been shown that most proliferating cells among the double negative Rag2-/- thymocytes 
are DN2, with a lesser extent at the DN1 subset322,324. 
In addition, the absence of precursors at the DN2 stage of development might also 
explain the lack of development in IL-17 secreting γδ lymphocytes. Shibata et al325 reported 
that IL-17 secreting γδ T cells develop from DN2 cells. In addition, they also observed that 
DN1 cells have also the potential to acquire IL-17 effector function, although with a lesser 
extent. Interestingly, they observed that IFNγ secreting γδ T cells were derived mainly from 
cells at DN3 stage of development. These results explain why we did not observe develop-
ment of the IL-17 secreting γδ T cells, probably because we missed the DN2 cells when per-
forming the transfection. 
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In summary, our experimental observations suggest that thymocyte development was 
not as efficient as it could be on OP9DL1 cells. Moreover, this decrease in the numbers of 
DN2 cells might be the cause of both, our low transduction efficiency and the absence of IL-
17 secreting γδ T cells. 
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5.5.2.4  Possible reasons for inefficient development of thymocytes on OP9DL1 cells 
The OP9DL1 co-culture system has been extensively used as an in-vitro model for T 
cell development264. In addition to the signal delivered by the Notch receptor, IL-7, Flt3 lig-
and and stem cell factor (SCF) are also critical for T cell development326. Flt3 ligand327 and 
IL-7328 were used in our culture system at concentrations of 5 ng/μl and 1 ng/μl, respectively. 
This resulted in inefficient thymocyte development when compared to Rag2-/- thymocytes 
cultured in conventional FTOC. A possible explanation for this could be that the concentra-
tion of IL-7 (1 ng/μl) in our OP9DL1 cultures was too high, in agreement with previous re-
sults showing failure of T cell differentiation from adult-derived lymphoid progenitors in an 
IL-7 dose-dependent manner329. However, Wang et al, using a similar system to ours, studied 
the effect of IL-7 and Flt3 ligand (both at 5 ng/μl) on T cell development in OP9DL1 culture. 
One of the conclusions of that study was that IL-7 is necessary for the differentiation of early 
T cell progenitors to later stages of development. In fact, the addition of a blocking IL-7 anti-
body arrested the development of 83% of the DN thymocytes at the DN1 stage326. Of note, 
they cultured the thymocytes with OP9DL1 cells for more than 15-days; this could explain 
why we do not see progression in our system, because we only left the thymocytes in culture 
for 9-days. 
In conclusion, we observed slow progression of thymocyte development in 9-day cul-
tures on OP9DL1cells with Flt3 ligand and IL-7 at 5 ng/μl and 1 ng/μl, respectively. We 
think, based on previous observations, that this might be a consequence of a short incubation 
period rather than a high concentration of IL-7. However, this is just a suggestion that needs 
to be further investigated, and a titration of IL-7 with WT E15 thymocyte culture is a logical 
next step. 
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5.5.3 Future Work 
The aim of this project was to develop a system to begin to understand the role of 
TCRγδ on the acquisition of certain γδ T cell effector fates during the development of early 
thymocyte progenitors. The major, albeit preliminary, finding from this work will be the ba-
sis of the continuation of this project in the Pennington Lab. This finding suggests that in our 
OP9DL1 culture system expression of a cloned TCRIL-17 in fetal Rag2-/- thymocytes does not 
drive commitment to an IL-17 secreting γδ T cell phenotype. Instead, γδ T cells committed to 
the IFNγ secreting pathway appear to be generated. This is presumably a consequence of cul-
turing cells on OP9DL1 cells in our hands, and may signify the absence of a factor(s), which 
permits IL-17 secreting γδ T cell development. This may be a result of sub-optimal concen-
trations of IL-7, Flt3-l or SCF. Thus, titrations of these factors would be a first important 
step. It may also be that the choice of OP9DL1 cells is not the best for the study of this prob-
lem. We could attempt to directly infect intact thymic lobes in hanging drop cultures. In this 
E14/E15 thymic lobes will be suspended in 25 μl drops containing infectious retrovirus. It is 
hoped that progenitors will be transduced and the intact lobe will facilitate “normal” T cell 
development. Alternatively, we could try to reconstitute depleted thymic lobes (of thymo-
cytes) with retrovirally-transduced E14/E15 Rag2-/- cells in hanging drops. After 2-days these 
reconstituted lobes would be transfer to filters for a further 7-days. 
It is likely that an understanding of why this IL-17-specific TCRγδ does not drive de-
velopment of IL-17-secreting γδ T cells on OP9DL1 cells will be of critical importance, it 
could suggest that a factor such as a IL-17-specific TCR-ligand could be missing. This factor 
presumably would reduce TCR signaling to permit IL-17 γδ development. The expression of 
Scart 1 and Scart 2, two potentially interacting partners for TCRγδ will be assessed on γδ 
Chapter 5 
 
382 
 
progenitors developing on OP9DL1 cells and compared to WT lobes. Scart 1 and Scart 2 are 
normally expressed on developing thymocytes and may dampen TCRγδ signaling when bind-
ing to stromal cells. This idea will be tested in future work. 
Development of novel chemical/biology approaches to elucidate the mechanism of T cell receptor signaling. 
 
383 
 
 
 
 
 
 
 
 
 
6 CHAPTER 6 
 
 
 
 
 
 
 
 
Chapter 6 
 
384 
 
6.1 FINAL CONCLUSIONS 
The integration of chemistry and biology has led to the development of the chemical-
biology field that has proven very useful to answer biological questions that could not be 
solved by pure chemical or biological approaches alone. In this project, we have aimed to 
elucidate the mechanism of T cell receptor signaling using a chemical-biology approach, 
based on the synthesis of a maleimide-porphyrin aggregation reporter linked covalently to 
one of the transmembrane segments of the γδ T cell receptor and liposomes as model mem-
branes (Chapters 2-4). In addition, we have also peformed functional studies in vitro with 
early thymocytes progenitors to understand the role of the TCRγδ receptor in the acquisition 
of effector function (Chapter 5).  
The starting point of this study was the synthesis of the aggregation reporter - 5-(4-
maleimide)-10, 15, 20 tris (4 - sulfonatophenyl) – porphyrin - denominated compound #5. In 
Chapter 2 we describe the synthetic pathway followed, which was based on previous work by 
Kochany et al129. Slight modifications were introduced ad hoc to improve the efficiency and 
the yield in some steps compared to the original protocol. The successful synthesis of Com-
pound #5 was achieved and the product characterized by 1H-NMR spectroscopy and mass 
spectrophotometry. 
In Chapter 3 we investigated the conditions required to perform the labeling of some 
model thiols e.g. N-acetylcyteine, γ-gluthathion and 1-hexadecanethiol with Compound #5 
prior to the work with the transmembrane peptide. We successfully achieved the model thiols 
labeling and determined that RP-HPLC was the best analytical technique to follow the reac-
tion. As was demonstrated before, the labeling reaction only proceeds if the sulfhydryl group 
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is in the reduced state therefore we explored different reducing agents and whether or not the 
reduction was compatible with the labeling in a one-pot reaction. Our results suggested that 
TCEP and sodium dithionite, the reducing agents tested here, both cross-reacted with the ma-
leimide group in compound #5. This indicated that reduction of the sulfhydryl group must be 
performed in a separate step.  
In Chapter 4 we designed and studied some analytical methods to determine aggrega-
tion in model membranes. We successfully calculated the binding constant of compound #5 
with phospholipids using an algorithm based on a 1:1 binding model. The Ka suggested that 
a fraction of unreacted Compound #5 was bound to the liposome membrane, which was con-
firmed by the experimental data. To remove the excess of unreacted porphyrin we deter-
mined that a GPC column combined with filtration using a concentrator was the best method. 
We also investigated the capacity of two reagents - p-Xylene –bis- (N-pyridinium bromide) 
(DPX) and 1,1′-diheptyl-4, 4′-bipyridinium dibromide (DPB) –to quench the fluorescence of 
Compound #5 and determined that DPB was the best quencher. The titration experiments 
with the peptides and lipids suggest that both peptides were inserted with the N-terminal fac-
ing the extra liposomal side. However, this result needs to be verified with further investiga-
tion. We successfully followed the reaction of the peptide control and the compound #5 by 
RP-HPLC. 
In Chapter 5 we studied the role of the TCRγδ in the acquisition of effector fate phe-
notype during early thymocyte development. We successfully cloned the TCRVγ4Vδ5 re-
stricted to the IL-17 secreting population into a retroviral vector. We achieved the generation 
of viral particles that successfully transduced the TCRγδ receptor to WT and Rag2-/- thymo-
cyte. Our results show development of thymocyte beyond the DN3 stage, which effectively 
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demonstrate that the transduced receptor was able to transmit signaling, and interestingly our 
analysis revealed that thymocyte develops along the IFN-γ secreting pathway.  
In summary, we have not obtained enough data to make firm conclusions regarding 
the ability of the TCRγδ transmembrane segment to aggregate when inserted in the model 
membrane. However, the results obtained here could serve as the basis for further study. On 
the other hand, we have demonstrated that the TCRγδ receptor that is restricted to the IL-17 
secreting phenotype leads the development of the IFN-γ pathways, which suggests several 
conclusions. First, the development system (OP9DL1) does not support the development of 
the IL-17 effector subset. Second, some important signals might be missing that abrogate the 
development of the IL-17 effector thymocyte. This preliminary result will be followed up in 
our laboratory to further investigate the role of the TCRγδ in the acquisition of the γδ effector 
phenotype. 
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6.2 APPENDIX 
 
Figure 6-2. MALDI-TOF of compound #5 in the negative ion mode. As reference, the exact mass of 
the compound #5 is 946.10g/mol. 
Figure 6-1. MALDI-TOF of compound #5 in the positive ion-mode. As reference, the exact mass of 
the compound #5 is 946.10g/mol. 
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Figure 6-3. 1H NMR (400 MHz, DMSO-d6) spectrum of the maleimide sodium salt (close ring), 
(Pure Compound #5) at 25° C. recovered from the ion exchange chromatography. 
 
Figure 6-4. UV-vis spectrum of the control peptide sample. 
The inset table shows the concentration of the peptide based on 
the absorption of tryptophan at 280 nm. 
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Figure 6-5. UV-vis spectra of two samples of full-length 
peptide recorded at time 0 and 1hr. The inset table shows 
the concentration of the peptide based on the absorption of 
tryptophan at 280 nm 
 
Figure 6-6. 1H NMR (400 MHz, MeOD and DMSO-d6) spectra of TCEP: A) 5 mM TCEP in 
MeOD; B) 5 mM TCEP DMSO. 
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Figure 6-8. 2 mM solution of liposomes prepared with com-
pound #5 at 2, 3, 4, and 5 μM. 
Figure 6-7. Plot showing the changes in the tryptophan fluo-
rescence intensity at 350 nm at different concentrations of 
[PC]. The sample at 3.75 x 10-4 M (S9) marked with an ar-
row represents the concentration from which the fluores-
cence started to be quenched. 
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Figure 6-10. Raw UV-vis spectral data of the titration of compound 
#5 with twelve solutions of liposomes. 
 
Figure 6-9. Raw UV-vis spectral data of light scattering of ten-
solutions of liposome at increasing concentrations of phosphatidyl-
choline. 
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 Product 10 (LeaderVγ4Jγ1Cγ1-P2A, 1062bp) (5’-3’) 
ctcggatccactatgaagaaccctggctcacaagccctgcttcctttatatcttccctgggaagccaacctggcagatga 
gaatccactcctgaaagtagtcattttcttatgcctcttgacatttggacaacctgaaatatcaatttccagagcaagag 
atgagactgcacaaatatcctgtaaagttttcatcgaaagctttaggagtgtaaccatacactggtaccggcagaaacca 
aaccaaggtttagagtttctattatatgtccttgcaacccctacccatattttcttagataaggagtacaagaaaatgga 
ggcaagtaaaaatcctagtgcttctacatcgatattgacaatatattccttggaggaagaagacgaagctatctactact 
gttcctacggcttatatagctcaggttttcacaaggtatttgcagaaggaactaagctcatagtaattccctctgcagac 
aaaaggcttgatgcagacatttcccccaagcccactattttccttccttctgttgctgaaacaaatctccataagactgg 
gacatacctttgtctccttgaaaagttctttccagatgttataagggtgtattggaaagaaaaggatggcaatactatcc 
tggactcccaggaaggggatacgctgaagactaacgacacatacatgaagtttagctggcttacagtgcctgaaagggca 
atggggaaagagcacagatgtattgtcaaacatgagaacaacaaaggaggagcagatcaagagattttctttccttcaat 
aaagaaagttgctgtgagtaccaagcctacaacttgctggcaagataaaaatgatgtgctgcagctccagttcacgatca 
cctctgcctactacacctaccttctcctgctcctcaagagtgtgatctacttggccatcatcagcttctctctgcttaga 
agaacatctgtctgtggcaatgagaagaaatccggctccggagccacgaacttctctctgttaaagcaagcaggagacgt 
ggaagaaaaccccggtcccatg 
 
 
 
 
Product 5 (LeaderVδ5Dδ2Jδ1Cδ1-vector, 975bp) (5’-3’) 
cgagctcggatccactagtaacggccgccagtgtgctggaattcaggatgattgtt-
gccgcgacccttacccttctgtttgcctacaaggatgtgctgtgcatcac-
gctgacccagagctccactgaccagacagtggcaagcggcactgaagtaacactgctctg-
cacgtacaatgcggattctccaaacccagatttattttggtatcgcaaaaggccaga-
cagatccttccagttcatcctttatagggacgacactagttcccatgatgcagatttt-
gttcaaggtcgattttctgtgaagcacagcaaggccaacagaac-
cttccatctggtgatctctccagtgagccttgaagacagcgc-
tacttattactgtgcctcggggtatatcggagggatacgagctaccgacaaactcgtcttt-
ggacaaggaacccaagtgactgtggaaccaaggagccagcctccggccaaac-
catctgttttcatcatgaaaaatggaacaaatgttgcttgtctggtgaaagatttc-
taccctaaagaggtgactataagtctcagatcatccaagaagattgtggaattcgaccctgc-
tatagtcatctcccccagcgggaagtacagtgctgtcaagcttggtcagtatggagat-
tcgaattcagtgacatgttcagttcagcacaacagtgaaactgtgcactcgactgacttt-
gaaccatatgcaaattctttcaataatgaaaaactaccagaac-
ctgaaaatgacacacaaatttcagagccttgctatggcccaagagtcacagttcacactga-
gaaggtaaacatgatgtccctcacggtgctgggcctacgactgctgtttgccaagaccatt-
gccatcaattttctcttgactgttaagttattcttttaacctgaattctgcaga-
tatccatcacactggcggccgctcgagcatgcatctagag 
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TCRγ-2A-TCRδ (1987bp) (5’-3’) 
ctcggatccactatgaagaaccctggctcacaagccctgcttcctttatatcttccctgggaagccaacctggcagatga 
gaatccactcctgaaagtagtcattttcttatgcctcttgacatttggacaacctgaaatatcaatttccagagcaagag 
atgagactgcacaaatatcctgtaaagttttcatcgaaagctttaggagtgtaaccatacactggtaccggcagaaacca 
aaccaaggtttagagtttctattatatgtccttgcaacccctacccatattttcttagataaggagtacaagaaaatgga 
ggcaagtaaaaatcctagtgcttctacatcgatattgacaatatattccttggaggaagaagacgaagctatctactact 
gttcctacggcttatatagctcaggttttcacaaggtatttgcagaaggaactaagctcatagtaattccctctgcagac 
aaaaggcttgatgcagacatttcccccaagcccactattttccttccttctgttgctgaaacaaatctccataagactgg 
gacatacctttgtctccttgaaaagttctttccagatgttataagggtgtattggaaagaaaaggatggcaatactatcc 
tggactcccaggaaggggatacgctgaagactaacgacacatacatgaagtttagctggcttacagtgcctgaaagggca 
atggggaaagagcacagatgtattgtcaaacatgagaacaacaaaggaggagcagatcaagagattttctttccttcaat 
aaagaaagttgctgtgagtaccaagcctacaacttgctggcaagataaaaatgatgtgctgcagctccagttcacgatca 
cctctgcctactacacctaccttctcctgctcctcaagagtgtgatctacttggccatcatcagcttctctctgcttaga 
agaacatctgtctgtggcaatgagaagaaatccggctccggagccacgaacttctctctgttaaagcaagcaggagacgt 
ggaagaaaaccccggtcccatgattgttgccgcgacccttacccttctgtttgcctacaaggatgtgctgtgcatcacgc 
tgacccagagctccactgaccagacagtggcaagcggcactgaagtaacactgctctgcacgtacaatgcggattctcca 
aacccagatttattttggtatcgcaaaaggccagacagatccttccagttcatcctttatagggacgacactagttccca 
tgatgcagattttgttcaaggtcgattttctgtgaagcacagcaaggccaacagaaccttccatctggtgatctctccag 
tgagccttgaagacagcgctacttattactgtgcctcggggtatatcggagggatacgagctaccgacaaactcgtcttt 
ggacaaggaacccaagtgactgtggaaccaaggagccagcctccggccaaaccatctgttttcatcatgaaaaatggaac 
aaatgttgcttgtctggtgaaagatttctaccctaaagaggtgactataagtctcagatcatccaagaagattgtggaat 
tcgaccctgctatagtcatctcccccagcgggaagtacagtgctgtcaagcttggtcagtatggagattcgaattcagtg 
acatgttcagttcagcacaacagtgaaactgtgcactcgactgactttgaaccatatgcaaattctttcaataatgaaaa 
actaccagaacctgaaaatgacacacaaatttcagagccttgctatggcccaagagtcacagttcacactgagaaggtaa 
acatgatgtccctcacggtgctgggcctacgactgctgtttgccaagaccattgccatcaattttctcttgactgttaag 
ttattcttttaacctgaattctgcagatatccatcacactggcggccgctcgagcatgcatctagag 
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6.2.1.1 Distribution of Vγ4+ γδ+ lymphocytes in the mouse skin 
To investigate the distribution of Vγ4+ γδ T lymphocytes within the two compart-
ments of the skin i.e. epidermis and dermis, we obtained single-cell suspensions from the ep-
idermis and dermis of C57BL/6 ears. In agreement with previous observations239 we found 
that almost all the CD3+ cells residing in the epidermis are γδ cells, from which approximate-
ly 80% accounted for Vγ5+, 4% for Vγ4+ lymphocytes and 13% other Vγ usage lymphocytes 
(Figure 6-11 D). We identified a small fraction of CD3+ lymphocytes (~1%) to be αβ T cells 
(Figure 6-11 B and C). 
In the dermis, similarly, the majority of the CD3+ cells were γδ lymphocytes (81%), 
however the percentage of the αβ cells homing to the dermis (5%) are higher compared with 
the epidermis (Figure 6-11 B and C ). The analysis of the Vγ usage within the γδ subset 
shows that 75% are Vγ5+ thymocytes, 2% represents the Vγ4+ subset, and around 19% other 
Vγ receptors.  
These results are at odds with previous observations in the mouse skin, that reported 
almost exclusively Vγ5+ γδ cells homing in the epidermis, with scarce representation of other 
Vγ subsets239, whereas in the dermis, in contrast, the proportion of the Vγ5+ was significantly 
lower compared with the Vγ4+ subset. 
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Summary 
Collectively, these data indicate that the epidermis contains a residing population of 
CD3+ cells that are predominantly Vγ5+ γδ cells with a minor representation of other Vγ sub-
sets or αβ lymphocytes. On the other hand, for the dermis compartment, under our experi-
mental conditions, we detect a sizable proportion of γδ cells, where Vγ5+ subset were the 
dominant subset, although a proportion of other subsets i.e. Vγ5-Vγ4- were also found. 
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6.2.1.1 Representation of Vγ4+ and Vγ1+ γδ+ lymphocytes in the mouse lymph nodes 
After the examination of the skin, we decided to explore the distribution of Vγ4+ and 
Vγ1+ subsets of γδ cells within the lymph nodes. To this end, we isolated lymphocytes from 
the brachial, inguinal and axillary skin-draining lymph nodes from C57BL/6 mice and ob-
tained a single-cell suspension (See section 5.3.3.1). Following the gating strategy shown in 
Figure 6-12 A we analysed the fraction of γδ+ cells for the expression of both Vγ4+ and Vγ1+, 
and evaluated the representation of each Vγ subset within one of the two effector fate com-
mitment pathways, following the methodology described in section 5.1.6. 
The γδ+ subset (~ 0.4%) was subdivided based on the expression of CD24, with a siz-
able proportion of γδ24- (~80%) representation over the γδ24+ (~15%). The γδ24- subset in the 
lymph nodes was composed of approximately 38% of Vγ1+, 38% of Vγ4+, and 16% of other 
subsets (Figure 6-12 C).  
The Vγ1+, Vγ4+, and Vγ1- Vγ4- subsets were further analysed for the expression of 
CD44 and CD45RB (Figure 6-12 B). The summary graph presented in Figure 6-12 D, shows 
that around 20% of Vγ1+ cells are CD44-CD45RB+ subset (“c”), which are committed to the 
secretion of IFN-γ, and nearly 10% are CD44+CD45RB- (“d”) and committed to the IL-17 
pathway. 
For the Vγ4+ subset, we observed that approximately 25% of the cells are skewed to-
wards the IL-17 effector pathway (CD44+CD45RB-) (“d”), whereas around 19% are CD44-
CD45RB+, thus committed to the IFN-γ secretion pathway.  
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The Vγ1- Vγ4- subset contains around 15% of γδ T cells engaged in both the IL-17 
and the IFN-γ effector commitment pathways as illustrated in Figure 6-12 C. 
Next, we decided to investigate the ability of the γδ+ lymphocytes to produce IFN-γ 
or IL-17 after 4 hours stimulation with PMA and ionomycin. As Figure 6-12 B shows, within 
population “c” (IFN-γ producers) around 5% of Vγ1+ and Vγ1- Vγ4- γδ+ lymphocytes readily 
produce IFN-γ, whereas this percentage is increased up to 18% for the Vγ4+ subset. The 
analysis of the population “d” shows that 6.7% of Vγ1+, followed by 16.4% of Vγ1- Vγ4-, 
and around 60% of Vγ4+ subset produce IL-17. These results are in agreement with previous-
ly reported data for γδ+ lymphocytes from the lymph nodes, although they observed a signifi-
cantly higher production of IFN-γ1.  
Summary 
In conclusion, the data presented in this section suggest that in C57BL/6 adult, the 
skin draining lymph nodes harbour a population of γδ+ lymphocytes composed of Vγ1+and 
Vγ4+ predominantly. We also observed that the Vγ1+ subset is almost two-fold increased in 
the IFN-γ effector pathway, whereas the Vγ4+ subset shows a preference towards the IL-17 
effector fate. The pool of Vγ1- Vγ4- lymphocytes seems to contribute proportionally to each 
effector fate pathway.  
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6.2.1.2 Characterization of the Vγ4+ and Vγ1+ γδ+ lymphocytes repertoire in the 
mouse spleen 
In a similar approach as the one described in section 5.4.7.5, we investigated the dis-
tribution of Vγ1+ and Vγ4+ γδ+ lymphocytes in the spleen of adult C57BL/6 mice.  
We observed that about 66% of the γδ+ lymphocytes are within the γδ24-, and they 
represent the mature population1. We went on to double stain for Vγ1+ and Vγ4+ to identify 
the representation of these receptors in the adult spleen (Figure 6-13 A). The analysis of the 
data shows that Vγ1+ represents approximately 42 % of the γδ24- splenocytes, the Vγ4+ subset 
account for around 29% and the pool of Vγ1-Vγ4- around 16% (Figure 6-13 C). 
Then we decided to further investigate each particular subset with the staining method 
described previously, i.e. CD44 vs CD45RB, to visualize the commitment of the splenocytes 
towards the IFN-γ or IL-17 secretion pathway (Figure 6-13 B and D). We observed that 28% 
of the cells within the Vγ1+ subset are CD44-CD45RB+ (“c”), whilst around 5% are commit-
ted to the IL-17 pathway (CD44+CD45RB-, “d”). Interestingly, around 33% of the Vγ4+ sple-
nocytes are engaged in the IFN-γ pathway (“c”), and nearly 22% of the cells enter the IL-17 
secretion pathway (“d”). For the Vγ1-Vγ4- γδ cells, the percentage of cells within each devel-
opmental pathway is similar, with 20% and 18% of splenocytes within “c” and “d” popula-
tions, respectively. 
The capability of the cells to synthetize cytokines was also evaluated (Figure 6-13 B). 
Although the stimulation does not seems to be have worked as well it is possible to see that 
within the “d” population some of the cells are readily synthetizing IL-17A, especially the 
Vγ4+ subset with approximately 23% of the cells. The cells within population “c” do not re-
spond to the PMA and ionomycin stimulation as readily as we expected. 
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Summary 
In the light of these results we can conclude that in the C57BL/6 adult spleen the 
Vγ1+ subset represents the majority of the mature splenocytes homing to the spleen, followed 
by the Vγ4+ subset, and some other Vγ subsets are also observed, although less abundantly. 
Importantly, we detected that most of the Vγ1+ splenocytes are biased towards the IFN-γ 
production, although the cells were less inclined to produce cytokine (IFN-γ) after stimula-
tion. The Vγ4+ population, instead, shows an increment in the number of cells within the “d” 
compartment, although the majority of the cells found are engaged in the IFN-γ secretion 
pathway. Similar to the previous observation in the last section, the pool of Vγ1-Vγ4- spleno-
cytes seems to contribute equally to each effector fate pathway. 
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6.2.1.1 Repertoire of Vγ4+ and Vγ1+ γδ+ lymphocytes in the mouse thymus 
To study the repertoire of Vγ1+ and Vγ4+ γδ+ lymphocytes in the thymus we harvest-
ed thymuses from adult C57BL/6 mice and obtained single-cell suspensions that were deplet-
ed of CD4+ and CD8+ cells but containing the γδ+ subset. 
The γδ+ population was subdivided and analysed by the expression of CD24. As can 
be observed in Figure 6-14 A the γδ24+ subset represents the majority of the γδ+ cells within 
the thymus. The double staining for Vγ1 and Vγ4 reveal that 50.0% of the γδ24+ are Vγ4+, 
followed by 26.6% of Vγ1+ and 16% for the Vγ1-Vγ4- pool (Figure 6-14 C). The CD44 and 
CD45RB staining of γδ24+ thymocytes revealed that these cells had not matured enough yet 
to enter any route of differentiation towards the IFN-γ or the IL-17 effector pathway. 
On the other hand, the γδ24- population represents a small fraction of the γδ+ subset 
(Figure 6-14 B). Unlike the γδ24+ subset, the staining for Vγ1 and Vγ4 shows that 56% of the 
cells are Vγ1+, followed by 22% of Vγ4+, and 12% of Vγ1-Vγ4- subset (Figure 6-14 D). As 
Figure 6-14 E shows, the staining for CD44 and CD45RB segregates each particular Vγ sub-
set into two populations, CD44-CD45RB+ (“c”) and CD44+CD45RB- (“d”), engaged towards 
the IFN-γ or IL-17 effector pathway, respectively. Moreover, we observed that within the 
Vγ1+ subset, 70% of the cells were differentiated towards the IFN-γ producer (population 
“c”). Interestingly, the majority of the Vγ4+ cells, around 82%, were biased towards the IL-
17 effector phenotype. Similarly, the same trend was observed within the pool of Vγ1-Vγ4- 
cells where 86% of the cells were found in the CD44+CD45RB- gate (population “d”). These 
results, in fact, are in agreement with previous observations from Sumaria et al1 described in 
the introduction section of this thesis. 
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Summary 
Collectively, the data obtained from these experiments suggest the majority of the γδ+ 
cells in the C57BL/6 adult thymus is represented by the immature γδ24+ subset. In addition, 
we identified that within that subset the Vγ representation was Vγ4+ > Vγ1+ > Vγ1-Vγ4-. 
However, the staining for CD44 and CD45RB reveal that γδ24+ thymocytes are double nega-
tive, thus their effector phenotype cannot be discriminated using this strategy at this early 
stage of development (data already published). Analysis of the mature γδ24- showed that this 
population were less abundant in the adult thymus compared to the γδ24+. The evaluation of 
the Vγ repertoire shows a different picture with Vγ1+ > Vγ4+ > Vγ1-Vγ4-. The CD44 vs 
CD45RB staining strategy within the mature γδ24- subset allows the recognition of the two 
distinct effector committed subsets. Analysis of each subset revealed that Vγ1+ thymocytes 
are skewed towards the IFN-γ production, whilst the Vγ4+ and Vγ1-Vγ4- cells are predomi-
nantly engaged in the IL-17 secreting pathway. 
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